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Abstract 
Myosins constitute a superfamily of motor proteins that convert energy from 
ATP hydrolysis into mechanical movement along actin filaments. Phylogenetic analysis 
currently places myosins into 18 classes based on class specific features of their 
conserved motor domain. 
To find how many myosin genes Drosophila has, we have analysed the 
Drosophila Genome Sequence. We identified 13 myosin genes. Phylogenetic analysis 
based on the sequence comparison of the myosin motor domains, as well as the presence 
of class specific domains, suggests that Drosophila myosins can be divided into nine 
major classes. Myosins belonging to previously described classes I, II, III, V, VI and 
VII are present. Molecular and phylogenetic analysis indicates that the fruitfly genome 
contains at least five new myosins. Three of them fall into previously described myosin 
classes, I, VII and XV. Another myosin is a homologue of the mouse and human PDZ-
containing myosins, forming the recently defined class XVIII myosins. The fifth 
myosin shows a unique domain composition and a low homology to any of the existing 
classes. We propose that this is classified when similar myosins are identified in other 
species. 
Myosin V is one of the best studied unconventional myosin in vertebrates. It has 
been implicated in a number of functions such as vesicular transport and polarised cell 
growth. didum which encodes Myosin V in Drosophila, is strongly expressed during 
oogenesis. RNA analysis revealed that the gene produces at least three alternative splice 
forms expressed differentially in the different tissues and developmental stages. We 
have generated antibodies to analyse the protein distribution. During the early stages of 
oogenesis its expression pattern localises to the nurse cells delivering materials (RNA 
and proteins) to the developing oocyte. Later (stagelOB-13) myosin V is expressed in 
the cytoplasm of all follicle. Additionally we have been able to identify two null mutants 
for didum. The mutants die as first instar larvae due to severely delayed development. 
The mutant larvae are unable to move showing a general larval system failure. 
V 
Vertebrate Myosin V was shown to be expressed mainly in the neurons participating in 
the intracellular transport of vesicles. It is possible that rnispositioning of the vesicles, 
due to myosin V deficiency could affect the developing CNS in didum mutants and 
contribute to the observed defects. 
The Broad-Complex (BR-C), an early ecdysone response gene that functions 
during metamorphosis and which encodes a family of zinc-finger proteins, is expressed 
in a dynamic pattern during oogenesis. Its late expression in the lateral-dorsal-anterior 
follicle cells is related to the morphogenesis of the chorionic appendages. All four zinc 
finger isoforms are expressed in oogenesis, which is consistent with the abnormal 
appendage phenotypes resulting from their ectopic expression. We investigated the 
mechanism by which the BR-C affects chorion deposition by using BrdU to follow the 
effects of BR-C misexpression on DNA replication and in situ hybridisation to ovarian 
RNA to evaluate chorion gene expression. Ectopic BR-C expression leads to prolonged 
endoreplication and to additional amplification of genes, besides the chorion genes, at 
other sites in the genome. The pattern of chorion gene expression is not affected along 
the anterior-posterior axis, but the follicle cells at the anterior of the oocyte fail to 
migrate correctly in an anterior direction when BR-C is misexpressed. We conclude that 
the target genes of the BR-C in oogenesis include a protein essential for endoreplication 
and chorion gene amplification. This may provide a link between steroid hormones and 
the control of DNA replication during oogenesis. 
VI 
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Chapter One: Introduction 
Introduction 
Drosophila melanogaster is a powerful model organism used for research 
into a number of fundamental aspects of development. A major task is to elucidate 
the complex mechanisms controlling the development of the oocyte. Much remains 
to be learned about the mechanisms by which a single cell develops and 
differentiates into all cell types of the multicellular organism. What mechanisms 
generate and maintain the cytoplasmic asymmetry within syncytial cysts during 
oocyte differentiation, what regulates the transfer of macromolecules and organelles 
from the nurse cells to the oocyte, what triggers the apoptotic events in the nurse 
cells and subsequently in the follicle cells, what kinds of interactions exist between 
the germline cells and the surrounding somatic follicle cells, and how is the 
positional information, essential for the establishment of body pattern, generated? 
The answers to these questions will provide insights into many aspects of cellular 
biology. 
1.1 	Overview of Drosophila oogenesis 
1.1.1 Morphology of Drosophila oogenesis 
An adult Drosophila female has a pair of ovaries connected to the uterus via a 
common oviduct (King 1970; Bownes and Dale 1982). Each ovary is composed of 
16-18 parallel strings (ovarioles) of progressively mature egg chambers which 
subsequently develop into mature eggs in the course of approximately 5 days 
(Fig. 1.1.1 A). Two layers of somatic muscle fibres, an outer peritoneal sheath and an 
inner epithelial sheath overlay the ovaries and assist with the progression of 
developing egg chambers. 
Drosophila oogenesis has been divided into 14 stages (King 1970; Spradling 
1993) representing morphologically distinct periods (Fig.1.1.1C). Oogenesis is 
initiated within the anterior compartment of the ovariole, the germarium. The 
germline stem cell divides to produce a cystoblast and regenerate a stem cell 
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Figure 1.1.IA Reproductive system of adult female D. melanogaster 
Dorsal view of Drosophila ovaries (King 1970). An adult female fly has two 
ovaries connected to the uterus by a common oviduct. Each ovary consists of 
approximately 16 ovarioles of progressively maturing egg chambers. At the distal tip of 
each ovariole there is a distinct  region, where oogenesis starts, called the germarium 
(adapted from Spradling et al. 1997). The mature eggs are fertilised in the uterus from the 
sperm stored in the seminal receptacle and spermathecac. 
Figure 1.1.I13 Pattern of intracellular bridges (ring canals) 
The cystoblast (oogomum) undergoes four synchronous rounds of division to 
produce a 16-cell germ-line cyst (cystocytes). Due to incomplete cytokinesis the daughter 
cystocytes remain interconnected by specialised cleavage furrows called ring canals. 
During the mitoses the fusome, a vesicular organelle, always associates with one of the 
poles of the mitotic spindle and is inherited by one of the daughter cells (labelled in dark 
blue). The daughter cell with four ring canals and a fusome always becomes the oocyte. 
The other 15 cells develop and differentiate into nurse cells. 
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The cystoblast undergoes four synchronous mitotic divisions to yield a cyst of 
16 interconnected cells, cystocytes. One of the cells, usually the posterior-most 
cystocyte with four ring canals develops into the oocyte (Fig. 1.1.1 B) (Robinson et 
al. 1994; Robinson and Cooley 1997). The remaining 15 cells become polyploid 
nurse cells that provide a variety of organelles, liposomes, and RNAs to the 
developing oocyte and embryo. The follicle cells also exhibit polyploidisrn, but to a 
lesser extent. 
Germaria can be subdivided into four cytologically distinct regions 
(Fig.1.1.1C) (King 1970; Spradling et al. 1997). Region 1 contains germ line cyst 
cells and the dividing cystoblast. In region 2a lie the newly formed 16-cell cysts, 
whereas in region 2b the cysts become lens shaped with the proocyte positioned in 
the centre of the cyst. Somatic stem cells are located at the border between 2a/2b 
regions and divide to produce profollicle cells. The completed 16-cell cyst acquires a 
monolayer of follicle cells in region 3 and buds from the germariurn as a new egg 
chamber. The cell complex in region 3 is referred to as a stage 1 egg chamber. At 
stage 1 the oocyte is located at the posterior pole of the cyst and remains in this 
position throughout the oogenesis. 
From stage 2 to 6 egg chambers increase in size and become more elongated 
in shape. The oocyte grows slower than the nurse cells during these early stages. 
From stages 7 through 10 the size of the oocyte increases rapidly compared to the 
nurse cells as a consequence of the uptake of yolk proteins. Yolk proteins are 
synthesised in the fat body and follicle cells (Hames and Bownes 1978; Isaac and 
Bownes 1982). The yolk protein produced in the fat body is secreted in the 
haemolyrnph, from where it is selectively endocytosed into the oocyte. The yolk 
from the follicle cells is directly transported to the oocyte. 
The somatically derived follicle cells remain as a single cell layer around the 
entire egg chamber until stage 8 (King 1970; Dobens and Raftery 2000). At stage 9 
the follicle cells start a series of migrations and differentiate into several subtypes 
(Fig.1.1.1C). Initially the majority of the follicle cells reorganise themselves to form 
a tightly packed, columnar layer around the oocyte. The remaining follicle cells, 
approximately 5%, form a thin stretched layer around the nurse cells (nurse cell 
associated follicle cells). 
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Figure 1.1.1C: Diagram of a single ovariole 
Each ovariole usually contains up to seven progressively mature egg chambers, 
separated by short stalks of specialised follicle cells. Staging based on King 1970. The 
germarium contains two types of cells: germ-line cells and somatically derived follicle cells. 
In region 1 a pro-oocyte is formed as a result of asymmetric stem cell division. The 
cystoblast undergoes four incomplete mitotic divisions to form a syncytial cyst, which 
flattens as it exits region 2A. As the cyst moves in a posterior direction one of the cystocytes 
is selected to become oocyte. The remaining 15, germ-line derived cells, become nurse cells. 
The cyst is enveloped by follicle cells in region 2B to form a stage 1 egg chamber (region 3). 
In addition various somatic cells are involved in the formation and maintenance of the 
developing egg chamber: somatic stem cells, terminal filament cells, and inner sheath cells. 
At stage 9 the egg chamber consists of three cell types: the oocyte with its nucleus 
(germinal vesicle), the nurse cells, and the follicle cells. In addition three distinct 
subpopulations of follicle cells can be recognised: the columnar follicle cells, the nurse cell 
associated follicle cells, and the border cells (see stagelO). At stage lOB the follicle cells 
begin dumping their cytoplasm into the developing oocyte. This process overlaps with the 
migration of the centripetal follicle cells to cover the anterior tip of the oocyte (stage 11). As 
the oocyte develops, the follicle cells stretch to maintain an intact epithelium. Two small 
groups of follicle cells migrate anteriorly to produce the dorsal appendages. The follicle cells 
surrounding the oocyte start depositing the eggshell. At stage 14 the mature egg is covered 
with an eggshell (chorion) containing several external chorionic structures. Two respiratory 
(dorsal) appendages protrude from the anterior end of wild type Drosophila eggs. Just below 
the appendages is located a structure called an operculum (the larval exit) with a centrally 
positioned micropyle. On the posterior pole is found an aeropyle, a small region of 
specialised chorion with respiratory functions in some Drosophila's species. 
The actin cytoskeleton is stained with fluorescently labelled phalloidin (Red). The 
nuclei are stained for DNA with DAPI (Blue). The cells are immunohystochemically stained 
with antibodies for nonmuscle myosin II (Green). The black and white graphics are 
reproduced from King 1970. 
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Figure 1.1.IC: Diagram of a single ovariole 
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At stage 1OA the oocyte occupies the posterior half of the egg chamber, while 
the 15 nurse cells fill the anterior half of the egg chamber. During stages 9-10 a 
group of 6-10 anterior follicle cells migrate through the nurse cells to form a cluster 
of border cells at the anterior surface of the oocyte (Montell et al. 1992; Edwards and 
Kiehart 1996) (Fig.l.l.1C). Later in oogenesis (stage 11) they will be required for 
formation of the micropyle, a structure through which the sperm enters the oocyte for 
fertilisation. At stage lOB the anterior columnar follicle cells move centripetally 
toward the border cells to cover the anterior end of the oocyte (Keyes and Spradling 
1997). 
The dorsal appendages are required to deliver oxygen through the eggshell to 
the developing egg (Spradling 1993). They are specified by two groups of columnar 
follicle cells from the dorsal-anterior region, which start to migrate anteriorly at stage 
11 (Deng and Bownes 1997). The elongation of the dorsal appendages is completed 
by stage 14. During stages lOB to 12 the nurse cells transfer their cytoplasm through 
the ring canals to the oocyte and degenerate at the subsequent stages, 13-14. During 
stages 9 and 10 the follicle cells secrete the vitelline membrane (Burke et al. 1987), 
which block completely the yolk uptake by stage 11. Then the follicle cells produce 
the end and exochorion layers to protect the mature egg. Then they too undergo 
apoptosis. The egg (Fig.1.l.IC) is able to develop to the blastoderm stage utilising 
the stored maternal mRNAs. 
1.1.2 Polarity determination and pattern formation 
1.1.2.1 	Germ/me differentiation in early oogenesis 
As oogenesis progresses, communication takes place between the germ line 
cells and the somatic follicle cells in order to determine the polarity and organisation 
of the developing egg chamber. These cell-cell interactions are critical in the 
establishment of firstly Anterior/Posterior polarity and subsequently the 
Dorsal/Ventral polarity of the egg (Spradling 1993; Deng and Bownes 1998). The 
actin and microtubule cytoskeletons have a central role in establishing and 
maintaining the polarity in the egg (Theurkauf 1994; Knowles and Cooley 1994). 
Developing germ line cysts contain a large cytoplasmic organelle called a fusome, 
which is built mainly of components of the submembrane cytoskeleton (Lin and 
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Spradling 1995). It was found that membrane cytoskeletal proteins (a-spectrin, f3-
spectrin, dynein), CyclinA, and Hu-11 tai shao (Hts), Drosophila homologue of the 
mammalian adducin, are major fusome constituents (Spradling et al. 1997; Zaccai 
and Lipshitz 1996). During the first cystoblast division, a vesicular structure called 
spectrosome is inherited asymmetrically by the daughter cells (Fig. 1.1.113). That 
determines which of the two daughter cells will become the oocyte. This in turn leads 
to the formation of an active MTOC (microtubule organising centre) in that single 
cell (Fig. 1.1.2.1). During the subsequent divisions the spectrosome continues to 
segregate asymmetrically, and grows to form a structure called a fusome that spans 
all the cystocytes by means of ring canals, before disappearing after the fourth 
division (McKearin 1997; Spradling et al. 1997). The fusome appears to have a 
crucial role in establishing and polarising the microtubule network. It is thought that 
the fusome is the "oocyte determination factor". Several genes have been shown to 
be critical for MTOC specification, such as: Bicaudal (Bic-D), egaliterian ('egl), and 
stonewall (stwl) (Clark and McKearin 1996). Mutations in these genes produce cysts 
of 16 nurse cells and no oocyte (Schupbach and Wieschaus 1991) 
1.1.2.2 	Origin of polarity 
The germline cyst is already formed in region 2 of the germarium. Selective 
transport of mRNAs and proteins to one of the 16 cystocytes, which will develop into 
the oocyte has been observed. The first sign of A/P polarisation is the pro-oocyte 
positioning at the posterior pole of the newly formed stage 1 egg chamber 
(Fig.1.1.2.3) (van Eeden and St Johnston 1999). This movement requires the 
products of several genes including armadillo (Peifer et al. 1993), five spindle genes 
(Morris and Lehmann 1999), and dicephalic (Gonzalez-Reyes and St Johnston 
1994). It was observed that the follicular epithelium forms a symmetrical pattern 
along the A/P axes prior to the oocyte movement, with the polar cells located at both 
anterior and posterior ends (Margolis and Spradling 1995). It was suggested that the 
polar cells send signals to regulate the movement of the oocyte , and maintain its 
posterior position (Peifer et al. 1993). The hedgehog (hh) signalling pathway appears 
to be required for the differentiation of pairs of polar follicle cells (Forbes et al. 
1993). The product of hedgehog has a morphogenetic function and regulates cyst 
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envelopment in the germariurn region 2. The Notch-Delta signalling pathway, 
including neurogenic genes, has been also shown to be involved in the processes of 
cyst encapsulation and cell differentiation. Delta encodes a transmembrane protein 
which interacts with the product of Notch. Muskavitch (1994) has found that Notch 
and Delta exhibit a lateral inhibition mechanism in specifying cell fate. Mutations in 
the genes result in a hyperplasia of stalk cells early in oogenesis and later in the loss 
of polar cells (Larkin et al. 1996). Some mutations in Notch lead to fused egg 
chambers resulting from the encapsulation of two or more germline cysts (Goode et 
al. 1996). 
1.1.2.3 	Anterior/Posterior axis determination 
Gurken (grk), a transforming growth factor alpha (TGF-(x) homologue 
signalling molecule has been found to be the key signal in defining the 
anterior/posterior axis (Gonzalez-Reyes et al. 1995; Roth et al. 1995). The grk 
transcripts and protein are positioned at the posterior pole of the oocyte in association 
with the germinal vesicle (Fig. 1. 1.2.3A). The Grk signal is sent by the germinal 
vesicle to the posterior follicle cells. It is received by torpedo/DER in the follicle 
cells, a Drosophila homologue of the EGF receptor tyrosine kinase (Roth et al, 
1995). The signal activates a signal transduction pathway in the follicle cells 
involving Ras, D-raf, and Dsorl. In response the follicle cells adopt a posterior fate 
and respond with an undefined signal that leads to the repolarisation of the oocyte 
microtubules (Fig. 1.1.2.313). In the early stages of oogenesis the microtubule 
network is used to transport rnRNAs and proteins to the previtellogenic oocyte. The 
reorientation of the microtubule network at stage 7 leads to relocalisation of the 
maternal determinants bicoid and oskar to the anterior and posterior pole 
respectively, a crucial movement for the establishing of the A/P axis(Fig. 1.1.2.313-
C). The repolarisation of the MTOC also leads to redistribution of grk rnRNAs and 
protein and migration of the oocyte nucleus to the dorsal-anterior position, where 
later they activate a number of genes required for D/V patterning of the eggshell. 
Protein kinase A (PKA) is involved in the processes of disassembling and 
reassembling of MTOC (Lane and Kalderon 1995). The product of the gene mago 
nashi is also required for the microtubule reorganisation (Micklem et al. 1997). The 
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anterior determinant bicoid (bed) encodes a transcription factor with a DNA binding 
site. It is localised to the anterior pole of the oocyte at stage 7 and is translated after 
fertilisation of the egg to produce an anterior to posterior gradient in the embryo 
(Berleth et al. 1988; St Johnston et al. 1989). It has been found that three genes are 
directly involved in bed RNA positioning: exuperantia (Wang and Hazelrigg 1994), 
swallow (Stephenson et al. 1988), and staufen (St Johnston et al. 1991). 
The differentiation of the follicle cells as posterior cells also requires 
signalling among the somatic cells. It has been found that the pre-differentiation of 
the polar follicle cells is important for this process, which indicates that pathways 
such as Notch-Delta and H/i are involved in axis determination (Forbes et al. 1993) 
1.1.2.4 	Dorsal/Ventral axis determination 
A crucial movement for the establishment of the Dorsal/Ventral polarity is 
the migration of the germline vesicle to the anterior region in a microtubule 
dependent manner at stage 8 (Fig. 1.1.2.3C).  As the germinal vesicle moves (Fig. 
1. 1.2.3D) it remains associated with the grk RNA and protein, which leads to their 
localisation at the dorsal-anterior part of the oocyte. That induces the follicle cells 
facing the gerrnline vesicle to adopt a dorsal fate. The subsequent signalling is 
similar to that determining A/P axis, involving the top/DER, Ras, D-raf, and Dsorl 
pathways (Fig. 1.1.2.3E). 
The gene fs('l)klO is required for the localisation of grk RNA to the dorsal-
anterior region. It encodes a helix-loop-helix DNA binding protein (Schupbach 
1987). The klO mRNA localises specifically to the oocyte nucleus requiring 
capucino and spire activity. Several other genes are needed for grk RNA localisation, 
such as: orb (Christerson and McKearin 1994; Lantz et al. 1994), Bic-D (Swan and 
Suter 1996), and squid (Norvell et al. 1999). 
The transfer of the Grk signal requires the function of cornichon (cni) and 
braniac (brn) genes. Cornichon is a small 144 aa protein with a characteristic large 
hydrophobic domain, which suggests a role for ciii in the localisation of the grk 
protein to the membrane (Roth et al. 1995). The neurogenic gene brii is required for 
the maintenance of the follicular epithelium in the established egg chamber, and for 
regulation of grk-top/DER interactions. Several genes have been found to be 
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expressed downstream of the grk-top/DER signalling pathway. A putative 
transmernbrane protein rhomboid was the first gene identified to regulate the 
signalling pathway. CF is a transcription factor active in the ventral follicle cells 
only, it is required for the formation of the eggshell. 
The Broad Complex is a gene responsible for the morphogenesis of the dorsal 
appendages and is found to be downstream of the grk-top/DER pathway. Br-C 
proteins, zinc-finger transcription factors, are expressed in a dynamic pattern in two 
groups of dorsal-anterior follicle cells at stage 13 of oogenesis. A gene pointed (pnt), 
that encodes a transcription factor with ETS domain, represses Br-C expression in 
the dorsal mid-line follicle cells. 
In the absence of a dorsal signal (the follicle cells do not receive the torpedo 
mediated signal) the follicle cells adopt a ventral fate by default. 
Fig. 1.1.2.3 Schematic representation of the main steps in the development of 
the AP and DV polarity during oogenesis (adapted from van Eeden and St 
Johnston 1999) 
At stage 5-6 the oocyte contains an active MTOC (microtubule organising centre) which 
extends to the nurse cells and polarises the egg chamber (MTOC is labelled in Red). During 
stage 5-6 the oocyte nucleus and the GRK signal it produces are located at the posterior part 
of the oocyte. Grk signals to the adjacent follicle cells and induces them to adopt a posterior 
fate (Blue). At that time the follicle cell at the anterior tip of the oocyte adopts an anterior 
fate (Yellow). 
During stages 6-7 the follicle cells send an undefined signal back to the oocyte. First this 
leads to disassembly of the MTOC and reorientation of the microtubules. 
Then (stage 8) the oocyte nucleus move in a microtubule dependent manner to the 
anterior compartment of the oocyte. 
At stage 9 oskar mRNA (Black) and Staufen are localised to the posterior of the oocyte 
while bicoid mRNA (Purple) act at the anterior tip of the oocyte. The microtubule 
cytoskeleton is required for this process. 
The late Grk signal activates the EGFR pathway in the adjacent follicle cells and induces 
a number of secondary genes, thus determining a dorsal fate. The activation of EGFR 
pathway restricts pipe expression (Orange) to the ventral follicle cells. 
During stage lOB Oskar is required to anchor the osk mRNA to the posterior part of the 
oocyte. 
The activation of EGFR by Spitz, Grk and Vein induces the dorsal expression of the 
EGFR inhibitor Argos. Argos represses the EGFR signal in the dorsal anterior follicle cells 
thus splitting it into two lateral peaks. 
In the fertilised egg bicoid mRNA is actively translated into the cytoplasm to produce a 
gradient of the anterior morphogen. From stage 12 onwards naiios inRNA is also translated 
and specifies abdomen formation. 
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Fig. 1.1.2.3 Schematic representation of the main steps in the 
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1.2 	Approaches used to isolate genes important for oogenesis 
1.2.1 Genetic and general molecular methods 
Considerable work has been carried out to elucidate the complex mechanisms 
controlling the development of the oocyte. The standard approach to study 
Drosophila development involves identifying mutations that disrupt the process of 
interest. The target gene then is characterised both genetically and at the molecular 
level by cloning, sequencing, and expression analysis. 
The best source for studying genes involved in oogenesis is female sterile 
mutations. These lead to abortive egg production or laying eggs which fail to develop 
normally. Several genetic screens have been done in Drosophila to isolate female 
sterile mutants (fs) (Swan et al. 2001; Lasko 1994; Schupbach and Wieschaus 1991; 
On et al. 1989; Kornitopoulou et al. 1983). 
A number of genes are difficult to identify using the standard method like 
those with a subtle function, with a high degree of redundancy or genes which have 
functions at more than one time during development. New techniques have been 
developed to overcome the difficulties. A widely used method to study important 
genes in oogenesis is generating heatshock inducible transgenic flies by P-element 
transformation. A heatshock treatment can rescue the lethal phenotype and can be a 
valuable tool when the investigated gene has multiple functions at different stages of 
oogenesis. 
An alternative method is to produce mosaic egg chambers, either by FLP-
mediated recombination (Theodosiou and Xu 1998; Fedorova et al. 2001) or by the 
dominant female sterile techniques (Perrimon and Gans 1983). 
A new method for targeted gene knockout has been developed by Rong et al. 
(2002). A donor construct is created to carry DNA from the gene to be targeted. This 
is introduced into the fly genome by P-element transformation. Transgenic 
expression of a FLP (site specific reconibinase) and 1-Scel endonuclease are used to 
generate extrachromosomal linear DNA molecules in vivo. Subsequently these 




1.2.2 Enhancer trap systems 
In order to isolate genes involved in cell determination, inter and intracellular 
transport, cell-cell communications and temporal and spatial regulation during 
oogenesis, P-mediated enhancer detection has proved extremely useful (Bellen et al. 
1990; O'Kane and Gehring 1987; Grossniklaus et al. 1989). The method uses a 
modified transposable element from a Drosophila P-element (Fig. 1.2.2A). This 
synthetic element carries the Escherichia co/i lac Z gene placed under the control of 
a weak constitutive promoter. The transposase gene is removed from the P-element 
and replaced by a dominant marker gene white, w). A separate helper plasmid is 
required to provide a source of transposase. It is only present for a single generation, 
after which it is removed by genetic crossing. Flies with a transformed genome have 
red eyes and can be easily selected on white (w+) background. 
/3-gal Reporter Gene Detection System 
P{LacW}element 	pIPS-IacZ 	MINI !JIIIIL 	pBR322 
Target genomic 
S'UTRj 	 TARGET GENE 	3'UTR I sequence  
Ga14 Enhancer Trap System 
Tissue Specific Ga14 Line 	X 	UAS-Marker Line 
Figure 1.2.2 P-element mediated enhancer detection technique 
The conventional approach using a separate source of transposase has been 
optimised by introducing a stable genomic source of transposase. New enhancer trap 
lines can be produced by direct genetic crosses of flies that carry a disabled P-
element, which encodes transposase with flies that already carry the enhancer trap 
(Robertson et al. 1988). 
Second generation enhancer trap system. 
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When the P-element is inserted near to an ovarian enhancer, it will be 
activated and n-gal is expressed in the same or a similar pattern to the adjacent gene 
that is normally regulated by that enhancer. Thus, lac Z acts as a tissue specific 
reporter gene. Expression patterns of interest can be identified and then the target 
gene cloned by excising the plasmid sequence of the P-element from the genome 
along with flanking DNA. It has been found that the P-elements exhibit some 
preference for inserting near the 5' end of genes, and they do not usually insert within 
heterochromatin. Berg and Spradling (1991); Kelley et al. (1987); Eggleston (1990) 
and Bownes (1990) showed that P-elements tend to insert into or near other P-
elements, with a particular preference for bases 19-26 of the target P-element. 
Second generation enhancer trap systems utilise yeast Gal-4 transcriptional 
activator in the P-element instead of the 3-gal reporter gene (Brand and Penimon 
1993; Deng et al. 1997) (Fig.1.2.2B). The product of Gal-4 can only activate 
expression of genes containing a Gal-4 binding site, known as UAS (upstream 
activation sequence). A second fly line contains a P-element construct with an UAS 
linked to a marker gene (lac Z). The progeny of a tissue specific Gal-4 line with a 
UAS-lac Z gene will express the marker in all cells in which the Gal-4 enhancer trap 
is active. This system can be a powerful tool for testing different marker genes in a 
single Gal-4 enhancer trap line. It was found that Gal-4 lines have no expression in 
the gerrnline cells. That makes them a perfect marker for sets of follicle cells, e.g. for 
investigating cell-cell interactions in oogenesis. This system is far more potent than 
the original enhancer trapping system. It provides a possibility of Gal-4-directed 
misexpression and antisense expression to study the processes of follicle cell 
determination, migration, and differentiation. 
The P-element mediated enhancer trap system has proved extremely useful in 
studying Drosophila development. A wide variety of genes involved in the oogenesis 
have been identified by using this technique. In our laboratory we have been 
examining a number of enhancer trap lines for interesting patterns of reporter-gene 
expression during Drosophila oogenesis. These screens led to the isolation of several 
lines with dynamic staining patterns in the ovaries. In this thesis I am presenting 
studies on two unrelated genes: The Broad Complex, a gene isolated from a P[Gal-4] 
enhancer trap line and Drosophila Myosin V, a gene isolated in the course of P[lacZ] 
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screen, both of which proved to be crucial for normal oogenesis. 
1.2.3 P-Hop mutagenesis 
When a P-line of interest has a lethal phenotype it is crucial to show 
unequivocally that the P-element is responsible for the lethality. The P-element is 
mobilised by crossing with a fly strain that contains non-autonomous (non-mobile) 
P-element (expresses functional transposase). If the P-insertion causes the lethal 
phenotype, a precise excision should show a reversion to wild type (Fig. 1.2.3B) 
Figurel.2.3 Possible outcomes from a mobilised P-element 
P-element remains in its original position. No change in the eye colour (red): 
— — 	— - .w — 	-  -  
Precise excision. Generates white eyed mutants. 
Precise excision. The excised P-element can transpose (hop) to a local or 
distant gene. If inserted into another gene exon it might cause lethality. Revertant 
flies are with red eyes: 
P-element impecise excision . Revertant flies are with red eyes 
17 
Introduction 
A common problem in molecular genetics is obtaining mutations in genes 
known only by their DNA sequence. P-elements tend to insert into sites closely 
linked to the donor site (Golic 1994; Bownes 1990). If no P-element insertions are 
known for a given target gene a P-Hop mutagenesis can be undertaken. For this 
reason P-lines are selected with P- insertions close to the target gene or located 
within the noncoding sequences (introns) of the gene. When the P-element of the 
target line is mobilised by crossing with a flyline containing a non-mobile P-element, 
the target P-element can jump (hop) to a new position into a near by exon (Fig. 
I.2.3C) or can delete a part of the target gene by imprecise excision, thus generating 
a mutation (Fig. 1.2.31)). 
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1.3 	Project aims and outcomes 
1.3.1 Molecular and functional analysis of didum, the Drosophila gene 
encoding unconventional Myosin V 
As the oocyte develops it enlarges as a result of deposition of various 
products synthesised in the nurse cells and the fat body. These include proteins, 
i-nRNAs, and organelles essential for oogenesis and later embryonic development. A 
highly developed transport system is required for proper direction of these products 
to the target subcellular localisations. Genetic and molecular data has implicated 
myosin V in a variety of cell trafficking and cell movements. One of the aims of the 
current work is to understand the function of the Unconventional Myosin V in 
Drosophila. In this thesis its function in oocyte/egg production is analysed. To do 
this the distribution of Myosin V mRNA and protein in the cells and the genetic 
pathways they interact with to influence oogenesis are studied. 
1.3.2 Identification, molecular and phylogenetic analysis of Drosophila 
myosin genes 
Myosins constitute a large family of motor proteins that use the energy of 
ATP hydrolysis to move along actin filaments. Currently phylogenetic analysis 
places myosins into 18 classes based on specific features of their conserved head 
domain. How many myosins are needed to ensure the proper development and 
function of eukaryotic organism? Previously three types of myosins were found in 
budding yeast, six in the nematode C. elegans, and at least 12 in human. How many 
myosin genes does Drosophila have? Analysis of the completed D. inelanogaster 
genorne project have been performed to determine the number of myosin-encoding 
genes. The evolutionary relationships between members of the myosin family in 
Drosophila and other phylogenetically diverse species are examined. In addition we 
analysed the molecular structure of the newly identified myosin genes. Finally we 




1.3.3 Analysis of the function of Broad Complex during oogenesis 
Over the last several years a number of developmentally important questions 
about cell activity and function of the somatic follicle cells have been studied. The 
data suggest that a crucial role is played by the follicle cells in oocyte determination, 
maturation and in polarity formation. However there are many more questions to be 
answered: how is the oocyte determined, what signals trigger follicle cell 
differentiation and what are the interactions between the subtypes of follicle cells and 
between the follicle cells and the germ line cells? The purpose of this work is to 
study the early function of Br-C, when it is expressed in all follicle cells at stage 6 of 
oogenesis. Its later expression in the dorsal-anterior follicle cells is related to its 
function in the formation of the chorion appendages (Deng and Bownes 1997). Since 
the chorion genes encode major eggshell components, and Br-C function has been 
reported to be necessary for chorion gene amplification during oogenesis (Orr et al. 
1989; Huang and Orr 1992), we investigated the relationship between the Br-C and 
chorion gene amplification and expression. 
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2.1 Materials 
2.1.1 Chemicals and radioactive isotopes 
General purpose chemicals were purchased from Sigma, BDH, Fisher 
Scientific and Fluka. A number of chemicals were supplied by other companies 
whose names will be stated accordingly in the text. 
Isotopes, such as [32P]dCTP, were obtained from Amersham Biosciences. 
Digoxigenin labelling and detection reagents were purchased from Roche 
Molecular Biochemicals. 
2.1.2 Restriction endonucleases and modifying enzymes 
Restriction endonucleases were obtained from New England Biolabs and 
Promega. 
Taq Polymerase and the accompanying buffers were supplied by Qiagen. 
High-fidelity Pfu Turbo DNA Polymerase was obtained from Stratagene. Klenow 
DNA polymerase was supplied by Roche Molecular Biochemicals. 
T4 DNA Ligase, T4 Polynucleotide Kinase, CIP (Calf Intestinal Alkaline 
Phosphatase) and SAP (Shrimp Alkaline Phosphatase) were purchased from New 
England Biolabs. 
T3, T7 and SP6 RNA Polymerases were obtained from Roche Molecular 
Biochemicals. 
Reverse Transcriptase (SuperScriptTM II) was supplied by Invitrogen, Life 
Technologies. 
2.1.3 Buffers and Solutions 
All buffers and solutions were prepared with double distilled water (ddH2O). 
Sterilisation, when required, was achieved by autoclaving for 30 minutes at 15 psi or 
by sterile filtering through a 0.22 pm filter (Sartorius). All solutions were stored at 
room temperature (23-25°C) unless otherwise stated. General solutions and buffers 
are listed in Table 2.1.3. (A) , buffers for gel electrophoresis in Table 2.1.3 (B), 
staining reactives and detection reagents in Table 2.1.3 (C), and mounting media for 
microscopy in Table 2.1.3 (D). 
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Table 2.1.3 (A) List of general solutions and buffers 
Solution Components/Preparation Final 
concentration 
Borax 1.9g Na2B407.10H20 (Mw: 381.4) 100mM 
Adjust the volume to 50m1 with ddH20 
Buffer FBBW 8501.11 1 M K-Phosphate Buffer, pH-6.8 17mM 
1.5m1 2.5M KCI 75mM 
250il 5M NaCl 25mM 
1651.11 1M MgCl2 3.3mM 
8m1 Formaldehyde (Formalin) .37% 6% 
Adjust the volume to 50ml with ddH20. 
Sterilised through a 221.1 filter. 
CaCl2 73.5g CaC12.21-120 (Mw: 147.0) 5M 
Adjust the volume to 1 OOml with ddH20 
DenhardVs (lOOx) ig BSA (bovine serum albumin) 2% 
ig Ficoll (Wt: 400,000) 2% 
ig Polyvinylpyrolidone (Wt: 360,000) 2% 
Adjust the volume to 50ml with ddH20 
DNA Hybridisation 125ml 20x SSPE 5x 
buffer 
25m1 10% SDS 0.5% 
25ml lOOx Denhardts 5x 
1 m 1mg/mI sssDNA (denatured) 20tg/ml 
325m1 ddH2O 
DNA Hybrix 25ml Deionised formamide (Mw: 45.04) 50% 
(for in-situ) 
12.5m1 20x SSC 5x 
250p.l dsssDNA [10mg/mI] 50ig/ml 
50pi [50mg/mI] Heparin 501g/ml 
500pi 10%Tween-20 0.1% 
11.5m1 ddH20 
dNTP mix lOjil 100mM dATP 10mM 
(10mM each dNTP) 
lOpi 100mM dCTP 10mM 
101.11 100mM dGTP 10mM 
101.11 100mM dTTP 10mM 
6Opi ddH2O 
EBR 7.5g NaCl (Mw: 58.44) 0.75% 
(Ephruzzi Beadle 
0.35gKCI (Mw: 74.55) 0.035% Ringer) 
Adjust the volume to 1 L with ddH20 
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Solution Components/Preparation Final 
concentration 
EDTA, 93g Na2EDTA.2H20 (Mw: 372.24) 0.51VI 
pH-8.0 
Adjust the pH to 8.0 with —20g NaOH 
Adjust the volume to 500ml with ddH20 
EGTA, 1.9g EGTA (Mw: 380.4) 0.5M 
pH-8.0 
Adjust the pH to 8.0 with 1 O NaOH 
Adjust the volume to 1 Omi with ddH20 
FIBS 2g Paraformaldehyde 4% 
5m1 1OxBPS lx 
45ml ddH2O 
Dissolve at 65°C. Sterilise through a 22t filter 
Glycine 1 	00m Glycine (Mw: 75.07) in 1 m ddH20 100mg/mi 
Glycine, 3.75g Glycine (Mw: 75.07) 0.1M 
pH-2.5 
Adjust the pH to 2.5 with cHCI 
Adjust the volume to 500mi with ddH20 
HCl 8.6m1 concentrated HCI 2N 
Adjust the volume to 50ml with ddH20 
Heparin 50mg Heparin 50mg/mi 
800il ddH20 
200ii 20xSSC 4x 
K Acetate 78.59g CH3COOK (Mw: 98.14) 8M 
Adjust the volume to 1 OOml with ddH20 
Kferricianide 1.65g K3[Fe(CN)6] (Wt: 329.25) (red) 0.1M 
50m1 ddH2O 
Kferrocyanide 2.11g K4[Fe(CN)6].3H20 (Wt: 422.4) (yellow) 0.1M 
50m1 ddH2O 
K2HPO4 17.42g K2HPO4 (Mw: 174.18) in lOOmI ddH20 1M 
KCI 7.46g KCI (Mw: 74.55) in lOOmI ddH20 1M 
KCI 18.64g KCI (Mw: 74.55) in lOOmI ddH20 2.51M 
KH2PO4 13.61g KH2PO4 (Mw: 136.09) in 1 00m ddH2O 1M 
KOH 28.06g KOH (Mw: 56.11) in 1 00m ddH20 SM 
Levamisole 0.24g Levamisoie (Mw: 240.8) 1M 
500pi H20 
500d Glycerol 50% 
Adjust the volume to 1 ml with ddH20 
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Solution Components/Preparation Final 
concentration 
Lysozyme 50mg Lysozyme 50mg/mi 
1 m ddH2O 
MgCl2 9.59 MgCl2  (Mw: 95.21) 1M 
Adjust the volume to I OOml with ddH20 
M9SO4 24.6g MgSO4.7H20 (Mw: 246.5) 1M 
Adjust the volume to 1 OOml with ddH20 
MnCl2 39.58g MnCl2.4H20 (Mw: 197.9) 2M 
Adjust the volume to 1 OOml with ddH20 
MOPS, 20.9g MOPS (Mw: 209.3) 1M 
pH-6.8 
Adjust the pH to 6.8 with dry NaOH. 
Adjust the volume to 100 ml with ddH20. 
Sterilise by filtration through a 0.22 pm filter 
Na Acetate, 13.6g CH3COONa.3H20 (Mw: 136.08) 2M 
pH-4.0 
Adjust the pH to 4 with Glacial Acetic acid 
Adjust the volume to 50m1 with ddH20 
Na Acetate, 40.8g CH3COONa.3H2O (Mw: 136.08) 3M Na 
pH-5.2 
Adjust the pH to 5.2 with Glacial Acetic acid 5M Acetate 
Adjust the volume to 1 OOml with ddH20 
Na Citrate, 14.7g Na3C6H5O7.2H2O (Mw: 294.1) 1M 
pH-7.5 
Adjust the pH to 7.5 with Citric acid 
Adjust the volume to 50m1 with ddH20 
NaCI 146.1g NaCl (Mw: 58.44) in 500m1 ddH20 5M 
NaOH 80g NaOH (Wt: 40.0) iON 
Adjust the volume to 20ml with ddH20 
NaOH 16g NaOH (Wt: 40.0) 0.4N 
Adjust the volume to 1 L with ddH20 
PBS (lOx), 40g NaCl (Mw. 58.44) 1.37M 
pH-7.5 
5.7g Na2HPO4 (Mw, 142.0) 80mM 
1.2g NaH2PO4 (Mw: 120) 20mM 
Adjust the pH to 7.4 with 1 ON NaOH 
Adjust the volume to 500m1 with ddH20 
PBT (lx) 50m1 1OxPBS ix 
450m1 ddH2O 
500pJ Tween 20 0.1% 
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Solution Components/Preparation Final 
concentration 
Phenol/Chioro- 50m1 Phenol (saturated with TE Buffer, pH-8.0) 
form* 
50m1 Chloroform 
Phosphate buffer, 866g K2HPO4 (Mw: 174.18) 1M 
pH-6.8 
6.8g KH2PO4 (Mw: 136.09) in lOOmI ddH20 
PMS 2g Paraformaldehyde 4% 
4Oml H20 
30l' 10M NaOH 
Dissolve at 65°C. Then add: 
5ml 0.5M PIPES, pH-7.0 50mM 
lOOpi 0.51VI EGTA, pH-8.0 1mM 
Adjust pH to 6.8 with 1 N HCl, then add: 
lOOpi 1M MgSO4 2mM 
Adjust the volume to 50ml with ddH20 
Proteinase K 20mg Proteinase K 20mg/mi 
lOpi 1M Tris-HCl, pH-7.5 10mM 
590pi ddH2O 
400pi Glycerol 
RbCI 12.09g RbCl (Mw: 120.9) in 1 00m ddH2O 1M 
Ringers saline for 6.8g KCI (Mw: 74.55) 180mM 
Drosophila, 
1.35g NaCl (Mw: 58.44) 45mM 
0.17g CaC12.21-120 (Mw: 147) 2.3mM 
0.6g Tris-base (Mw: 121.14) 10mM 
Adjust the pH to 7.2 with 1 N HCI. Adjust the 
volume to 500ml with ddH20. Sterilise through a 
0.22pm filter. 
RNA Hybridisation 125ml Formamide (Mw: 45.04) 50% 
buffer 
62.5m1 20xSSC 5x 
Sml 1M Na-Phosphate buffer, pH-6.8 20mM 
25ml 10% SDS 1% 
12.5m1 lOOx Denhardts 5x 
2mg total yeast RNA or sssDNA (denatured) 8pg/ml 
Adjust the volume to 500ml with ddH20 
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Solution Components/Preparation Final 
concentration 
RNA Hybrix, 25m1 Deionized formamide (Mw: 45.04) 50% 
pH-6.5 
(for in-situ) 
12.5ml 20x SSC 5x 
lOOp] [50mg/mi] tRNA (RNase free) iOOj.tg/ml 
50p.l [50mg/mi] Heparin 50tg/ml 
SOUP] 10%Tween-20 0.1% 
12m1 ddH2O 
Adjust the pH to 6.5 with HCI 
RNase Dissolve 10mg RNase in 1 ml. Aliquot into 4 10mg/i ml 
(DNase free) 
eppendorfs. Heat up to 110°C for 20min at the 
heating block. Leave in the bloke to cool down 
gradually to RT. Store at —20°C. 
SBE buffer 20g NaHCO3 (Mw: 84.01) 2% 
2ml 0.51VI EDTA, pH-8.0 1mM 
Adjust the volume to 1 L with ddH20 
SDS SOg SDS (Mw: 288.38) 10% 
Adjust the volume to SOOmI with ddH20 
SSC (20X), 87.65g NaCl (Wt: 58.44) 3M 
pH-7.0 
44.1 Na3C6H5O7.2H20 (Wt: 294.1) 300mM 
Adjust the pH to 7.0 with 1 O NaOH 
Adjust the volume to 500ml with ddH20 
SSPE, 87.65g NaCl (Mw: 58.44) 3M 
pH-7.4 
15.6g NaH2PO4 (Mw: 156.01) 200mM 
4.7g Na2EDTA.2H20 (Mw: 372.24) 25mM 
Adjust the pH to 7.4 with 	3m1 1 O NaOH 
Adjust the volume to 500m1 with ddH20 
sssDNA 10mg Sonicated salmon sperm DNA 10mg/mi 
1 m ddH2O 
Sucrose 8.56g Sucrose (Mw: 342.3) in lOOmI ddH20 250mM 
TB Solution 0.3g PIPES (Mw: 302.4) 10mM 
2.75m1 2M MnCl2 55mM 
300p] SM CaCl2 15mM 
lOmI 2.51VI KCI 250mM 
Adjust the pH to 6.7 with ION KOH prior to 
adding the MnCl2!!! 
Adjust the volume to lOOmI with ddH20 
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Solution Components/Preparation Final 
concentration 
TBS (1 Ox) 12.1g Tris Base (Mw: 121.14) 200mM 
40g NaCl (Mw: 58.44) 1.37M 
Adjust the pH to 7.6 with cHCI 
Adjust the volume to 500m1 with ddH20 
TBS-T (lx) 50m1 TBS (lOx) lx 
450m1 ddH2O 
500tl Tween-20 0.1% 
TE, 1 m 1M Tris, pH-8.0 10mM 
pH-8.0 
200pi 0.5M EDTA, pH-8.0 in 100m] ddH20 1mM 
Tris-HCl, 60.55g Tris Base (Mw: 121.14) 1M 
pH-7.4 
pH-7.6 For pH-7.4 add —35m1 cHCI 
pH-8.0 For pH-7.6, add —30m1 cHCI 
For pH-8.0, add -'20m1 cHCI 
Adjust the volume to 500m1 with ddH20 
Triton X-100 0.5m1 Triton X-100 0.1% 
Adjust the volume to 500m1 with ddH20 
Triton X-100 5m1 Triton X-100 10% 
Adjust the volume to 50m1 with ddH20 
tRNA (RNase free) 50mg tRNA in 1 ml ddH20 50mg/mi 
Tween 20 5m1 Tween 20 10% 
Adjust the volume to 50m1 with ddH20 
* This Phenol/Chloroform mix is for DNA deproteinisation. The phenol for RNA 
purification is acidic, with pH-4.3. 
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Table 2.1.3 (B) List of loading buffers and running buffers for gel 
electrophoresis 
Buffer Components/Preparation Final 
concentration 
DNA Sample buffer 3ml 0.1% Bromphenol Blue 0.03% 
(6x) 
3m1 Glycerol 30/s 
4m1 ddH2O 
MOPS buffer (lOx), 20.9g MOPS (Mw: 209.3) 200mM 
pH-7.0 
5.44g CH3COONa (Mw: 136.08) 80mM 
lOmI 0.5M EDTA, pH-8.0 10mM 
Adjust the pH to 7.0 with 2N NaOH. 
Adjust the volume to 500m1 with ddH20 
Sterilise through a 0.24tm filter. 
PIPES, 15.lg PIPES (Mw: 302.4) 1M 
Adjust the pH to 6.5 or 7.0 as needed with cHCI 
Adjust the volume to 50ml with ddH20 
Protein Sample 1.25m1 1M Tris-HCI, pH 6.8 125mM 
buffer (2x) 
2m] Glycerol 10/s 
4m1 10% SDS 4% 
1 m 14.4M 	-Mercaptoethanol (Mw: 78.01) 1.44M 
1 m 0.1% Bromphenol Blue 0.01% 
0.75m1 ddH20 
RNA Sample buffer 500tl Deionised formamide (Mw: 45.04) 50% 
(1.5x) 
100tl lOx MOPS lx 
270tI 37% Formaldehyde 10% 
lOOpi Glycerol 10% 
30d 0.1% Bromphenol Blue 0.003% 
4il 10mg/mI EtBr 20.tg/mI 
TAE (50x) 121g Tris Base (Mw: 121.14) 2M 
28.55m] Glacial Acetic acid 
50m1 0.5M EDTA, pH-8.0 50mM 
Adjust the volume to 500m1 with ddH20 
TGS buffer (1 Ox) 15.15g Tris base (Mw: 121.1) 250mM 
(Running buffer for 
72g Glycine (Mw: 75.07) 1.92M 
5g SDS (Mw: 288.38) 1% 
Adjust the volume to 500m1 with ddH20 
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Table 2.1.3 (C) List of colour reactives and detection reagents 
Name Components/Preparation Final 
concentration 
Coomassie gel lOOmI Methanol 10% 
destain 
lOOmi Glacial Acetic acid 10% 
800mi ddH2O 
Coomassie gel ig Coomassie Blue R-250 0.1% 
stain 
450m1 Methanol 45% 
450m1 ddH2O 
1 	00m Glacial Acetic acid 10% 
DAB (11 Ox) 20mg DAB-4HC1 (Diaminobenzydine 2mg/mi 
tetra hydochloride) 
lOmi lx PBS 
DAB Staining 900pi lx PBS 1xPBS 
solution 
lOOpI lOx DAB solution 0.2mg/mi 
1 p 30% H202 0.03% 
Galactosidase 500p1 1M Phosphate buffer, pH-7.0 10mM 
staining buffer 
3m1 0.1M K3[Fe(CN)6] (or 99mg) 8mM 
3m1 0.1M K4[Fe(CN)6] (or 127mg) 8mM 
1.5m1 5M NaCl 150mM 
50pi 1M M902 1mM 
Adjust the volume to 50m1 with ddH20 
Hoechst (1 000x) 1 	m Hoechst 33258 1mg/mi 
lmi lx PBS 
IPTG 120mg isopropyl 3-D-thiogalactoside (Mw: 0.51M 
238.3) 
Adjust the volume to 1 ml with ddH20 
Maleic buffer, 5.8g Maleic Acid (Mw: 116.1) 100mM 
pH-7.5 
4.3g NaCl (Mw: 58.44) 150mM 
Adjust the pH to 7.5 with dry NaOH 
Adjust the volume to 500m1 with ddH20 
NBT 75mg 4-Nitro blue tetrazolium chloride 75mg/mi 
700pi N,N'-Dimethylformamide (NBT) (Mw: 70% 
73.09) 
300p.l ddH20 
Phalloidin, 100tg Phalloidin, rhodamine conjugated 200pg/ml 
rhodamine 
conjugated (20x) 400iiJ 99.7% EtOH =150pM 
Name Components/Preparation Final 
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concentration 
Ponceau S (lOx) 2g Ponceau S 2% 
30g Trichioracetic acid (Mw: 163.39) 30% 
30g 5-Sulfosalicylic acid dihydrate (Mw: 254.22) 30% 
Adjust the volume to lOOmI with ddH20 
Staining solution 5m1 1M Tris-HCI, pH-9.5 100mM 
imi 5M NaCI 10mM 
2.5mllM MgCl2 50mM 
500 ji 10% Tween 20 0.1% 
41m1 ddH2O 
p-Coumaric acid 0.15g p-Coumaric acid (Mw: 164.2) 90mM 
Stock 
lOmi DMSO 
Luminol 0.44g Luminol (Mw: 177.2) 250mM 
Stock 
lOmi DMSO 
ECL Reagent 250.tI Luminol Stock 1.25mM 
11 Opi p-Coumaric acid Stock 0.2mM 
5m1 1M Tris-HCI, pH- 8.5 100mM 
Adjust the volume to 50m1 with ddH20 
X-Gal 50mg X-Gal (5-Bromo-4-chloro-3-indolyl 3-0- 50mg/ml 
galactoside, Wt: 408.64) 0.3M 
1 m N,N'-Dimethylformamide (Mw: 73.09) 
X-Gal 80mg X-Gal (5-Bromo-4-chloro-3-indolyl 13-0- 8% 
galactoside, Wt: 408.64) 
1 m N,N'-Dimethylformamide (Mw: 73.09) 
X-Phosphate (BCIP) 50mg X-Phosphate (5-Bromo-4-chloro-3-indolyl 50mg/ml 
phosphate p-toluidine salt 
1 m N,N'-Dimethylformamide (Mw: 73.09) 
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Table 2.1.3 (D) List of mounting media for conventional and fluorescent 
microscopy 
Media Components/Preparation Final 
concentration 
FISH media 5m1 1M Tris-HCI, pH-8.5 100mM 
1.25g DABCO (Mw: 112.2) 2.5% 
45ml Glycerol 90% 
Glycerol/PBS, 5m1 lOx PBS, pH-7.4 lx 
pH-7.4 
40m1 Glycerol 80% 
5m1 ddH2O 
Glycerol/PIPES, 2.5m1 1M Pipes, pH-6.5 50mM 
pH-6.5 
40m1 Glycerol 80% 
7.5m1 ddH20 
Hoyers media 6g Arabic gum in lOmI ddH20 15% 
Dissolve completely 0/N. Then add: 4g 
Glycerol 10% 
40g Chloral hydrate (Mw: 165.4) 100% 
Centrifuge for 2 hours at maximum 
speed and collect the cleared 
supernatant 
Hoyers mount media 20m1 Hoyer's media 50% 
20m1 Concentrated Lactic acid 50% 
2.1.4 Media preparation 
All types of media (Table 2.1.4) were prepared by Institute media staff and 
sterilised by autoclaving (15 minutes at 15 psi). Subsequently the media was stored 
at room temperature. 
Table 2.1.4 Media list 
Media type Components / Preparation Final 
concentration 
LB (Luria Broth) lOg NaCl 1% 
lOg Bacto-tryptone 1% 
5g Yeast extract 0.5% 
Adjust the volume to 1 L with ddH20 
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Media type Components I Preparation Final 
concentration 
LB agar lOg NaCl 1% 
log Bacto-tryptone 1% 
5g Yeast extract 0.5% 
15g Difco agar 1.5% 
Adjust the volume to 1 L with ddH20 
NZY Top Agar 1LofNZY+ 
7g Agarose** 0.7% 
NZY Agar 1LofNZY+ 
15g Agar 1.5% 
NZY Broth* 5g NaCl 0.5% 
2g MgSO4.71-120 (Mw: 246.5) 8mM 
1 Og NZ amine (casein hydrolysate) 1% 
5g Yeast extract 0.5% 
Adjust the pH to 7.5 with 5N NaOH. 
Adjust the volume to 1 L with ddH20 
SM Buffer (Phage 5.8g NaCl (Mw: 58.44) 100mM 
buffer) 
2.Og MgSO4.71-120 (Mw: 246.5) 8mM 
50ml 1M Tris-HCI, pH-7.5 50mM 
5m1 2% (wlv) gelatine 0.01% 
Adjust the volume to 1 L with ddH20 
SOB Broth* 20g Bacto tryptone 2% 
5g Yeast extract 0.5% 
0.58g NaCl (Mw: 58.44) 10mM 
1 ml 2.5M KCI 2.5mM 
5g MgSO4.71-120 (Mw: 246.5) 20mM 
Adjust pH to 7.0 with SN NaOH 
Adjust the volume to 1 L ddH20 
SOC+  Broth* 1 L of SOB Broth 
Autoclave. Add: 
1 OmI 2M filter sterilised Glucose 20mM 
* "+" Indicates that Mg salt is added to the media. 
**Agarose  is used in place of agar since agar can inhibit enzyme activity. This might present 
a problem when analysing the phage colonies later. 
***In  event of mite infection, strips of Whatman 3MM filter paper soaked in 3% (v/v) 
Benzyl Benzoate in Ethanol and air dried are placed on top of the food. 
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2.1.5 Antibiotics 
Stock solutions from all antibiotics were prepared at the recommended 
concentrations (Table 2.1.5) and stored at -20°C. 
Table 2.1.5 Antibiotics list 




Ampicillin 50mg/mi 50ig/rni 
Chioramphenicol 68mg/mi 12.5 1g/ml* or 50tg/mi 
Kanamycin 25mg/mi 50tg/mi 
Tetracycline 5mg/mi 50tg/mi 
* Chioramphenicol in lower working concentration is required for selection and growing of 
ESTs strains. 
2.2 	Bacterial strains and plasmids 
Table 2.2 (A) List of bacterial strains 
Host strain Genotype/Source 
BL2I(DE3) F ompT hsdSB(rB MB ) gal dcm X (DE3) [pLysS Cam'] 
pLysS 
(Stratagene) 
SCSI 10 rpsL (Strt) thr leu endA thi-1 lacY ga/K ga/I ara tonA tsx dam dcm 
(Stratagene) 
supE44 A(/ac-proAB) [F traD36 proAB /aclZM15] 
SOLR e14 (mcrA ) A(mcrCB-hsdS M R-mrr) 171 sbcC recB recJ uvrC 
(Stratagene) 
umuC::Tn5 (Kan)  lac gyrA96 re/Al thi-1 endAl XR  [F proAB 
5] Su (nonsuppressing) 
Top 10 F mcrA A(mrr-hsdRMS-mcrBC) cD80 /acZAMlS A/acX74 deoR recAl 
(Invitrogen) R araDl39 A (ara-leu)7697 ga/U ga/K rpsL (Str ) endAl nupG 
XLI Blue recAl endAl gyrA96thi-1 hsdR17 supE44 re/Al /ac[F'proAB 
(Stratagene) aC,q ZAM 15 TnlO (Tet)] 
XL 10-Gold TetrA(mcrA)183 A(mcrCB-hsdSMR-mrr)173 endAl supE44 thi-1 recAl 
(Stratagene) 
gyrA96 re/Al lac Hte [F proAB 	 TnlO (Tet) Amy Ca Mr] 
XLI -Blue MRF A(mcrA)183 A(mcrCB-hsdSMR-mrr)173 endAl supE44 thi-1 recAl 
(Stratagene) 
gyrA96 re/Al lac [F proAB 	 TnlO (Tet)] 
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Table 2.2 (B) 
Construct Insert Vector Cloning Selec- Strain 
name  enzymes tion  
pMl Myosin V pBluescript SK- EcoRl+XhoI Amp' XLI Blue 
cDNA clone (Stratagene) 
pM2 Myosin V pBluescript SK- EcoRI+XhoI AmpR XL1 Blue 
cDNA clone (Stratagene) 
pM3 Myosin V pBluescript SK- EcoRI+XhoI ArnpR XL1 Blue 
cDNA clone (Stratagene) 
pM4 Myosin V pBluescript SK- EcoRl+XhoI Amp   XLI Blue 
cDNA clone (Stratagene) 
pSK- n/a pBluescript SK- n/a AmpR XL1 Blue 
(Stratagene) 
pGSK pBluescript SK- pEGFP-N1 KpnI+HindTII AmpR+ XL1 Blue 
7.6 kb 
(Stratagene) (Clontech) R Kan 
pRSK pBluescript SK- pEGFP-RI KpnI+HindIll Amp '+ XLI Blue 
7.6 kb 
(Stratagene) (Clontech) Kan 
pGFT* Myosin V Tail pGSK SpeI+AgeT Kan" SCS 110 
(sense) 
pRFW* Mayosin V ORF pGSK SpeI+AgeI Kan' SCSI 10 
(sense) 
TOPO n/a pCR Il-TOPO n/a Kan' Top 10 
(Invitrogen) 
7137 c15 Chorion Protein pBR322 EcoRI AmpR XLI Blue 
(Spradling et at. (New England 
1980) Biolabs) 
7C8 c38 Chorion Protein pBR322 EcoRl AmpR XLI Blue 
(Spradling et al. (New England 
1980) Biolabs) 
Br-C ZI Broad Complex pCR 1000 TA cloning Amp' XLI Blue 
Isoform Z 	(Bayer et (Invitrogen) 
al. 1996) 
Br-C Z2 Broad Complex pCR1000 TA cloning AmpR XLI Blue 
Isoform Z2 (Bayer et (Invitrogen) 
al. 1996) 
Br-C Z3 Broad Complex pCR1000 TA cloning Amp  XL1 Blue 
Isoform Z3 (Bayer et (Invitrogen) 
at. 1996) 
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Br-C Z4 Broad Complex pCR 1000 TA cloning AmpR XLI Blue 
Isoform Z4 (Bayer et (Invitrogen) 
al. 1996) 
Bs-cD5 Broad Complex pBluescript SK- EcoRI AnlpR XLI Blue 
Core domain (Bayer (Stratagene) 
et al. 1996) 
p32* Myosin V Tail (anti- pRSET-C EcoRl+Dral Amp' BL2IDE3 
sense) (Maciver et al. (Invitrogen) fragment in 
pLysS 
1998) PvuII site 
p33* Myosin V Tail pRSET-C EcoRI+Dral AmpR BL21DE3 
(sense) (Maclver et (Invitrogen) fragment in 
pLysS 
al. 1998) PvuII site 




pUGT Myosin V Tail—GFP pUASp SpeI+XbaI Amp  Top 10 
(pGFT) (Rorth 1998) 
pUGW Myosin V ORF—GFP pUASp SpeI+XbaI Amplz Top 10 
(pGFW) (Rorth 1998) 
pUN2 pEGFP-N1 pUASp KpnI+XbaI AmpR XLI Blue 
(Clontech) (Rorth 1998) 
pUR3 pEGFP-R1 pUASp KpnI+XbaI AmpR XLI Blue 
(Clontech) (Rorth 1998) 
N110 n/a pEGFP-N 1 n/a KanR + SCSI 10  
(Clontech) Neo' 
RhO n/a pEGFP-R1 n/a Kan R+ SCSI10 
(Clontech) NeoR 
GFP-N1 n/a pEGFP-N1 n/a Kan '+ XLI Blue 
(Clontech) NeoR 
GFP-R1 n/a pEGFP-R1 n/a KauR + XLI Blue 
(Clontech) Neo' 
pUASp n/a pUASp n/a AnlpR XLI Blue 
(Rorth 1998) 
pMSH Myosin V (mutant TOPO-3519 bp Blunt end KanR Top 10 
fragment) (Invitrogen) cloning 
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pWTSH Myosin V (wild type TOPO-3519 bp Blunt end Kan R Top 10 
fragment) (mvi trogen) cloning 
pHSMR Myosin V ORF pCaSpeR-hs XbaI Amp' XL 10- 
(antisense) (Thummel and Gold 
Pirrotta 1992) 
pHSMS Myosin V ORF pCaSpeR-hs XbaI Ampk XL 10- 
(sense) (Thummel and Gold 
Pirrotta 1992) 
pUAM Myosin V ORF pUASp Spel+Hpal AmpR XL 10- 
(sense) (Rorth 1998) Gold 
HS-Casper n/a pCaSpeR-hs n/a AmpR XLI Blue 
(Thummel and 
Pirrotta 1992) 
* Fusion constructs. In brackets is indicated the orientation of the subcloned gene, either 
sense or antisense. 
2.2.1 Growing bacteria on agar plates 
Bacterial cells are streaked onto agar plates to obtain an independent isolate. 
This is done to reduce the likelihood of working with a culture which has become 
contaminated and/or has accumulated mutations. The cells can be streaked from 
another plate, a stab or from a frozen glycerol stock. 
Bacteria were picked by a sterile inoculating loop and streaked onto a LB 
plate in a sequential manner. A flamed glass spreader was used when larger volumes 
of cells (e.g. transformed competent cells) were to be plated. Subsequently plates 
were grown ON at 37'C. 
2.2.2 Growing bacteria in liquid cultures 
Routinely, small scale bacterial cultures were required. Overnight cultures 
were prepared by inoculating 5m1 of LB with a single bacterial colony. The 
appropriate antibiotic was added and the cultures grown 0/N at 37°C with shaking 
(150rpm). 
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Larger scale cultures were prepared by subculturing an ON culture in 50-
500ml fresh LB. The appropriate antibiotic was added and the cultures grown at 
37°C with shaking (200-250rpm) until the required 0D590 was attained. 
2.2.3 Storage of bacterial cultures 
For short term storage, single colony was streaked on a LB plate 
supplemented with the appropriate antibiotic (Table 2.1.5). The culture was grown 
overnight at 37°C and stored at 4°C for up to one month. 
For long term storage (up to five years) bacterial stabs were prepared. 
Toothpicks were used to pick and stab a single colony into a vial with LB-broth 
supplemented with 0.6% agar. The stabs were incubated for 6 hours at 37°C and 
stored at RT in dark. 
Glycerol stocks were prepared for indefinite storage of the bacterial strains. 
800p1 of an ON culture was added to 200pJ sterile glycerol in a sterile 2m1 screw-
top tube. The mixture was homogenised by vortexing and stored at -80°C. 
2.3 	Manipulation of bacteriophage 
2.3.1 Preparation of plating cells. Plating of bacteriophage library 
A small amount of the bacterial glycerol stock, XLI Blue MRF' was streaked 
onto agar plates. The plates were incubated 0/N at 37°C. A single colony was picked 
and grown in SOmI LB supplemented with 0.5m1 20% Maltose (0.2% final 
concentration) and 0.5ml 1M MgSO4 (10mM final concentration). The culture was 
incubated 0/N at 30°C with shaking (the lower temperature keeps the bacterial cells 
from overgrowing). Alternatively the culture was grown for 5-6 hours (during the 
day) at 37°C with shaking. The culture was monitored spectrophotometrically to 
ensure the cells did not grow past 0D600 of 1.0. The cells were pelleted down by 
centrifugation (500x g, 10 minutes). The supernatant was decanted and the cells 
gently resuspended in —10m1 10mM MgSO4 to give an 0D600 of 0.5. The cells were 
stored at 4°C for up to 1 week. 
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2.3.2 Determination of the bacteriophage library titer. 
A series of phage dilutions (1:1xl04, 1:1x105, 1:1x106, 1:1x107) were made in 
SM buffer. ip] of each dilution was used to inoculate 200p] of Plating cells. After a 
15 minute incubation, 3m1 of NZY top agar (preheated to 48°C) were added and the 
mix plated onto NZY plates (preheated to 370C). The plates were incubate 0/N at 
370C. On the following day the number of plaques was counted and the plaque 
forming unit (pfu)/ml concentration was determined based on the dilutions. 
2.3.3 Library screens. In-vivo excision of pBluescript phagemid from 
AZAP bacteriophage (Stratagene) 
Two square plates (22x22cm) were preheated to 37°C and NZY top agar 
melted to 48°C. 150,000 pfu/il of the library (1t1 of the appropriate dilution) were 
added to 1.2 ml of XL1 Blue MRF' (0D600 of 0.5). The library reaction was 
incubated for 15 minutes at 37°C to allow the phage to attach to the cells. 60m1 of 
NZY top agar were added and the mix plated onto the NZY agar plates (30ml mix 
on each or 75,000 pfu per plate). The plates were incubated at 37°C for 6-8 hours. 
Once pinpoint size colonies have developed the plates were cooled down to 4°C to 
prevent the NZY top agar from sticking to the nylon membrane. 
The subsequent steps of the library screen are described elsewhere. The 
transfer of the plaques to a nylon membrane (plaque lifts) is described in 2.5.13.3. 
The subsequent probe labelling and hybridisation are described in 2.5.13.1 and 
2.5.13.2 respectively. 
Typically three rounds of screens were carried out to isolate positive clones. 
The latter were plugged and transferred to eppendorf tubes containing 0.5ml phage 
buffer and 20p1 chloroform. The construction of the XZAP-cDNA library allowed 
simple in-vivo excision and recircularisation of any cloned insert contained within 
the 2 vector to form a pBluescript SK(-) phagemid containing the cloned cDNA 
insert. For the in-vivo excision a 250pi aliquot from the eluted phage was added to 
200p1 XL1-Blue MRF cells (0D600=1.0) with 1il of ExAssist helper phage 
(concentration lxi 06pfu/il) supplied by Stratagene. The mix was incubated for 15 
minutes at 37°C to allow absorption of the phage. 3ml of LB were added and the mix 
incubated for 3 hours at 37°C with shaking (150rpm). The culture was then heated 
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for 20 minutes at 70°C and centrifuged at 1000 x g for 15 minutes. The supernatant, 
containing the excised phagemid, was collected and stored at 4°C. lOjtl and 100i.tl of 
the phagemid stock were mixed with two 200 j.tl aliquots of SLOR cells (0D600=1 .0). 
The tubes were incubated for 15 minutes at 37°C and 200 jil of each plated on LB-
ampicillin plates. The developing colonies contained double stranded pBluescript 
SK(-) phagemid with the cloned eDNA insert. 
2.4 Drosophila methods 
2.4.1 Drosophila measurements 
The size of different Drosophila stages significantly varies. In many 
experiments, such as Developmental Northern and Western, the exact weight of 
tissue is needed for designing a meaningful and accurate experiment. 
Table 2.4.1 Drosophila measurements 
Developmental stage Weight Volume 
I Pair of ovaries 600tg 0.6p1 
I Testes 35ng (size: 0.1mm x 0.1mm x 0.5mm x 7) 35n1 
I Embryo 12ig (size: 0.175mm x 0.175mm x 0.5mm) 12n1 
I Third Instar larva 1.5-1 .6mg 1 .5p1 
I pupa 1.5mg 15tI 
I Male fly 700tg 0.7iI 
I Female fly 1 .3mg 1 .3I 
2.4.2 Maintenance of Drosophila stocks 
All fly stocks were maintained on cornmeal food at 18°C. Some stocks with 
reduced viability were kept at 25°C (Table 2.4.2 (A)). In the event of mite 
infestations, filter paper strips soaked in 3% (v/v) Benzyl benzoate (in EtOH) were 
placed on the top of the fly food. 
Genotypes of stocks used for mapping didum and in genetic and P-element 
screen experiments are given in the relevant chapters. Fly stocks for general use, like 
Wild type flies and balancers are given in Table 2.4.2 (B). 
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Table 2.4.2 (A) Fly food and related media 
Food name Components/Preparation Final 
concentration 
Fly food*** 25g Cornflour 2.5% 
(Staffen) 
50g Sugar 5/0 
17.5g Lyophilised yeast 1.75% 
lOgAgar 1% 
Dissolve in 1L of boiling water. Add: 
0.5m[ 10% Nipagin in 95% Ethanol 0.005% 
Apple juice plates 5g Bacto-agar 2.5% 
5g Sucrose 2.5% 
150m1 H20. Boil, then add: 
50m1 Apple juice 25% 
0.2m1 10% Nipagin in 95% Ethanol 0.01% 
GFP plates 4g Agar 2% 
5g Sucrose 2.5% 
200m1 H20. Boil, then add: 
50m1 Red grape juice 
0.2m1 10% Nipagin in 95% Ethanol 0.01% 
Table 2.4.1 (B) Common wild type and balancer fly stocks 
Stock! Genotype Chr Comments! 
Synonym  Donor 
Oregon R Wild type Red eyed wild type, 
(+38, B**) 
John Roote 
w 8 Wild type White eyed wild type, 
(3605, B) 
Bloomington 
5194 w*; L2 Pin1/CyO, P{w m GAL4-Kr.C}DC3, 1;2 2 Chr. GFP balancer, 
(CKG30, B) p{W+mCUASGFpS65DC7 Thomas Kornberg 
4533 w*; ln(2LR)noc4LScoI9R, 91 /Cy0, 1;2 2 Chr. GFP balancer, 
(B) P{W+mCAtGFp}JMR1 Michael Ashburner 
TM3ITM6 yl w*;  TM3, Sbl/TM6B, Tb+ 1;3 3 Chr. balancer, 
(3720, B) 
David Cribbs 
* "Chr" from Chromosome. Specifies the chromosome position of the insertion or mutation. 
** In brackets are given the Bloomington Stock center numbers. 
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2.4.3 Collection of embryos 
Embryos were collected on apple juice plates that were smeared with a small 
amount of yeast paste. Unless otherwise stated, the collection period was 18 hours. 
The embryos were washed off the plate with some water and collected onto a fine 
plastic sieve. The eggs were rinsed with 0.1% Triton X-lOO to prevent them from 
sticking to the filter walls 
2.4.3.1 Drosophila egg preparation for dark-field microscopy 
Flies were left to lay eggs on apple juice plates for approximately six hours. 
The eggs were washed off the plate with some water and collected onto a fine plastic 
sieve. The eggs were collected into a clean eppendorf tube and rinsed with PBS. 15 
to 20 eggs were placed into a drop of Hoyer's mounting media on a microscope slide 
and covered with a coverslip. The slides were then incubated at 65°C 0/N and stored 
at RT. 
2.4.3.2 Collection of GFP embryos and larvae. Fluorescent microscopy 
GFP embryos (containing a GFP balancer chromosome) were collected on 
special non-fluorescent grape juice plates. The plates were analysed on a fluorescent, 
dissecting microscope (Leica) with the filter combination required for GFP 
observation (450-90/515). When necessary GFP and/or non-GFP embryos were 
selected and transferred into a drop of FISH mounting media and covered with a 
cover-slip. The slides were analysed at higher magnification and photographed on a 
fluorescent microscope fitted with a digital camera. 
GFP embryos were left to hatch on the grape juice plates. First, second and 
third instar larvae were picked out of the plates and transferred into a drop of 4% p-
Formaldehyde on a microscope slide and covered with a cover slip. The slides were 
incubated at RT for 15 min and the immobilised larvae photographed on a 
fluorescent microscope fitted with a digital camera. 
2.4.4 Collection of late (third) instar larvae, pupae and sexed adults 
Newly eclosed flies were placed in a freshly yeasted, 250m1 fly bottle for 4 to 
6 hours and then removed. The bottles were incubated at 26°C for the appropriate 
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time. After 96 hours the third instar larvae have crawled up the bottle walls. From 
there they were collected with a paintbrush. 
Early pupae were picked out from the bottle walls after 120 hours of 
incubation. 5 to 15 hours later dark (late) pupae were collected. 
Generally adult flies no older then 10 days were collected. The flies were 
anaesthetised with CO2 (occasionally diethyl ether was used), sexed and placed in 
eppendorf tubes. Males and females were distinguished by identifying the specific 
sexually dimorphic characteristics such as: body size and shape, abdomen colour and 
the presence of sex combs in males. 
2.4.5 Collection of virgin flies and crosses 
Virgin flies were collected in one of the following ways. Generally the fly-
bottles were emptied from any eclosed flies. Then every 6 hours (26°C) the newly 
eclosed flies were collected and sexed. Flies from the same sex were transferred 
together into vials with fresh flyfood. 
When a limited number of pupae were available a different approach was 
undertaken. Dark pupae were picked out with a paintbrush and placed individually 
into vials with fresh flyfood. The newly eclosed flies were anaesthetised and sexed. 
Generally, fly crosses were carried out by transferring 2 virgin females and 2-
4 male flies into the same vial, containing fresh flyfood, supplemented with yeast 
paste. The flies were incubated at 18 or 26°C (depending on the genotype of the flies) 
for up to 4 days and then removed. 
2.5 	Nucleic acid methods 
2.5.1 Common techniques for DNA and RNA purification 
2.5.1.1 Phenol/Chloroform extraction 
Protein impurities were removed from nucleic acid preparations by 
phenol/chloroform extraction. For DNA purification a phenol solution equilibrated to 
pH-8.0 is required; for RNA a phenol with pH-4.3 is required (see Table 2.1.3 (A)). 
An equal volume of phenol/chloroform was added to the DNA (RNA) solution, 
which was then mixed thoroughly by repeated gentle inversions for 5 minutes. The 
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suspension was centrifuged at 14,000 x g for 5 minutes and the top aqueous phase 
was transferred to a clean tube. This step was repeated until a clear interface between 
the phases was achieved. A final extraction with an equal volume of chloroform 
ensured complete removal of the phenol. 
2.5.1.2 Precipitation of nucleic acids 
DNA/RNA was precipitated from solution by adding 0.1 volume of 3M 
sodium acetate (pH-5.2) and 2.5 volume 99.7% EtOH. Alternatively DNA was 
precipitated with 0.6 volumes isopropanol. Typically the nucleic acid was 
precipitated for lh at -20°C (no incubation was needed for the isopropanol 
precipitation) and centrifuged at 22,000 x g for 15 minutes at 4°C. The resulting 
pellet was washed once with 75% EtOH and centrifuged at 22,000 x g for 5 minutes 
at 4°C. The DNA pellet was air dried and resuspended in the appropriate volume of 
10mM Tris-HC1, pH-8.0. The RNA was resuspended in RNase free water. 
2.5.1.3 Estimation of the concentration of nucleic acids by UV 
spectropho tome try 
UV spectrophotometry was used to determine the concentration and purity of 
nucleic acids. The DNA/RNA absorbance was measured at 260nm and 280nm using 
a two-beam Hitachi spectrophotometer. The concentration of the sample was 
calculated using the following formula: 
DNA/RNA Concentration in ng/.d = A
260 x DF x Sc 
1000 
DF - Dilution Factor 
Sc - Spectrophotometric conversion (Specific DNA/RNA absorption value) 
Sc = 50 (double stranded DNA) 
Sc = 40 (RNA or single stranded DNA) 
The purity of DNA was estimated by assessing the ratio A260/A260: DNA was 
considered to be sufficiently free of protein at ratio greater than 1.8 (2.0 for RNA). 
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2.5.2 Genomic DNA preparation 
Approximately 130mg of flies were ground in 250pi Fly Buffer using a 
plastic pestle. The volume was adjusted to lml with an additional 750 jil of Fly buffer 
(Table 2.5.2). 8iI of RNase was added (80tg/rnl final concentration) and the 
homogenate incubated for 30 minutes at 37'C. 60jil of Proteinase K was then added 
(620tg/rnl final concentration), followed by a 30minute incubation at 50°C. Cell 
debris was pelleted by centrifugation (22,000 x g, 15 minutes, at 4°C). The 
supernatant was transferred to a clean eppendorf tube and extracted with 
phenol/chloroform. 
The plasmid DNA was recovered from the solution by isopropanol 
precipitation. After a brief wash with 75% EtOH the DNA pellet was air dried at 
42°C and resuspended in 70p1 10mM Tris-HC1, pH-8.0. 
Table 2.5.2 Solutions required for genomic DNA preparation 
Reactives/Chemicals Composition/Preparation Final 
concentration 
Fly Buffer 5m1 1M Tris-HCI, pH-8.5 100mM 
800pJ 5M NaCl 80mm 
2.5g Sucrose 5% 
2.5m1 10% SOS 0.5% 
5m1 0.51VI EDTA, pH-8.0 50mM 
Adjust the volume to 50m1 with ddH20 
Proteinase K 10mg Proteinase K 10mg/mi 
101.ii 1M Tris-HCi, pH-7.5 10mM 
59Opi ddHO 
400pi Glycerol 40% 
2.5.3 Plasmid DNA preparation 
2.5.3.1 General purpose DNA miniprep 
A 5 ml 0/N culture was centrifuged to pellet the bacterial cells. The pellet 
was then resuspended by vortexing in 250p1 Resuspension buffer. 350p.l of Lysis 
solution was added and the mix was gently inverted several times. After a 5 minute 
incubation 350i.il of Neutralising solution was added. The mix was inverted gently 
Eel 
Materials and methods 
four times and centrifuged at 22,000 x g for 15 minutes at 4°C. The supernatant was 
transferred to a clean eppendorf tube and the plasmid DNA recovered from the 
solution by isopropanol precipitation. 
Table 2.5.3 Solutions required for plasmid DNA preparation 
Reactives/Chemicals Composition/Preparation Final 
concentration 
Resuspension buffer 500tl 1M Tris-HC1 pH-7.6 50mM 
200pI 0.51VI EDTA pH-8.0 10mM 
lOOiil 10mg/mi RNase (DNase free) 1001g/mi 
Adjust the volume to lOmi with ddH20 
Lysis 2m1 1 O NaOH 0.21VI 
Solution 
lOmi 10% SIDS 1% 
Adjust the volume to 1 OOmi with ddH20 
Neutralising solution 3.24g CI-13000K (Mw: 98.14) 1.32M 
Adjust the pH to 4.8 with Glacial Acetic 
acid (-2m1) 
Adjust the volume to 25m1 with ddH20 
2.5.3.2 High purity plasmid miniprep 
High quality DNA was required for sequencing and cloning experiments. 
QlAprep® Spin Miniprep kit (Qiagen) was used to isolate and purify for up to 20-
30.tg of plasmid DNA. 
2.5.3.3 DNA midiprep 
QIAfilterTM Plasmid midiprep kit from Qiagen was used to prepare up to 
150j.tg of plasmid DNA following the supplier's instructions. 
2.5.4 DNA agarose gel electrophoresis 
Agarose gel electrophoresis was used to separate DNA molecules according 
to their size. 1.2% agarose gels were used for up to 8kb DNA molecules; for DNA 
molecules in the range 8-20kb 0.7 % gels were prepared. EtBr was added to the gel 
to a final concentration of 0.2mg/ml. The samples were premixed with loading buffer 
(Table 2.1.3) to a final concentration of lx. The DNA samples were loaded on the 
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gel, and electrophoresed at 4-7 V/cm in 1xTAE buffer until the appropriate degree of 
separation was obtained. 
Molecular standards were used to determine the size of the DNA fragments. 
Approximately 0.5 jig of Invitrogen 1kb Ladder was applied per gel. To estimate the 
approximate amount of DNA in an unknown band Bioline HyperLadder was used. 
Spi of the ladder would produce a set of bands with a known amount of DNA in each 
band. These were then compared to a particular fragment with an unknown amount 
of DNA. 
Band size (bp) 
12,216 
!_11,198 10.180 9162 












1 KB Ladder, Invitrogen 
I






p 	'"-5000 50 












Bioline HyperLadder I 
Nucleic acids stained with EtBr were visualised on a long-wavelength UV 
transilluminator (365nm). A video imager was used to obtained permanent records of 
the gel pattern on thermal paper. These were subsequently scanned on desktop 
scanner and stored as JPG picture files. 
2.5.5 Recovery of DNA fragments from agarose gel 
QJAEX® II Gel Extraction Kit (Qiagen) was used to recover up to 15kb DNA 
fragments from agarose gels. The supplier's procedure was modified as follows: the 
DNA fragment was excised from the gel and dissolved in 3 volumes QX1 buffer 
with 2 volumes ddH20 at 65°C for 5-10 minutes. 10jil of 3M Sodium acetate (pH-
5.2) and lOjil QIAEX II resin were added. The sample was incubated for 10 minutes 
at RT with mixing every 2 minutes to keep the QIAEX II in suspension. The QIAEX 
11 particles were pelleted at 14,000 x g for 1 minute and then washed once with QXI 
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buffer and two times with PE buffer (Qiagen). The pellet was air-dried at 37°C for 5-
10 minutes. To elute the bound DNA 30i1 of 10mM Tris-HCI, pH-8.0 were added to 
the pellet and the mix incubated for 5 minutes at 65°C. The sample was centrifuged 
at 22,000 x g and the cleared supernatant transferred into a new eppendorf tube. The 
elution step was repeated and the eluates combined. 
2.5.6 DNA sequencing and sequence analysis 
A typical (lx) sequencing reaction consisted of 8il Labelling Mix 
(Rhodamine or Big DyeTM Terminator for Cycle Sequencing, ABI PRISM, Applied 
Biosysterns), 3.2pmol of the appropriate primer, 50-200ng (PCR product) or 400ng 
(plasmid DNA) high quality DNA template and water to a final volume of 20 1. The 
program for thermal cycling was as follows: 25 cycles, 95°C for 30 seconds, 50°C for 
20 seconds and a 4 minute extension step at 60°C. To remove the unincorporated dye 
terminators the sequencing reaction was passed through a purification column. Either 
Edge Gel Filtration Cartridges (ver.11) from Edge BioSystems or genCLEAN 
columns supplied by Genpack were used for purification, following the 
manufacturer's instructions. 
The amplified and labelled products were analysed on ABI PRISM 377 DNA 
sequencer (Perkin-Elmer Corporation) by Nicola Preston (ICMB-Edinburgh 
University) or Jill Lovell (ICAPB-Edinburgh University). Occasionally the products 
were analysed on ABI PRISM 3100 DNA Sequencer by Helen Williamson (ICMB-
Edinburgh University). 
2.5.7 Enzymatic reactions 
2.5.7.1 Endonuclease restriction of DNA 
Typically a 20jil reaction was carried out. When needed the standard reaction 
was scaled up proportionally. DNA sample (0.2-1.0ig), appropriate restriction buffer 
and IOU of the restriction enzyme were used per reaction. The reaction was 
incubated for 2 to 6 hours at the recommended temperature (usually 37'C) and then 
stopped by heat inactivation of the enzyme (20minutes at 65°C). The results of the 
restriction enzyme digest were analysed using agarose gel electrophoresis. 
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2.5.7.2 DNA phosphorylation 
Phosphorylation of DNA is achieved by using T4 polynucleotide kinase and 
ATP. Common application of this reaction is a 5' DNA labelling and recovering the 
5' Phosphate in dsDNA linkers to enable them to ligate with other DNA fragments. 
In general a 20.il reaction was set, containing liM ATP, lx of the provided by the 
manufacturer buffer and 3-5U of the enzyme. The reaction was incubated for 30 
minutes at 37'C. 
2.5.7.3 DNA dephosphorylation 
DNA dephosphorylation was carried out in 20p1 reaction volume. The 
reaction contained the following components: the sample DNA, lx of the supplied 
buffer, and 1-2U of alkaline phosphatase. For sticky end ligation, the mix was 
incubated for 30 minutes at 37°C and then another unit of the enzyme added. When 
ligating DNA fragments with blunt ends the incubation times were extended to 1 
hour. Either ClAP or SAP alkaline phosphatases were used in the experiments. ClAP 
required the completed reaction to be stoped with 2itl of 0.5M EDTA and the DNA 
purified by phenol/chloroform and recovered by EtOH precipitation. SAP was 
simply inactivated by incubation at 65°C for 20minutes and the DNA precipitated 
with EtOH. 
2.5.7.4 DNA ligation 
DNA ligation was performed by incubating DNA fragments with 
appropriately linearised cloning vector in the presence of lx buffer (with ATP) and 
400U T4 DNA ligase (NEB) in 20i.0 reaction volume. The reaction was incubated 
0/N at 4°C when joining dsDNA with cohesive ends or 18°C for blunt ended DNA 
molecules. The T4 DNA ligase was then heat inactivated (20minutes at 65°C) and 1-
2tI of the reaction used for transformation to competent cells. 
2.5.8 DNA transformation to chemically competent cells 
2.5.8.1 Preparation of competent cells 
Sml 0/N culture (usually XL1 Blue cells) was used to inoculate 200rnl S0B 
media (no antibiotic was added). The culture was grown at 37°C, 250rpm, until an 
50 
Materials and methods 
0D590 of 0.6 was reached (typically 5-6 hours). The cells were cooled down to 4°C 
and pelleted by centrifugation at 2500 x g for 10 minutes at 4°C. The pellet was 
resuspended gently in 14m1 ice-cold TB buffer and lml DMSO added (7% final 
concentration). The cells were incubated for 10 minutes on ice, aliquoted in 100tls 
and snap frozen in liquid nitrogen. The competent cell were then stored at -80°C for 
up to 6 months. 
2.5.8.2 Transformation 
A 100tl aliquot of competent cells was thawed on ice for 5-10 minutes. Up to 
50ng of plasmid DNA, in a volume not exceeding 4tl, was added to the aliquot. The 
reaction was incubated for 30 minutes on ice and then heat-shocked at 42°C for 60-
90 seconds. After the cells were cooled briefly on ice, 600p1 of SOC media were 
added and the mix incubated at 37°C for 45 minutes. 2000 of the transformed cells 
were plated on appropriate selective agar plates. 
2.5.9 Polymerase chain reaction (PCR) 
The standard polymerase reaction consisted of the following components: 
Sopmol of the forward and reverse primer, 0.2mM of each dNTP (dATP, dCTP, 
dGTP, and TTP) supplied by Amersham Biosciences, lx Taq Polymerase Buffer 
(Qiagen), lx Q Solution (Qiagen) and 3U Taq Polyrnerase (Qiagen), approximately 
50-100ng of DNA template and nuclease free water to a final volume of 50tl. The 
PCR reaction was carried out as follows: Initial denaturing step at 94°C for 2 
minutes; then 30 cycles, step one at 94°C for 40 seconds, step two at 50-60°C 
(depending on the annealing temperature of the primers used) for 40 seconds, step 
three at 72°C for 30 seconds to 15 minutes (depending on the length of the amplified 
product, allowing 1 minute per 1kb). This was completed by a final 72°C elongation 
step for 10 minutes. Either a Touchdown Thermal Cycler (Hybaid) or Hybaid PCR 
Express Cycler (allowing a gradient PCR to be carried out) were used in the PCR 
experiments. Subsequently 5 to 10 tl of the total reaction were analysed by gel 
electrophoresis. Information about general sequencing primers is given in Table 
2.5.8. The sequence of primers used in the analysis of Br-C, diduin and the newly 
identified myosin genes in Drosophila are given in the relevant chapters. 
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Table 2.5.8 General purpose primers specific to pBluescript and other 
cloning vectors, used for sequencing and PCR experiments 




T3PR AAT TAA CCC TCA CTA AAG GG 20 56 
T7-20 TAA TAC GAC TCA CTA TAG GG 20 56 
T7-LN GTA ATA CGA CTC ACT ATA GGG 21 60 
SP6 TAT TTA GGT GAC ACT ATA G 19 50 
SP6-LN ATT TAG GTG ACA CTA TAG AA 20 52 
M13-17 GTA AAA CGA CGG CCA GT 17 52 
MI3REV-19 GGA AAC AGC TAT GAC CAT G 19 56 
G70202 GGA ATT CTT TTT TTT TTT TTT TTT 24 37 
OligodT TTT TTT TTT TTT TTT 15 34 
RP491 AAG CCC AAG GGT ATC GAC AAC 21 62 
RP492 ATT GAA CTC GGC ACT GGC ACA 21 62 
2.5.10 Reverse transcription and PCR (RT-PCR) 
Reverse transcription was carried out in a 40jil reaction volume and contained 
the following: 4ig mRNA (total RNA), ltM oligo (dT) primer, 10mM DTT, lx RT 
buffer, 0.5mM of each dNTP (dATP, dCTP, dGTP, and TTP), and 200U Superscript 
II. Experiments were performed either with oligo (dT)15 primer or PolyT-EcoRl 
primer (70202). The latter produced PCR products with higher quality due to its 
higher annealing temperature. The RNA and Oligo primer were premixed and heated 
to 70°C for 5 minutes and snap cooled on ice before adding the other reaction 
components. This step is needed to remove any secondary structures from the RNA 
template. The RT mix was incubated for 1 hour at 42°C and then stopped by heat 
inactivation of the enzyme at 70°C for 15 minutes. 2p1 of the RT reaction was used 
as a template for subsequent PCR amplification. Standard PCR conditions were used 
as described in the previous section, 2.5.8. 
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2.5.11 Inverse PCR 
Genornic DNA was prepared from flies containing P-element insertion(s) 
according to the protocol in section 2.5.2. Approximately 8.ig of the gDNA was 
digested with Sau lilA for 6 hours at 37°C. The reaction was stopped by heating the 
mix at 65°C for 20mm. The digest was directly used in a 200pJ ligation reaction with 
800U of T4 DNA ligase (NEB). The reaction was incubated 0/N at 4°C. The 
following day the DNA was recovered by EtOH precipitation and resuspended in 
1500 10mM Tris-HC1, pH-8.0. 5tl of the religated genornic DNA was used as a 
template for subsequent PCR amplification with P-element specific primers (Table 
2.5.10). Standard PCR conditions were used as described in section, 2.5.8. 
Table 2.5.10 Primers for Inverse PCR 




PLaci (5'PZ) CAC CCA AGG CTC TGC TCC CAC AAT 24 64 
PLac4(5'PZ) ACT GTG COT TAG GTC CTG TIC AlT GTT 27 65 
SpLac2 (5'PZ) GAA TIC ACT GGC CGT CGT ITT ACA A 25 64 
Pry l(3'PZ) CCT TAG CAT GTC CGT GGG GTT TGA AT 26 65 
Pry4(3'PZ) CAA TCA TAT CGC TGT CTC ACT CA 24 62 
W3-1 (3'IacW) TGT CGG CGT CAT CAA CTC C 19 60 
Spepi (3'PZ) GAC ACT CAG AAT ACT ATT C 19 52 
Spi (5'PZ) ACA CAA CCT TTC CTC TCA ACA A 22 62 
Sp3(3'PZ) GAG TAC GCA AAG CTT TAA CTA TGT 24 62 
Sp5(3'IacW) GCA TCA CAA AAA ICC ACG CTC AAG T 25 64 
LACF(IacZ) AGC TOG CGT AAT AGC GAA GA 20 60 
LACS(IacZ) CAC ACT TCG GCA COT GAA IT 20 60 
2.5.12 RNA preparation and electrophoresis 
2.5.12.1 	Methods for preparation of total RNA 
TRizol® Reagent (Life technologies) was used for general preparation of total 
RNA. The manufacturer protocol was changed slightly as follows: Approximately 
50mg of tissue was homogenised in 300 jd TRIzol for 1.5 minutes. A further 700fl 
TRIzol were added and the homogenate mixed by inverting. After a 5 minute 
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incubation at RT, 200d of chloroform was added. The sample was vortexed for 15 
seconds and then incubated at RT for 2 minutes. The phases were separated by 
centrifugation at 14,000 x g, for 15 minutes at 4°C. The top water phase, containing 
the RNA, was collected (600jtl) and mixed with 500il of isopropanol. After 10 
minutes at RT the RNA was pelleted by centrifugation at 14,000 x g, for 10 minutes 
at 4°C. The pellet was washed once with 75% EtOH and air-dried for 15-20 minutes 
at RT. The RNA was resuspended in 70pi RNase free water for 10 minutes at 65°C. 
Then the sample was centrifuged for 5 minutes at maximum speed (22,000 x g) and 
the cleared supernatant, containing the reconstituted RNA, transferred to a clean 
eppendorf tube. Usually up to 120pg of total RNA was isolated with this method. 
Small amounts of total RNA (up to 50 jig) were isolated with RNeasy Mini 
Kit (Qiagen), following the suppliers protocol. This was the preferred method when 
hard to obtain tissues like testes and ovaries were to be processed. 
	
2.5.12.2 	RNA gel electrophoresis 
A 1.2% agarose gel was prepared in DEPC treated water. The gel was cooled 
down to 60°C. Then 20x MOPS (lx final concentration) and 37% formaldehyde 
(1.8% final concentration) was added and the gel allowed to solidify for 1 hour. 
RNA samples (at least 10jig of total RNA or ljig of mRNA per lane) were 
premixed with RNA sample buffer (Table 2.1.3) in a ratio 1:3. The probes were 
incubated at 65°C for 5 minutes, to remove any secondary structures from the RNA, 
and snap cooled on ice. 
Gels were run in lx MOPS buffer at 7 V/cm for 1-2 hours (check up gels) or 
0/N at 2-3 V/cm, for Northern blot experiments. 
2.5.13 Hybridisation techniques 
2.5.13.1 	Radio labelling of DNA probes 
Ready-To-GoTM DNA Labelling Beads (-dCTP) from Amersham Biosciences 
were used to label DNA probes with [32P]dCTP (Amersham Biosciences), as 
instructed by the manufacturer. Approximately bOng of DNA was used per 
labelling. Unincorporated nucleotides were removed by passing the probe through 
NICK 
TM
Columns (Amersham Biosciences). These were preboaded with G-50 
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Sephadex for gel filtration allowing the high molecular weight DNA to pass faster 
through the column than the unincorporated nucleotides. The radio-labelled probes 
were denatured for 5 minutes in boiling water and snap cooled on ice. 
	
2.5.13.2 	Southern Blotting 
The alkaline blotting technique was used for DNA transfer to HybondTM-N+ 
(Amersham Biosciences) nylon filter, following the manufacture's instructions. After 
gel electrophoresis DNA was depurinated in 0.25N HC1 acid for 15 minutes (this 
step was not required when DNA fragments smaller than 10kb were processed). The 
transfer was carried out 0/N in 0.4N NaOH. On the following day the filter was air 
dried and DNA fixed to the membrane by UV crosslinking (254nm + 365nm UV 
light) for 10 minutes. 
2.5.13.3 	Colony and plaque lifts 
The cells or the bacterophage were plated in the usual way described in 
sections 2.2.3 and 2.3.1 respectively. The plates were precooled to prevent smearing 
of the colonies and separation of the top agar in the phage plates. The transfer was 
performed by placing a nylon membrane on the surface of the agar for 2 minutes. 
The membrane was stabbed asymmetrically with a needle to ensure correct 
orientation of the colonies/plaques in the subsequent manipulations. The membranes 
were denatured for 2 minutes in Denaturing buffer, then placed for 2 minutes in 
Neutralising buffer and washed for 30sec in Rinse buffer. The nylon filters were air-
dried and the DNA fixed by UV crosslinking (254nm + 365nm UV light) for 10 
minutes. 
55 
Materials and methods 
Table 2.5.13.3 Solutions required for colony and plaque lifts 
Solution Components/Preparation Final 
concentration 
Denaturing buffer 150m] 5M NaCI 1.5M 
25m1 1 O NaOH O.5M 
325m1 H20 
Neutralising buffer 150m1 5M NaCI 1.5M 
250m1 1M Tris-HCI, pH-8.0 O.5M 
1 00m H20 
Rinse buffer 50m1 20x SSC 2x 
lOOmI 1M Tris-HCI, pH-7.5 O.2M 
350m1 H20 
	
2.5.13.4 	Northern Blot 
The transfer of RNA from agarose gel to nylon filter (Hybond1M -N+) was 
similar to the DNA transfer, with the following differences: After completion of the 
electrophoresis the RNA gel was pre-soaked in lOX SSC for 30 minutes at RT. The 
transfer was allowed to proceed 0/N in lOx SSC. On the following day the filter was 
air-dried and the RNA fixed to the membrane by UV crosslinking (254nm + 365nm 
UV light) for 5 minutes. 
2.5.13.5 	Hybridisation with (32PJdCTP radio-labelled probes 
Filters were prehybridised in pre-hybridisation solution (DNA hybridisation 
buffer without the probe) at 65°C for 6 hours to 0/N. The denatured radio-labelled 
probe was added to the prehybridisation buffer and the membranes incubated at 65°C 
0/N. The day after the membranes were washed as follows: 15 minute low 
stringency wash at 65°C in 2x SSPE, 0.1% SDS; 20 minute medium stringency wash 
at 65°C in lx SSPE, 0.1% SDS, and 15 minute high stringency wash at 65°C in 0.1x 
SSPE, 0.1% SDS. 
RNA blots were prehybridised and hybridised in a similar way, to DNA blots, 
but in RNA hybridisation buffer at 45°C. The membranes were washed two times for 
20 minutes at 45°C in lx SSC, 0.1% SDS (medium stringency wash) and once in 
0.1x SSC, 0.1% SDS at 45°C (high stringency wash). The filters were then sealed in 
polythene bags, placed in a autoradiography cassette with intensifying screens, and 
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exposed to blue sensitive film (Kodak) at -70°C. The films were developed in an X-
ograph CompactX2 automatic film processor. 
	
2.5.13.6 	Removal of probe and re-use of blots 
Southern and Northern blots were stripped by placing them in boiling 0.1% 
SDS and allowing it to cool to RT. Films were autoradiographed to check that the 
probe had been removed. 
2.5.14 In-situ hybridisation to mRNA 
2.5.14.1 	Preparation of digoxigenin-labelled probes 
Single-stranded digoxigenin- labelled DNA probes were generated by 
using cloned cDNA as a template. To avoid any enzymatic restrictions a PCR was 
performed with primers surrounding the MCS, thus amplifying only the cDNA, 
excluding the vector sequence. Then a second round PCR was carried out using DIG 
DNA labelling mix (Roche Molecular Biochemicals) and specific primer to generate 
ssDNA (antisense for the probe or sense for the negative control). 51 of the probe 
was checked on agarose gel. Prior to hybridisation the digoxigenin-labelled probe 
was boiled for 30 minutes to remove any secondary structures and break down the 
DNA to shorter, easy to penetrate fragments. 
Single-stranded digoxigenin-labelled RNA probes were generated by in 
vitro transcription, using the Roche Molecular Biochemicals DIG RNA labelling kit, 
as instructed by the accompanying manual. 
2.5.14.2 	In-situ hybridisation to whole-mount ovaries using DNA probes 
The protocol is based on the procedure previously described (Tautz and 
Pfeifle, 1998) and modified as follows. The ovaries were collected in Ringer's saline 
and fixed for 20 minutes in PMS at RT. After rinsing in PBT (3 times, 5 minutes 
each) the ovaries were digested in 10ig/ml Proteinase K for 20 minutes at RT. The 
digest was stopped by washing in PBT containing 2mg/ml Glycine. This was 
followed by three 5 minute washes in PBT. The ovaries were re-fixed for 10 minutes 
in PMS and then washed 3 times (5 minutes each time) in PBT. Prehybridisation was 
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carried out for 1 hour at 45°C in 500p0 DNA Hybrix. The ovaries were hybridised 
overnight at 45°C in DNA Hybrix containing digoxigenin labelled probe (1:20 
dilution). 
After the hybridisation the ovaries were washed with preheated to 45°C 
PBT/DNA Hybrix for 20 minutes. This was followed by three washes, 10 minutes 
each in PBT. For detection a 1:1000 dilution of anti DIG-AP conjugated antibody 
was used (Table 2.6.2.3 (A)). The anti DIG-AP antibody was preabsorbed with 
postfixed wild type (Oregon R) ovaries at 4°C overnight. 
The staining reaction was performed in Staining buffer containing 5mM 
Levarnisole, 4.5pi/ml NBT and 3.5p1/ml X-Phosphate (Table 2.1.3 (C)). The colour 
reaction was stopped by washing the ovaries in PBS. The ovaries were mounted in a 
mixture of Glycerol/PBS media and analysed on a Nomarski microscope. 
2.5.14.3 	In-situ hybridisation to whole-mount ovaries using RNA probes 
The in-situ hybridisation using DIG-labelled RNA probes is similar to the 
hybridisation with DIG-labelled DNA probes. RNA Hybrix was used instead of 
DNA Hybrix and the hybridisation was carried out at 65°C. This method produced 
very strong staining with insignificant background. Since it proved to be very 
sequence specific, it was only used with probes that have shown better staining with 
this procedure than with the hybridisation utilising DNA labelled probes. 
2.5.15 Nuclear Hoechst staining 
Ovaries were dissected in Drosophila Ringer's and fixed in FBS buffer for 20 
minutes. This was followed by two 10 minute washes in PBT. The ovaries were 
stained for 5 minutes in 1tg/rnl Hoechst 33258 dissolved in PBS. Residual Hoechst 
was removed by two PBT washes, 20 minutes each. The ovaries were mounted in 
PBS/Glycerol (1:4) and examined under a fluorescent microscope. 
2.5.16 BrdU labelling 
Ovaries were dissected at room temperature in lx Grace's medium (Flow 
laboratories) and incubated for 1 hour in 15iiM BrdU (Sigma) in Grace's medium 
(Lilly and Spradling, 1996). After washing in EBR the ovaries were fixed for 20 
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minutes in FBBW Buffer (Lin and Spradling, 1993), followed by 1 hour denaturing 
in 2N HCl and 2 minute neutralisation in 100mM Sodium tetraborate. The tissue was 
rinsed several times in PBT and blocked for 1 hour in 5% NGS in PBX (0.5% Triton 
X-100 in lx PBS). After an 0/N incubation in 1:20 dilution of the anti-BrdU 
antibody (Becton-Dickinson) a detection was carried out with HRP-conjugated 
secondary antibody (1:25 dilution). Sigma FastTM  DAB peroxidase substrate was 
used in the peroxidase colour reaction. The latter was enhanced with 20p.l 1M Ni 
SO4 per 1 ml staining solution. 
2.6 Protein techniques 
2.6.1 Protein sample preparation 
2.6.1.1 Protein preparation from Drosophila tissues 
Protein samples from different developmental stages of Drosophila were 
prepared in the following way (Table 2.6.1). Tissues were dissected in Drosophila 
Ringer's and homogenised in the appropriate volume of Protein sample buffer (Table 
2.1.3 (B)). Samples were boiled for 5 minutes and cooled on ice. The cell debris and 
body particles were removed by centrifugation at 22,000 x g for 5 minutes and the 
cleared supernatant transferred to a clean eppendorf tube. The samples were stored at 
-80°C. 
Table 2.6.1 Protein probe preparation 
Developmental stage Protein sample buffer 
3 Ovaries 10p1 
30 Testes 1 00tl 
40 Embryos 60tI 
2 Third Instar larvae 1 5OtI 
2 Light pupae (LP) 1 5Od 
2 Dark pupae (DP) 150tI 
3 d flies (carcass) 11 OpI 
2 Y flies (carcass) 150.il 
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2.6.1.2 Protein preparation of cell extracts 
Proteins samples from bacterial cultures were prepared by centrifuging imi 
of 0/N culture (0D600= 2.0) at 14,000 x g for 1 minute. The pellet was resuspended 
in loop' of Protein sample buffer, vortexed and the suspension boiled for 5 minutes. 
The cell debris was removed by centrifugation at 22,000 x g for 5 minutes and the 
cleared supernatant transferred to a clean eppendorf tube. The samples were stored at 
-80°C. 
A solution of the recombinant protein was prepared by pelleting down 3ml of 
induced BL21DE3 Lys cells (0D600-1.6) containing the recombinant expression 
vector, pBMF33 (the expression vector was produced by Bryce McIver, personal 
communications). The pellet was resuspended in imi PBS, mixed with 20p' 
Lysozyme from a Stock and incubated on ice for 40 mm. The suspension was then 
sonicated for 2 minutes at maximum power and centrifuged to remove the cell 
debris. As a control in the western blots we used protein extract prepared from the 
sonication of induced BL21DE3 cells that contain only the cloning vector pRSET-C 
before the subcloning of myosin V tail sequence. 
2.6.1.3 Protein preparation from inclusion bodies 
Cells containing the recombinant construct were induced with 1mM TPTG for 
4 hours to express the recombinant protein. The bacterial culture (usually 500m1) was 
centrifuged at 10,000 x g for 15 minutes. The cell pellet was resuspended in 3m1 X 
buffer (Table 2.6.6) and stored at -20°C for up to two weeks. 
Next, the X buffer was removed by centrifugation at 10,000 x g for 10 
minutes and the cells resuspended in XI Buffer (3ml XI buffer per ig cells). 80j.il of 
Lysozyme stock was added to the cells and the solution incubated for 40 minutes at 
4°C. The cells were placed into an ice bucket and sonicated for 3 minutes at full 
power. The suspension was centrifuged at 10,000 x g for 15 minutes and the pellet 
washed in 5m1 X  Buffer. After a second centrifugation at 10,000 x g for 15 minutes 
the pellet was resuspended in X1U buffer (4.5m1 per ig cells) and incubated 0/N at 
4°C. on the following day the solution was centrifuged for 40 minutes at 10,000 x g. 
The supernatant containing the solubilised protein was collected and stored at -80°C. 
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2.6.2 Bradford assay 
The Bradford assay was used to determine the concentration of the 
recombinant protein. The methods is based on the proportional binding of the dye 
Coomassie to proteins. The assay is colorimetric; as the protein concentration 
increases, the colour of the tested sample becomes darker. The protein concentration 
of a test sample is determined by comparison to that of a series of protein standards 
known to show a linear absorbance profile in this assay. To build a standard curve 
two stock solutions of BSA (Bovine Serum Albumin) were prepared, 25mg/rnl and 
50mg/nil. They were diluted accordingly to obtained a set of working solutions with 
known protein concentration (Table 2.6.2A). 














0.1 4 	(25mg/mI stock) 996 0.115 0.123 0.119 
0.2 8 	(25mg/mI stock) 992 0.231 0.232 0.232 
0.4 16 (25mg/mI stock) 984 0.404 0.433 0.418 
0.6 24 (25mg/mI stock) 976 0.574 0.603 0.588 
0.8 32 (25mg/mI stock) 968 0.710 0.726 0.718 
1.0 40 (25mg/mI stock) 960 0.771 0.809 0.790 
1.2 24 (50mg/mI stock) 976 0.890 0.963 0.926 
1.4 28 (50mg/mI stock) 972 0.950 0.973 0.960 
Each sample was prepared by mixing 50il of protein standard with 2.5m1 of 
Bradford reagent. The samples were incubated for 10 minutes at room temperature. 
The absorbance was measured spectrophotometrically at 595nrn and a standard curve 
was built based on the obtained absorbance values. 
To determine the concentration of the recombinant protein 50i.tl of the protein 
solution was diluted in 350It1 1xPBS buffer (eight fold dilution) and 501..d of this 
solution was diluted again in 350p1 PBS (64x dilution). Three samples of each 
dilution were made by mixing 50il of the protein with 2.5m1 Bradford reagent. Two 
measurements were taken from each sample (in Table 2.6.2B are shown the averaged 
values). 
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8x 0.241 0.259 0.261 0.253 2.0 mg/ml 
64x 0.036 0.039 0.037 0.037 2.4 mg/ml 
The mean value obtained from the measurements of the two protein samples 
is 2.2mg/mi. Thus the amount of recombinant protein recovered from the two affinity 
purifications was estimated to be 4.4 mg based on spectrophotometrical analysis. 
Approximately half of this protein was used to generate antibody in sheep. 
Solution Components/Preparation 
Bradford 100mg Coomassie Brilliant Blue G-250 
Reagent 
50m1 Et-OH (95%) 
1 00m Phosphoric acid (85% wlv) 
Adjust the volume to 1 litre 
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2.6.3 SDS-Polyacrilamide gel electrophoresis (PAGE) 
The PAGE glass plates were set according to the manufacturer's instructions. 
Approximately 20m1 of Separation mix (Table 2.6. 1) was poured between the plates 
and overlaid with 2m1 H20 to even the surface. The gel was allowed to set for 20 
minutes at RT. Then the water was decanted and 5m1 of Stacking mix was poured on 
the top of the separation gel. After polymerisation the gel assembly was fixed to the 
electrophoresis tank and lx TGS buffer added. Protein samples were loaded and the 
gel run at 40V 0/N or at 150 V for 4 hours. 
Table 2.6.1 Solutions required for SOS-PAGE 
Solution Components/Preparation 
Separating mix 20m1 10% (for 21-1OOkDa proteins) 
7.9m1 ddH20 
5m1 1.5M Tris-HCI, pH-8.8 
200il 10% SIDS 
6.7m1 30% Protogel [30%Acrylamide/0.8%Bisacrylamide (37.5:1)] 
200pi 10% (w/v) (NH4)2S208 
20tI TEMED 
Stacking mix 3.44m1 ddH20 
630tI 1M Tris-HCI, pH 6.8 
50tI 10% sos 
830pi 30% Protogel [30%Acrylamide/0.8%Bisacrylamide (37.5:1)] 
SO.tI 10% (w/v) (N H4)25208 
lO.iI TEMED 
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2.6.4 Western Blot and immunodetection 
2.6.4.1 Semi-dry transfer 
Proteins were transferred from a polyacrylamide gel to HybondTM-C super 
nitrocellulose membrane (Amersharn Biosciences) by semi-dry transfer. The transfer 
assembly was set according to the manufacturer's instructions. The stacker from the 
ready protein gel was removed and the gel placed on the top of pre-cut to the same 
size membrane. The transfer was run at 400mA (approximately 15V) for 2 hours. 
Assembly sandwich 
Cathode (-) 
3x Whatman paper 	I 	 I 
Gel 
Membrane 
3x Whatman paper 	I 	 I 
Anode (+) 
2.6.4.2 Ponceau S staining 
To check the efficiency of the transfer the nitrocellulose membrane was 
stained with Ponceau S for 10 minutes. The excess stain was removed by briefly 
rinsing in H20. 
2.6.4.3 ECL immunodetection 
The membrane was incubated in 50m1 Blocking buffer 0/N at 4°C. 
Alternatively the incubation was carried out for 1 hour at RT with shaking (40rpm). 
The membrane was transferred to a nylon bag containing 16m1 lx TBS and the 
Primary antibody added at the appropriate dilution (Table 2.6.2.3 (A)). 
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Table 2.6.2.3 (A) List of primary antibodies 
Antigen Host Working concentration Source, 
animal Immuno Western Product number 
Histochemistry Detection  
Br-C (Zi, Z3, Mouse 1:50-100 n/a Hodgetts (1995) 
and Core)  
BrdU Mouse 1:20 n/a Becton Dickinson 
(mono*) 
No: 347580 
Calmodulin Mouse 1:25-50 n/a Sigma 
(mono*)Cy3 
0-7055 
Digoxigenin Sheep 1:1000 1:10000 Roche 
-AP 
No: 1 093 274 
Myosin VA**  Sheep 1:50 1:4000 Bownes lab 
(Drosophila)  
Myosin VS**  Sheep 1:10 1:2000 Bownes lab 
(Drosophila)  
Non-muscle Rabbit 1:100 1:4000 Kiehart and Fegali 
myosin II 
(Drosophila) (1986) No: 656 (RAM 
#V, pgOl5, 4/16/86 
Non-muscle Rabbit 1:20 n/a Biogenesis: 
myosin II 
(vertebrate)  No: 6490-1004 
* "mono" from monoclonal antibodies 
** "S" stays for non-purified serum; and "A" for affinity purified antibodies 
After 0/N incubation at 4°C the membrane was washed three times, 10 
minutes each, in TBST with shaking at 40rpm. Then the membrane was blocked for 
20 minutes at RT in 0.4% Normal serum from the animal species in which the 
secondary antibody has been generated. Subsequently the membrane was placed in a 
nylon bag containing 16m1 lx TBS with the appropriate concentration of Secondary 
Antibody (Table 2.6.2.3 B). 
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Table 2.6.2.3 (B) List of Secondary antibodies 
Antigen Host Labelling Working concentration Source, 
Immuno Western Product number 
Histochemistry Detection  
Mouse lgG Goat HRP 1:100 1:4000 Promega 
W4021 
Mouse lgG Goat TRITC 1:80 n/a Sigma 
T7782 
Rabbit lgG Goat HRP n/a 1:4000 Sigma 
A8275 
Rabbit lgG Goat FITC 1:100 n/a Sigma 
F9887 
Sheep lgG Donkey HRP n/a 1:4000 Sigma 
A3415 
Sheep lgG Donkey FITC 1:100 n/a Sigma 
F7634 
Sheep lgG Donkey Cy2 1:50 n/a Jackson Immuno 
Research 
No: 713-225-147 
After 1 hour incubation at RT the membrane was washed three times, 10 minutes 
each, in TBST with shaking at 40rpm. Then the membrane was immersed into 20m1 
ECL Reagent with 8i.il  30% H202 and incubated for 1 minute (Table 2.6.2.4). The 
membrane was then sealed in a polythene bag, placed in an autoradiography cassette 
with intensifying screens, and exposed to blue sensitive film (Kodak) for 1 to 10 
minutes at RT. 
2.6.4.4 Membrane Stripping 
The membrane was submerged in stripping buffer (Table 2.6.2.4) and 
incubated at 50°C or 70°C (for higher stringent conditions) for 30 minutes with 
agitation. 
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Table 2.6.2.4 Solutions required for ECL detection 
Solution Components/Preparation Final 
concentration 
Blocking Buffer 15g Casein 5% 
15m1 Ethanol 
Add 50m1 lx TBS. Mix well. 
Add additional 100m1 ix TBS and make sure 
that the casein is completely dissolved. 
Add 135 ml 1x TBS 
Stripping buffer 3.47m1 14.4M 3-Mercaptoethanol (Mw: 78.01) 100mM 
1 00m 10% sos 2% 
31 .25m1 1 M Tris-HCI, pH-6.7 62.5mM 
2.6.5 Immunohystochemical detection in whole mount ovaries 
Ovaries were dissected from yeasted for two days flies in Ringer's solution. 
The anterior parts of the ovaries were torn apart to facilitate antibody penetration. 
The ovaries were transferred to an eppendorf tube containing FBS and fixed for 20 
minutes at room temperature. The fixative was carefully removed and the ovaries 
washed twice in PBS. Endogenous peroxidases were destroyed by treating with 1% 
H202 for 5-10 mm (this step was required only when HRP-conjugated secondary 
antibody was used). The ovaries were washed again in PBS for 10 minutes and 
blocked in 5% NGS in PBX (0.5% Triton X-100 in lx PBS) for 1 hour at RT (The 
blocking agent should always be the normal serum from the animal species in which 
the secondary antibody was generated). Primary antibody was added at the 
appropriate dilution and the ovaries incubated ON at 4°C. Residual antibody was 
washed away with three changes of PBT with 1 hour incubation per change. The 
ovaries were blocked for 30 min in 5% NGS in PBX. Secondary Ab (antibody) was 
then added at the appropriate dilution and the ovaries incubated for 1 hour at RT. 
Excess secondary antibody was removed with three PBT washes at 30 minutes 
intervals. 
When a HRP-conjugated secondary antibody was used for detection, DAB 
staining solution was added and the ovaries allowed to stain for 10-30 minutes before 
washing with PBS to stop the reaction. The DAB colour reaction was enhanced with 
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the addition of 20i.tl 1M NiSO4 per 1 ml staining solution. Stained ovaries were 
mounted in PBS/Glycerol (1:4) and analysed on a Nomarski microscope. 
Fluorescently stained ovaries (fluorescent secondary antibody was used for 
detection) were analysed and photographed on a fluorescent microscope fitted with a 
digital camera. 
2.6.6 13-Galactosidase staining 
Ovaries were dissected in Drosophila Ringer's and stained at room 
temperature for 3 hours to 0/N in Galactosidase Staining buffer (Table 2.1.3) 
supplemented with 0.2% X-Gal. On the following day the ovaries were rinsed in PBS 
and mounted in PBS/Glycerol (1:4) for microscope analysis. 
2.6.7 F-actin staining 
Ovaries were dissected in Drosophila Ringer's and fixed in FBS for 20 
minutes. The tissue was permeabilised for 10min in PBX (0.5% Triton X-100 in 
IxPBS), and then stained for 30min in 6tM solution of Rhodamine-conjugated 
phalloidin at RT. The stained ovaries were washed twice for 10 min in PBS and 
mounted in FISH media for fluorescent microscopy. 
2.6.8 Purification of Histidine-tagged proteins on Ni-Agarose column 
2.6.8.1 Column preparation 
To purify the protein we used Ni-NTA-Agarose. This resin allows the 
purification of His-tagged fusion proteins. In general the recombinant protein is 
adsorbed on a column prefilled with Ni-NTA-Agarose. The column is then washed 
and the protein eluted under high salt conditions. 
2.5m1 (drained volume) of Ni-NTA-Agarose (Qiagen) was placed in lOml 
syringe, plugged with glass wool. The column was washed with 20ml Xl buffer and 
left in storage overlaid with 1 Oral X  buffer. 
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2.6.8.2 Affinity purification 
The Ni-NTA-Agarose column was washed once with lOml XI buffer and 
then equilibrated with lOml X1U buffer. The protein solution in X1U buffer was 
passed three times through the column. 1 5m1 of Wash buffer was passed through the 
column to remove the unbound proteins. The recombinant protein was eluted with 
lOml Elution buffer. Ten lml fractions were collected and analysed on a PAGE 
(polyacrylamide) gel. The protein was usually in fractions from 2 to 5. 
2.6.8.3 Protein dialysis 
The fractions containing the recombinant protein were combined 
(approximately 15m1 in total) and dialysed against 2L lx PBS, 0/N. The protein was 
concentrated by ultracentrifugation using UFV4BTK2 5, Ultrafree®-4 Centrifugal 
Filter unit from Millipore. 
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Table 2.6.6 List of solutions required for protein purification 
Buffer Components/Preparation Final 
concentration 
Imidazol, 1.36g Imidazol (Mw: 68.08) 1M 
pH-8.0 
Adjust pH to 8.0 with cHCI 
Adjust the volume to 20m1 
Lysozyme 50mg Lysozyme 50mg/mi 
1 m ddH2O 
X Buffer 5m1 1M Tris-HCI, pH-8.0 10mM 
0.5m1 1M Imidazol, pH-8.0 1mM 
50m1 5M NaCl 500mM 
0.5m1 Tween 20 0.1% 
50m1 Glycerol 10% 
Adjust the volume to 500m1 with ddH20 
Xl Buffer 5m1 1M Tris-HCI, pH-8.0 10mM 
1 m 1M Imidazol, pH-8.0 2mM 
50m1 5M NaCl 500mM 
0.5ml Tween 20 0.1% 
Adjust the volume to 500m1 with ddH20 
XIU Buffer 5m1 1M Tris-HCI, pH-8.0 10mM 
1 m 1M Imidazol, pH-8.0 2mM 
50m1 5M NaCl 500mM 
0.5m1 Tween 20 0.1% 
36g Urea (Mw: 60.06) 6M 
Adjust the volume to 500m1 with ddH20 
Wash Buffer 1 m 1M Tris-HCI, pH-8.0 10mM 
imI 1M Imidazol, pH-8.0 10mM 
lOmI 5M NaCl 500mM 
1 m 10% Tween 20 0.1% 
36g Urea (Mw: 60.06) 6M 
Adjust the volume to 1 OOml with ddH20 
Elution Buffer 1 m 1M Tris-HCI, pH-8.0 10mM 
1.36g Imidazol (adjust the pH to 8.0 with c. HCI) 200mM 
lOmI SM NaCl 500mM 
1 m 10% Tween 20 0.1% 
36g Urea (Mw: 60.06) 6M 
Adjust the volume to 1 00m1 with ddH20 
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2.6.9 Purification of antibodies 
2.6.9.1 Caprylic acid precipitation 
Caprylic acid, at the right concentration and at a particular pH, will 
precipitate most serum proteins, except IgG. To purify the IgG fraction, 50m1 of 
polyclonal antiserum was transferred to a suitable container with 2 volumes of 
60mM Sodium Acetate pH-4.0 (Table 2.6.7). The solution was set on a magnetic 
stirrer and 3.75m] caprylic acid slowly added. This was achieved by setting up a 
disposable syringe barrel, fitted with a 19-G needle, over the beaker and adding the 
caprylic acid to the syringe barrel. This was followed by a 30 minute incubation on 
the magnetic stirrer. The precipitate was removed by centrifugation at 2000 x g for 
20 minutes at RT. The supernatant was filtered through grade 4 paper to remove the 
fines and dialysed against lx PBS. Subsequently the irnmunoglobulins were 
concentrated by ultracentri fugation using UFV4BTK2 5, Ultrafree®-4 Centrifugal 
Filter unit from Millipore. 
2.6.9.2 Affinity purification of antibodies 
Antibodies against HIS-tagged proteins were purified by binding to 
recombinant protein already attached to Ni-NTA-Agarose (Qiagen) and then eluting 
them with low or high pH buffer. 
Ni-NTA-Agarose column was prepared and recombinant protein attached to 
the agarose as described in section 2.6.6. The column was then washed with 20m1 
PBS. 5m1 of the caprylic acid purified antibody was diluted with lOml PBS and 
passed three times through the column. This was followed by a column wash: once 
with lOml PBS and once with lOml High salt buffer. The antibodies were eluted with 
lOml Glycine, pH-2.5. Ten lml fractions were collected in eppendorf tubes each 
containing 100tl 1M Tris-HC1, pH-8.0. The column was washed with lOml 50mM 
Tris-HC1, pH-8.8. A high pH elution was carried out with lOml Triethylamine, pH-
11.5. Ten lml fractions were collected in eppendorf tubes each containing lOOpi 1M 
Tris-HC1, pH-7.4. Next, the column was washed twice: once with lOml 50mM Tris-
HC1, pH-8.8, and once with lOmi PBS. The column was stored in 20% EtOH in PBS 
at 4°C. 
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The collected fractions were analysed by PAGE. The fractions containing the 
purified antibodies were combined and dialysed against 2 litres of PBS, 0/N. The 
antibodies were concentrated by ultracentrifugation  using UFV4BTK25, Ultrafree®-4 
Centrifugal Filter (Millipore). 
Table 2.6.7 List of solutions required for antibody purification 
Buffer Components/Preparation Final 
concentration 
Na Acetate, 4.08g CH3000Na. 3H20 (Mw: 136.08) 60mM 
pH-4.0 
Adjust the pH to 4 with Glacial Acetic acid 
Adjust the volume to 500m1 with ddH20 
High salt buffer 2m1 1M Tris-HCI, pH-7.5 20mM 
lOmI 5M NaCl 500mM 
Adjust the volume to lUOmI with ddH20 
Glycine, 3.75g Glycine (Mw: 75.07) 100mM 
pH-2.5 
Adjust pH to 2.5 with cHCI 
Adjust the volume to 500m1 with ddH20 
Triethylamine, 0.506g Triethylamine (Mw: 101.19) 50mM 
pH-1 1.5 
Adjust pH to 11.5 with cHCI 
Adjust the volume to lOOmI with ddH20 
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Chapter Three: Molecular characterisation of 
Drosophila Myosin V 
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3.1 Introduction 
3.1.1 Myosin motors 
Myosins constitute a superfamily of motor proteins that convert energy from 
ATP hydrolysis into mechanical movement along actin filaments (Hasson and 
Mooseker 1995; Mooseker and Cheney 1995). Phylogenetic analysis currently places 
myosins into 18 classes based on class specific features of their conserved motor 
domain (for detailed discussion on the myosin superfamily see Chapter Six) (Sellers 
2000; Berg et al. 2001). Traditionally the myosins have been divided into two classes 
depending on whether they form monomers or dimers (Fig. 3.1.1). The conventional 
myosin of muscle and non-muscle cells form class II myosins. They are complex 
molecules of four light chains bound to two heavy chains, that form bipolar filaments 
via interactions between their coiled-coil tails (type II). Class I myosins are smaller 
monomeric myosins referred to as unconventional myosins. 
Figure 3.1.1 Model for the structure of myosin molecules 
Each myosin molecule is composed of three main domains: a motor head 
domain, a regulatory neck domain and a tail domain. The head domain is highly 
conserved among all myosins. The neck domain may consist of a variable number of IQ 
motifs that bind light chains. The tail is the most divergent part in each myosin. The 
presence of coiled-coil motifs in the tail determines whether the molecule will be a 
dimer or not. 
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Now there are at least 16 other classes of unconventional myosins (Berg et al. 
2001). Recent studies have shown that myosins are involved in a variety of cellular 
functions such as membrane trafficking, cell movements, maintenance of the cell 
architecture and signal transduction (Wu et al. 2000; Mermall et al. 1998; Berg et al. 
2001). 
All known myosins comprise an N-terminal head domain, a neck regulatory 
domain and a class specific tail domain (Fig.3.1.1) (Mooseker and Cheney 1995; 
Berg et al. 2001). The motor head domain (approximately 80kDa) is highly 
conserved among the myosins of the same class and amongst various classes of 
myosins. It contains ATP and actin binding sites and is responsible for the 
mechanochernical properties of the protein (Gilbert and Mackey 2000). Myosins 
show an actin stimulated Mg2tATPase  activity, thus converting the energy stored in 
ATP into mechanical force (Volkmann and Hanein 2000). The latter is used to move 
the myosin molecules along actin filaments or to translocate other molecules (Hasson 
and Mooseker 1995; Langford 1995). 
The neck domain contains regulatory sites composed of IQ 
(isoleucine/glutamine) motifs, repeats of 23-30 amino acids. The consensus sequence 
of the IQ motifs is IQxxxRGxxxRK (Mercer et al. 1991). Each IQ motif provides a 
binding site for a calmodulin, a small 17 kDa subunit or related proteins of the EF-
hand family (Kawasaki et al. 1998; Khan and Komiyama 2001). EF proteins have 
helix-loop-helix motifs in which the loop contains highly conserved residues that 
bind Ca 2+  ions (Maki et al. 1997; Ikura 1996; Niki et al. 1996). The size of the neck 
domain varies from one to seven IQ repeats. Additionally the neck is often the site of 
alternative splicing. This produces necks with variable lengths (different number of 
IQ motifs), which are associated with its regulatory function. In general, calmodulin 
activates a diverse group of target cellular proteins when bound to Ca 2+  including the 
myosins. Since each calmodulin molecule binds four Ca 2+  ions and binding each 
Ca2 	facilitates binding of additional Ca 2+  a small change in the concentration of Ca 2+  
leads to a large change in the level of active calmodulin. This in turn leads to a rapid 
change in the myosin activity. Interestingly most of the unconventional myosins 
contain IQ motifs that bind calmodulin with the highest affinity in the absence of 
Ca2 . The regulation may proceed either as a direct consequence of 
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association/dissociation of the calmodulin molecules from the myosin heavy chain or 
because of Ca2tinduced  allosteric effects in the calmodulin light chains (Wolenski 
1995). 
Following the neck domain, each myosin has some form of a class-specific 
tail domain. The tail domain is the most divergent part of the myosin molecule. It 
consists of coiled-coil ct-Helix which promotes the formation of dimers and bipolar 
filaments (except the Myosin I monomer, which does not have a-helical repeats, but 
has a highly basic domain shown to bind to phospholipid membranes (Mooseker and 
Cheney 1995; Hayden et al. 1990). The function of the C terminal domain is 
associated with targeting of specific molecules to specific subcellular localisation 
(Mermall et al. 1998; Oliver et al. 1999). 
3.12 Class V myosins 
	
3.1.2.1 	Domain structure of myosin V 
The myosins from class V are two headed and do not appear to form bipolar 
filaments (Fig.3.1.2.1). The head, located at the N-terminus, contains the ATP 
hydrolysis site and the actin binding site. The neck domain consists of six IQ 
domains (12 in a dimer molecule) binding eight molecules of calmodulin and four 
light chain molecules of dynein or tissue specific myosin light chains (Espindola et 
al. 2000). The myosin V tail is composed of a coiled-coil domain, which allows 
dimer formation with a second myosin molecule, and a unique globular domain 
(Mooseker and Cheney 1995; Larson 1996). The sequence in the medial and distal 
parts of the tail domain are highly conserved among vertebrate myosins but show 
little similarity to myosins V tails from more phylogenetically diverse species (Fig. 
3.1.2.1). The function of the globular domain is associated with directing myosin V 
to its targets and/or determining the cargo molecule to which it binds. 
3.1.2.2 	Distribution of myosin V 
Class V myosins are one of the most well characterised groups of the 
unconventional myosins (Mooseker and Cheney 1995; Larson 1996; Titus 1997). 
Members have been cloned from the slime mould D. discoideum (MyoJ), yeast 
77 
Drosophila myosin V gene 
(Myo2 and Myo4), C. elegans (hum-2), frog (myoV), chicken (p190), mouse (dilute), 
rat (myr6) and human (Myoxin). Several plant myosins were also identified as class 
V myosins. These currently are placed in a separate class since their globular tails 
showed a number of differences when compared to other class V myosins. The 
vertebrates have three distinct myosin V genes, Va, Vb and Vc. Currently from the 
invertebrates only C. elegans is known to have two myosin V genes. Interestingly 
plants expresses a multiple of myosin V genes. So far have been identified 13 myosin 








Figure 3.1.2.1 Structural 3D model of Myosin V 
The myosin motor head domain associates with actin 
filaments. The neck binds eight molecules of calmodulin and 
four subunits of essential light chains. The globular tail 
domain is attached to its cargo. 
3.1.2.3 Regulation of the motor activity of myosin V 
Three main factors are necessary for the activation of the myosin molecule. 
As in all myosins the Mg-ATPase activity is induced by the addition of actin 
filaments. Ca2 ions are also required for the Mg-ATPase activity and the activity is 
further stimulated by the presence of calmodulin (Wang et al. 2000) 
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At low Ca2 levels the Mg-ATPase activity is also low. It was found that at 
high Ca 2+  levels inhibition of the motility occurs too. Recent studies have shown that 
this is due to conform 	 2+ confor ational changes of the calmodulin upon Ca binding to the 
high affinity site, but not due to dissociation of calmodulin from the myosin heavy 
chain (Homma et al. 2000). Interestingly when Ca 2+  is added to motility assays in 
vitro, the movement of the myosin molecules is inhibited (Cheney et al. 1993b; 
Wolenski et al. 1995) 
3.1.2.4 	Myosin V stepping kinetics 
Myosin V moves processively along actin filaments. Kinetic studies with 
truncated molecules have greatly contributed to our understanding of the mechanism 
underlying ATP turnover and movement (De La Cruz et al. 2000). To understand the 
processive mechanism of myosin V Rief et al. (2000) has studied a full-length dimer 
molecule. He proposed a hand-over-hand stepping model where one hand is making 
a stroke while the other is reaching out for the next site, without loosing contact with 
the underlying actin network. Because of the long neck domains the heads of the two 
heavy chains in a dimer are spread apart from each other, thus allowing the molecule 
to reach adjacent actin filament. It is believed that this can facilitate cargo transport 
within a loose actin network. 
3.1.3 Myosin V distribution and function 
The function of any myosin is determined to a great extent by the 
composition of its tail domain. While the proximal coiled-coil domain has been 
implicated in the dimerisation of the myosin molecule the medial and distal globular 
domains are thought to determine the exact roles and subcellular locations of the 
myosin molecule. At present evidence suggests a role for myosin V in organelle and 
particle transport and RNA localisation (Evans et al. 1997; Mermall et al. 1998). 
3.1.3.1 	Myosin V genes In plants 
Plant cells exhibit an active intracellular motility, based to a great extent upon 
actin-based processes, such as cytoplasmic streaming and directed vesicular transport 
(Kinkerna et al. 1994). The motor proteins responsible for the actin-based transport 
are myosins. Plants express at least eight distinct classes of myosin genes. The first 
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member of the class V myosin was isolated from Arabidobsis thaliana (Kinkema and 
Schiefelbein 1994; Reddy and Day 2001). It is a 173 kDa protein structurally similar 
to class V myosins from animal species. Subsequently a myosin V was cloned from 
Zea mays (Liu et al. 2001), Helianthus annuus and Chara corallina (Kashiyama et 
al. 2000). Currently all class V myosins from plants are placed in a separate class, 
XI. 
3.1.3.2 Myosin V genes in social amoebae 
Cellular slime moulds are simple eukaiyotic organisms. However they 
express multiple myosin genes (Soldati et al. 1999). A single myosin V gene, named 
MyoJ was isolated from Dictyosteliuin cells (Hammer and Jung 1996). It encodes a 
big 258 kDa protein which shows the typical domain structure for myosin V. MyoJ 
differs slightly from other myosin Vs since the head domain contains a 30 amino 
acid insert in the proximity of the nucleotide binding pocket. In addition the globular 
tail shows no similarity to tails from vertebrate myosin Vs. Phylogenetic analysis of 
the head domain has shown that MyoJ is more closely related to plant myosin Vs and 
currently is placed into class, XI. 
3.1.3.3 	Myosin V genes in yeast 
Cells in S. cerevisiae divide by budding. The daughter cells differ only in that 
the mother cells express the HO endonuclease and thus switch mating types. Two 
Myosin V are present in the budding yeast, Saccharomyces cerevisiae. Myo2p is an 
essential myosin of fundamental importance for polarised growth. Cells lacking this 
myosin fail to deposit the chitin ring which is required for bud formation (Johnston et 
al. 1991; Brockerhoff et al. 1994). The cells remain as large unbudded cells showing 
accumulation of numerous vesicles. Temperature sensitive mutants are able to 
complete the cell division when shifted to restrictive temperatures after chitin ring 
formation, suggesting no role for this gene in nuclear migration and cytokinesis. 
Interestingly the Myo2p IQ motifs bind not only calmodulin but a novel protein 
termed Mlclp from the EF-hand family (Stevens and Davis 1998). Thus IQ-
associated chains are believed to regulate the motor activity. 
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MY04 is a second class V myosin gene in yeast. Evolutionarily it is most 
close to MY02 (Haarer et al. 1994). It encodes a 170kDa protein with a short 
potential coiled-coil domain. Myo4p is necessary for restricted localisation of Ash 
mRNA in the daughter cell. As a result ASHIp, a repressor of mating type switching 
(repressor of HO), is selectively expressed in the daughter cells (Jansen et al. 1996). 
Deletions in MY04 yield no phenotype indicating that the function of the gene is not 
essential in yeast (Haarer et al. 1994; Merrnall et al. 1998). However overexpression 
of either gene MY04 or MY02 results in a severe decrease in growth rate, as well as 
aberrant phenotypes such as formation of short strings of unseparated cells in diploid 
strains or clusters of cells in haploid strains. 
	
3.1.3.4 	Myosin Vin nematodes 
A single myosin V gene was isolated from the round worm Caenorhabditis 
elegans (Baker and Titus 1997). The gene hum-2 codes for approximately 226 kDa 
protein. HUM-2 is closely related to vertebrate myosin V proteins. It has the typical 
head, six IQ domains and a tail with 3 coiled-coil motifs. The final part of the tail 
shows high homology to the tail domain of class V unconventional myosins. Since 
this is the domain responsible for the neurological function of the protein it is 
suggested that mutants with uncoordinated movements or a lethal phenotype are 
candidates for HUM-2 function (Baker and Titus 1997; Mooseker and Cheney 1995). 
3.1.3.5 	Myosin V in echinoderms 
Sea urchin has a single myosin V gene (Sirotkin et al. 2000). It encodes a 210 
kDa protein that shares a significant degree of sequence identity with studied myosin 
V proteins. Protein comparison of the tail domain with sequences from vertebrate 
myosin V showed 72% homology, which suggest that these domains may have 
similar function. 
3.1.3.6 	Myosin V in cephalopods 
The first myosin V from cephalopods was cloned from the squid, Loligo 
pealei (Molyneaux and Langford 1997; Molyneaux et al. 2000). The protein isolated 
from a brain fraction is approximately 196 kDa (Cohen 2001) and is abundantly 
expressed in the squid giant axon. P196 has been implicated in the transport of 
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axoplasmic organelles along the actin filament in the axon. Molyneaux et al. (2000) 
has demonstrated that antibodies to myosin V inhibit this transport. Further research 
showed that purified p196 is a calmodulin (CaM) binding protein that possesses 
calcium-stimulated actin-activated ATPase activity. 
3.1.3.7 Myosin V genes in amphibians 
The proper function of the mechanoelectrical transduction mechanism in the 
hair cells of the auditory and vestibular systems in frogs appears to be dependent on 
the tension of the mechanosensitive transduction channels. Evidence suggests that 
members of the myosin family can control this tension. In a screen for myosin 
candidates for this function the frog homologue of myosin V gene was isolated (Soic 
et al. 1994). 
It has been known that melanosome movements in amphibians and fish are 
dependant on microtubules and their associated motors. Rodionov et al. (1998) 
demonstrated that both actin and microtubule systems are involved in transport from 
the perinuclear region to a uniform distribution in the cytoplasm. In addition Rogers 
et al. (1999) has shown that the association of myosin V with melanosomes is cell 
cycle dependent. They found that metaphase extracts of myosin V are highly 
phosphorylated compared to interphase extracts. Thus the organelle transport by 
myosin V is controled by phosphorylation during mitosis. 
3.1.3.8 	Myosin V genes in birds 
Low levels of myosin V are expressed in most vertebrate tissues, but it is 
most abundant in nervous tissue and neurosecretory cells (Espindola et al. 1992). 
Myosin V was identified in chicken as a 190 kDa protein (p190) (Espreafico et al. 
1992). Immunodetection of  190 in brain showed that the protein is most abundant in 
the cell bodies and dendrites of Purkinje cells. In tissue cultures of neurons and glia, 
myosin V shows a characteristic distribution in the region of the Golgi complex and 
in the tips of the neuronal growth cones (Espreafico et al. 1992). Purification of 
chicken Myosin V allowed electron microscopic visualisation of the two headed 
dimer it forms. It was also found that chick myosin V, when bound to actin, exhibits 
a magnesium-ATPase activity (Cheney et al. 1993b). 
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This myosin was demonstrated to have the unusual property of binding 
calmodulin in the absence of calcium (Cheney etal. 1993a; Nascimento et al. 1997). 
Analysis of purified chick brain myosin V revealed that four of the IQ domains bind 
calmodulin. Two new proteins, subunits of 17 and 23 kDa, have been found to 
associate with the remaining IQ motifs. The 17 and 23 kDa proteins are encoded by 
Li 7 and L23 genes and are members of the essential light chain family. In myosin II 
they bind to the first of the two IQ domains. An additional 10 kDa protein subunit 
was found to co-immunoprecipitate with the globular tail domain. This was first 
characterised as DLC8, one of the axonemal and cytoplasmic dynein light chains. 
Subsequently it was found that DLC is a potential inhibitor of the neuronal form of 
NO synthase (PIN). It was demonstrated by Crepieux et al. (1997), that DLC8/PIN 
interacts with I KBcY transcriptional regulator as well as with Bim, a member of the 
Bcl-2 family of membrane proteins. These additional proteins are believed to play 
critical role in the structure and function of myosin V (Espindola et al. 2000). 
The role of Myosin V in growth cone dynamics was examined by a laser 
inactivation technique (Wang et al. 1996). Laser inactivation of Myosin V inhibited 
the ability of myosin-V to translocate actin filaments resulting in rapid filopodial 
retraction, suggesting a specific role of this myosin in filopodial extension. 
3.1.3.9 Myosin V genes in mammals 
The mouse dilute gene was the first member of the family to be cloned 
(Mercer et al. 1991; Espreafico et al. 1998). In normal cells the melanocytes 
synthesise pigment packed in melanosomes. Then they deliver the melanosomes by 
means of dendritic processes to the keratinocytes. Mutations in dilute lead to 
defective pigment granule (melanosomes) transfer which results in lightening of the 
coat colour from black to grey. Recent studies revealed that melanin is produced at 
normal levels but accumulates in the perinuclear region of melanocytes. Null 
mutations of dilute cause severe neurological disorders (Provance et al. 1996; Wu et 
al. 1997). After birth these mice exhibit ataxia, abnormal behaviour, disrupted 
balance and convulsions which lead to early postnatal death. 
A second dilute-like myosin, myr 6 has been isolated and characterised from 
rat (Zhao et al. 1996). A homologue of myr 6 has been found in mouse (McIver and 
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Bownes, unpublished). Since the sequence of myr 6 is very similar to that of dilute it 
is believed that the two genes will have overlapping functions. Consistent with this 
model is the presence of DIL (AF-6/canoe) domain in the tails of both genes. AF-6 
and canoe are PDZ/DHR (Disc-large homology region/PSD95, Disc-large, ZO-l) 
domain proteins participating in cellular junction formation, receptors or channel 
clustering and signal transduction. 
Myoxin (MYHI2), the human homologue of the mouse dilute gene was 
identified by Engle and Kennett (1994) and Moore et al. (1995). The gene was 
mapped to chromosome 15. Recent studies have shown that in human, as in mouse, 
there are a number of tissue specific alternative-splice forms of the myosin V gene. 
All transcripts (different combinations of A-B-C-D-E-F exons) are present in skin 
cells, particularly in the melanocytes, while brain transcripts lack exon F. This 
produces a myosin V with a truncated C-terminal tail. Since this is the region where 
the synaptic vesicles bind to myosin V (by means of the membrane proteins 
synaptobrevin and synaptophysin) it was suggested that the binding to different 
targets is regulated by producing different splice variants (Prekeris and Terrian 
1997). Humans with Griscelli syndrome have pigmentary dilution, in which the 
melanosomes are not present in the melanocytes dendrites, but are clustered in the 
perinuclear region. Linkage analysis has placed Griscelli syndrome in the proximity 
of myosin V. Two thirds of the patients with Griscelli syndrome are found to have 
mutations in the gene for myosin V. 
3.2 Drosophila Myosin V 
A number of enhancer trap lines containing P[lacZ;rosy] insertions have been 
screened in our laboratory. Several lines with staining patterns of interest in the 
ovaries were selected for further study. One of these lines demonstrated a temporal 
and spatial expression pattern in a subset of follicle cells. The target gene was cloned 
but its expression pattern was unrelated to the original reporter gene expression 
pattern (Maclver et al. 1998). However the revealed pattern was highly interesting. In 
situ hybridisation with the rescued flanking DNA showed that the transcripts were 
localised to the anterior region of the oocyte from very early in oogenesis (stages 3 to 
7). Later stages (9-11) showed strong expression in the nurse cells, and a strong 
Drosophila myosin V gene 
anterior band in the oocyte. The pattern in the oocyte is similar to that seen for the 
orb and oskar mRNAs suggesting a function in oogenesis and/or embryogenesis. The 
correct transcript localisation was found to require genes involved in oocyte 
determination, anterior and posterior patterning, as well as neurogenic genes 
involved in oocyte-follicle cells signalling. Molecular analysis showed that the newly 
cloned gene, named didum, encodes a class V unconventional myosin (Maclver et al. 
1998; McCormack et al. 1998). 
A developmental profile of diduni by Northern blotting showed strong 
expression in adult ovaries and testes with transcripts of 5.5kb and 6kb respectively. 
Low levels of expression were detected throughout the development in non-gonadal 
tissues (McCormack, personal communications).. 
The gene was mapped to position 43Cc on the right arm of the second 
chromosome. All known genes corresponding to position 43Cc (position of 
saturation mutagenesis, are essential genes and lead to an embryonic lethal 
phenotype (Heitzler et al. 1993). 
didu,n encodes a 1792-residue, 207kDa heavy chain polypeptide; an actin-
binding head domain of 771-residue, a neck region with six IQ motifs (139-residue), 
and a tail domain of 882-residue with coiled-coil motif required for dirnerisation 
(Maclver et al. 1998; Bonafe and Sellers 1998). A unique substitution for Drosophila 
Myosin V is the replacement of the third IQ motif with LS (leucine, serine) (Maclver 
et al. 1998). The domain structure of Drosophila myosin V will be discussed in detail 
in chapter five. 
A region from the C-terminal tail of the gene was expressed in Escherichia 
coli and the recombinant protein was used to raise antibodies in rabbits (Maclver et 
al. 1998). Immunolocalisation with the unpurified antibodies showed no specific 
staining, but diffuse overall cytoplasmic staining. This together with the fact that 
extensive washing with detergent removes most of the staining, suggests the 
antibodies bind unspecifically. 
From the loss of transcript localisation in ovaries treated with colchicine it 
could be concluded that an intact microtubule cytoskeleton is required for 
localisation of myosin V mRNA (McCormack, personal communication). 
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3.3 	Determining the chromosome position of didum 
The Drosophila myosin V gene was previously mapped to position 43Cc on 
the right arm of the second chromosome (Bonafe and Sellers 1998; Maclver et al. 
1998). It was named didum for dilute-like Drosophila unconventional myosin. With 
the release of the Drosophila Genome Sequence we were able to precisely map the 
gene to position 43D1. didum is positioned immediately downstream (genetically) of 
dpa (disc prolifration abnormal) with a known chromosome position, 43D1. We 
verified its exact location by genomic PCR (the template is genomic DNA) using 
specific for the dpa forward primers (DPi and DP2) and a reverse primer for didum, 
RACE3 (for primer sequences and information see Fig. 3.3B). As a control a primer 
from the 5 end of didum (5'UTR) combined with the same RACE3 primer 
(Fig.3.3A) was used. 
Primers: 	DPI DP2 5UTR RACE3 
dpa 




DPI+RACE3 (1.43 kb) 
DP2+RACE3 (1.28 kb) 
5UTR+RACE3 (0.68 kb) 
Figure 3.3A Genomic PCR for verifying the position of didum 
Three different primer combinations were use to verify the genomic position 
of didum. The primers used in the PCR are depicted by arrows. The products 
amplified by the PCR were with the expected sizes thus confirming our predictions. 
The PCR was carried out as follows: 94°C-1.5 mm, then 25 cycles at 94 °C -30 sec., 
55 °C - 30 sec. and 70 °C - 4 mm. and a final extension for 4 mm. at 70 °C. The PCR 
amplified single products with the expected size of 1.43 kb (for the DPI+ RACE3), 
1.28 kb (DP2+RACE3) and 0.68 kb for the control (5'UTR+RACE3). The obtained 
products were excised from gel, purified and sequenced. The sequencing results 
confirmed the position of didum in relation to dpa. 
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Figure 3.313 Primers used in the analysis of didum (Myosin V): 
Primer 
name 




DPI GTC TCC ACA TCT TGC GAC G 19 60 
DP2 GGC TTG ACA TTT CCT TAG AGA 21 60 
5UTR AAC CTA ACG GGA TTT ATG CAC 21 60 
BSMI CCG GCT TCT TGA AGA TAT G 19 56 
STM1 GGC GTA CAC AAA ACT GGA G 19 58 
STM2 AAT ATG TGA TAG TTG CGG TCT C 22 62 
RACE3 GCC TTT AGC TTG ACC TCT TTC 21 62 
did8 ACA ACA GTT CCC GCT TTG 18 54 
did5 CCA TTC AAC AGA TCG CTG 18 54 
SH-1R CGA GGG AGT TGG CGG TGA 18 60 
SH-2R GGC GAA ATT AGT AGG TCG TG 20 60 
did9 ACC AGC ATG TCT TCA AGC 18 54 
didlO TCC AAG AAT CCC TTC ACG 18 54 
did4 TTC CGC TAA ATC CTC CAC 18 54 
did3 AGT TTG GAG CGG TAA ACC 18 54 
1806 GGC CAC GTC GAT TGG AGC 18 60 
926Y GCG GAT TAT CAT GCC AGT C 19 58 
MR3 GGC TTG CAT AGT CTA ACG AC 20 60 
3UTR5 TTT AAA CGT CGC GTG CCT 18 54 
3UTR3 TAP. TAT ATA ATA TTT GTA TGT 21 46 
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Using the Drosophila Genome sequence we were able to locate myosin V 
gene (didum) on the (+) strand of DNA. The position of didum in relation to the 
nearby genes is shown on Fig. 3.3C. 
+ strand 	 CG2146 (didum) 
-strand CG1621 CG162O CG1616 	 CG12736 CG1605 
Figure 3.3G. Genomic position of didum 
The diagram shows the relative position of diduni in the region 43CD on the 
right arm of chromosome 2. CG1621 is a transcription factor, CG1620 is a replication 
factor, CG1616 (DPA) regulates initiation of DNA synthesis, CG12736 is a 
translation factor, and CG 1605, also known as az2, is a zing finger transcription 
factor (McCormack et al. 1998). 
3.4 	Molecular structure of didum 
Most of the myosin V sequence including the ORF (open reading frame) has 
been cloned and published (Maclver et al. 1998) and (Bonafe and Sellers 1998). 
Previous attempts to sequence the very 5' end of didum were not successful. From a 
sequence analysis of the products generated by PCR for verifying the position of 
didum we were able to determine the potential start site of the gene. We used the 
Neural Network Promoter Prediction Program, available at the page of the Berkeley 
Drosophila Genorne Project, (http://www.frujtfly.org/seq_tools/prornoter.html) to 
find the possible promoter sites. Setting the default parameters produced several high 
score results which were inconclusive because the predicted promoter sites were 
obviously from the ORF (open reading frame) sequence. When the score cut off limit 
was lowered we obtained a number of low value scores in the expected region (the 
lower the score cutoff, the more potential promoters will be shown). To verify their 
accuracy we analysed the promoters of several Drosophila genes (with known 
promoters) and compared them to the predicted didum promoter sequence (Fig. 
3.4A). 
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Gene 	 Score Promoter sequence Transcription start 
Din EF-la Fl 0.89 AAAAAATGTATAAATAAATGAAACGTATTACATAAATTTAAACGATCTCA 
Dm EF-la' F2 0.44 TTTAAGAGAATATAAAATATTCCATGAPTGGTAGTAAAATTGTATTACTA 
Dm[42A]actin cp 1.00 TAAAATTTTAAAAAAAGTCCGCTCTCCGTCTTCCCGTTTCCAACTT 
Dm[5C]actin El+ 1.00 AAGCGGGCTTTATAAACGGGCTGCGGGACCGTTTTCATATCNNNNNNN 
Dm[5C]actin E2 0.77 CGWCATGACCATATATGGTCACAAAACTTGGCCGCCGCAATTCAACAC 
Dm[87E] actin (musci) 0.99 CAGATGGTATAAATATTAGCGCATCTCGGTCCAGCGACCPCTCGCAGTT 
Din tropomyosin I 0.50 AGAP.GCGCATAAATTTCACGAGPATGCAGCCCA.AP.GAGAGAGCATCG 
Din paramyosin P1 0.67 CTCAGGGTATATCCCACTCGGATCCGATCGGCGGGGAGCCGATGGCGCCC 
Dm paramyosin P2 0.67 CTCAGGGTATATCCCACTCGGATCCGATCGGCGGGGAGCCGP.TGGCGCCC 
Din Ininiparamyosin 0.92 GTGCGACAATATAACGCCGACGAGATCGTCCGATTGTCGCACCTGCGCCG 
Din chorion p.s38 0.86 TCCGGAGCTATTTAAAGTAGTCGGCCACCAATGGAGGGCAGCAGAAGAC 
Din chaoptin 0.91 CCATATTCTATACWGGCCAGCATGACCPGCATTTGGCCTTCCTCCAG 
Din calmodulin 0.97 AATAAAACCGTATATATGGCGACGCAGCGCTATTTTGAACACWGTTTT 
Dm[Krueppel] 0.82 NGTAGACTTTTATAAGACAATTTTTGTGAATCTCTCTACCTCWGT 
Dm[Krueppel2] 0.27 ACCTCAAAGTACP.AAAGTGTGTACAAAAATTATTCATATCCCTGAAAGTG 
Dm[engrailed] 0.73 ATT.TTGCTGCCTAACAAGCCCCCCTCGCCWTTGGCAAGAGPGAGTGAG 
Dm[ninaE] opsin/Rhl 0.99 CATTGCGA\AACTATAAP.AGCCACGCGGCAGAATGCAGACATTGCAGGTT 
Din Myosin V 	(I) 0.18 TGCCAACAACAAAACATAAQTCAGTCAGTCAGGCGGTGACAGGGACGGAA 
Din Myosin V (II) 0.48 AAATTATCAATGTTTTTATAAATTATTCCTGGCTAATTTTAAGTAATTTA 
Din Myosin V 	(III) 0.81 CATTTACATAACCC1PAAAAGACCACGAAAATGGTAATTTWTGGC 
Din Myosin V (IV) 0.47 ACCACGAAAATGGTAATTTAAATAGGCTGTCAGAGCCAGAAAAAAAACGT 
Figure 3.4A Alignment and comparison of selected Drosophila promoters 
A number of genes were selected from the Drosophila promoter database 
(http://www.fruitfly.org/seqtools/datasets/Drosophilalpromoterl) and compared. The 
program is based on an algorithm recognising functional sites in the primary DNA that 
are involved in the polymerase binding, such as GC box, TATA box, CAAT box and 
transcription start. The data was used to clarify the possible promoter start sites of 
didum. The TATA binding sites are shaded in blue, the transcription starts sites are 
coloured in red. 
Four potential promoters were found with scores of 0. 18, 0.48, 0.8 1, and 0.47 
respectively (Fig. 3.413). The Ps (promoter score) 0.18 and Ps 0.43 are the best 
candidates because they show comparatively high similarity to the conserved 
promoter sequence, and coincide with the experimental data from the isolated eDNA 
clones (for more details see next subchapter). 
Figure 3.413 cDNA (mRNA) sequence for didum 
Translated sequence is shown in black. Untranslated sequences (51JTR and 3'UTR) 
are coloured in red. The promoter sequences are given in blue and the cut off scores are 
shown above the promoter sites. The transcription start sites (there are two transcriptions 
sites) are underlined and coloured in blue. The polyadenylation signals (AATAAA) and the 
subsequent cleavage sites (AAGA) are coloured in purple. The PCR primers used in the 
analysis of the gene are shown with arrows. 	 10 
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Figure 3.4B cDNA (mRNA) sequence for didum 
Ps 0.18 
1 CTTTC•GCAJIC CCT GCCCTTT TGCCA Ci C AAAACATAAG TCAGTCIGTC AC;GCGGTG1C 
Ml and M3 S cDNA start 
ExI 61 AGcjE;J\CGGJ\A GTTTGTTTGT TTTTCTCACA CTTTGGCGTT GCGATCTAA AATTATCAAT 
Ps 0.48 	 Ps 0.81 
121 GTTTTTATAA ATTATTCCTG GCTAPITTTA AGTAATTTAG GACAGTACAT TTACATAAAC 
Ps 0.43 
181 CCAAAAAAAG ACCACGAAAP TGGTAATTTA AATAGGCTGT CAGAGCCAGA AAPAAAACGT 
241 ACCACCAAGG AAATTAAACC TAACGGGATT TATGCACCCA ACTCACTCCC ACGCGGAGTA 
5UTR 	M2 cDNA start 
301 GGAAGAAGGA c;;\GG:6GA(rI66A ACAAGGAC1CG CGJ\AC4CGGAA CCTGGAGTAG GAGGAGGACC 
Start Codon 
36L CGTGGAACC ATGTCTAGCG AGGAGATGCT ATACGCGCAG GGCGCCAAGA TCTGGGTGCC 
Ex2 421 CCATGCGGAT CTGGTGTGGG AGAGCGCCAC CTTGGAGGAG AGCTACCGCA AGGGCGCCGG  
30 
481 CTTCTTGAAG ATATTACGG ACTCCGGAAA ACTGAAGAG GTCAGCTAA AGGCCGATGG 
BSMI 	 RACE3 
541 CAGCGATCTG CCTCCACTGC GCAATCCGGC CATTCTGGTG GGACAGAACG ACTTGACCAC 
601 CCTGTCCTAC CTGCATGAGC CGGGGGTGTT GCACAATCTG CGTGTCCGCT TCTGCGAGCG 
661 CCAGATTATC TACACCTACT GCGGCATCAT TCTGGTGGCC ATCAACCCGT ACGCGGAGAT 
721 GCCTCTTTAC GGGCCCAGCA TAATCCGAGC GTATCGGGGT CATGCTATGG GTGATCTGG 
781 GCCGCACATC TTTGCCCTGG CGGAGGAGGC GTACACGAAA CTGGPGCGCG AGALCTGCAA 
STMI 
841 CCTGAGCATC ATCGTCAGTG GGGAGTCGGG TGCGGGCAAG ACGGTGTCCG CCAAATACGC 
901 CATGAGGTAC TTTGCCGCTG TTGGAGGTTC CGAGTCGGAG ACCCAGGTCG AACGCAAGGT 
961 GCTGGCATCT TCGCCGATCA TGGAAGCCTT CGGAAATGCC AAGACGACCC GGAATGC4 
1021 CAGTTCCCGC TTTGAGT TTACCAAGCT GCTGTTCCGG AACCAGATGG GTGTGPTGTT 
did 8 
1081 CCTGCAGGGA GCCACTATGC ACACCTACCT ACTGGAGAAG TCACGTGTGG TGTACCAGGC 
1141 CCAGGGAG CGCAACTATC ACATATTCTA TCAGCTGTGC GCGGCGCGPT CGAGTACCC 
STM2 
1201 TGAACTGGTG CTGGATCACC AGGACAAATT CCAGTTTCTG AACATGGGTG GCGCTCCTGA 
Ex3 1261 AATTGAPLCGA GTTTCGGATG CGGAGCAGTT TAACGAAACC GTGCAGGCCA TGACAGTTCT 
1321 GGGCTTCTCC ATTCAACAGA TCGCGATAT CGTANG1TC CTGGCAGGAP TACTCCATTT 
did 5 
1381 AGGAAACATT CAGGTTTCCA AGAAGTTCAA CGAGGGCAGC GAAGPGGAGG ACAGTGACTC 
1441 TTGCGATATA TT CATACG ACATCCACCT GCAGATCACC GCCGPTCTAC TGCGGGTGAG 
Ex4 1501 CGCCGATGAT CTGCGCCGGT GGCTTTTG7T GCGTAAGATA GAGTCGGTCA ATGA1TATGT 
1561 GCTGATACCG AATAGCATTG AGGCGGCTCA GGCGGCTCGA GACGCTCTGG CCAAGCACAT 
1621 CTATGCGAAA CTGTTTCAGT ATATAGTCGG TGTGCTGAJ\C AAGAGCCTCA ACAACGGTAG 
1681 CAAGCAGTGC AGCTTCATTG GCGTCCTCGA TATCTACGGC TTCGAAACGT TCGAGGTGAA 
1741 CTCCTTTGAA CAATTTTGCA TAAACTATGC AAACGAJ\AAG CTTCAGCAGC 	 LCA  
1801 GCATGTCTTC AAGJ TGGAGC AGGAGGAGTA CCTTAPLGGAA GGAATCACCT GGACGATGAT 
did 9 
1861 TGACTTTTAC GACAATCAAC CGTGTATCGA TCTAATTGAP TCTCGCTTGG GAGTGCTGGA 
1921 CCTGCTCGAC GAGGAGTGTC GAATGCCAAA GGGCTCGGAC GAGAGCTGGG CTGGCAAGCT 
Ex5 1981 CATCGGAAG TGCAPLTAAAT TTCCGCATTT CGJGAAGCCA CGCTTTGGCA CAACC2GCTT 
Ex6 2041 CTTTATCAAA CATTTCTCGG ACACGGTCGA GTATGACTG AACGGATTCT TGGAAAAGAA 
did 10 
2101 TCGTGACACA GTCTCCAAGG AGTTGACGCA AGTGCTAAGC GAGTCCAACA TGTCTCTGGC 
KE 
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2161 CAAGCAGGTG ATGACCCTGG AGGAAATAGA TACTCTGTGC GTGGATTCCG CTAAATCCTC 
did  
2221 CACCTTGGGC GGCCGCGTCG TGATCAGTGC TGGCCGCAAA CAGGTGGTGC CATCCAAGCA 
Ex7 2281 GCATAGAAAA ACGGTGGGAT CGCAGTTCCA GGAGAGTCTG GCGTCGCTGA TATCTACGTT 
2341 ACATGCCACA ACTCCGCACT ATGTGCGCTG CATCAAGCCC AACGATGACA AAGTCGCCTT 
Ex8 2401 TAAGTGGGAG ACGGCCAGA TCATACAGCA GTTAAGGGCC TGTGGTGTGC TGGAAACGGT 
2461 GCGCATCTCC GCAGCGGGAT TCCCCTCGAG ATGGCTCTAT CCCGACTTCT ATATGCGGTA 
2521 CCAGCTGCTG GTTTACCGCT CCAAACTCGA CAAAACGAC ATGAAGCTGT CGTGCCGGAA 
did3 
2581 CATTGTGATG AAGTGGATCC AAGACGAAGA TAAGTACCGA TTTGGCAACA CGCAGATTTT 
2641 CTTCCGCGCC GGCCAAGTGG CCTTCCTTGA ACAGGTTCGG GCTAATCTGC GCAAGAAGTA 
2701 TATCACCATT GTGCAGTCGG TTGTGCGGCG ATTCGTCTAC CGGCGCCAGT TCCTGCGCAT 
2761 TCAGAAAGTA ATTAATGGCA TTCAGAAACA TGCGCGCGGA TATCTTGCTC GCGAGCGTAC 
did 11 
2821 TCAGAAAATG CGCGAAGCTC GTGCGGGATT AATCCTGTCG AAGTACGCCC GCGGTTGGTT 
2881 ATGCCGTCGT CGTTACTTGC GCCTACGCCA CTCCATTTCC GGCATACAGA CCTACGCCCG 
2941 CGGCATGCTG GCGCGCAACA AGTTCCACGC GATGCGGGAT CACTACCGGG CAGTTCAGAT 
3001 CCAGCGTTTC GTGCGTGGTG CTTTGGCACG GCGAGCTTAC CAAAAGCGGC GTCGCAACAT 
3061 CATCATTTGT CAAGCGGCGA TTCGGAGATT CTTGGCCCGT CGTAAGTTTA APCGCATGAA 
3121 GGCCGAGGCC AAGACCATCT CGCACATGGA AAACAAATAC ATGGGGCTGG APACAAGAT 
3181 TATTTCCATG CAGCAGCGGA TCGATGAGCT GAATCGCGAC AACAGTAATC TGAAGCACAA 
3241 GACCAGCGAA ATCAGTGTAT TGAAAATGAA GCTTGAGCTG AGAAGACCC TGGAGGCTGA 
Ex9 3301 ATTCAAPT GTCAAGGCCG CCTGCCAGGA CAAGGACAJG CTGATCGAAG CACTTAACAA 
3361 GCAGTTGGAG GCGGAGCGAG ACGAAAAAAT GCAGTTGCTG GAGGAGAACG GACATGCTCA 
3421 AGAGGAGTGG ATCAGCCAGA AGCAGACGTG GCGCCAAGAG AACGAGGAGC TGCGCCGTCA 
3481 GATAGACGAG ATAATCGATA TGGCAAAGAA CGCAGAAGTC AACCAGCGTA ACCAGGAGGA 
3541 CCGAATGCTA GCCGAGATTG ATAACAGGGA GCTCAACGAG GCCTACCAAC GAGCTATTAA 
3601 GGACAAGGAG GTCATCGAGA ACGAAAACTT CATGCTGAAG GAAGAGCTCA GTCGATTAAC 
3661 GGCTGGCAGT TTCAGTTTGC ACGGCCGCAA GGCTAGCAAC GCCTCCAGCC AAAACGAGGA 
3721 CGATGTGGGA TACGCCTCCG CCAAGAACAC TCTGGATATC AATCGGCCCC CGGATTTGTT 
3781 AAGCAAAAAT TACTCGTACA ATGACTCTAC CAGTCTGGTG GTGAAGTTGA GATCCATTCT 
ExlO 3841 CGAGGAGGAG AAGCAAAAGC ACAAGGTCTT GCAGGAGCAG TACATTAAGT TGTCCAGTCG 
3901 GCATAAGCCC ACCGAGGATT CCTTCCGCGT CTCCGAGCTT GAGGTAGAGA ATGAAAAGCT 
ExIl 3961 GCGCAGCGAG TACGATCAGC TGCGAACGAG CATTAAACAC GGTGTTGAGA TCAACGAGCT 
4021 CAATGCACAG CATGCCGCCT TGCAGGAAGA GGTACGTAGG CGGCGCGAGG AGTGCATCCA 
Ex12 4081 ATTAAAGGCA GTCCTGCTGC AGCAGAGCCA GTCCATGAGA TCGCTCGAGC CGGAAAGTCT 
4141 ACAGATGCGT GGCAACGATG TCAACGAACT GATGGAAGCC TTCCATTCCC AGAAGCTAAT 
4201 TAATCGTCAA TTGGAGTCTG AGCTCAAGGC CATCACCGAG GAGCACAACA GTAAGCTCGT 
EXI3 4261 GGAGATGACA CAGGAGATCG AGAGATTGAA CAATGAGAAG GATGAGCTGC AAAAGGTAT 
4321 GTTCGAGAGC ATCGACGAGT TCGAAGATTC CAATGTGGAT ACGCTGAGAC AGAACGATCG 
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4381 CTATCTGCGA CGAGAACTGC AGAAGGCTGT AGCCCAGTTC CTGCTCGTTC AGGAGGAGCT 
4441 CAA2CTGGCA A1TGCCAAGC TTAAAGCTTA TCGGCAGGAT GGAGGCCAGC TGGAGCACA 
4501 GATAGAGGPG G1GATGATTC GCAPCAAGTC CAACGGAACG TCCGCCGATG TAGGCGCGAP 
4561 TGTGACGAAG CAAAAGTCTC AGAATCCGCA AGGGCTGATG AJAGTTCCACA GCAGCGATCT 
4621 GGACAPGATC TTGCAACGCC TGCTTAGCGC CTTGACTCCA CGCACAGTGG TCGGGCTCCT 
4681 CCCTGGTTTT CCAGCATATC TCATCTTTAT GTGTATTCGA TACACCGATC TGACAAATGC 
Ex14 4741 CGACGATGAT GTGCGCGAGT TGCTAAGCAA GTTCGTTATT CAGATTAAGA AAATGCATCG 
4801 TACGCCGCAT CCGATCGAGA ATCGTGTTAT TTGGCTCGTC A7TTCCATTA CGCTGCTAA1 
Ex15 4861 TCTTATGAAG CAATACGGCG ACGTGGATGA GTACGTCAAG TTCATACTG AGAAGCAGAA 
4921 TCAGCAGCAG CTGAAGAPCT TCAATCTCTT TGAATACCGT CGCGTAJTTC TTGATTTAAT 
4981 TGTGA1CCTG TACCAGGCGC TGATCATGCA GATCCAGGGT CTGTTGGACC CAAAAPTAGT 
5041 GCCAGCGATT CTCAACAATG ATGAGATTCA GCGTGGGCGG CAGGCGCACG GPATGCGTAG 
5101 TCGGGCCACG TCGATTGGAG CATCCTCGTC ACCGGAGCAC GGTGGCGGTC CGGCCTGGAJ 
1806 
5161 GCAACTGATC GGGCAGCTGG AGCATTTCTA CAAACAGTTT CAGCACTTCG GCTTGGACAA 
5221 CTGCTATGCG GAGCAGATAT TCCATCAACT GCTTTACTTC ATTTGCGCTG TGGCCCTTAP,. 
5281 TTGTCTGATG CTTAGGGGCG ATATTTGCAT GTGGGAGACT GGCATGATAA TCGCTACA2 
926Y 
5341 TATCGGCTGC ATTGAGGATT GGGTGCGCAG TAAAAAGATG TCTAACGATG TGCTGACAGC 
Ex16 5401 TTTGGCGCCT CTGAPTCAGG TCTCCCAATT GCTGCAGTCT CGGAPGAGCG AGCAGGATGT 
5461 TCAGACCATT TGTGATCTGT GTACTTCTCT GAGCACGGCG CAGGTCCTCA AGGTGATGAA 
5521 GTCCTACAAA CTGGACGATT ATGAGAGCGA AATAACGAAC GTTTTTCTGG AGAAPCTAPC 
5581 CGAGAAACTG AACGCCCGAC AAATGCAAAA GAGCAATAGT GACGAATTCA CCATAGACCA 
Ex17 5641 GAGTTCATT CAGCCATTTA AGGTTGTCTT CAGGTATAGT GACATCAPGC TGGAGGATAT 
Stop Codon 
5701 TGAACTACCG TCGCATCTTA ATCTGGACGA GTTCCTTACA AAGATTTAAA CGTCGCGTGC 
301R-5 
5761 CTGCGTCTTG CCGGTCGAGA ACTTTGCCAT TTTGGATGAC ATTACACTGC TTAGTTTTTG 
5821 TGTATTATAC GAGTATAACG ATTCTAGAA1 TTTAkTTTGT TCTTATATTT AGAAPJTCGA 
5881 TTAGATA1TG AAACATTGAG TAGAGCCGTT TTGCCGAJ½AT GTTTGTTAG T1CCTGTTTA 
5941 GCTTAAATAC CCGTTGTTTA TCCACTCCAA TAGTATCCAT TCCGAGTATC CAATGGCGTA 
6001 CCCGTCCCGA GATGCCA1GT GTTTTTTTTT GTTGTACGA1 CTATTTGTAG CAAAPGTAAT 
6061 GGPAGGTTAA GAACCAACCT TAATATGTGA ACGCAATAA ATGCTTGGAG TTAGACTCTG 
Ml and M2 cDNA end 
6121 ACCATAAGAA ATCATTTCTT GCCTAAACCT TGTACCTTA2k ATCATAACTA AATATTTATA 
6181 TACA2TGATT GTACTTAACC AGGCTGATTT GTTGCCTTA7L AGACGTGTAP AGCCTACAGA 
6241 TGATAGAGTA AGACTCATAG AGCTCACCGA TGATGCATTG CTGTTGCATT CCATCTATTT 
6301 ATGTATTCTC ATTTTCTGCG TAGCTTGTAA CTCGTTAGTT GGGTTTCTTA GATATGTCGT 
6361 TAGACTATGC AAGCCTAAAC TACGTTGGCA TTTGTTTGAA ACATTCTAAG CAGATTACCT 
MR3 
6421 AAACACATAC AAATATTATA TAT TAGAAAG AAAGTACTCG TGTGTAATGA ACAGCAATTT 
3UTR3 	 M3cDNAends 
6481 ATGAATTTTT ACATACAT CTCGAGTCGT TAACAATCCA CGAAGACTTT TGATAACTTG 
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Analysis of the 3'UTR sequence showed two potential polyadenylation sites. 
These were confirmed when cDNA clones for the gene were isolated (Fig. 3.413) (see 
next chapter for details). 
3.5 	Myosin V transcripts and their localisation 
3.5.1 Isolation and analysis of didum cDNA clones 
To study the molecular organisation of didum transcripts three new cDNA 
clones were isolated from an ovarian cDNA library (this was done by Timothy 
Wood). Initially the clones were analysed with PCR with specific primers for didum. 
The results (not shown here) indicated that these are full length clones based on the 
known sequence for the gene (Fig. 3.5. 1A). 
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The 5' and 3' sequence of each of the clones were sequenced. The sequencing 
results showed that Ml and M3 clones ("M" for Myosin V) start at promoter Ps 0.18 
while M2 utilises one of the other potential promoter sites, Ps 0.48, 0.81 or 0.43 (Fig. 
3.4), most likely the Ps 0.43 since the start of the isolated cDNA matches exactly 
with this region (Fig3.5.1A) 
The sequence at the 3' end showed that Ml and M2 have shorter 3'UTR 
which match well with the predicted two polyadenylation sites (Fig. 3.5. IA). 
Restriction analysis of the three clones showed that the M2 transcript contains 
an internal intron. When translated this will shift the ORF (open reading frame) and 
introduce a STOP codon, thus producing a truncated form of myosin V protein (Fig. 
3.5.1B). 
	
Size in Kb 	_ XhoI digest, products (kb): 
5 w 
4 	 MI 	M2 	M3 
2.5 	 4.49 	4.23 	4.49 
2 	 2.02 	2.02 	2.38 
15 	
1.36 	1.5 	1.36 
0.88 	1.36 	0.88 
1 	 0.29 	0.29 	029 
0.05 
Figure 3.5.1 B Restriction mapping of the obtained myosin V cDNA clones 
Plasmid DNA from the three cDNA clones were digested with Xhol. M2 clone 
showed a larger band ofl .5 kb compared to the expected 1.36 kb product. 
Analysis of the diduin sequence indicated that this might be due to the 
presence of Intron six. To check this possibility we sequenced M2 with did4 and did3 
primers (shown on Fig3.413). The results confirmed our hypothesis that Intron six is 
spliced together with the exons encoding myosin V to produce the transcript 
represented by the M2 clone. 
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3.5.2 Construction of M4 hybrid clone 
Ml and M3 have identical start sides but the sequences were found to differ 
slightly at the 5' end at a site in the polylinker of the cloning vector. Thus, the M3 
cDNA clone lacked the very 5'EcoRI restriction site. As this site was needed for 
cloning experiments (see chapter five) we created a hybrid between Ml and M3 
called M4. Ml and M3 were digested with Stul and Spel endonucleases and the 
fragments purified from agarose gel. The 5' part of Ml was ligated to the 3' part of 
M3 (the part containing the cloning vector). Thus the produced hybrid contain the 5' 
EcoRl restriction site and the full length 3'UTR belonging to M3 cDNA (Fig. 3.5.2). 




XbaI HpaI KpnI 
XbaI Smal BglII 
	
XhoI Noti I KpnI EcoRl I XhoI XhoI BgIII 
	
EcoRl XhoI XhoI 
0 
	
1 	 2 	 3 	 4 	 5 
	
6 k 
M4 in pBluescript SK- (9.42 Kb) 
BgIII 	5.20+4.22kb 
EcoRl 3.86 + 3.24 + 2.32 kb Spel 9.4 kb 
HpaI 	9.4 kb Stul 9.4 kb 
KpnI 5.35+4.05kb XbaI 5.81 + 3.61 kb 
Nod 	7.22 + 2.20 kb Xhol 4.47 + 2.37 + 1.36 + 0.88 + 0.29 + 0.05 kb 
Figure 3.5.2 Restriction map of the hybrid M4 clone 
The hybrid was constructed by combining the 5' end of Ml containing the 
EcoRl restriction site and exons coding for head and neck domains and the 3' end of 
M3, containing the exons for the tail domains, the 3'UTR and the vector sequence. 
3.5.3 Northern analysis of didum transcripts 
To find out the actual number and size of didum transcripts we used Northern 
analysis. 1 5p.g of mRNA of different developmental stages were electrophoresed and 
transferred to a nylon membrane. The blotted mRNAs was hybridised with a probe 
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made to specifically detect the myosin tail sequence. The probe was generated by 
PCR using didl 1 and MR3 primers and radioactively labelled. 
The analysis showed that all studied stages abundantly express myosin V. 
Two transcripts were detected: a 6.0 and 6.5 kb. The 6.5 kb mRNA is expressed at all 
developmental stages. The 6.0 kb transcript showed lower levels of expression in 
testes and male carcasses, and increased levels during larval stages (Fig. 3.5.3). As a 
loading control we used an Rp49 probe. Rp49 is a ribosomal protein expressed 
throughout the development at comparatively constant levels. We used PCR and 
specific primers (RP491 and RP492) to generate the control probe. These primers 
should produce a 400 bp PCR product. The PCR was carried out as follows: 94°C-
1.5 mm, then 30 cycles at 94 °C - 30 sec., 62 °C - 30 sec. and 70 °C - 1 mm. and a 
final extension for 4 mm. at 70 °C. 
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Figure 3.5.3 Developmental northern analysis of didum expression 
The first picture shows the denaturing agarose gel used to separate the 
rnRNAs. Total RNA from D. melanogaster should have two heavy ribosomal RNA 
bands at about 3.9 kb and 2.0 kb, and a lighter smear of mRNA centered around 2.0 
kb (Tautz et al. 1988). In fact the 3.9 rRNA splits into two subunits, under denaturing 
conditions, to produce 1.7 kb and 2.2 kb products. The 2.2 kb and 2.0 kb bands 
partially overlap producing a wider band on agarose gels and a separate 1.7 kb band. 
Two myosin V transcripts were detected (6.0 kb and 6.5 kb) differentially expressed 
throughout the Drosophila development. RP49 was used as a loading control. 
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3.5.4 ESTs analysis 
A BLAST search using the complete myosin V sequence was done to identify 
all EST sequences that match with diduin. The database search showed that there are 
at least three different groups of ESTs available: sequences that contain all exons and 
UTR regions; ESTs with a short 3'UTR region and ESTs lacking exon 11. This data 
was combined with the information obtained from the analyses of the isolated diduni 
cDNA clones to summarise all possible transcript variants (Fig. 3.5.4). 
Groups 	 Transcripts 	 EST name 
Group I RE30195.5prime 
(all exons) 
1 	2 	3 	4 	5 6 	7 8 	9 	10 11 12 	13 14 15 	16 	17 
AT291 69.5prime 
6.5 kb III LI[]flflII AT30743.5prime 
GH04445.5prime 
AT20539 5p rime 
6.1 kb iinnniiniinnnrinni•u• AT20260.5prime 
AT06823.5prime 
LD25801 5 rime 
6.2 kb 	R)IRRFWJV'VIY 
AT20454.5prime 





GH 1 0272.3prime 
AT01 176.3prime 
GH04445.3prime 
Ml cDNA clone 
M3 cDNA clone 
Group II AT27186.5prime 




(+intron 6) 7.1 kb M2 cDNA clone 
Figure 3.5.4 Diagram showing the structure of didum transcripts 
At least three different groups of myosin V transcripts were identified. The 
information shown here is a combined data from the analysis of the EST database and 
the isolated cDNA clones for myosin V (these are given in bold). Black boxes represent 
untranslated regions. Shaded boxes show the ORFs (open reading frames). Only the 
clones shown in bold have been fully sequenced. 
97 
Drosophila myosin V gene 
3.6 Discussion 
We used a PCR based strategy to precisely map the Drosophila myosin V 
gene, didurn, to region 43D1 on the polytene chromosome. A detailed analysis has 
shown that all known genes corresponding to position 43C-43D (position of 
saturated mutagenesis (Heitzler et al. 1993), are essential genes and lead to an 
embryonic lethal phenotype. 
To further study didum we isolated eDNA clones and searched the EST 
database to elucidate the molecular structure of the gene. The analysis showed that 
the gene has a complex structure. It contains 17 exons that are spliced differentially 
to produce various transcripts expressed at different levels during the Drosophila 
lifecycle. The gene is transcribed from at least two putative promoters, thus 
producing transcripts with different 5'UTR regions. The 3'UTR contains two 
polyadenylation signals resulting in the production of two main groups of transcripts: 
long (6.5 kb) and short (6.0 kb) transcripts. 
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Chapter Four: Expression analysis of Drosophila 
Myosin V 
Expression Analysis of Drosophila Myosin V 
4.1 	Production of Myosin V antibodies 
Recent studies have revealed that unconventional myosins perform a variety 
of essential cellular function such as organelle, RNA and protein transport, 
maintenance of the cell architecture, cell movements and signal transduction. Myosin 
Vs have been specifically implicated in vesicular and rnRNA trafficking. Drosophila 
Myosin V contains a tail region very similar to the tails of other myosins from the 
same class. To gain insight into the function of Drosophila Myosin V we generated 
antibodies to a recombinant Myosin V from Drosophila and studied its subcellular 
localisation. 
An antibody to Drosophila Myosin V have been previously generated in our 
lab (Bryce McIver, personal communications). Unfortunately this antibody was not 
able to recognise native Myosin V from Drosophila well. To check its specificity we 
performed a Dot-Blot Western analysis (Fig. 4.1A, see materials and methods, 
chapter 2.6.2). The Dot-Blot experiment showed that the generated antibodies to 
Myosin V bind with equal intensity to both the recombinant protein and to proteins 
from the nonexpressing Myosin V cell extract. This suggests that the antibodies can 
not be used to accurately detect Myosin V in Drosophila. We assumed that if the 
recombinant protein used for generating the antibodies has not been completely 
purified, this might have led to the production of small amount additional antibodies 
against the native E. coli proteins. When used for immunodetection these antibodies 
will generate unspecific staining and mask the Myosin V signal. To avoid the 
unspecific staining we blocked an aliquot of the antibodies with cell extract not 
expressing Myosin V (250tl serum with 50p1 cell extract). This step was expected to 
deactivate the contaminating antibodies and to increase the signal to noise ratio in 
favour of Myosin V. The antibodies purified in this way were used for 
developmental Western analysis to detect native Drosophila protein (Fig. 4.1B). 
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M 	
Concentration of Primary 
YO (Myosin V) antibody 
1:1000 
MyoV 
C 	 1:5000 
MyoV 
C 	 1:10,000 
MyoV 
C 	 1:20,000 
MyoV 
C 	 1:50,000 
1 	10 1 102 io b" 
Dilutions of the loaded protein extracts 
Figure 4.1 A Western Dot-Blot analysis of the generated in rabbits Myosin 
V antibodies 
Five nitrocellulose filters were spotted with ten fold dilutions (1 j.il each) of the 
recombinant protein (see materials and methods, chapter 2.6). The membranes were 
incubated with the Myosin V antibody with the shown concentrations. The 
concentration of the secondary antibody was constant (1:4000) for all five 
membranes. No difference was noted between the staining of the recombinant protein 
and the control E. coli proteins, suggesting that the antibodies bind unspecifically to 
cytoplasmic E. coli proteins. MyoV stays for Myosin V recombinant protein, C for 
control (extract from cells that do not contain expression vector and do not produce 
recombinant protein). 
Samples from different developmental stages were collected and prepared for 
gel electrophoresis (see materials and methods, 2.6 chapter). The samples contain 
approximately the same amount of protein. The Western analysis showed that the 
preabsorbtion step has definitely improved the quality of the Myosin V antibodies. 
The antibodies were able to distinguish well the recombinant protein (80kDa) but 
were still binding to an unknown protein of approximately 45kDa (Fig. 41B). 
Unfortunately the antibodies were not able to detect the native Myosin V well. They 
produced a number of bands including a strong band of - 60 kDa from ovaries. It 
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should be noted that the antibodies did showed a diffuse band of approximately 200 
kDa, which is the expected size for a single Myosin V heavy chain (the 
electrophoresis was carried out under denaturing conditions). This was especially 
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Figure 4.IB Developmental Western analysis of Myosin V expression 
Immunochemical detection of native Myosin V in protein extracts from 
different developmental stages showed that the purified antibodies bind to native 
Myosin V (diffuse 200 kDa band) but also bind unspecifically to a number of other 
proteins. As controls cell extracts expressing and not expressing the recombinant 
protein were used. The molecular weight marker is SyproOrange, Broad range. It is 
not visible on the Western because the antibodies used does not recognise any of the 
proteins it containes. 
4.1.1 Production and purification of recombinant Myosin V protein 
4.1.1.1 Production of recombinant Myosin V protein 
Myosin V antibody showed certain reactivity against Drosophila native 
protein. However further purification by affinity techniques was needed to increase 
its specificity. Since the antibody was generated in rabbits only 5m1 of the immune 
serum were available after the preliminary experiments. Unfortunately this was not 
enough for further experiments. For this reason we decided to generate a second 
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batch of Myosin V antibody. This time the antibody was produced in sheep using the 
same recombinant protein as immunogen as the one used for the generation of the 
first antibody (Fig.4. 1. 1 .1 A). 
EcoRV 	 EcoRl Oral EcoRl 
rHis Myosin  
pBMF33 
Figure 4.1.1.1A Expression vector used for the production of 
recombinant Myosin V protein 
The vector pBMF33 was generated by Bryce McIver (personal 
communication). An EcoRV-Dral fragment (1986 bp) was excised from a Drosophila 
Myosin V cDNA clone. This fragment was cloned into pRSET-C expression vector at 
the PvuII site to produce an in-frame fusion with the N-terminal histidine tag 
sequence. The orientation of the insert was verified by EcoRI restriction. 
Five stocks for pBMF33 (in BL21DE3-Lys) were stored from previous 
experiments. The cells were revived and grown to 0D600=1.3 and then induced with 
1mM IPTG for 4 hours. Interestingly some of the stocks did not show any expression 
of recombinant protein (Fig. 4.1.1.1 B). 
To check the integrity of the expression vector we obtained plasmid DNA 
from these stocks. The DNAs were digested with EcoRJ to check whether the studied 
clones are expressing the right protein. The digested samples produced a smear on 
agarose gels (data not shown), thus providing us with no information about the 
plasmid content. Some E. coil strains are known to express exonuclases. Since the 
cells expressing the recombinant protein showed the same smear on a gel when 
analysed, we assumed that this strain of BL1DE3-Lys also produces exonucleases. 
Thus if the obtained DNA is not perfectly purified, when digested with restriction 
endonucleases, the produced linear DNA molecules will become targets for the 
exonucleases. Unfortunately we did not find any relevant information about this in 
the literature. To check our hypothesis we transformed XL1B1ue cells with the 
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expression plasmid DNA. Plasmid DNA obtained from p33XL (pBMF33 in 
XLlBlue cells) produced the correct restriction pattern. In addition we sequenced the 
plasmid to be sure that this is the correct expression vector. Interestingly p33XL cells 








. 	 (-80 kDa) 
45 	 - — 
Ml 2345 
Figure 4.1.1.IB Recombinant protein expression 
Five separate stocks of BL21DE3-Lys expressing the recombinant 
pBMF33 construct are shown. Cells from only stocks two and five expressed 
recombinant Myosin V. It was found later that the other three stocks also contain 
the expression construct but either the regulatory sequences of the vector or the 
cloned gene itself were damaged. The marker is SyproOrange, Broad Range. 
We used plasmid DNA from the checked p33XL cell to transform back into 
BL21DE3-Lys strain. This strain is optimised for protein expression. It encodes T7 
RNA polymerase under the control of lacUV5 promoter. Induced with IPTG the 
promoter transcribes T7 RNA polymerase that is used to drive the expression of the 
recombinant protein (pRSET-C is T7 promoter driven vector). In addition BL21DE3-
Lys strain constitutively expresses low levels of T7 lysozyme which inhibits the 
promoter. This is especially useful to control the expression of toxic proteins or those 
damaging to the cells. When the cells are induced with IPTG they express high levels 
of T7 RNA polymerase which overcomes the lysozyme repression and the 
recombinant protein is produced. 
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One of new BL21DE3-Lys clones (called 2N33) expressing the recombinant 
Myosin V was selected. The cells were grown to 0D600=1 .3 and induced with 1mM 
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Figure 4.1.1.1C Recombinant Myosin V expression 
BL21DE3-Lys cells containing the recombinant expression vector were 
induced with IPTG. Aliquots were taken from the cell cultures on the first, second, 
third and forth hour after the induction. The cell concentration was determined 
spectrophotometrically and the same amount of cells were taken for electrophoretical 
analysis. It was noted that after induction the cells almost stopped growing and 
switched to producing recombinant protein. Cells induced for four hours demonstrated 
the highest levels of expression and this time was set as the standard default in all 
subsequent experiments. 
4.1.1.2 Affinity purification of recombinant Myosin V protein 
To purify the protein we used Ni-NTA-Agarose. This resin allows the 
purification of His-tagged fusion proteins. In general the recombinant protein is 
adsorbed on a column prefilled with Ni-NTA-Agarose. The column is then washed 
and the protein eluted under high salt conditions. 
Fractions H, III, and IV appeared to contain most of purified recombinant 
protein. To obtain enough protein we repeated the purification step two more times. 
Fractions II to IV from the three purifications were combined and dialysed twice to 
remove the elution buffer and to adjust the pH to physiological levels (pH--7.4). 
Approximately 14ml of dialysed protein were recovered. The protein solution was 
ten fold concentrated using Millipore concentration filters (UFV4BTK25). 
106 
Expression Analysis of Drosophila Myosin  
The amount of recombinant protein recovered from the two affinity 
purifications was estimated to be 4.4 mg based on spectrophotometrical analysis. 
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Figure 4.1.1.2 Affinity purification of recombinant Myosin V protein 
A Ni-NTA-Agarose preloaded column was saturated with recombinant 
protein (1). Low concentration salt solution was used to wash the unbound protein 
(2). The protein was eluted with high concentration Imidazol buffer (see materials 
and methods). Ten fractions were collected, only six of which are shown on the 
figure. Most of the purified protein was in fractions II, ifi, and IV. 
4.1.2 Sheep immunisation program 
The antibody to Drosophila Myosin V was generated in sheep by Diagnostics 
Scotland (Scottish National Blood Transfusion Service). A pre-immune serum was 
isolated for control purposes. Then the animal (no: S256A) was immunised with 
250ig of the recombinant protein. Three additional injections (250.tg protein each) 
were carried out afterwards. The injections were spaced out approximately one 
month apart. Seven days after each injection serum was collected and processed 
(centrifuged to remove the cell debris) by staff members of Diagnostics Scotland. 
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4.2 	Affinity purification of Myosin V antibodies 
4.2.1 Preliminary Results with whole serum 
Samples from the pre-immune serum and the first bleed were analysed by 
Western Dot-Blot. Cell extracts prepared from cells expressing the recombinant 
protein and cells that do not contain the expression vector (control) were spotted onto 
nitrocellulose membranes. The membranes were incubated either with the pre-
immune serum or with serum from the first (immune) bleed. Both the pre-immune 
and the immune serum were blocked with a small amount of protein extract prepared 
from BL21DE3-Lys cells.10jd of serum were mixed with 20jil sonicated BL21DE3 
cells containing pRSET-C and incubated for 40 minutes at room temperature. The 
antibodies (serums) were used for detection immediately after the blocking. This step 
would eliminate any unspecific binding of the antibody. The westerns were 
processed as previously described (materials and methods, chapter 2.6). 
The results clearly show that the generated Myosin V antibody recognises the 
recombinant protein (Fig4.2.IC and D). When used at 1 to 20,000 time dilution of 
the sheep anti-Myosin V antibody produced a strong specific signal in comparison to 
the signal produced by the pre-immune serum (Fig.4.2.1D). 
Serum obtained from the second and third bleed produced similar results 
(data not shown) demonstrating an adequate immune response in the organism in 
which they were generated. We decided to use the serum from the third bleed for our 
future experiments, because it showed a stronger signal when analysed on a Dot-Blot 
Western than serums from the other two bleeds. 
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Serum concentration 
C 
A 	 1:2000 Pre-immune serum 
MyoV 
C 
B 	 1:20,000 Pre-immune serum 
C 	 1:2000 First bleed serum 
MyoV I I 
C 
1:20,000 First bleed serum 
MyoV 
I 	10' 10 2 10 3 1010 5 
Dilutions of the loaded samples 
Figure 4.2.1 Western Dot-Blot analysis of the newly generated Myosin V 
antibodies 
Four nitrocellulose filters were spotted with different dilution of the recombinant 
protein. Extract from cells that do not have the expression vector was used as a 
control. Two of the membranes were incubated in different dilutions of the pre-
immune serum, and two in dilutions prepared from the immune first bleed. The 
concentration of the secondary (anti-sheep donkey lgG peroxidase-conjugated) 
antibody was constant (1:4000) for all four membranes. MyoV stays for Myosin V 
recombinant protein, C for control. 
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4.2.2 Western analysis of the recombinant protein with the new Myosin 
V antibody 
To further analyse the specificity of the newly generated antibody we 
separated protein extracts from cells expressing the recombinant protein and cells 
that do not contain the expression vector (control) on PAGE (polyacrylamide gel 
electrophoresis). The separated proteins were transferred to a nitrocellulose 
membrane (materials and methods, chapter 2.6.2). The membrane was stained with 
Ponceau (a red dye that binds to protein) to visualise the protein bands. This was 
needed to confirm that the protein transfer was successful and that approximately the 
same amount of protein has been loaded on each line (Fig. 4.2.2). 
Western Blot 
M 	pRSET-C 2N33 (Induced) M pRSET-C 	2N33 (Induced) 
Figure 42.2 Western analysis of the recombinant protein with the new 
Myosin V antibody 
Immunochemical detection of the recombinant Myosin V in protein extracts 
from BL2 1 DE3-Lys containing the expression 2N3 3 vector is shown. As a control a 
extract from BL21DE3-Lys with pRSET-C was used. The antibody detects a band of 
approximately 80 kDa (black arrow) only in the cells expressing the recombinant 
protein. The size corresponds to the recombinant protein. The marker is 
SyproOrangc, Broad range. It is not visible on the Western because the antibodies 
did not recognise any of the proteins it contained. 
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The results showed that the new Myosin V antibody detects only the 
recombinant protein, a band of approximately 80 kDa. Almost no background 
staining was observed in the control lanes where there were only BL21DE3-Lys 
containing pRSET-C vector (but not the expressing recombinant vector). 
4.2.3 Detection of wild-type Myosin V with the new Myosin V antibody 
The results from the previous two experiments indicated that the new 
antibody might be capable of recognising the wild-type protein from Drosophila 
tissues. To check this we prepared protein extracts from different developmental 
stages (see materials and methods, chapter 2.6). The wild-type proteins were 
separated on PAGE and transferred to a nitrocellulose membrane. The membrane 
was blocked in Blocking buffer and the Myosin V antibody added at 1:20,000 
dilution in 40m1 TBS-T (one volume of antibody was pre-blocked for 30 minutes 
with three volumes of the cell extract prepared from BL21DE3-Lys). The membrane 
was then washed and blocked with 0.5% Donkey serum in TBS-T. This step was 
required to eliminate the unspecific binding of the secondary antibody to sites on the 
membrane. The secondary antibody (anti-sheep donkey IgG peroxidase-conjugated) 
was used in 1:4000 dilution. 
The antibody did recognise the native Myosin V, a weak band of 
approximately 200 kDa (Fig. 4.2.3). However a strong background was present. This 
might have been because too much protein was loaded on the gel or because the 
antibody was not affinity purified and could bind non-specifically. To check the first 
possibility we repeated the Western analysis with lower amount of protein. Almost 
no difference was observed when compared to the previous Western (results not 
shown). 
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Ovaries 	 5. Light pupae 
Testes 6. Dark pupae 
Embryos 	 7. Male carcasses 
Larvae (Ilird instar) 	 8. Female carcasses 
Figure 4.2.3 Western blot with Drosophila samples 
Protein extracts from different developmental stages are analysed. The Ponceau 
staining indicates that protein has been loaded equally in each lane. The new Myosin V 
antibody detects a high molecular weight protein around 200 kDa corresponding well 
with the expected size for native Drosophila Myosin V (marked with an arrow). The 
antibody binds also to proteins with lower molecular weight. These might be either 
different Myosin V isoforms (produced by alternative transcripts), or unspecific binding 
to other proteins containing domains similar to the myosin tail. 
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4.2.4 Caprylic acid purification of the crude serum 
Caprylic Acid, at the right concentration and at a particular pH, will 
precipitate most serum proteins except IgG. This step alone often yields more than 
85% purity. Crude serum (third bleed) was processed as described in chapter 2.6.7.1. 
The purified antibody solution was concentrated ten fold using UFV4BTK25 filters 
from Millipore (Fig. 4.2.4). 
kDa  Crude serum 




IgG Heavy chains 
45 (-53 kDa) 
31 
*—IgG Light chains 
(-25 kDa) 
M 	1 	2 
Figure 4.2.4 Caprylic acid purification on Myosin V antibody 
The polyclonal antiserum was subjected to caprylic acid 
precipitation. This removed the bulk of extraneous serum proteins such 
as albumins. The figure shows the two chains of IgGs dissociated from 
each other (denaturing PAGE). 
I 1' 
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4.2.5 Affinity purification of Myosin V antibody 
To further purify the immunoglobulin fraction it was subjected to affinity 
chromatography using Affigel beads (Bio-Rad). Approximately 2 mg of recombinant 
protein was coupled to Affigel beads 10 and processed in accordance with the 
manufacturer's instruction. Unfortunately no antibody was recovered using this 
method. PAGE analyses showed that no recombinant protein binds to the Affigel 
beads 10. 
We developed a method for antibody affinity chromatography based on Ni-
NTA Agarose (materials and methods, chapter 2.6.7.2). In previous experiments Ni-
NTA Agarose was shown to bind the recombinant protein. We used approximately 
0.5 mg of recombinant Myosin V to couple with Ni-NTA Agarose. The caprylic acid 
purified antibody was then allowed to bind to the recombinant protein. The column 
containing the Ni-NTA Agarose-Recombinant protein-Antibody complex was 
washed with buffer and the antibody eluted. We carried out two elutions, one with 
acidic Glycine buffer (pH-2.5) and a second one with a basic Triethylamine buffer 
(pH-i 1.5) (Fig4.2.5). 
Usually antibodies are eluted at specific pH. In our case both buffers eluted 
antibodies. We assumed that the each buffer eluted a specific fraction of the 
polyclonal antibody. The two fractions were combined for the subsequent 
experiments (Fig.4.2.5). The combined fractions were dialysed against PBS and 
concentrated 10 fold on UFV4BTK25, Ultrafree-4 centrifugal filters from Millipore. 
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M 	1 	2 3 	4 	5 	6 	7 	8 9 10 M 	II 12 13 14 	15 16 1718 19 20 
M. (SyproOrange) BR Marker M. (SyproOrange) BR Marker 
1. Diluted Protein (arrow) before loading on the column 11. Tris HCI, pH-8.8 wash I 
2. Diluted Protein after loading on the column 12. Tris HCI, pH-8.8 wash II 
3. Diluted Antibody before loading on the column 13. Tris HCI, pH-8.8 wash Ill 
4. Diluted Antibody after loading on the column 14. Triethylamine, pl-1-11.5 elution I 
5. Salt wash I 15.Triethylamine, pH-11.5 elution II 
6. Salt wash II 16. Triethylamine, pH-11.5 elution Ill 
7. Salt wash III 17. Purified antibody, 50x dilution 
8. Glycine elution I 18. Purified antibody, 300x dilution 
9. Glycine elution II 19. Concentrated antibody, 500x dilution 
10. Glycine elution Ill 20. Concentrated antibody, 1.10-3 dilution 
Figure 4.2.5 Affinity purification of Myosin V antibody 
To purify the antibody we used a method based on Ni-NTA Agarose. The 
separate steps of the purification were monitored by sampling. The antibody-containing 
fractions 8.9,10.14, 15 and 16 were combined and used for further experiments. 
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4.3 	Western analysis of Myosin V antibody 
4.3.1 Detection of recombinant protein 
Protein extracts from cell expressing the recombinant protein and 
nonexpressing cells were separated on PAGE. Western Blot showed that the affinity 
purified antibody clearly recognises the recombinant protein (Fig. 4.3.1). The 
antibodies did not produce any background staining and detected a single band with 
the expected size, 80 kDa of the recombinant Myosin V. 
kDa 
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p33XL-1 (overloaded) 
	
6. 2N33, induced (2 hours) 
p33XL-2 (overloaded) 
	 7. 2N33, induced (3 hours) 
4.2N33, non-induced 
	
8. 2N33, induced (4 hours) 
Figure 4.3.1 Western blot with recombinant protein 
The antibody used was affinity purified from a Ni-NTA Agarosc column. The 
Marker is a SyproOrange, Broad range. it is not shown on the picture because it is 
not visible on Westerns-the antibodies do not recognise any of the proteins it 
contained. 
4.3.2 Detection of wild-type Myosin V 
Extracts from different developmental stages were analysed on a Western 
Blot (Fig. 4.3.2). This time the antibody produced much less background and was 
clearly able to detect the 200 kDa of Drosophila wild-type Myosin V. 
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Figure 4.3.2 Western blot with Drosophila extracts 
Protein extracts from different developmental stages are analysed. The new 
Myosin V antibody detects a high molecular weight protein, around 200 kDa, 
corresponding well with the expected size for native Drosophila Myosin V (marked 
with an arrow). The antibody also binds to proteins with lower molecular weight. 
These might be either different Myosin V isoforms (produced by alternative 
transcripts), or unspecific binding to other proteins containing domains similar to the 
myosin tail used to generate the antibody. 
Currently we do not have explanation why the antibody binds to other 
proteins and produces multiple bands on the Western Blot. It seem that this is 
unspecific binding because when Western Blot is done with protein extracted from 
embryos, a single stage where the conditions (blocking time, amounts of antibody 
used, temperature) could be optimised easily, the result is clear Blot showing only 
two bands, a strong 200kDa and faint band at 40kDa (see results in chapter 5). 
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4.4 	Immunolocalisation of Myosin V in Drosophila ovaries 
To study the subcellular distribution of Myosin V during Drosophila 
oogenesis we used both whole serum and affinity purified antibodies. The method is 
described in materials and methods, chapter 2.6.3. We used fluorescent secondary 
antibodies which were later visualised and photographed on fluorescent microscope. 
To show the precise localisation of Myosin V we performed triple staining 
experiments. 
4.4.1 Myosin V/Actin and non-muscle Myosin Il/Actin staining 
Myosins bind and move along actin filaments. Studies have shown that non-
muscle Myosin II is expressed during oogenesis (Edwards and Kiehart 1996). We 
know from our Western experiments that Myosin V is also produced during 
Drosophila oogenesis. Immunostaining of Drosophila ovaries showed that non-
muscle Myosin II is expressed abundantly through out the oogenesis. During stages 
1-10 the protein is detected in the somatically derived follicle cells, as well as in the 
germ-line nurse cells (Fig. 4.4.1A, C). The protein is also seen in the cells of the 
epithelial sheet overlaying the developing egg chambers. The levels of Myosin II 
decrease with the advancing of the oogenesis. In later stages, 11-13 there is less 
protein in the degenerating nurse cells and the protein in the follicle cells from being 
diffuse becomes localised to the cell membrane (but not the nuclear membrane) (Fig. 
4.4.1E, G). 
Actin is a major cytoskeletal protein and is expressed at all stages of 
oogenesis. It localises mainly to and closely to the cell membrane and the diffuse 
immunostaining indicates its presence throughout the cell cytoplasm. Generally 
Myosin II co-localises with Actin. However Actin is a main constituent of the ring 
canals (Fig. 4.4.]C-yellow triangles) while Myosin II is not. In addition Actin is 
more strongly expressed in the periphery of the oocyte at the base of the follicle cells 
(Fig. 4.4.1C-yellow arrows). 
Myosin V is mainly localised in the nurse cells at stages 1-13 from where it is 
likely to be transferred to the growing oocyte - a weak staining is observed in the 
oocyte at stage 1-10. Expression was also observed in the follicle cells which was not 
detected by in situ hybridisation to mRNA, presumably due to low transcripts levels. 
118 
Expression Analysis of Drosophila Myosin V 
At stage 10-12 Myosin V was observed in a region surrounding the border cells, but 
not in the border cells themselves (Fig. 4.1.1D). At this stage the columnar follicle 
cells start to migrate centripetally to cover the anterior end of the oocyte (Fig. 
4.1.1D, F). Since the oocyte remains connected to the nurse cells by the ring canal, 
the latter becomes localised centrally being surrounded by the migrating follicle 
cells. Our observations show that Myosin V staining is localised to that part of the 
ring canals. In addition Myosin V staining is detected in the anterior part of the 
oocyte close to ring canal opening. In later stages,10-13, a dynamic pattern was 
observed in the columnar follicle cells but not in the stretched follicle cells. Myosin 
V staining is confined to the cell cytoplasm (Fig. 4.4.2D) and almost no staining is 
present in proximity to the cell membrane, compared to the expression of Myosin II 
at these stages (Fig4.1.1G, H). 
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Figure 4.4.1 Myosin V/Myosin II expression during Drosophila oogenesis 
Antibody staining to Myosin II compared to Myosin V is shown. Both Myosin V 
and Myosin II have been detected using FITC labelled antibodies (Green); Actin is labelled 
with TRITC labelled phaloidine (Red); DNA content is labelled with Hoechst (Blue). 
Immunostaining with specific antibodies to Myosin II revealed its presence throughout 
the oogenesis. The protein is expressed abundantly in both nurse and follicle cells during the 
early stages of oogenesis. Its co-localisation with Actin is shown. 
Myosin V is expressed in a pattern similar to that produced by Myosin II, however the 
expression levels are lower. 
Localisation of Myosin II at stage 10 of oogenesis. Myosin II is strongly expressed in the 
nurse cells and all types of follicle cells. Actin ring canal localisation is indicated with 
yellow triangles. High levels of Actin expression are also detected in the oocyte just under 
the follicle cells (yellow ar-rows). 
Dynamic staining of Myosin V at stage 10. The protein is localised in the ring canal 
connecting the nurse cells with the oocyte (white arrows). Diffuse staining indicates the 
presence of Myosin V in the anterior part of the oocyte. 
Low levels of Myosin II expression are detected in the follicle cells and degenerating 
nurse cells at stage 12. 
The localisation of Myosin V protein in the ring canal and the anterior part of the oocyte 
is still detectable at stages 11-13 of oogenesis. 
High magnification of egg chamber stage 10. Myosin II is localised to the follicle cell 
membrane. 
Dynamic expression of Myosin V in the follicle cells cytoplasm, stage 10. 	 10 
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Figure 4.4.1 Myosin V/Myosin II expression during Drosophila 
oogenesis 
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4.4.2 Myosin V/Calmodulin staining 
Myosin V has a long neck domain with six IQ motifs. It has been shown that 
at least four of the IQ motifs bind to calmodulin. The other two bind additional 
25kDa and a l7kDa light chains (Chenney et al. 1993). A dimer molecule should 
associate with eight calmodulin subunits. This suggests that Myosin V and 
calmodulin should co-localise. In this way we can check the specificity of our 
Myosin V antibody. To study the distribution pattern of Myosin V compared to 
calmodulin we performed a double staining using specific antibodies. 
The results from the immunostaining confirmed our hypothesis. During 
stages 1-10 the expression pattern of calmodulin closely matched the Myosin V 
expression pattern (Fig. 4.4.2A, B). The calmodulin signal like the Myosin V signal 
was confined to the same region at stage 10. The calmodulin was detected in the ring 
canal that links the nurse cell with the oocyte and in the anterior part of the oocyte 
(Fig. 4.4.213, C, yellow arrows). At stage 10-13, the cytoplasmic localisation of 
calmodulin in the follicle cells did not match the dynamic Myosin V pattern. This is 
clearly seen when the two expression patterns were overlaid. 
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Figure 4.42 Immunolocalisation of Myosin VlCalmodulin during Drosophila 
oogenesis 
Antibody staining to Myosin V versus calmodulin is shown. Myosin V has been 
detected using FIX labelled antibodies (Green); calmodulin is labelled with TRITC labelled 
antibodies (Red); DNA content is labelled with Hoechst (Blue). 
The early expression patterns of calmodulin and Myosin V match closely. In addition, the 
calmodulin is localised to the perinuclear region. This produces characteristic red dots when 
the two images are overlaid (red arrow). 
Expression pattern at stage 10 of oogenesis. Myosin V (white arrows) and calmodulin 
(yellow arrows) localise to the ring canal connecting the nurse cells with the developing 
oocyte; both proteins are delivered to the oocyte (anterior staining). 
The characteristic ring canal pattern is maintained until stage 13 of oogenesis 
High magnification of Myosin V and calmodulin expression patterns in the follicle cells, 
stages 10-13. Both proteins show a cytoplasmic distribution. Interestingly when overlaid 
they do not co-localise. If they did the green and red layers should have produce a yellow 
image as was the case in B and C. 
123 
Expression Analysis of Drosophila Myosin V 
4.5 Discussion 
Antibodies to Drosophila Myosin V have been generated in sheep. The 
antibodies have been purified by affinity chromatography to increase their 
specificity. Western Blot experiments have shown that both crude serum and purified 
antibodies recognise the recombinant protein which was used as immunogen. The 
affinity purified antibodies were used to detect wild-type Drosophila protein and to 
build a developmental profile of Myosin V expression. Immunolocalisation 
experiments demonstrated that Myosin V is localised in the nurse cells at stages 1-
13, from where it is transferred to the oocyte. A characteristic staining pattern was 
observed at stage 10 when the protein is seen in the region where the ring canal 
connects to the developing oocyte. At later stages, 10-13, a dynamic pattern was 
observed in the columnar follicle cells, where the protein is localised to the cell 
cytoplasm. The correlation between cell distribution and function will be discussed 
in details in chapter 5. 
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Chapter Five: Genetical analysis of Myosin V function 
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5.1 	Search for mutations in didum 
5.1.1 Search for P-element lines 
P-element lines with a P-element inserted in the coding sequence of a gene of 
interest can be mutant for this gene. If no P-insertions are known for a given gene of 
interest a P-hop mutagenesis can be undertaken to create mutants (see the 
introduction chapter, 1.2.3). 
We initially chose to study Line H14 because this was the original enhancer 
trap line which led to the discovery of myosin V because of a co-ligation. The line 
gave an interesting and dynamic expression pattern in the follicle cells. In situ 
hybridisation to the polytene chromosomes showed two P-element insertions 
(Maclver et al. 1998; A. McCormack Thesis, 1998) in region 41-43. It was possible 
that this was close enough to undertake a P-hop mutagenesis to generate a myosin V 
mutant. For this purpose it was decided to separate the two P-elements by 
recombination. Thus we generated A27 and A35 lines (McCormack Thesis, 1998). 
The two lines contained only one P-element but unfortunately it was the same one. 
To see if this P-insert is preferentially inserted we analysed the expression patterns of 
the reporter gene of the original (1-114) and derived lines (A27, A35) (Fig. 5.1.1A). 
The reporter gene was expressed in subsets of follicle cells throughout oogenesis, 
except at stages 2-5. A27 and A35 showed an identical expression pattern that was 
similar to the one observed in H14. The expression pattern was highly interesting. 
Initially the reporter gene is expressed in the germanium. In later stages 6-12 a 
dynamic pattern is observed in the columnar follicle cells and the border cells, but 
not the stretched follicle cells. A27 and A35 expression pattern differ from H14 only 
in that that not all columnar follicle cells are stained at late stages, 10-12. Our 
analysis confirmed that the original H14 line has two P-elements both of which map 
to novel genes. The Inverse PCR experiments showed that they were inserted in 
region 41E and 42E which is relatively far from didurn (43Da) to be used for P-hop 
mutagenesis. Lines H14, A27 and A35 were used for further analyses. Studying a 
gene with such a dynamic expression pattern can contribute to our knowledge of cell 
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Figure 5.1IA Reporter gene expression in lines H14, A27 and A35 
Line H14 contains two P-elements. Lines A27 and A35 are identical and 
contain only one of the H14 P-elements. 
A, B: Reporter gene expression in the parental H14 line. The gene is expressed in 
the germanium (black arrow). During stage 2-5 no staining is observed. At stages 6-7 
the reporter gene is expressed in the follicle cell layer that covers the egg chamber. 
At stage 8-9 the staining is confined to the posterior follicle cells (black arrow). 
Staining is detected in all columnar follicle cells at stages 10-13. Strong expression 
is observed in the migrating border cells (red arrow) 
C, D, E, F: A27 and A35 show identical staining patterns. This pattern is similar to 
the one observed in H14 where the pattern is a result of combined expression of two 
reporter genes. A27 and A35 expression pattern differ from H14 only in that that not 
all columnar follicle cells are stained at late stages, 10-12. The staining is confined 
to two patches of follicle cells: the posterior-most follicle cells and group of anterior 
follicle cells (purple arrows). A strong expression in the migrating border cells is 
also observed (red arrow). 
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A search of the available fly stocks, identified 14 lines with insertions in the 
4313-E region (Table 5.1.IA). These were analysed by Inverse PCR to recover 
(rescue) the genomic sequence flanking the P-element (Fig. 5.1.113, C, D). The 
recovered genomic sequences were sequenced to determine the position of the P-
element insertion (materials and methods, chapter 2.5.11). 
Table 5.1.IA P-element lines used in the screen for transposone 
insertion in didum 
Stock no Genotype Chr* Reference 
H14 P[IacZ, ,y]; P[IacZ, ry] 2 Maclver et at. (1998) 
A27 P[IacZ, ,yJ 2 Maclveretal. (1998) 
A35 P[IacZ, ,y4] 2 Maclver et at. (1998) 
BL-11412 P{ry+t7.2=PZJDscamO5518 cn[1]/CyO; 2:3 Spradling et at. (1999) 
or P1412 ty[506] 
k16128 yl w67c23; P{w+mC=IacW}cosk16128/CyO 1;2 Torok et at. (1993) 
BL-11156 yl w67c23; P{w+mC-IacW}cosk161O1/CyO 1;2 Torok et at. (1993) 
or k16101 
or k16122 
BL-11382 P{ry+t7.2=PZ]I(2)43Bb04614a cn[1]/CyO, 2;3 Spradling et at. (1999) 
or 04614 nec[JR]; ty[506] P{PZ)04614b 
k13522 Df(1)w[67]c[23], y[1]; P{1acVV}I(2)43Bd 2 John Root. (1995) 
[k13522] / In(2LR)O, Cy dp[IvI] pr cn[2] 
654 or ms P{ry+t7.2-PZ}ms(2)43C00919/CyO; ty[506] 2;3 Castritton et at. (1993) 
(3)00919 
BL-10818 yl w[67]c[23]; 1;2 Spradling etal. (1999) 
or P818 P{w+mC=IacW}dpIdk08815/CyO 
or 08815 
11342 P{ry+t7.2=PZ]AIdh-11103610 cn[1]/CyO; 2;3 Spradling et at. (1999) 
or P1342 iy[506] 
05467 P{ry+t7.2=PZ}I(2)03610[05467] 2 Spradling et at. (1999) 
4403 ylw[67]c[23]; 1;2 Kaniaetal. (1995) 
or k08255 P{w+mC=IacW}I(2)k08255k08255/CyO 
10467 yl w[67]c[23]; 1;2 Spradling et at. (1999) 
or P467 P{w+mC=IacW]I(2)k00107k00107/CyO 
* Chr for Chromosome. Specifies the chromosome position of the P-element insertion. 
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Sau3A 	 Sau3A 
Genomic DNA 
Sau3A restriction 
Recovered genomic DNA 
Ligation 
Pryl, ,D Pry4 
$ PCR 
Amplified genomic fragment 
Figure 5.1.I13 Principle of Inverse PCR 
Described is 3' Inverse PCR. The techique of 5' Inverse PCR is similar. 
Genomic DNA is isolated from the target fly strain and digested with Sau3A restriction 
endonuclease. This enzyme has a site close to the 3' end of the P-element. In general 
Sau3A cuts approximately every 300-400 bp, thus there is a very high probability that 
there will be a Sau3A site close to the P-element in the flanking genomic DNA. The 
produced linear fragments are ligated with T4DNA ligase. To recover the genomic DNA 
adjacent to the P-element a PCR is terformed. Subsequently the rescued seouence is 
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Figure 5.1.ID Inverse PCR 
The PCR was performed at two different temperatures to chose the best 
conditions for amplification of H14, A27 and A35. The bands were excised from 
gel, purified and sequenced. Line 1114 produces two bands because it contains 
two p-elements. Lines A27 and A35 derive from H14 and contain only one of the 
two P-elements. The marker used is HyperLadder (Bioline). 
To determined the position and orientation of the inserted P-elements we used 
the sequenced DNA fragments to search the NCBI BLAST database (Table 5.l.IB, 
Fig. 5.1.1E). It was found that some of the lines contain two P-elements. In 654 the 
second P-element was located on chromosome 3, while in H14 it was inserted near 
the first P-element. k13522 had a single P-element inserted on the third chromosome. 
The results from the Inverse PCR showed that none of the studied lines have 
a P-element in didum and are not mutants of this gene. In addition the precise 
mapping of the P-insertions revealed that all of them are too far away from didum to 
be useful for P-hop mutagenesis (see the introduction, chapter 1.2.3). 
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Table 5.1.IB Chromosome position of the studied P-element lines 
P- Rescue PCR primers Gene of Locus Accession no/ 
element !Sequencing Insertion* Position** 
primer  
H14 5' LACF+LACS CG17508+ 2R, 41E6 AE003786 
[Ryl]>  LAOS 7098-7099 
H14 5' LACF+LACS LD28616*** 2R, 42E4 AE003790 
[Ry2]>  LAOS 180054-180055 
A27 5' LACF+LACS LD28616- 2R, 42E4 AE003790 
[Ry2]>  LAOS 180054-180055 
A35 5' LACF+LACS LD28616- 2R, 42E4 AE003790 
[Ry2]>  LAOS 180054-180055 
BL-11412 5' n/a 0G17800- 2R;43131-133 AE003841*** 
[PZ]> Dscam 111005-111006 
AQ0341 65 
ki 61 28 n/a n/a 0G1708-cos 2R; 43B3 AE003841*** 
[IacW]>  
BL-11156 5' n/a 0G1708-cos 2R; 43B3 AE003841*** 
[IacW]> 132448-132449 
AQ034038 
BL-11382 3' Pryl+ Pry4 0G1845- 2R, 43A4 AE003841 
[PZ] < Pry4  23983-23984 
k13522 3' Pryl+ Pry4 0G2604- 3R; 82F4 AE003603 
[lacW] < Pry4  77624-77625 
654 3' 5p3+Pry4 0G7620+ 3R, 87D12 AE003698 
[PZ-1]<  Pry4 (I(3)87Df)  110346-110347 
654 5' Spl+SpLac2 0G11143- 2R; 4306-07 AE003841 
[PZ-2]>  SpLac2 (Inos)  203987-203988 
BL-1 0818 5' Sp3+Pry4 0G2064+ 2R; 43E1 1 AE003840 
[lacW]> Pry4 143985-143986 
AQ0341 3# 
BL-11342 3' Pryl+ Pry4 0G11140- 2R, 43D1 AE003841 
[PZ]>  Pry4 Dhap  218999-219000 
05467 3' Pryl+ Pry4 0G11140- 2R; 43D1 AE003841 
[PZ]>  Pry4 Dhap  218999-219000 
4403 3' Pryl+ Pry4 0G2064+ 2R; 43E1 1 AE003840 
[lacW] < Pry4 143978-143979 
10467 5' Spl+SpLac2 0G2140+ 2R,43E1 AE003840 
[lacW] < 	I I SpLac2 (Cyt-b5) 16883-16884 
A "+" or "-' indicates whether the gene is on the + or - DNA strand. 
**The  P-element is inserted between the base pairs indicated. 
***LD28616 is an EST for gene that is located between CG15242 and CG3567 (Cyp6ul) 
Sequenced by Spradling et al. (1999) 
<or> shows the orientation of the P-element 
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Figure 5.1.IE Position and orientation of the analysed P-element lines 
The chromosome position of the P-element was determined by comparing the 
isolated flanking sequence to Drosophila genomic sequence. The genes in which the 
studied P-elements are inserted are listed in Table 5.1.1 B. The genetic position of diduin 
is shown in bold. Line H14 has two P-elements designated as 1 and 2. The H14-2 P-
element is equivalent to the P-element in A27 and A35 lines. Line 654 also contains 
two P-elements. Only one of them is shown on the figure, the second one being located 
on a different chromosome (3R). Line K13522 is not shown because the only P-element 
it contains is inserted on the 3 d chromosome (Table 5.1.1B). 
5.1.2 Search for deficiency lines 
To elucidate the function and the molecular interactions of Drosophila 
Myosin V it was necessary to isolate a line(s) with a mutant phenotype. A database 
search found no mutant strains for didum, however 19 potential deficiency lines were 
revealed (Table 5.1.2). Deletions in the deficiency lines may cause alterations in the 
size of restriction fragments. The latter can be detected by Southern analysis where 
they appear as bands additional to the bands produced in wild-type DNA restriction 
digests. 
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2395 NCX5 Df(2R)NCX5 cn' bw'sp1 /In (2LR)O, Cy 
dp''1 pr' cn2  
Heitzler et al. (1993) 
John Roote (1995) 
42896G 43Cc1  1(2)43Cc1 bw'/CyO, Cy' dppr1 cn' Heitzler et al. (1993) 
2398 NCX6 or 
43Cb1  
I(2)43Cb1 cn' bw' sp1 /In (2LR)O, Cy 
dp'pr' cn2  
Heitzler et al. (1993) 
John Roote (1995) 
2399 NCX7 or 
43Cc 7 
1(2)43Cc4 cn1 bw1 sp1 I/n (2LR)O, Cy 
dp pr' cn2  
Heitzler et al. (1993) 
John Roote (1995) 
4120 43Cb1  I(2)43Cb1 cn' bw1 sp1 /CyO Heitzler et al. (1993) 
4121 43Cc4 1(2)43Cc4 cn' bw7  sp1 /CyO Heitzler et al. (1993) 
4124 43Da1  I(2)43Da1 / CyO Heitzler et al. (1993) 
4125 43Db1  1(2)43Db1 bw°, Dp(?;2)bw'/CyO Heitzler et al. (1993) 
4126 dpa1  dpa7  bw', Dp(?;2)bw'/CyO Heitzler et al. (1993) 
4129 43Ea1  I(2)43Ea1 bwD,  Dp(?;2)bw'/CyO Heitzler et al. (1993) 
42896E 43Ca, 
ordpa1  
dpa7  bw"/CyO, Cy1 dppr1 cn2  
synonym I(2)43Ca1 
Heitzler et al. (1993) 
John Roote (1995) 
428961 43Db1  w 1(2)43Db1 b'/  CyO, Cy1 dphl  pr' cn Heitzler et al. (1993) 
42896J 43Ea1  1(2)43Ea1 bwV/ CyO, Cy' dphl  pr1 cn2  Heitzler et al. (1993) 
45987 UTT7 Df(2R)Drr71 /CyO, Cy' dp' pr' 
cn2synonym Df(2R)Dr1R7  
Heitzler et al. (1993) 
45992 DrI 22 Df(2R)Drf'' 22 / CyO, Cy1 dp pr1 cn2  
synonym Df(2R)DrI' 22  
Heitzler et al. (1993) 
2379 T(2;3)H36 T(2;3) H36, I(2)43Ca °/In(3LR)TM3, 
y ri pp sep Sb bx 34 e Ser 
John Roote (1995) 
2579 cos-2 Df(2R)cos-2 cn bw sp/In(2LR)O, Cy dp1 	pr cn2  Heitzler et al. (1993) 
2580 cos-3 Df(2R)cos-3 cn bw sp/In(2LR)0, Cy dp''1 pr C17L Heitzler et al. (1993) 
2614 Drl Df(2R)Drf"/In(2LR)O, Cy dp'v prcn2  Heitzler et al. (1993)_- 
A series of genomic Southerns were carried out using the potential deficiency 
lines. At this time we did not have the frill length cDNA clones (M1-M4 clones) 
isolated and we used pBMF3 1 to generate DNA probes to be used in the Southern 
analyses (Fig. 5.1.2A). 
Genomic DNA was prepared from heterozygous flies, strains 42896G, 2398, 
2399, 2395, 2379, 2579, 2580, 2614 (the other strains shown in the table, 5.1.2 were 
not available for experiments at this point). Oregon R (wild-type) genomic DNA was 
used as a control. 10ig of genomic DNA was digested with EcoRI, XhoI and PstI 
restriction endonucleases and separated on 1.0 % agarose gel overnight (see 
materials and methods, 2.5.13 chapter). Plasmid DNA from pBMF31 was labelled 
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radioactively with 32P and used in the subsequent hybridisations. We labelled total 
plasmid DNA because the labelled vector DNA from the construct hybridises with 
the DNA marker used in the elelectrophoretic separation of the genornic samples. 
Thus we were able to visualise the marker on the film. The results are shown in Fig. 
5.1.2B; 5.1.2C and 5.1.2D. 
BhI Psi RI 
	
RVXIXI 	Hill Hill 	 RI DI 
	
Hill XbI 




Xba (XbI): 6.0 
EcoRI(RI): 2.2 + 3.8 
EcoRV(RV): 6.0 
Hind!!! (Hill): 2.0 + 4.0 
EcoRI+Xho!: 0.2 + 0.5 + 0.8 + 1.5 + 3.0 
Xho! (XI): 0.3 + 2.3 + 3.5 
EcoR!+Hind!I!: 0.8 + 1.0 + 1.2 + 3.0 
BamH! (BhI): 6.0 
EcoR!+BamHI: 2.2 + 3.8 
DraI(DI): 17bp + 0.7 + 1.2 + 4.1 
EcoR!+Dra!: 17bp + 0.15 + 0.7 + 1.2 + 1.9 + 2.2 
Figure 5.1 .2A Restriction map of pBMF3I 
The restriction map was produced using a number of different enzymes 
conventionally included in restriction digests. BMF3 I was the most complete cDNA 
available at the start of this work (Maclver et al. 1998). The DNA was used to 
generate radioactively labelled probes to be used in Southern analysis experiments. 
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Figure 51.213 Deficiency lines analysis-EcoRl digest 
Southern blot of genomic DNA from deficiency lines (see Table, 5.1.2). EcoRl 
digest produced 2.3 and 0.9 bands. The additional band (3.4 kb) in 42896G, 2399 and 
2395 is marked with an arrow. The marker used is HyperLadder (Bioline). 
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Figure 5.1.2C Deficiency lines analysis-Pstl digest 
Southern blot of genomic DNA from deficiency lines (see Table, 5.1.2). Pstl 
digest produced 1.1, 3.2 and 3.6 kb bands. The additional band (-5.0 kb) in 42896G, 
2395 and 2379 is marked with an arrow. The marker used is HyperLadder (Bioline). 
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Figure 5.1.20 Deficiency lines analysis-Xhol digest 
Southern blot of genomic DNA from deficiency lines (see Table, 5.1.2). Xhol 
digest produced 0.5, 1.36, 2.4 and 9.0 kb bands. No additional bands were observed in 
XhoI digest. Interestingly Oregon R (wild-type) genomic DNA lacked the 9.0 kb band 
and 2579 lacked the 2.4 kb band. This is probably due to polymorphism of the 
background strains used to generate the deficiencies. The marker used is HyperLadder 
(Bioline'). 
The Southern Blot analysis showed that four of the studied deficiency lines 
produce an extra band when restricted with EcoRI and PstI but not XhoI. 42896G, 
2399, 2395 and 2379 strains were chosen for further analysis. 
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5.1.3 Complementation mapping 
To determine if the four deficiency lines, isolated from the Southern analysis 
belong to the same complementation group, the lines were crossed to each other 
according to the scheme shown on Fig. 5.1.3A. 
P 	 Deficiency 1 	X 	Deficiency 2 
CyO 	 CyO 
F 	Deficiency 1 ; Deficiency I ; 	Deficiency 2 ; çQ 
Deficiency 2 	CyO 	 CyO 	CyO 
Heteroallelic 	Heterozygous 	Heterozygous 	Homozygous 
mutant (wild-type) (wild-type) balancer 
(lethal) 
Figure 5.1.3A Crossing scheme for complementation of the potential 
deficiency lines 
If two deficiency lines disrupt the same function individuals containing 
deficiency alleles from both parents will die (non-complementation). Alternatively 
if different functions are disrupted, complementation will occur and the flies will 
have wild-type phenotype. 
Complementation analysis of 42896G, 2399, 2395 and 2379 showed that 
each cross produces wild-type flies. This indicated that the four lines are in different 
complementation groups and disrupt different functions. 
During the preliminary complementation test we were able to collect a 
number of new deficiency lines (listed in Table 5.1.2). At the same time the Genome 
sequence of Drosophila melanogaster was released. Thus we were able to select 
lines that map very closely to didum. Lines 42896G, 2399 and 2395 but not 2379 
were shown to map closely to didum and was analysed further. 
The new deficiency lines as well as the three lines from the previous analysis 
were subjected to complementation crosses. For each cross 2-3 female virgin flies 
were crossed to 3 male flies. Approximately 80 to 100 individuals from the offspring 
were counted for statistically representative results. The complementation results are 
presented in Table 5.1.3. 
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Table 5.1.3 Complementation analysis of the potential deficiency lines 
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N IqT Iq . . . 
2395 - - + + + + + + + + + + + - - 
NCX5 
42896G - - + + + + + + + + + + + - - 
cc,  
2398 + + - - + + + + + + + + + - - 
Cb1 
4120 + + - - + + + + + + + + + - - 
Cb1 
2399 + + + + - - + + + + + + + - - 
Cc4 
4121 + + + + - - + + + + + + + -- 
Cc4 
4124 + + + + + + + + + - * 
Da' 
4125 + + + + + + + - - + + +++- 
Db1 
428961 + + + + + + + - - + ++++ 
Db1 
42896E + + + + + + + + + - - + + - - 
d pa1 
4126 + + + + + + + + + - - + + - 
dpa' 
4129 + + + + + + + + + + + - - + + 
Ea' 
42896J 1- -1- + -t- + + + + + + -  - ++ 
Ea' 
45987* - - - - - - + + - - ±± -- 
Dr I   rvl 7 
45992* - - - - - - - - - - - + + - - 
DI 2  
* These lines are large deletions in chromosome region 43Ca-43Da. 
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Using the data from the complementation test and cytological data from the 
Flybase (http://flybase.bio.indiana.edu/) we were able to built a complementation 
map (Fig. 5.1.313). 
didum 
42896G 
412P 	4121 4126 	 4124 412 
Cb cc 4 dpa 2395 	Dal Db 
rv2 412  45992 (DrI 2) 	Ea 
45987 (DrI 17) 
43-C* 	 43E 
Figure 5.1.3B Complementation map 
The analysed deficiency lines were placed in ten complementation groups. For 
lines that fall in the same complementation group only one is shown on the diagram. These 
lines are: 2398 group with 4120, 2399 with 4121, 428961 with 4125, 42896J with 4129, 
and 42896E with 4126. The relative position of didum (myosin V on the chromosome map 
is shaded. 
5.2 	Analysis of the isolated potential Myosin V mutants 
5.2.1 Generating GFP-balanced deficiencies 
To check whether the potential 2395 and 42896G lines are mutants for 
myosin V we needed to isolated homozygous individuals. Since both lines are 
homozygous lethal we marked the deficiency alleles with GFP (green fluorescent 
protein) marker. Thus when self crossed the flies would produce 25% non-
fluorescent individuals that are homozygous for the deficiency (Fig. 5.2.1A). 
Initially we used a GFP marker where the GFP is fused to Kr (Fig. 5.2.IA). 
Strains 2395, 4124 (Da), 4125 (Db), Driv7  and Dri"22 were crossed to Kr-GFP 
balancer strain. We found it impossible to generate a 4125/GFP line with the shown 
cross. No offspring were produced when GFP virgin females were crossed to 
deficiency males. To overcome this problem we performed a reciprocal cross with 
virgin females (deficiency) with GFP males (Fig. 5.2.1B). 
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We found that this fluorescent balancer is difficult to work with because it 
produces a weak fluorescence almost indistinguishable from the auto fluorescence of 
the fly embryos. Thus it was difficult to separate fluorescent from non-fluorescent 
embryos. In our subsequent experiments we used a GFP marker (GFP-Actin) 
Fig. 5.2. 1C). 
P 	 Y L,Pin 	x 
CyO, Kr-GFP 
F0 	L, Pin 	L, Pin 
Deficiency CyO 
Discard flies with small eyes (L) 















Keep the progeny as a stock: 
F1 	Deficiency CyO, Kr-GFP Deficiency 
Deficiency CyO, Kr-GFP CyO, Kr-GFP 
Embryos, larvae and 	Embryonic 	Embryos, larvae 
adults do not show lethal 	 and adults show 
fluorescence 	 fluorescence 
Figure 5.2.IA Cross for generating GFP balanced deficiency lines 
The original CyO (wing) marker was crossed out and substituted for a 
fluorescent GFP marker, Kr-GFP. The generated flies with a deficiency over 
Kr-GFP were self crossed and established as stock. 
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P 	 Deficiency 
	X d L, Pin 
CyO CyO, Kr-GFP 
F0 	L, Pin 	L, Pin 
Deficiency CyO 
Discard flies with small eyes (L) 
and short, thick thoracic bristles 
(Pin) 




Select for Curly 
wings (Cy) 




I Keep the progeny as a stock: 
F1 	Deficiency CyO, Kr-GFP 	Deficiency 
Deficiency CyO, Kr-GFP CyO, Kr-GFP 
Embryos, larvae Lethal 	 Embryos, larvae 
and adults do not and adults show 
show fluorescence fluorescence 
Figure 5.2.1 B Cross for generating GFP balanced deficiency lines 
A reciprocal cross for generating 4195/GFP line. The original CyO 
(wing) marker was crossed out and substituted for a fluorescent GFP marker, 
Kr-GFP. The generated deficiency over Kr-GFP were self crossed and 
established as stock. 
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P 	 Deficiency 
CyO 
F0 	Sco, b 	Sco, b 
Deficiency CyO 
Discard dark bodied (b) flies with 
missing scutellar bristles (Sco) 
X d Sco,b 
CyO, Act-GFP 
Deficiency 
CyO, Act-GFP CyO, Act-GFP 
Select for Curly 	Lethal 
wings (Cy) 
P1 	Y Deficiency X 6 Deficiency 
CyO, Act-GFP 	CyO, Act-GFP 
Keep the progeny as a stock: 
F1 	Deficiency CyO, Act-GFP 	Deficiency 
Deficiency CyO, Act-GFP CyO, Act-GFP 
Embryos, larvae and 	Lethal 	 Embryos, larvae 
adults do not show and adults show 
fluorescence 	 fluorescence 
Figure 5.2.1 Cross for generating GFP balanced deficiency lines 
Generating Act-GFP balanced deficiencies. Using a Kr-GFP balancer 
proved to be impractical because of difficulties in distinguishing homozygous 
from heterozygous. For subsequent experiments a GFP marker fused to Actin 
was used. The original CyO (wing) marker was crossed out and substituted for 
a fluorescent GFP marker, Act-GFP. The generated deficiency over Act-GFP 
were self crossed and established as stock. 
5.2.2 Molecular analysis of the deficiency lines 
Genomic DNA was isolated from deficiency lines 2395, 4124 (DA), 4125 
(Db) and 42896G. Genomic DNA from Oregon R (wild-type) was used as a control. 
The DNA was amplified in a PCR reaction, using 5'UTR and MR3 primers (Fig. 
5.2.2A). The PCR amplified approximately 9.0 kb of genomic DNA that covered 
completely the myosin V gene. The products were restricted with XhoI, XbaI and 
EcoRI endonucleases in single and double digests (Fig.5.2.2B). We expected that 
when digested the DNA from heterozygous flies would produce extra band(s) on 
agarose gel. This is possible only when the aberration is a significant duplication or 
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deletion. Point mutations would remain undetected with this method. Generating a 








lit 	 0 
0) 	 . 
0 
C'J 	 a 
Figure 5.2.2A Genomic PCR of the potential deficiency lines 
5'UTR and MR3 primers were used to amplify the 9.0 kb genomic sequence 
of didurn (myosin V). To optimise the amplification conditions the PCRs were carried 
out with a mixture of Taq polymerase and proof-reading Pfu polymerase in 3:1 ratio. 
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Figure 52.213 Restriction digest of 5UTR+MR3 PCR product 
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The restriction analysis revealed an additional band in line 2395 digest. To 
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Figure 5.2.2C Restriction digest of 2395 (5UTR-MR3 PCR product) 
All digests were carried out with 500ng of the 5UTR+MR3 PCR amplified 
product. The reaction were performed overnight to ensure completion of the 
reaction. Oregon R (wild-type) was used as a background control. The marker used 
is Hyper Ladder (Bioline). 
A restriction map was built using the data from the two restriction digests 
(Fig5.2.21)). Analysis of the restriction products showed the presence of 
approximately 150-200 bp insertion in the region between XbaI and PstI restriction 
sites. A PCR approach was chosen to map down the exact location of the extra DNA. 
5UTR, STM2, did5, didlO and BSM1 primers were used to amplify the region 
between XbaI and PstI restriction sites. Since the template in that PCR was from 
heterozygous flies we expected to obtained two amplification products; one wild-
type sequence and the mutant sequence containing the additional DNA. The PCR did 
produce two amplification products (Fig. 5.2.2E). Interestingly the mutant sequence 
was always much weaker than the wild-type. 
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XbaI 	 PstI 	EcoRV PstI XhoI Ec0RV PstI 
Insertion 	 I I 	I 	I 	I 	 I 
482 	 1392 	 615 	 XbaI+XhoI 
1232 	 525 12 ,4 398 217 Psfl+Xhol 
	
II 	 P4 
1559 	 321 	 500 	Ec0RV+XhoI 
482 	 1744 	 xi,ai 
1232 	 525 	 521 	217k PstI 4 	 P4 
Figure 5.2.213 Restriction map of 5UTR+MR3 amplified product 
Restriction digest was carried out with selected restriction endonucleases. 
Comparison of the restriction products generated from wild-type sequence with these 
from 2395 sequence showed the presence of additional , -200 bp longer band in the 
mutant seauence. The insertion site is shown in red. 
The products of 5UTR +didlO and BSM1+STM2 were purified from agarose 
gel and blunt-end cloned in TOPO vector (see materials and methods). To check for 
correct cloning the recombinant TOPO constructs were digested with EcoRl. Since 
there are two EcoRl site in the TOPO linker sequence, one on each site of the cloned 
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sequence a restriction would produce two products: the vector sequence itself and the 






STM2+BSMI product (mutant) 
STM2+BSMI product (wild-type) 
5UTR+didl0 product (mutant) 
5UTR+didl0 product (wild-type) 
Figure 5.2.2F Restriction analysis of the subcloned STM2+BSMI and 
5UTR+didl0 sequences 
STM2+BSM1 products (1kb for the mutant and 0.8 kb wild-type sequence) 
were cloned successfully in TOPO vector. Unfortunately none of the 5UTR+didlO 
products were cloned into the vector. The 4.0 kb band is the TOPO vector. The 
marker used is HyperLadder (Bioline). 
The recombinant constructs containing the STM2+BSM1 amplified products 
were named as follows: pMSH, containing the mutant fragment and pWTSH 
containing with the wild-type sequence. Both constructs were subjected to 
sequencing. It was extremely hard to sequence the mutant sequence because it 
proved to be a repeat sequence (Fig. 5.2.2G). Approximately 200 bp of CT-rich 
sequence was inserted between bases 635-636 (TTGCAC-AATCTG) of myosin V 
second exon. The complementary sequence of the insert is the well known AGAG 
sequence found in gene enhancers. 
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Wild-type sequence: 5 T  —AATCTGCGTGTCCG--3' 
Mutant sequence: 	5 '—GCCGGGGGTGTTGCACCTCTCCTCTCCTCTCCTCT 
CCTCTCCTCTCCTCCCCT (CTCCT) 150CTTCTGCGAGCGCC-3' 
Figure 5.22G Mutant sequence found in strain 2395 
Analysis of pMSH and pWTSH recombinant constructs showed an insertion of 
approximately 200 bp CT-reach sequence in the mutant construct. Instead the wild-type 
sequence (given in blue) the insertion (shown in red) was identified. 
The complementation test showed that line 42896G fail to complement 2395. We 
analysed 42896G by additional restriction digests to see if any extra bands will be identified. 
The presence of such band could help us to map the mutation site in 42896G. We did detect 
an extra band of approximately 750 bp in the products of XhoI+DraI digest (Fig. 5.2.2H). 
Unfortunately time limitation did not allows to further analyse the 42896G sequence. 
- 	. 	4, 	• . 
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Figure 5.2.21-1 Restriction analysis of 42896G strain 
Additional band is detected in XhoI+DraI digest (white arrow). Oregon R was 
used as a control. The marker used is HyperLadder (Bioline). 
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5.1.1 Expression analysis of the isolated mutant lines 
To show that the mutation in 2395 and 42896G interfere with the normal 
function of myosin V we analysed the protein expression of myosin V in these lines. 
Homozygous embryos were collected from the GFP balanced 2395 and 42896G 
strains (non-fluorescent individuals) Fig. 5.2.3A). Protein extracts were prepared 
from the embryos and the proteins separated on PAGE. Immunodetection with the 
purified Myosin V antibody was carried out (Fig. 5.2.3B). 
Figure 5.2.3A Distinguishing between homozygous and heterozygous 
GFP embryos 
Initial experiments generated deficiencies balanced over Kr-GFP. As can be 
seen from the picture the GFP expression is weak and homozygous deficiency 
embryos (lack GFP balancer) can not be isolated accurately. Later experiments were 
performed with GFP balancer where the GFP is fused to Actin. 
The Western analysis showed that both lines, 2395 and 42896G do not 
express Myosin V or the expression levels are reduced to levels undetectable by 
Western blot. As a positive control we used protein extract from wild-type Oregon R 
embryos. These produced a well defined band of approximately 200 kDs, the 
expected size for 1815 amino-acid protein. As a loading control we used specific 
antibodies to detect non-muscle Myosin II expression (228 kDa). The expression of 
Myosin II proved to be unaffected in all studied lines. These results indicate that the 
mutations in 2395 and 42896G disrupt the function of Myosin V. 
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4 ( 	Myosin II (non-muscle) 
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M 	42896G 2395 2395/Rv22 OrR 
Figure 5.2.3 Western analysis of the myosin V expression in the mutant 
strains 
Protein extracts from homozygous 42896G and 2395 larvae were analysed by 
inimunodetection with the specific Myosin V antibodies. Oregon R embryos were 
used as a positive control for Myosin V wild-type expression. Protein from 
heteroallelic 2395fDrf"22 embryos was used as a negative control. The latter would 
show reduced levels of Myosin V expression even if mutation in 2395 is not affecting 
this expression. 
5.1.2 Analysis of the mutant phenotype 
From the complementation test we knew that both lines, 2395 and 4289 are 
homozygous lethal. Even when grown in large population no escaper flies were 
observed. To determine the lethal stage we collected 2395/GFP and 42896G/GFP 
embryos. These were studied on a fluorescent microscope and photographed (Fig. 
5.2.4A). All embryos, homozygous and heterozygous, were normal and hatched 
without problems. 
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Figure 5.2.4A Mutant phenotype associated with the disruption of 
Myosin V function 
A, B: Initial experiments with Kr-GFP balanced flies. 
C, D: Heterozygous larvae from 2395 and 42896G. These larvae develop normally. 
E, F, G: Homozygous mutant phenotype (no GFP expression). 2395 die by the end of 
first instar stage, 42896G larvae die shortly after hatching. 
H, I, J: Homozygotes mutant larvae that show fluorescence due to feeding on 
heterozygous (GFP expressing) larvae. 
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We observed that approximately 96% of the heterozygous larvae from both 
lines proceeded through normal development. The remaining 4% showed abnormal 
development dying during the first instar period. Approximately 74% of the 
homozygous 2395/2395 larvae appeared normal until the end of the first instar stage 
when they died in a short period of time. The rest, 26%, had shorter and rounder 
bodies and showed abnormal behaviour (slow and indecisive movements). They also 
died by the end of the first larval instar. Occasionally we found 2395/2395 larvae that 
move backwards. These were examined closely but they showed normal 
segmentation and intact epithelial structures such as denticles and bristles. Similar 
phenotype was observed in homozygous 42896G individuals. More than 95% of the 
42896G embryos acquired rounded bodies shortly after hatching. All individuals 
with 42896G mutant phenotype died before the end of first instar stage. Most of the 
homozygous 42896G/42896G larvae were immobile with certain individuals 
showing slow and uncoordinated, short distance movements. 
To look for any cuticle abnormalities we mounted homozygous and 
heterozygous larvae in Hoyer's medium (see materials and methods). These were 
examined on a light transmission microscope and photographed. We found no 
changes in the internal structures of the heterozygous and 2395 homozygous 
embryos. In 5% of the examined homozygous 4896G larvae we found healed scars 
on the larval cuticle which we believe are from abnormal dorsal closure during 
embryogenesis (Fig. 5.2.413) 
2395/ActGFP 	 2395/2395 
Figure 5.24B Mutant phenotype associated with the disruption of 
Myosin V function 
A cuticle scar was found in 5% of the 42896G homozygous embryos 
(red arrow). 
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5.2 	Targeted silencing and activation of Myosin V expression 
during Drosophila development 
Overexpression or suppression of the gene expression will disrupt the 
function of Myosin V at specific developmental stages and in specific cell types, thus 
allowing the function of the gene to be studied. Two different systems were chosen 
to carry out experiments where inducible sense or antisense Myosin V RNA is to be 
transformed in wild-type flies: In the Ga14-UAS system a tissue specific Ga14 
induces expression of a UAS that is fused to a sense or antisense transgene-spatial 
specific expression. In the second system the transgene is under the control of a 
heatshock promotor thus allowing us to control its expression in a temporal-specific 
manner. In this thesis we describe the construction of these recombinant constructs. 
Due to time limitations we were not able to transform and study their effect in flies. 
5.2.1 Cloning of myosin V into pCaSpeR-hs vector 
The vector allows subcloning of genes in sense and antisense direction under 
the control of inducible heatshock promotor. The vector provides P-element ends 
which are necessary for effective germline transformation. 
XbaI 	 xbaI 	 XbaI 
(U 	Myosin V 	 (4hsP7O) MCS hsp7O 3'UTRI...,1  
pM4 (in pBSK-) 	 I 	pCaSpeR-hs 	I 
Amp I 1HWhite 
3'PI 
AmpR>@jJ 
hsp7OP 	Myosin V >jhsP7O  3'LJTR 
I 	 pHSMF 
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5.2.2 Cloning of myosin V into pUASp vector 
The vector allows subclonmg of genes in sense and antisense direction under 
the control of UAS (upstream activating sequence), (Ga14 activated) driven promotor. 
The vector provides P-element ends necessary for germline transformation. We 
chose this vector because it is expressed in the germline cells (Rorth 1998), and 
myosin V is also expressed in these cells during oogenesis. 
XbaI 	 XbaI 




Amp" 	Mini-White 	Amp" I 
(!hS!P7 	MjvsinV 	 p7O 3UTR
pUAM 
'" 	15'PI Amp" 13'PI 
or 
rh9P7O 	MyosnV II hsplO 3'UTRpHSMRF White 	5'PI Amp"  13'PI 
5.3 	In vivo analysis of Myosin V expression 
5.3.1 Construction of universal GFP vector for P-element mediated 
transformation 
To study the subcellular distribution of Myosin V and any rapid spatial and/or 
temporal changes in its distribution in vivo we constructed chimeras between myosin 
V and GFP (green fluorescent protein). To control the expression of these fusion 
constructs the advantages provided by the Ga14-UAS system were used. A universal 
154 
Genetical analysis of Myosin V function 
vector (pUN2), a combination of pUASp and GFPN1 vectors was constructed. Our 
plans were to clone different parts (domains) from myosin V in pUN2. Expressing 
the complete myosin V-GFP sequence will gives us information about the 
distribution of the wild-type Myosin V. Expressing only the head domain (head-
GFP) will serve as a control (the head contains the actin binding site). Expressing the 
tail (tail-GFP) will help us to understanding the function of Myosin V, and find out 
what is the cargo to which the tail binds. Unfortunately the myosin V cDNA 
contained all the restriction sites need for cloning in pUN2. An alternative cloning 
approached is discussed below. 
KpnI 	 XbaI 	 KpnI XbaI 
MCS 	
Ci-White 




KanR  	H Amp' 
Agel KpnI BamHI Agel 	Xbai 
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5.3.2 Cloning of myosin V-GFP sequence in pUASp 
To create a fusion between myosin V and pUASp the construction of an 
intermediate construct was needed (Fig. 5.4.2A). For this reason we combined 
pEGFP-N1 with pBluescript to make the pGSK vector. Thus we could choose from 
wide range of restriction sites for the subsequent cloning of the myosin V domains. 
Figure 5.4.2A Construction of pGSK vector 
Hindill KpnI 	 Hindill KpnI 
MCS 
  =pBluescript 
 
L------KanR-- AmpR  
Hindill EcoRl BamHI Spel XbaI Noti 
KpnI Agel 




The complete ORF (open reading frame), the head domain and the tail 
domain of myosin V were amplified by PCR using specific primer which introduce 
Spel and Agel restriction site at the ends of the amplified products (see Fig. 5.4.2B 
for further details). The latter were digested with AgeI+SpeI and ligated to pGSK 
vector. Because of time limitations only the constructs containing the total myosin V 
eDNA and the one with the tail domain were further processed. 
The Myosin V-GFP (total and tail domain constructs) fusions were excised 
from pGFT and pGFW with SpeI+XbaI restriction digests and cloned into pUASp to 
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generate pUGT and pUGW vectors. The latter could be introduced to flies using P-
element mediated transformation. 
Figure 5.4.2B Construction of pUGT and pUGW vectors 
speI_HESJ  spel  HEF 	(TAR Agel 
L< 
NJOSIfl V 	 PCR with gene specific primers design to 
introduce Spd or Agel restriction sites. Spel, 
pM3 (in pBSK-) Age! digest. Select band 2.6 kb (tail) and 5.7 
kb (myosin V ORF) and purify from gel. 
I
Spel 	Agel 
I Spel l NvcsinTaff lAgell 
ISpell 	 *P,osInV lAgell 	
PGSK r! Ka n 
I Liga. hh 	SpeI + Age! digest 4.7 kb (GFP) band purified from gel. 
Spel 	Agel 	 xbar 
V 
pGFT (Tail) or 
pGFW (Whole Myosin 'd) 
Spel Kpnl Nod BamHI Xbal 
_M_CS I3'UR 
pUA Sp  
__ 
pUASp vector digested with Spel and Xbat 
Ligate 7 
	
GAGA f UAS P Myosin V 	 3'UTRj 
I 	pUGT (Tail) or 
I pUGW (Whole Myosin '.) 
Kan' 	I 
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5.4 Discussion 
5.4.1 Functions of Myosin V in species other than Drosophila 
	
5.4.1.1 	The role of myosin V in mRNA transport 
In yeast mother cells are able to switch mating types. A HO endonuclease 
induces switching by causing a double stranded break at the MAT locus in mother 
cells. In daughter cells a transcriptional inhibitor Aship represses the HO 
endonuclease. Myosin V (Myo4p) is responsible for the restricted localisation of 
ASH] mRNA and protein (Jansen et al. 1996). As a result Aship is selectively 
expressed in the daughter cells only. Deletions in Myo4 yield no obvious phenotype 
but ASH] mRNA remain in the cytoplasm of the mother cells and no long range 
directed movements can be detected (Bertrand et al. 1998). 
5.4.1.2 	The role of myosin V in synaptic transmission 
Nerve cells contain a specialised class of secretory vesicles called synaptic 
vesicles. These can store small neurotransmitter molecules such as acetylcholine, 'y-
aminobutiric acid, and others, and mediate the rapid signalling from one cell to 
another. The regulated neuronal exocytosis involves a cascade of protein-protein 
interactions. After the synaptic vesicles are filled with neurotransmitter they are 
transported to the synaptic membrane and docked at defined sites. When an action 
potential arrives at the nerve terminal it causes an increase in the cytosolic calcium 
which triggers the vesicles to fuse to the membrane and release their contents into the 
synaptic cleft. The neurotransmitters then diffuse across the synaptic gap and trigger 
the adjacent nerve cell. The empty vesicles undergo endocytosis and are locally 
recycled. 
A number of proteins are essential for membrane fusion and are conserved in 
phylogenetically diverse species. SNARE proteins (Soluble NSF-Attachment 
protein) are believed to be key participants controlling the vesicular docking and 
fusion. SNARE (Soluble NSF-Attachment protein) on the plasma membrane bind 
with other SNARE on the synaptic vesicle to forin a docking complex. 
Synaptobrevin or VAMP (vesicle-associated membrane protein) is a SNARE protein 
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in neurons. It binds to syntaxin and SNAP-25 (Soluble NSF-Attachment protein) on 
the plasma membrane. 
Ohyama et al. (2001) showed that myosin V form a complex with 
synaptophysin and VAMP in the presence of calmodulin and C2 ions. The binding 
site to VAMP is the myosin globular tail. In the absence of calmodulin only 
syntaxin-VAMP or myosin-V complex are formed. This findings suggest that VAMP 
acts as receptor of myosin V on the vesicles and in the presence of C2 the complex 
between myosin V/VAMP binds to syntaxin. 
A 	 B 
Vesicle 
Synaptic cleft 	 - 	 r. j 
Syna!rc vesicle 





Figure 4.5.12 Delivery and docking of synaptic vesicle 
Formation of synaptic vesicles. The synaptic vesicle is delivered to the nerve 
synapse where it is loaded with neurotransmitter. The vesicle is then docked to a 
defined site on the membrane. 
Proteins needed for correct docking and fusion of the synaptic vesicle to the 
nerve membrane and the place of myosin V in this complex (see text for details). 
5.4.1.3 The role of Myosin Vin membrane trafficking 
Al-Haddad et al. (2001) showed that Myosin Va is involved in ATP-regulated 
binding of phagosomes to F-actin. Initially the phagosomes bind to receptors on the 
cell surface and are enclosed by the plasma membrane. Then they are acidified and 
fuse with lysosomes containing hydrolytic enzymes which degrade the engulfed 
microorganisms. These processes together with the subsequent stages of intracellular 
159 
Genetical analysis of Myosin V function 
transport from the periphery to the centre of the cells are dependent on cytoskeletal 
proteins. The newly formed phagosomes are surrounded by a thick layer of F-actin 
and actin binding proteins. The fusion with endocytic organelles is blocked if the 
cells are treated with drugs that depolyrnerise F-actin or microtubules. It was found 
that myosin Va colocalises with fully internalised phagosomes (Swanson et al. 1999). 
When Al-Haddad et al. (2001) analysed the phagosome movement in normal and 
dilute macrophages, they observed a rapid accumulation of phagosomes in the 
perinuclear region. 
Using a two-hybrid screen (Lapierre et al. 2001) have identified that rabbit 
myosin Vb interacts with Rabila a member of the small GTP-binding proteins in 
mammals. Additional test showed that myosin Vb tail binds to all members of the 
Rabi 1 family: Rablia, Rablib, and Rab25 while myosin Va does not bind to any of 
them. Immunolocalisation and "GFP-myosin Vb" experiments have revealed that 
myosin Vb is associated with the plasma membrane recycling system in nonpolarised 
cells and with the apical recycling system in polarised cells. Overexpression of the 
"GFP-Myosin Vb tail" fusion delayed the transferrin recycling and induced 
transferrin and transferrin receptor accumulation in pericentrosomal vesicles. These 
results indicate that myosin Vb is required for transport out of the plasma membrane 
recycling systems. 
5.4.1.4 	The role of myosin V in vesicular transport 
It has been shown that myosin V (Myo2p) is essential for yeast viability. 
Myo2p is required for the movement of a portion of the lysosome (vacuole) into the 
bud and subsequently for its correct inheritance during the division (Catlett and 
Weisman 1998). Myo2p was first found to deliver the chitosome to the plasma 
membrane (Santos and Snyder 1997). In addition Myo2p is implicated in post-Golgi 
vesicle transport and polarised growth. 
Class V myosins have a unique tail that contains a coiled coil region and a 
globular domain which mediate myosin-cargo interactions. Mutations in the globular 
tail lead to cells with defective vacuole inheritance but with intact polarised growth. 
A second group of mutations deleting 1459-1491 amino acids of the tail specifically 
affect polarised growth, thus demonstrating the presence of two distinct regions, 
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receptors for different cargoes (Catlett et al. 2000). Genetic data suggest that myosin 
V tail interacts with Smyip, a kinesin homologue and sec4p, a vesicle associated Rab 
protein (Schott et al. 1999). 
	
5.4.1.5 	The role of myosin V in cell division 
The localisation of myosin Va was investigated in cultured primary and 
immortal mammalian cells (Espreafico et al. 1998; Wu et al. 1998). 
Immunolocalisation with antibodies specific to myosin Va showed that the protein 
associate with the MTOC (microtubule organising centre) in interphase cells and to 
the mitotic asters, spindle and midbody in the dividing cells. In fibroblast cultures 
prepared from dilute cells (null mutant for Myosin Va) no such associations were 
observed. In addition it was found that the fibroblasts in the dilute cultures are twice 
as likely to be binucleated compared to the wild type fibroblasts. 
When cells were treated with detergent to remove the membranous structures, 
myosin Va remained associated with the microtubule-rich domains. Since no Actin 
was found on these domains it was suggested that myosin V may bind to 
microtubules either directly or by means of a microtubule associated protein. 
5.4.1.6 	The role of myosin V in filopodia! extension 
Myosin V is present in most of the vertebrate tissues but is especially 
concentrated in nervous tissue and neurosecretory cells. It was shown that myosin V 
molecules are present in the central and peripheral neurons (Mercer et al. 1991; 
Espreafico et al. 1992). 
To investigate the function of myosin V in growth cone dynamics (Wang et 
al. 1996) have used chromophore-assisted laser inactivation (CALl) technique. They 
showed that CALl of myosin-V growth cones of chick dorsal root ganglion neurons 
increases the rate of filopodial extension while not affecting the rate of filopodial 
retraction. (Evans et al. 1997) have investigated the distribution of myosin V in 
superior cervical ganglion (SCG) growth cone. The growth cone contains two well 
distinguishable cytoplasmic regions: a central microtubule-rich domain and a 
peripheral domain rich in F-actin. A part of the Myosin V has a diffuse cytoplasmic 
distribution. It was observed that most of the protein is concentrate in the central 
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domain. There it appears to associate with small vesicles. In the intermediate region 
between the central and the peripheral domains myosin V associates with small 
organdies, actin filament and plasma membranes (Suter et al. 2000). In general 
organdies associated with myosin V are evident on both microtubules and actin 
filaments. This suggests that organelles normally transported along microtubules 
might also be able to move along actin filament using the myosin as a connector 
molecule. Interestingly no abnormalities were found in growth cones from dilute 
mutants indicating that myosin V is not needed for the traction force for growth cone 
locomotion or for organisation of the actin cytoskeleton. 
5.4.2 Function of Myosin V in Drosophila 
Myosin V is expressed abundantly during Drosophila oogenesis. It subcellular 
localisation in the ring canal that connects the nurse cells to the developing oocyte 
implies that this myosin is involved in specific intracellular transport. In addition its 
accumulation at the anterior pole of the oocyte should be noted. A number of 
niRNAs and proteins have been shown to localise to the anterior margin of the 
oocyte. It is possible that Myosin V is involved in the transport and/or docking of 
molecules or vesicles to the cell membrane. 
Myosin V late function during larval development remain to be elucidated. 
Mutants for inyosin V demonstrate abnormal morphology and uncoordinated 
movements. It is likely that Myosin V is involved in vesicular transport of 
components for the developing CNS (central nervous system). It has been shown that 
Myosin V in vertebrates is involved in the regulation of neural transmission 
(Ohyama et al. 2001). The observed myosin V mutant phenotype is a likely outcome 
if the function of myosin V in regulation of neural transmission is disrupted. 
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5.5 Future work 
5.5.1 Roles of myosin Vtranscripts 
Our analyses revealed that myosin V produces multiple transcripts. Most of 
the transcripts differ at their 5' and 3'UTRs. Currently we know that transcription is 
initiated at at least two promoter sites and there are two polyadenylation signals. The 
difference in some of the transcripts arises from alternative splicing. Additional 
analysis is needed to elucidate the mechanism controlling this differential expression 
and determine the tissue and temporal expression of the alternative transcripts. This 
information is needed to understand the effect of myosin Von the cellular processes. 
5.5.2 Function of myosin V during Drosophila development 
Having specific antibodies to Myosin V will help us to study the subcellular 
localisation of the protein. Currently we know that a dynamic expression of myosin V 
occurs during oogenesis. The expression pattern of Myosin V needs to be studied in 
embryos and larvae where the mutant phenotype is most severe. It is likely that 
myosin V is involved in vesicular transport of components for the developing CNS 
during embryonic development. Co-localisation experiments with antibodies 
recognising known protein involved in these processes are essential. 
The phenotype of myosin V mutations in yeast, mice and humans suggests a 
role for this myosin in vesicular transport. In addition myosin V appears be important 
for normal central nervous system function. In all studies myosin V has been shown 
to localise to vesicular or organelle membranes except one case when it is 
responsible for the restricted localisation of ASH 1 mRNA in yeast. 
It is believed that motor-cargo interactions require three components: the 
motor protein, a cargo binding receptor and accessory components. The question is 
what are the cargoes and receptors for each motor protein, how it is regulated and 
which subunit of the motor domain binds the cargo. Studies based on co-
immunoprecipitation techniques have indicated that myosin V associates with small 
GTPases like Rab27a or Rab 11 a. In addition myosin V was found to bind to SNARE 
protein to form a docking complex. These proteins have homologues in Drosophila. 
To show whether these are potential targets for myosin V constructs containing the 
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cargo binding domain (myosin tail) are to be made and tested in two hybrid 
experiments. 
5.5.3 Functional analysis in vivo 
Since homozygous mutants for myosin V are lethal to study its function will 
require the production of clones of mutant cells. There are different techniques to 
make germ-line and somatic clones to look at myosin V function in the germ-line and 
follicle cells. 
The mutants can be used with other mutated genes to establish genetic 
pathways and hierarchies. This will show which genes depend on the correct function 
of myosin V for normal expression. 
Further analysis of the function of myosin V can be done by mis-localisation 
of its expression by using transgenic flies. Expressing Myosin V at a wrong place 
will allow us to look at any defects in the organisation of the oocyte and egg 
chamber. 
Recombinant constructs carrying sense and anti-sense RNA driven by 
heatshock promoter have been generated. These need to be transformed in flies. 
Inducing the promoter can disrupt the function of myosin V at specific developmental 
times and in specific cell types. 
5.5.4 GFP fusions 
To study the subcellular distribution of Drosophila Myosin V, its interactions 
with other molecules (e.g. actin, calmodulin, dynein and cargo molecules), and any 
rapid temporal and spatial changes in the distribution of the protein in vivo we 
constructed chimerical GFP fusions. Two different constructs were made: in the first 
the complete ORF of myosin V is fused to a GFP tag, in the second only the tail 
domain is fused to the GFP. In these constructs GFP can be used as a real time 
reporter for gene expression reflecting the dynamic events during Drosophila 
development. 
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Chapter Six: Identification and phylogenetic analysis 
of Drosophila melanogaster myosin genes 
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6.1 Introduction 
The past decade has seen a significant increase in research into myosins. A 
major effort has been put into finding novel members of this family of actin-based 
motor proteins. More than 16 classes of myosins have been discovered and 
characterised, and this number is still rising (Hodge and Cope 2000; Sellers 2000). 
These myosins are often referred to as unconventional (Mooseker and Cheney 1995). 
The total number of known myosins is 17 if the conventional two-headed filament 
forming myosin-11 are included in the classification. Myosins have been identified in 
a wide variety of eukaryotic organisms. Some myosin classes are found in 
phylogenetically diverse organisms, whereas others, which have arisen later in 
evolution, have been found in a single organism only (Table 6.1). 
Current research concentrates on the functional analysis of these new types of 
myosins. A number of studies suggest that these motors play important roles in a 
variety of cellular functions including organelle, RNA and protein transport, 
maintenance of cell architecture, cell movements, and signal transduction. 
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Table 61 Species diversity of the myosin genes 
Myosin I Myosin II Myosin Ill 
Acanthainoeba castellanii Acantliamoeba castellanii Linuilus polyphemus 
Saccharomyces cerevisiae Saccharomyces cerevisiae Drosophila melanogaster 
Diclyostelium disco ideuin A equipecten irradians Homo sapiens 
Caenorhabditis elegans Dictyostelium disco ideuin 
Drosophila melanogaster Caenorhabditis elegans 
Rana catesbeiana Drosophila melanogaster 
Gal/us gal/us Xenopus /aevis 
Rattus norvegicus Gal/us gal/us 
Bos taurus Rattus norvegicus 
Homo sapiens Homo sapiens 
Myosin IV Myosin V Myosin VI 
Acanthainoeba castellanii Saccharomvces cerevisiae Caenorhabditis elegans 
Caenorhabditis elegans Morone saxa ti/is 
Drosophila melanogaster Drosophila melanogaster 
Gallus gal/us Mus musculus 
Mus musculus its scrofa 
Rattus norvegicus Homo sapiens 
I-loin o sapiens 
Myosin VII Myosin VIII Myosin IX 	-- 
Dictyosteliuin discoideitin A rahidopsis thaliana C'aenorhabilitis elegans 
Caenorhabditis elegans Helianthus annuus Mus musculus 
Drosophila melanogaster Zea mays Rattus norvegicus 
Mus musculus Homo sapiens 
Sus scrofa 
Homo sapiens 
Myosin X Myosin XI - 	Myosin XII 
Caenorhabditis elegans Ivius musculus (7ilanu'domonas reinhardtii 
Box taurus Chara coral/ma 
Homo sapiens Arabidopsis thaliana 
Helianthus annuus 
Zea mays 
Myosin XIII Myosin XIV Myosin XV 
Acetahiilaria clijionif Toxoplasma gondii Drosophila melanogaster 
P/as in odium falciparum Mus musculus 
Homo sapiens 
Myosin XVI Myosin XVII Myosin XVIII 
Raitus norvegicus Aspergillus ii idu Ions Drosophila melanogaster 
Magnaporth e grisea Mus musculus 
Homo sapiens 
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6.1.1 Myosin domains 
	
6.1.1.1 	Myosin motor domain 
All known myosins comprise an N-terminal head domain, a neck regulatory 
domain, and a specific carboxy-terminal tail domain (Figure 6.1.1.2) (Mooseker and 
Cheney 1995). The head or motor domain contains ATP and actin binding sites, and 
is responsible for the mechanochemical properties of the protein (Gilbert and 
Mackey 2000). In addition the head contains three loops and two switches (see 
appendix I). The first loop is responsible for the speed at which myosin moves, loop 
2 is part of the actin binding interface and is believed to control the rates of 
phosphate release and to set the maximum speed for ATPase activity. Switch I and 
switch 2 have been shown to control the rate of ATP hydrolysis (Onishi 1998). 
Myosins show an actin-stimulated Mg 2+  ATPase activity, thus converting the energy 
stored in ATP into mechanical force (Volkmann and Hanein 2000). The latter is used 
to move the myosin molecules along actin filaments or translocate other molecules 
(Hasson and Mooseker 1995; Langford 1995). 
6.1.1.2 	Myosin neck domain 
IQ motifs 
The neck domain contains regulatory sites, composed of IQ (isoleucine 
/glutamine) motifs, repeats of 23-30 amino acids (Mercer et al. 1991; Rhoads and 
Friedberg 1997; Friedberg and Rhoads 2001). The consensus sequence for the IQ 
motif is IQxxxRGxxxRR ('x" is any residue). Each IQ motif binds to light chains 
that are related to the EF-hand family of proteins that include calmodulin (CaM) and 
troponin C (Kawasaki et al. 1998). The size of the neck domain varies from one to 
seven IQ tandem repeats (Figure X) and can vary among members within a particular 
class. In addition the neck is often the site of alternative splicing. This produces 
necks with variable length (variable number of IQ repeats), which are associated with 
regulatory function. The number of the IQ motifs is unrelated to myosin 
classification. 
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PM 
1111111 yosin 11 Non IIIIi 
- 
Domain key: 
Motor domain 0 SH3 domain (TI-13) 
J IQ-motif (11111111 Globular tail domain • Basic domain (THI) • Reverse Gear 
N-terminal extensions or insertions IllTII Zinc binding 
fl Coiled Coil GAP-domain • Kinase domain 0 Pleckstrin homology (PH) domain 
GPA/Q-rich domain (1112) Ankyrin repeats/protein phosphatase • MyTH4 • 
D FERM (Talin homology) PDZ domain 
Figure 6.1.1.2 Domain structure of conventional and unconventional 
myosins 
The domains are colour coded and explained in the figure legend. For more 
information see the text. 
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It has been proposed that the neck domain associated with its light chains serves 
as a lever arm for force transduction and determines the step size with which the 
myosin molecule moves forward along the actin filaments (Highsmith 1999). 
Myosin light chains 
Myosins from class II have two IQ motifs in their neck domain and bind two 
light chains. The First IQ motif (proximal to the motor domain) binds an essential 
light chain (ECL) and the second IQ motif binds regulatory light chain (RLC). Most 
of the unconventional myosins associate with one or more copies of CaM as light 
chains. Unconventional myosins with up to six IQ motifs have been shown to bind 4-
5 CaM light chains and 1-2 class specific light chains (Espindola et al. 2000; 
(Stevens and Davis 1998). 
Drosophila has two genes encoding ELC, one muscle specific and one 
nonmuscle specific light chains (Edwards et al. 1995; Edwards and Kiehart 1996). 
The nonmuscle isoform associates with nonmuscle myosin II and is thought to bind 
to myosin V, by analogy with the chicken myosin V (Espindola et al. 2000). In 
addition there two RLC: a non muscle isoform encoded by spaghetti-squash, (sqh) 
gene and a muscle isoform expressed in all muscle tissues (Kiehart and Feghali 
1986). The activity of RLC is regulated by phosphorylation (Karess et al. 1991). The 
phosphorylation site is usually a serine residue located near the N-terminus which 
often is accompanied by a second (one amino-acid apart) threonine phosphorylation 
site. Only one calmodulin gene has been found in Drosophila. There is also a testes 
specific protein, androcam, that shows a limited similarity to calmodulin. Analysis of 
the recently annotated Drosophila genome identified at least one other calmodulin-
like gene (Yamashita et al. 2000). 
Calmodulin signalling via the IQ motif 
In general, the light chains activates a diverse group of target cellular proteins 
when bound to Ca2 . These IQ-containing proteins include spindle associated 
proteins, neuronal growth proteins, conventional and unconventional myosins, ion 
channels, phosphatases, Ras and Ras-GAP like proteins. The majority of IQ-
containing proteins bind calmodulin in the presence of Ca 2+  (calcium-dependent 
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regulation). In this way the Ca 2+  signal is transferred to the calmodulin to control the 
molecular motor activity, cytoskeletal organisation, mitosis, etc. (Bahler and Rhoads 
2002). 
Interestingly most of the unconventional myosins carry IQ-motifs that bind 
calmodulin with higher affinity in the absence of Ca2 . This is due to conformational 
changes of the calmodulin upon Ca 2+ binding but not due to dissociation of 
calmodulin from the myosin. These conformational changes modulate the myosin 
ATPase activity and are not just on/off switches (Bahler and Rhoads 2002; Homma 
et al. 2000). 
6.1.1.3 	Myosin tail 
Following the neck domain, each myosin has a highly divergent tail domain. 
A subset of myosin tails have predicted coil-coil a-helical domains, which promote 
dimer formation; a typical example being the two-headed conventional myosin-11. 
Some other myosins lack coiled-coil domains but contain structural domains found in 
other proteins (Figure 6.1.1.2 and Table 6.1.1.3). 
6.1.2 Myosin classification 
The classification of myosins is based on the sequence comparison of their 
core motor domains (myosin head), equivalent to amino acids 88 to 780 of chicken 
skeletal myosin II (Cope et al. 1996). The motor domain is highly conserved among 
all myosins, reflecting the high conservation of its function. However, they have a 
number of class specific features (characteristic inserts or substitutions) which might 
be important in defining the precise function of a given myosin (Table 6.13). 
Phylogenetic analysis of the tail domain sequences produces similar results, 
indicating that heads and tails have co-evolved (Korn 2000). 
6.1.3 Structure and function of conventional and unconventional 
Myosins 
All myosins are composed of a head domain, neck and a class specific tail 
domain. It is the tail domain that is largely responsible for the class-specific 
functions (Table 6.1.3A). It has been shown that myosins are involved in a variety of 
cell functions such as organelle and mRNA transport, endo- and exocytosis, cell 
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division, maintenance of the cell architecture, regulation of the actin assembly and a 
role in the dynamics of actin-rich cell extensions, coordination and cooperation 
between microtubule- and actin dependent transport and signal transduction. Recent 
studies have identified a variety of segments (motifs) in the myosin tail domains (for 
review see (Oliver et al. 1999). Some of these are predicted to form coiled-coil 
domains that promote homodimerisation of two myosin heavy chains. Some remain 
with unknown function. Others showed high homology to domains with known 
function found in other proteins (Table 6.1.313). 
6.1.3.1 	Myosin  
Class I myosins have a variable number of IQ domains (one to six) in their 
neck domain. They lack coiled-coil domains in the tail region. Instead, following the 
tail domain there are three tail homology (TH) domains. TH1 has been shown to bind 
to phospholipid membranes and implicated in targeting myosin chains to membranes. 
TH2 domain or GPAIGPG is a proline-rich domain. It contains an actin-binding 
motif that is ATP insensitive. The TH3 domain is believed to promote binding to 
proline rich proteins (Osherov and May 2000; Barylko et al. 2000). Studies have 
shown that actually it is the SH3 motif found in the TH3 region that is important for 
actin binding. It was shown that the SH3 domain is able to induce cytosol-dependent 
actin-polymerisation in yeast (Geli et al. 2000). 
Ameboid class I myosins have role in actin-dependent movements and are 
responsible for the shape of a variety of subcellular structures such as vacuoles, 
endosomes and cell protrusions like pseudopodia (Ostap and Pollard 1996; Vargas et 
al. 1997; Senda et al. 2001). 
In vertebrates myosin 10 was found to localise primarily to the tip of 
stereocilia protrusions that are found on the top of hair cells (Hasson et al. 1997; 
Barylko et al. 1992) Overexpression of myrl in NRK (Normal rat kidney) cells 
showed no phenotype suggesting its function is not essential. In contrast 
overexpression of BBMI (brush border myosin I) in hepatoma cells caused defects in 
endocytosis and structural changes, while overexpression in epithelial cells disrupted 
the traffic of basolaterally internalised molecules to the apical surface (Osherov and 
May 2000). 
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Table 6.1.3A Domain structure and function of myosin classes 




Other (N- and C 	 Function 
Myosin terminal) Domains 
	
I Subclass 1 1-2 1 	TB!, GPAIGPQ and SH3 	Vesicle transport, cell growth and cell motility. 
Subclass 2 3-6 	1 TH1 domain 	 Function in the microvilli of the brush border. 
Subclass 3 3 1 TH1 domain 
Subclass 4 2 1 TH1 domain 
II Muscle 2 2 CC 
Nonmuscle 2 2 CC 
III 1-2 1 N-terminal protein kinase 
IV I I MyTH4 and SH3 
V 6 2 CC, Transmembi-ane, 
specific, DIL domain 
VI 1 2 ? CC, Reverse gear, specific, 
Globular tail domain 
VII 4-5 2? CC, MyTH4, FERM, and 
SH3 
VIII 3-4 2 ? CC, Serine-rich domain, 
C-terminal domain 
IX 4-6 1 N-terminal extension, Zinc 
binding and Rho-GAP 
X 3 2? CC, PH, MyTH4, FERM 
Xl 5-6 2? CC 
XII JQ? 2? CC, N-terminal, MyTH4 
XIII 4-7 1 - 
XIV IQ? I - 
XV 2-3 1 N-terminal extension 
MyTH4, FERM, and SH3 
XVI 2 1 Ankyrin repeats 
XVII IQ? 1 Chitin synthase domain 
XVIII 1-2 2? CC, KE, and PDZ domain 
Epithelial morphogenesis and hair cells function. 
Epithelial morphogenesis. 
Smooth or skeletal muscle contraction. 
Maintenance of the cell architecture, cell motility 
and phagocytosis. 
Role in prototransduction. 
? (Only in Acanthainoeba species). 
Mci'nbrane trafficking, polarised cell growth. 
Vesicle, protein and/or mRNA transport. 
Vesicle transport, epithelial morphoge-nesis, and 
stereocilia function. Spermatid individualisation. 
Moves toward the "-"end of actin filaments. 
Membrane trafficking, hair and photoreceptor 
cells function. 
Cell wall function in plants, intracellular 
transport. 
Signalling (GTPase activating). 
Localised to regions of dynamic actin. Signal 
transduction. 
Vesicular transport in plants. 
? (In C. elegans only). 
? (In plants only). 
? (In Toxoplasma and Plasmodium species) 
Hair cell function 
Neuronal cell migration 
? (In Pyricularia and Enüricella sp.) 
? Maintenance of the stromal cell architecture 
Note: *The number of heavy chains reflects their ability to dimerise (based on coiled-coil 
predictions). Key to domain abbreviations: TH1- Tail Homology basic 1 domain, GPA-
glycine/proline/alanine rich domain, GPQ-glycine/proline/glutamine rich domain, SH3-Tail 
Homology 3 domain (binds to proline-rich motifs), CC-Coiled-Coil, MyTH4-Myosin Tail 
Homology 4 domain, Rho-GAP-domain (activates small GTPases of the Rho family), PH-
Pleckstrin Homology domain, KE-lysine/glutamate rich domain, PDZ or DHR (DIg 
homologous region. For recent reviews on the structure and properties of the unconventional 
myosins see (Wu et al. 2000; Oliver et al. 1999; Baker and Titus 1998; Mermall et al. 1998). 
In the construction of this table data was used from these reviews, the myosin home page and 
Cope et al. (1996). 
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Table 6.1 .3B Function of myosin domains 
_PriJL Full name Function fi 	Distribution 
MYSc Myosin motor Binds actin and ATP. Hydrolysis ATP to All myosins 
generate mechanical force. 
IQ motif - Binds calmodulin and/or other light chains All myosins, 
of the EF-hand family. except XIV, XVII 
CC Coiled-coil Responsible for dinierisation. Involved in In myosins II, 
the assembly of myosin thick filaments. V,VI, VII, VIII, 
X, Xl, XII, XVIII 
TH1 Tail homology basic 1, Involved in membrane binding. Myosin I 
GPA Tail homology 2 (Gly- Role in actin binding in an ATP- Myosin I 
(TH2) Pro-Ala-rich) insensitive manner. 
GPQ Tail homology 2 (Gly- Role in actin binding in an ATP- Myosin I 
 Pro-Glu-rich) insensitive manner. 
SH3 Tail homology 3 Involved in signal transduction. Binds Myosin I, IV, VII 
 proline-rich motifs. and XV 
MyTH4 Myosin tail homology 4 I.Jnknown Myosin IV, 1,111, 
doiiiain X, XII and XV 
Kinase - Binds ATP. Signal transduction from the Myosin III 
domain photo-complex to the cytoskeleton. 
DIL Globular tail with AF-6 Function unclear. Implicated in cargo Myosin V 
homology binding. 
FERM Band 4. 1, ezrin, radixin, Possible role in connecting the Myosin VII, X 
moesin homology cytoskeleton to the plasma membrane, and XV 
Reverse - Directs a movement towards the minus end Myosin VI 
gear of actin filaments 
DAG-PE- Zinc binding Binds Zn2 ions. Though to bind to Myosin IX 
bind diacyiglycerol, a protein kinase C 
activator. 
Rho-GAP - Activates small GTPases of the Rho family Myosin IX 
(signal transduction). Reorganisation of 
the actin cytoskeleton. 
Rho GEF - Activates small GTPases of the Rho family Dictyostelium 
(signal transduction). Known to associate MyoM 
with PH domains. 
RA (RAS Association) Known to associate with RasGTP. Myosin IX 
Unknown function in the myosins. 
PH Pleckstrin homology Known to hind to: G proteins, lipids, Myosin X 
phosphatidylinositol, phosphorylated 
Ser/Thr residues and membranes. 
Ank Ankyrin repeats/protein Adaptors, associating with spectrin-based Myosin XVI 
phosphatase cytoskeleton and membrane proteins. 
Protein/protein interactions. 
Chitin - A role in cell wall synthesis. Myosin XVII 
synthase 
PDZ Dig homologous region Signal transduction. Targeting signalling Myosin XVIII 
molecules to sub-membranous sites. 
KE Lysine-glutamate-rich Unknown function Myosin XVIII 
WD40 Similar to motifs found Unknown function Plasmodium 
in beta- transducing Myosin 
subunits of G proteins 
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6.1.3.2 	Myosin II 
Myosins from class II were the first members of the myosin superfamily to be 
identified. They have a long a-helical domain in the tail that allows formation of 
homodimers. The dimers can further assemble into bipolar anti-parallel filaments. 
Lower eukaryotes like Dictyosteliurn and Acanthamoeba species have 
relatively divergent types of myosin II. They have been implicated in a variety of 
functions such as receptor capturing, generation of cortical tension and cytokinesis 
(Cheney et al. 1993b). 
In vertebrates myosin-Ils are divided into two major groups: striated the 
muscle myosin and the nonmuscie (and smooth muscle) group. Skeletal muscle 
myosin is responsible for generating the force for muscle contraction. In skeletal 
muscle myosin II filaments are surrounded by thin actin filaments in complex arrays. 
Thus ATP-driven sliding of the actin filaments results in muscle contraction. 
Nonmuscle myosins have role in cytokinesis and capping surface receptors (Boyne et 
al. 2000), cytoplasmic transport, maintenance of the cell architecture, cell motility 
and phagocytosis (Edwards and Kiehart 1996; Ikonen et al. 1997). 
6.1.3.3 	Myosin III 
A member of this class was first identified from Drosophila and named 
ninaC (Montell and Rubin 1988). NinaC myosins have also been found in human 
retina (MY03 and MY0313), fish retina (FM3a and FM3b) (Berg et al. 2001) and 
(Dose and Burnside 2002) and in horseshoe crab, Limulus polyphemus (Battelle et al. 
1998). 
Nina C protein has 300 amino-acid kinase domain located on its N-
terminus. The gene has been shown to express two alternatively spliced forms p132 
and p174 the larger of which contains a rhabdomere localisation signal (Montell and 
Rubin 1988; Hicks and Williams 1992). NinaC expression is detected only in 
photoreceptor cells. The protein localises to the tip of the rhabdomere, that is a site of 
phototransduction. There ninaC binds to maD scaffolding protein and links it to the 
actin filament at the core of the rhabdomere. maD is a key scaffolding protein which 
associates via its five PDZ domains with most of the proteins responsible for the 
phototransduction signalling (rhodopsin, phospholipase C, protein kinase C and TRP 
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and TRPL cation channels) to form a signalling complex known as "transducisome" 
(Wes et al. 1999). Defects in ninaC leads to abnormal electrophisiological response 
and retinal degradation, indicating a need for phosphorylation in regulating the 
termination of photoresponse. 
	
6.1.3.4 	Myosin IV 
Currently M4 from Acanthamoeba is the only member of this class (Horowitz 
and Hammer 1990). M4 does not have coiled-coil motifs and does not form dimers. 
The protein contains a single IQ motif thought to bind calmodulin. The tail domain 
contains one SH3 domain which can bind to proline-rich motifs. A proline-rich 
ligand, Acan 125 has been identified for the SH3. Acan 125 belongs to the 
superfamily of leucine-rich repeat proteins (Xu et al. 1997). In addition the tail has 
one MyTH4 domain with unknown function (Oliver et al. 1999). 
6.1.3.5 	Myosin  
This type of myosin is extensively discussed in chapter 3. 
6.1.3.6 	Myosin VI 
Drosophila myosin 95F was the first member of this family to be described 
(Kellerman and Miller 1992). Later two genes were identified in C. elegans (Baker 
and Titus 1997) and a single gene in vertebrates (pig, mouse, chicken and human). 
Analysis of the myosin VI structure shows that the protein has a 25 amino-acid 
insertion in the conserved head domain and a threonine substitution at the TEDS rule 
site. This suggests that myosin function is regulated by head phosphorylation. The 
neck domain contains a single IQ motif preceded by a unique 53 amino-acid reverse 
gear (RG) domain. The latter has a role in reversal of lever arm movements. Analysis 
of the sequence showed that RG domain is positioned after the converter region, at 
the base of the long a-helix that forms the backbone of the lever arm. This shows that 
the insert (RG) does not replace the converter but modulates its function to redirect 
lever arm movement (Hasson and Cheney 2001). The myosin VI tail contains a 
coiled-coil domain, responsible for dimerisation and a distal globular domain. Recent 
studies have shown that the globular tail associates with microtubule-binding protein 
CLIP-170 (Lantz and Miller 1998) demonstrating the presence of dynamic 
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interaction between components of the microtubule- and actin- based transport 
systems. Deng et al. (1999) have shown that Myosin VI is required for follicle cell 
epithelial morphogenesis during Drosophila oogenesis. It was shown that Drosophila 
Myosin VI has a role in sperm individualisation (Hicks et al. 1999). 
Class VI myosins are one of three classes (the others are class VII and XV) 
that are associated with deafness. Mutations in mouse myosin VI (Snell's waltzer 
mouse) result in deafness and vestibular problems (Avraham et al. 1995). Both 
defects are associated with abnormal development of the organ of Corti. The latter 
projects more than a 100 actin-packed stereocilia from its apical surface.. The base of 
each stereocilia is anchored into the cuticular plate. When the stereocilia bundles are 
deflected due to interaction with sound waves, this result in stretching the links 
between the stereocilia in different rows which opens transductions channels. This in 
turn leads to depolarisation of the hair cell and release of neurotransmitter (Holme 
and Steel 1999). The Snell's waltzer mice lack hair cell stereocilia and are unable to 
engage in mechanotransduction. 
6.1.3.7 	Myosin VII 
Myosin VII has a typical structure for the unconventional myosins. The 
molecule has a neck domain composed of five IQ motifs and a very long tail domain. 
The tail contains a number of motifs that are believed to interact with other proteins: 
a short coiled-coil domain, which has been shown to promote homodimerisation, two 
MyTH4 domains, two FERM domains and a poorly conserved SH3 domain. The 
FERM domains of these proteins have been shown to bind membrane proteins 
(directly or via an adapter). 
Mutations in myosin VITa cause the shaker-] phenotype in mice and Usher 
syndrome 1  in humans (Friedman et al. 1999). These phenotypes are characterised 
by deafness and vestibular dysfunction. In addition the mutants exhibit abnormal 
microtubule organisation in the sperm-tail axonemes, photoreceptor cells, and nasal 
cilia! cells. The expression pattern of myosin VII in the sensory hair cells in both the 
cochlea and vestibular apparatus correlates well with the sites that are affected in the 
pathogenesis (Oliver et al. 1999; Holme and Steel 1999). In addition myosin VII is 
expressed in a variety of organs: brain, intestine, liver, kidney, adrenal gland and 
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testis. Interestingly an abnormal phenotype was only observed in the inner ear and 
eye. 
Recent studies have demonstrated a role for myosin VII in phagocytosis in 
Dictyostelium amoeba (Titus 1999). 
	
6.1.3.8 	Myosin VIII 
Members of this class are plant myosins. Myosin class VIII have a large 
coiled-coil motif in their tail known to promote dimer formation. Immunolocalisation 
experiments have shown that A. thaliana myosin 1 (class VIII) appears to be 
localised in the plasmodesmata in the newly formed cell walls. It was suggested that 
myosin VIII is involved in the maturation of the cell plate and restablishment of the 
actin network at sites of intercellular communication (Reichelt et al. 1999). 
6.1.3.9 	Myosin IX 
Myosins from class IX have been isolated from a number of species. Analysis 
of the genomic sequence of C. elegans indicates that it has a single gene for myosin 
IX (Baker and Titus 1997). Vertebrates were shown to have two types of myosin IX: 
a and b subtypes. Myosins MY09A and MY09B have been cloned from human 
(Wirth et al. 1996; Berg et al. 2001). In rat M9b was cloned first and is known as inyr 
5. Recently the second member, M9a has been identified and named myr 7. 
(Reinhard et al. 1995). 
The heads of these myosins have a 60 amino-acid extension and large 
insertions of approximately 120 amino-acids in the actin-binding region. The tail 
lacks any coiled-coil motifs suggesting that the myosin functions as a monomer. The 
tail contains regions found in the chimerins, with a putative C61-12 zinc binding 
domain and a GAP (GTPase activating protein) domain of the rho/rac family of ras-
like G-proteins. The ras-related rho subfamily of small GTP binding proteins (Rho, 
Rac and Cdc42Hs) has a role in actomyosin-dependent processes and in actin 
reorganisation. It was demonstrated that MY09b and myr 5 exhibit GAP activity for 
rho but almost no activity for rac or Cdc42Hs. Transgene expression of myr 5 in 
insect cells resulted in variety of changes in the thin processes (numerous processes 
of rapid growth and retraction during dendritic development). Overexpression 
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experiments in mammalian cells caused cell rounding and loss of actin stress fibers 
(Oliver et al. 1999; Chieregatti et al. 1998) have shown that myr 5 is expressed 
mainly in lung, spleen, liver and testis, while myr 7 (MY09a) is abundantly 
expressed in brain. It is believed that it plays a role as a negative regulator of rho-
mediated actin morphology and function in neurons. 
6.1.3.10 Myosin  
Myosin X was first isolated from a bovine aorta library. Later members have 
been identified in human and mouse (Hasson et al. 1996; Oliver et al. 1999). 
Myosins class-X have a neck with three IQ motifs, short coiled-coil domain, three 
plextrin homology domains (PH) followed by MyTH4 and FERM domains. All these 
domain are known to have role in protein-protein interactions. The presence of all 
these domain in a single molecule makes it a potential candidate to form a part of a 
multicomponent signalling complex. 
6.1.3.11 Myosin X1 
This class contains a number of plant genes which were previously classified 
as class-V myosins due to structural similarities with the animal class-V myosins 
(Liu et al. 2001). As such these were discussed in chapter 3. It was shown that that 
plant myosin XI localises to the root tip cells and is highly concentrated in 
mitochondria and low-density membranes. It is believed that myosin XI has a role in 
vesicular transport and membrane trafficking. 
6.1.3.12 Myosin XII 
This class is defined by the hum-4 gene isolated from C. elegans (Baker and 
Titus 1997). The gene encodes an unusually large heavy chain of 307kDa. 
Phylogenetic analysis showed that the head domain show only 20% identity to other 
myosins. The function of HUM-4 remain unknown. Sequence analysis has shown the 
presence of two inserts in the head domain, two MyTH4 domains and a small coiled-
coil domain implicated in dimer formation. 
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6.1.3.13 Myosin XIII 
There is little information about these myosins. So far only two genes have 
been isolated, both from the green algae Acetabularia cliftonii. Myosin XIII has a 
large neck domain composed of up to seven IQ motifs implying a complex 
regulation. The tail domain is short and contains no domain with known function. 
6.1.3.14 Myosin XIV 
These myosins are found only in obligate intracellular parasites such as 
Plasmodium falciparuin and Toxoplasma gondii (Hettmann et al. 2000). The 
Plasmodium expresses a multiple of short tailed myosin XIV genes: TgMA, TgMB 
and TgMC, while only a single gene have been identified in T. gondii so far. It has 
been shown that class-XIV myosins are targeted to the cell periphery where they 
associate with the membrane. This localisation is actin independent. Site directed 
mutagenesis revealed that two arginine residues in the distal part of the tail are 
responsible for the specific membrane localisation. A function in the invasion 
process has been suggested for these proteins. 
6.1.3.15 Myosin XV 
Myosins from this class have been identified in mouse, human and recently in 
Drosophila (Liang et al. 1999; Tzolovsky et al. 2002). The human (MY015) and 
mouse (Myol5) encode approximately a 360 kDa heavy chain that is unique among 
the myosins. The protein has two to three IQ motifs followed by a very long tail 
domain composed of two MyTH4 domains, two FERM domains and a single SH3 
domain. Myosin XV is abundantly expressed in the pituitary gland and the sensory 
epithelia of the cochlea and vestibular system in the inner ear (Lloyd et al. 2001; 
Friedman et al. 1999). Mutations in myosin XV are responsible for congenital 
profound deafness DFNB3 in humans and deafness and abnormal behaviour due to 
defects in the vestibular system in shaker-2 mice. 
6.1.3.16 Myosin XVI 
A single member of this class has been isolated from rat and designated as 
myr 8 (Patel et al. 2001). The gene expresses two alternatively spliced isoforms, 8a 
and 8b. The head of myosin XVI contains a large N-terminal extension that contains 
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multiple ankyrin repeats. They are known to associate with protein phosphatase 1 
(PP1) catalytic subunits la and l'y. The neck containing a single IQ motif is followed 
by a short tail that is positively charged in 8a and bearing no charge in 8b. It was 
shown that 8b is the predominant isoform expressed in brain. It is believed that 
myosin XVI selectively targets protein phosphatase catalytic subunits to the 
developing brain. 
6.1.3.17 Myosin XVII 
The first member of this class was cloned from Aspergillus nidulans 
(Fujiwara et al. 1997). The gene was named csmA for chitin synthase with a myosin 
motor-like domain. It encodes a large chitin synthase domain situated at the C-
terminus. No putative IQ motifs have been identified so far in the neck domain. 
Recently a second member has been found in Pyricularia oryzae (Park et al. 1999). It 
was suggested that myosin XVII has a role in directing the chitin synthesis. 
6.1.3.18 Myosin XVIII 
Using a differential display method Furusawa et al. (2000) have isolated a 
gene with expression levels correlated with the hematopoetic supportive ability of the 
stromal cells. The gene proved to be a novel member of the myosin family. Recent 
studies have identified myosin XVIII genes in human (Berg et al. 2001) and 
Drosophila (Tzolovsky et al. 2002). Myosin XVIII contains a lysine/glutamine-rich 
sequence (KE sequence) followed by a single PDZ domain. The neck contains one or 
two IQ domains. The tail has a long coiled-coil domain similar to that of class-11 
myosins, followed by a unique, 100 amino-acid globular tail. Currently the function 
of myosin XVIII remain unknown. It is believed that it functions as a part of a 
mobile scaffolding complex through interactions with the PDZ domain. In general 
the role of PDZ domains is to position correctly target ion channels, receptors or 
other signalling molecules to specialised sites in the cell (Bezprozvanny and 
Maximov 2001). 
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6.1.4 Myosin genes in eukaryotic organisms 
Five myosin genes have been identified in yeast (S. cerevisiae) falling into 
three classes: there are two class I myosins, one class II, and two class V myosins 
(Brown 1997). It was suggested that the whole yeast genome has undergone a 
duplication in ancient times followed by a number of modifications. As a result a 
small fraction of the genes were retained in duplicate (most being deleted), thus 
explaining the loss of the second myosin II gene (Wolfe and Shields 1997). S. 
cerevisiae is the organism with the lowest known number of myosin genes. This 
demonstrates that a eukaryote can function with a set of only three types of myosins. 
Multicellular organisms have the ability to express some 10 to 40 myosin 
genes encoding at least six types of myosin. It seems that multicellular organisms 
require many more specialised myosins than the single cell yeast. This has raised the 
question of what is the degree of functional redundancy between the classes and 
between the members of a given myosin class? 
So far 11 myosin genes have been identified in the slime mould D. 
discoideum. Despite the fact that this is one of the simplest multicellular organisms, 
it expresses a diverse set of myosin genes (Soldati et al. 1999). They encode at least 
six different classes of highly specific myosins. There are six class I myosins (MyoA, 
B, C, D, E, K and probably MyoF), a single member of class II (MhcA), class VII 
(Myol) (Titus 1999) and class XI (MyoJ) (Hammer and Jung 1996). The highly 
divergent MyoM is still to be classified (Schwarz et al. 1999). 
Fourteen myosin genes have been identified in the nematode C. elegans 
(Baker and Titus 1997). They encode two structurally distinct class I myosins, six 
class II, one class V, two class VI, one class VII and one class TX myosin. It was 
found that C. elegans has a highly divergent type of myosin, being the founding and 
only member of class XII myosins. 
The situation with vertebrates appears even more complex. They express 
some 40 myosin genes grouped in 12 classes. In human there are eight class I, 
sixteen class II, two class III, three class V, one class VI, two class VII, two class IX, 
one class X, two class XV, and one class XVI myosins (Hasson et al. 1996; Berg et 
al. 2000; Berg et al. 2001). Recent studies have discovered two PDZ-containing 
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myosins (Furusawa et al. 2000) as well as a novel unclassified myosin (Berg et al. 
2001). 
6.1.5 Myosin genes in Drosophila 
In Drosophila eight different myosin genes were described thus far (Fig. 
6.1.5, Fig. 6.2 and Table 6.3). There are two class I myosins, members of subclass 3 
(myosin-IB) and subclass 4 (myosin-IA) (Morgan et al. 1994; Cheney et al. 1993a; 
Mooseker and Cheney 1995). Only a single muscle myosin II gene was found in 
Drosophila (Hastings and Emerson 1991; Bernstein and Milligan 1997). It encodes 
more than 13 protein isoforms with complex temporal and spatial expression patterns 
(Bernstein and Milligan 1997; Zhang and Bernstein 2001). Drosophila has a second 
myosin-11 gene that encodes a cytoplasmic nonmuscie myosin (Kiehart et al. 2000; 
Mansfield et al. 1996). The founding member of class III myosins was discovered in 
Drosophila (Montell and Rubin 1988). The ninaC-Ill gene encodes two isoforms 
resulting from alternative RNA splicing. These differ in the composition of their C-
terminal tails and show differential expression patterns (Porter et al. 1992; Li et al. 
1998). A single myosin V gene, with at least two different splice forms, was 
identified in Drosophila (Bonafe and Sellers 1998; Maclver et al. 1998). Kellerman 
and Miller (1992) cloned a novel unconventional myosin from Drosophila - the first 
member of class VI myosins. The gene encodes multiple protein isoforms, which are 
present throughout Drosophila development (Mermall and Miller 1995; Deng et al. 
1999 Hicks et al. 1999). Drosophila myosin VIIA was the first member of this class 
to be described (Cheney et al. 1993b; Kiehart et al. 1998). 
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Figure 6.1.5 Schematic diagram of the domain structure of Drosophila 
myosins 
The previously described Drosophila myosins. Their sequence and structure have 
been studied and confirmed. For DNA and protein accession numbers see Table 6.3 
The five new or previously uncharacterised Drosophila myosins. Their domain 
structure is based on the predicted cDNAs for these myosins (see Table 6.3). The 
presence of some domains (e.g. the PDZ domain in Mhcl myosin) was verified with 
RT-PCR. A colour key to the domain names is given on the left. Some of the names are 
abbreviated, these being: MyTI-14-Myosin Tail Homology 4 domain, FERM (Band 4.1, 
ezrin, radixin, moesin-homology domain), QPA-glutamine/ proline/alanine rich 
domain, PDZ- a domain with potential for targeting to membrane sites. 
6.2 	Analysis and Manipulation of Sequences 
We have used the completed Drosophila melanogaster Genome Project to 
determine the number of myosin encoding genes in this species and to classify them. 
The new myosin genes were identified by comparing the Drosophila genome 
sequence with the conserved head (equivalent to amino acids 88 to 780) of chicken 
skeletal myosin II. Comparison to the Genbank Data Base was done using the 
BLASTP algorithm on the National Center for Biotechnology Information 
(http://www.ncbi.nlm.nih.govIBLAST/), the Pole Bio-Informatique Lyonnaism 
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server (http://pbll.univ-lyonl.fr/BLAST/blast.html), and The Berkeley Drosophila 
Genome Project BLAST at http://www.fruitfly.org/blast/. This search retrieved the 
eight previously described myosin genes as well as three new genes: Myo 28B1 
(AAF52536), Myo]OA (AAF47980), and Mhcl (or Myo89B) (AAF55271). 
Subsequent detailed analysis was done using the conserved head or specific tails 
from all known classes of myosins to search the translated Drosophila genome 
sequence (TBLASTN on the NCBI server). These searches identified two other 
sequences highly similar to myosins: Myo29D (AAF52683, AF454348) and Myo95E 
(AAF56246, AF454350). 
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Figure 6.2 Polytene chromosome position of Drosophila 
melanogaster myosin genes (based on the data provided by the 
Berkeley Drosophila Genome Project (BDGP) 
The figure presents all myosin genes, new and previously identified, in 
relation to their chromosomal locations. So far no myosin genes have been 
found on chromosome four. 
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6.2.1 Domain Analysis. Multiple Sequence Alignment 
The domain structure was predicted with (SMART), Simple Modular 
Architecture Research Tool server, at http://smart.embl-heidelberg.de/ (Schultz et al. 
1998), Pfam HMM database at http://pfam.wustl.edu/hrnmsearch.shtrnl or 
http://www.sanger.ac.uk/Soft-ware/Pfam/ search. shtml (The Sanger Centre), and the 
ProFile Scan Server of ISREC (Swiss Institute for Experimental Cancer Research) at 
http://www.isrec.isb-sib.cli/software/ PFSCANform.html. Alignments of the 
detected domains were performed with CLUSTAL W (Thompson et al. 1994) 
available from the Gene Jockey II software package distributed by Biosoft or from 
the WEB based package at http://www2.ebi.ac.uklclustalw/. Subsequently the 
sequences were run on WEB based BoxShade Server (http://ludwig-
sun I .unil .ch:8 080/software/BOX form.htrnl) and manually adjusted in Microsoft 
Word 98. Coiled-coil regions were predicted with the Paircoil program developed by 
Berger and colleagues (Berger et al. 1995) at http://nightingale.lcs.mit.edu/cgi-
bin/score.  
Primers used in the analysis of Myo 95E (Myosin 95E): 




ST95E(EFI) TGT TGC TCG CCA GCA CAT G 19 60 
IBR GTG CCG ATT TCC TGC TCC AT 20 62 
46F(EF2) ATG GAG CAG GAA ATC GGC AC 20 62 
3FOR(EF3) CAT CAG CGG CCT TCC TGA AT 20 62 
4BAK TTA GAA CCA CTG CGA TGA CC 20 60 
ESR(ERI) AGG CAG CGC TTA TGT ACT TC 20 60 
ESF(EF4) GAA GTA CAT AAG CGC TGC CT 20 60 
PIEF CGC ACC GTA TAT GAG TTG GA 20 60 
9512R CTA AGA TGA CGA GAG GCA TC 20 60 
46R(ER2) ACA ATT ATC TCC ATG CGG TTC G 22 62 
13F CAT GTC GGA CTT AGC ACA AG 20 60 
3UT95(ER3) ACG TAG ATG CCT GAA CTA TC 20 58 
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Primers used in the analysis of Myo IOA (Myosin IOA): 




INF(AFI) OCA GCA ATG AAT CAA COG GT 20 60 
HYST(AF2) TGA TCT GGT CTG GTT CGA TC 20 60 
510R AGC AGG GTC ATG TCC TCC A 19 60 
10-AR (ARI) CAT OTT GTA CGG ATT CAC CG 20 60 
PI5F(AF3) TCA GTG TCC AGA GGC ATG TG 20 62 
MYTH4-10(AF4) TGG AGT GGC GTG COT GGA 18 60 
FERM-10(AR2) TCC GCA CGC GCA ACT TCC A 19 62 
AR3 OTT GCG GAA OTC CTG GAO A 19 60 
FERM-12R GAA GTT GCG CGT GCG GAA G 19 62 
Primers used in the analysis of MhcI (Myosin 8913): 




EVEI (MFI) CAA OTT TAT GAA GAA GAG CCC 21 60 
NYP2 ATG OTA TTG CGO AAO ACC TTT 0 22 62 
PDZF-1(new)(MF2) AAG GCA GOT AGT GAT CAG GO 20 62 
PDZ.2R TOO GOT GTT COG TAT OAT CT 20 60 
589R(MRI) AGO TOG CAG ATG TOO TOG A 19 60 
89DR(MR2) ACA TGG AGA CAA OCT TOT CG 20 60 
CHF(MF3) TOG CAT AGG ACC CAG OCA G 19 62 
89-9F GGT TOA CAA GTC OTA GAA GO 20 60 
EXF(MF4 ATG TGG TOG GAT AAA AGT GCA 21 60 
EXR(MR3) TAT ACG GAO GCA GGC GAT AG 20 62 
INIF(IFI) TTA OCT OCA TAA ACC TGC GG 20 60 
INIR(IRI) AAC GAT TOG GAG GTG CAC G 19 60 
IN2F(1F2) GTC GOC GAG CCC GP GAG 18 62 
IN2R(1R2) CTA GOT CTG OGA AGA TOT CA 20 60 
IN3F(1F3) AAO GTC GCG TTC GCA AGA GG 20 62 
IN3R(1R3) CGT TOA TGG CTG OTA GTA CC 20 62 
IN3SP GAA GAG GAG ACA TOA TOA CC 20 60 
389F AGT GAA CTG GAA GOC AAG CG 20 62 
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PRPDZF(MF5) GCT CTC AGA TCG CAT TAT ACA C 22 62 
8912R CTC ACT GCG ATC ACA CTC G 19 60 
89-14F CCG AGA AGT TCA CAC TGG AG 20 62 
8914R GCA GAT CGT TCA TCT CGT TG 20 60 
89-15F GTA GCT CGA AGA ACG TCA AC 20 60 
8916R GTA CTT CTT CCA GCT CTT CG 20 60 
PRPDZR(MR4) TCT TCC AGA TCA CTG ATA GAG 21 60 
Primers used in the analysis of Myo 29D (Myosin 29D): 
Primer name Sequence in 5' > 3' direction Length 
(nt) 
Tm 
595F-A(DFI) ATC CGC ACA ACA TTC TGC AC 20 60 
SECF(DF2) ATG CAT CTT CAT CCA ACG AG 20 58 
TRIF(DF3) AAT CAC AGC TTC AGC CAC AC 20 60 
595F-B ATT GCC ATT CAT CCC GCA CT 20 60 
595-R(DR2) GTG CTT GAA GGC ATC AGT CT 20 60 
595F-C(DF4) GAG ACT GAT GCC TTC AAG CAC 21 62 
PHex29 AGA CAA TTT GCT GAG APIC CCT G 22 62 
P29F(DF5) ACT TTG TGC GCT GCA TCC G 19 60 
LASR(DR3) AGG AAG AGT TGA ACA GAT GGA 21 60 
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6.3 Results 
The BLASTP and BLASTN searches with the conservative chicken skeletal 
myosin II head, against the completed Drosophila Genome sequence, retrieved the 
previously identified genes and five new myosin genes (Fig. 6.1.5, Table 6.3). We 
selected a limit of 30-40% identity for a myosin to fall into a given myosin class, and 
25-30% was considered as the lower threshold for a protein to be classified as a 
myosin. The new myosins (Fig. 6.1.5) were named according to their chromosome 
position (Fig. 6.2). Interestingly half of the myosin genes are located between 
polytene bands 27F-36A, thus forming a myosin hot spot on the left arm of the 2 
chromosome. 
In the cases of Myo 95E, MyolOA, Mhcl and Myo29D we did a detailed 
analysis of the molecular structure of the genes and the transcripts they produce. The 
main reason for this was the predicted sequences for these genes encode proteins that 
produced low homology scores to other myosins. They were obviously myosins, 
containing all the conserved sequences and structural parts defining them as myosins 
and at the same time showing no more than 15-29 % identity to other myosins. This 
implied either incorrectly predicted genes or incorrectly predicted splicing of 
transcripts. Open reading frames (ORF), 5 'UTRs (untranslated regions), 3 'UTRs, 
and the presence or absence of given motifs were tested by RT-PCR and subsequent 
sequencing of the products obtained. In these experiments we employed an ovarian 
Uni-ZAP XR® library produced in our lab, along with cDNAs produced by reverse 
transcription RNA from larvae and adult flies RNA (see materials and methods). As 
a result we determined a number of new myosin sequences and submitted them to the 
MEDLINE Database. The accession numbers for these are: for Myo95E (AF454350, 
AF454351 and AF454352), For MyolOA (AF454346, presents a part of the first 
three exons including the 5 'UTR), Mhcl (AF454347, presents a part of the first four 
exons including the sequence encoding the PDZ domain), Myo29D (AF454348 and 
AF454349). Myo28B was not subjected to detailed analysis because it was found to 
be almost identical to the other myosin VII (crinkled) from Drosophila at both the 
DNA and protein level. 
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Table 6.3 A list of Drosophila melanogaster myosins 
Chromo- DNA mRNA Protein 
Gene! Protein some Length Length Length (aa) EST 
position (bp) (bp) 
Myo31DF I 2L(31133-6) A0003628 U07595 AAA19590, LP03284.5, [P04189.5, 
(CG7438)* (15084) (3886) AAF52966 
Myosin IA (1011)  
Myo61F 1 3L (01 [6-7) A[003471 U07596 AAA 19591 GIl 	3657.5, 1.005759.51  
(CG9155)* AC005847 (3382) (1026) GH13670.5, LP08690.5, 
Myosin lB (5057) GH25605.5, GI 123689.5, 
CKO 1057.5 
Myo95E I 3R (95E1 -4) AE003746 AF454350 AF454350 (1278) GH25580.5, GH25580.3, 
(CG5501) (4604) (5285) AF454351 (1258) 111-05373.5 
Myosin IC AF454351 
(5225) 
A 04543 52 
(5301) 
zip (zipper) II 2R (60E7-8) Al)003465 U35816 AA0473 II, GM04963.5, SD07905.5. 
(CG15792)* (21711) (6734) AAB09048 GH27070.5 
Nonmuscle (2056) 
myosin-11 
Mhc (CG I 7927)*  II 2L (36A8-9) V161229, M61229 AAA28686, GH2 1445.5, GI-106021.5, 
Myosin heavy A0003652, (5889) AAA28687 (1962) Gl-102291.5, LP07131.3, 
chain AC005I 19 1.D16079.5, 111,04385.5, 
(22663) GIll 1211.5, LD35610.3, 
111.03720.5, (3M03715.5, 
GM 038 76 .5 
ninaC Ill 2L (27F5-6) A17003617, M20230 AAA287 18 (1501) [002603.5, [P02603.3 
(CG5125)* J03131, (4809) AAA28719 (1135) 
Nina C protein (7220) M20230 
(3643) 
didum V 2R (3D1-3) AC004280, AF003826 AAF59241, GH04445.5, GH04445.3 
(CG21 46)* A0003841 (6214) AC99496 
Myosin (8217)  (1792)  
jar (jaguar) VI 3R (9511-2) AE003747 X67077 AA056269, 11.03149.5. (3111)9735.5 
(CG5695)* (6312) (4280) CAA47462 
Myosin VI (1253) 
ck (crinkled) VII 2L (35C I) AE003646 AE003646 AAF53435, LI) 14917.5, 1,D14917.3 
(CG7595)* (12392) (7030) AAF44915 
MyosinVIlA  (2167)  
Myo28Bl VII 21- (2$B3-C1) AI)0036I8, AF233269 AAF52536, G1125551.5, GH25551 .3 
(CG6976) AC005834 (6590) AAF348 10 
MyosinVIlB (10519) (2129) 
MyolOA XV X(IOAI) A1(003484 A0003484, AAF47980,Q9VZ48 [P03318.5 
(CG21 74) (10235) A 0454346 (2424) 
Myosin XV (7275) (2333) 
Mhcl (CGI 0218) XVIII 3l( ($9117) A[0037 II AF)0037 1! AAK92927, (0103004.5, GM I 0421)5. 
Myosin heavy (21620) AF454347 AF454347, G1104935.5, 1-I304491.5, 
chain like, AY051503 AAF55271, 01-I1 5471.5, GH15471 .3 
(PDZ) Myosin AAF55272 
(6603) (6603) (6420) 
Myo29D 7 2L(29D1) AE003621 AF454348 AF454348 (1313) LD47348.5, LD47348.3, 
(CG10595) (5732) (4402) AF454349 (689) 1.P07 160.5, A1124339 
Mynsin AF454349 AAF52683, 
(2530) Q9VI ,K6,AF405293 
AAK97502 
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Table 6.3 A list of Drosophila melanogaster myosins 
Myosins denoted with * have been previously identified and characterised. The 
others resulted from analysis of the published genomic sequence for Drosophila 
melanogaster and molecular studies undertaken in this study. Their classification is based on 
domain and phylogenetic analysis of the predicted mRNAs for these myosins. In several 
cases the presence or absence of certain motifs was verified by RT-PCR (for detailed 
explanation of this see text). The accession numbers show the most recent and complete 
sequence reports on the presented myosins. ESTs for all of the predicted genes have been 
identified and partially sequenced. In the case of Mhcl the presented mRNA sequences were 
combined and the longest three transcripts shown. 
.4 
To examine the evolutionary relationships between members of the myosin 
family in Drosophila and other phylo genetic ally diverse species we used two 
different phylogenetic methods. We applied Distant-matrix, and Maximum-
Parsimony methods (PROTDIST and PROTPARS from the PHYLIP package) to 
compare the conserved head domains. These methods were chosen because they tend 
to outperform other methods (i.e., lower variance), such as the Maximum Likelihood, 
when dealing with large datasets. The two programs produced trees with similar 
topology (see the unrooted consensus tree in Fig. 6.3). Multiple sequence alignments 
were performed with CLUSTAL W, without corrections for gaps or multiple 
substitutions. Excluding the positions with gaps would have omitted a significant 
proportion of the data, a problem that occurs when large amounts of input sequences 
are dealt with. CLUSTAL W (GCG software package) is provided by the Human 
Genome Mapping Project Resource Centre, Cambridge at http://www. 
hgmp.mrc.ac.uk/ (Thompson et al. 1994). The reliability of the tree structure was 
checked by bootstrapping (1000 trials) and re-ordering the alignments randomly 
(bootstrapping was performed with SEQBOOT from the PHYLIP package). The 
tests produced trees with similar branching order. A consensus tree was produced by 
the CONSENSE program of the PHYLIP package and graphically drawn with the 
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Figure 4 Phylogenetic analysis of the myosin superfamily in Drosophila 
melanogaster 
The head domains of Drosophila myosins (equivalent to amino acids 88 to 780 of 
chicken skeletal myosin) were compared to selected myosins representing phylogenetically 
diverse organisms. The alignment of 67 myosins (performed with the CLUSTAL W 
package) was used to generate data for an unrooted tree to scale, based on sequence 
divergence (for details see in the text). Each separate myosin class is defined by the first 
node represented in > 95% of bootstrap trials (starting from the tree centre) and is colour 
coded. For simplicity only the Drosophila myosins are presented with the names of the 
genes: Mhc(Myosin heavy chain), zip (zipper), jar jaguar), ck ('crinkled) and Mhcl ('Myosin 
heavy chain like). The accession numbers for the myosins used in the alignment are given 
below. These are produced for the protein sequences except in the case of Dm95E (Myo95E 
gene) and Dm29D (Myo29D gene), where the eDNA accession numbers are given: 
MYOSIN CLASS I: Ac-lB (AAA27708), Ac-IC (AAA27707), ScMyo3-IA (AAB34 124), 
ScMyo5-IB (CAA89745), Cehum5-IA (CAA53244), CehumIIB*, Dm31D-IA 
(AAA19590), Dm61F-IB (AAA19591), Dm95E (AF454350), Re-lB (AAA57192), Gg-Bb 
(AAB3 8373), Gg-IB (CAA49850), Rnmyrl-IA (CAA48287), Rnmyr2-IB (CAA52807), 
Rnmyr3-IC (CAA52815), Rnmyr4-ID (CAA50871). MYOSIN CLASS II: ScMYO1-IIA 
(CAA37894), ScMYS1-IIB (P08964), Dd-nmII (AAA33227), Cemyo3-11A (CAA30856), 
Cemyo4-IIB (AAA28124), Cemyo2-11C (CAA30855), Cemyol-IID (CAA30854), Dm-
mhcll (AAA28686), Dmzip-nmII (AAF47311), Xl-nmllb (AAA49915), Gg-FSkII 
(P13538), Gg-nmII (AAA48974), Gg-smlI (CAA29793), Hs-FSkEII (CAA32167), Hs- 
CaA (BAA00791), HsnmIIA (AAA59888). MYOSIN CLASS III: Lp-III (AAC16332), 
DmNinaC-III (AAA28718), HsMY03A (AAF70861). MYOSIN CLASS V: ScMyo2p-Va 
(AAA34810), ScMyo4p-Vb (AAC37409), Cehum2 (AAA97926), SpMyo-Va 
(AAF78910), Dmdidum-Va (AAC99496), Ggp190-Va (CAA77782), Mmdilute-Va 
(CAA4065 1), Rnmyo5-Va (BAA8 8350), Rnmyr6-Vb (AA133 8840), HsMY05A 
(AAD00702), HsMY05C (AAF78783). MYOSIN CLASS VI: SpMyo-VI (AAF72176), 
Cehum3 (AAC67447), Dmjar-VI (CAA47462), Ms-VIA (AAD52005), Ms-VIB 
(AAD52006), GgMyoVI (CAB965 36), MmWaltzerVl (AABOO 194), HsMY06 
(AAC5 1654). MYOSIN CLASS VII: Cehum6-VII (AAB37988), Dmck-IIA (AAF53435), 
Dm28B-VTIB (AAF525 36), DrMyo-VTIA (CAC054 18), Mmshaker-VIIA (AAB4070 8), 
HsUsherlb-VIIA (AAB03679). MYOSIN CLASS XV: Dm1OA-XV (AAF47980), Mm-
Myo15 (AAF05904), HsMYO15 (AAF05903). MYOSIN CLASS XVIII: Dm89B-PDZ 
(AAF55271), Mm-PDZ (BAA93660), Hs-PDZ (BAA13206)**. MYOSIN CLASS ?: 
Dm29D (AF454348). 
* This is a joint sequence from the first 72 amino acid of T21544 and from the 11th amino 
acid to the end of AAA97925. 
** The sequence for the human PDZ-containing myosin is truncated. This does not seem to 
affect its evolutionary position in the phylogenetic tree. 
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The protein sequences for the new Drosophila myosins are theoretical 
predictions. Myosins are large multi-exon genes and are difficult to assemble with 
100% accuracy from sequence data. There are also various isoforms of some 
myosins, which can lead to some misalignments; hence it is unlikely that the tree 
shown perfectly reflects the evolution of Drosophila myosins. 
It is possible that some of the new Drosophila myosins could be 
pseudogenes. However, we found that the probability for this was low. Pseudogenes 
generally lack introns and are not transcribed into mRNA. We identified ESTs 
(expressed sequence tags) for all the myosin genes we predicted (the accession 
numbers for these are given in Table 6.3) which confirms their in vivo expression. 
The new myosins are described in details below. 
6.3.1 Myo95E (Myosin IC) 
This myosin was not found during the initial searches of the fly genome. It 
was subsequently identified in the AE003746 genome scaffolding. The predicted 
sequence for this gene is unusually short, resulting in only 59 amino acid protein 
(accession number AAF56246). Detailed analysis showed that the gene was not 
predicted correctly by the Genome Project. The sequence for Myo95E was manually 
assembled, taking into account the reported sequence for this gene, along with the 
identified ESTs (Table 6.3), as well as the homology of the translated genomic DNA 
to other myosins (preserving the exon-intron spacing). To test our theoretical 
predictions we used two splice-site prediction programs: The Neural Network at 
http://www.fruitfly.org/scq_tools/splice.html and the GENSCAN Server at MIT: 
http://genes.mit.edu/GENSCAN.html. Using the artificially assembled sequence we 
were able to design primers, create a PCR product and hence sequence the cDNA for 
Myo95E (Fig. 6.3.1 and Appendix II). The resulting sequence differed from the 
predicted sequence showing the presence of an unusually long exon 3 and variations 
in exon 4. Analysis of the available ESTs and RT-PCR analysis showed that the gene 
produces at least three different transcripts expressed during oogenesis, larval and 
adult stages (Fig.6.3.1B). 
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PCR Primers Expected product Amplified/Sequenced 
product 
46F+ESR 2315 bp 2315 bp 
46F + 46R 3849 bp 3849 bp* 
ESF+46R 1554 bp 1554 bp 
ST95E + BRI 279 bp 279 bp 
3FOR+4BAK 914 bp 914 bp 
PIEF+46R 1085 bp 1085 bp 
P1 EF + 3UTR95 2084 bp 2084 bp 
13F+ 3UTR95 1021 bp 1021 bp 
Figure 6.3.1 RT-PCR analysis of Myo95E transcripts 
mRNA was prepared from different developmental stages and reverse 
transcribed. An ovarian eDNA library was also used as a source of mRNA. Gene- 
specific primers were used to generate overlapping PCR products. The latter were 
analysed by sequencing and assembled into full length niRNA using the program 
GeneJockey. New primers, based on this sequence, were developed to analyse the 
exon structure of Myo95E. The available ESTs for the gene were also considered 
(Fig.6.3.1 B). 
*The  amplification with 46F and 46R primers produced two bands. Only the 
large 3.8 kb band is genuine while the small 1.1 kb band is a product of mispriming. 
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Figure 6.3.I13 Molecular organisation of Myo95E, MyolOA, Mhc!, and 
Myo29D myosin genes 
Myo95E 
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Figure 6.3.I13 Molecular organisation of Myo95E, MyolOA, MhcI, and Myo29D 
myosin genes 
The exon structure of the myosin genes is represented by grey boxes. Arrows 
indicate the primers used in the RT-PCR analysis. The primer sequences are given in the 
materials and methods. The first letter of the primer name is specific for each myosin, the 
second letter indicates whether the primer is in the forward (F) or reverse (R) orientation. 
The length of the predicted mRNAs is noted on the left side of the transcript maps. Shaded 
boxes represent open reading frames (ORFs); solid boxes represent untranslated sequences 
(5'UTR or 3'UTR); dotted boxes represent intron sequence in the spliced mRNA; wave 
pattern boxes represent exons from genes located within the myosin gene (the first letter of 
the primer name for this genes is I from Intron). The gene depicted by IF1 and IR1 primers is 
at least a 3 exon gene, but for simplicity it is presented with a single box here (for more 
information see text). 
Two of the transcripts (I-AF454350 and II-AF45435 1), which represent 5-
10% of the total amount of Myo95E transcripts, translate into two protein isoforms: 
of 1278 and 1258 amino acids, respectively. Transcript One (5285 bp) comprises all 
16 exons of the gene. Transcript Two (5225 bp) lacks exon 12. The major third 
transcript (III-AF454352) has a longer 4thi  exon (a downstream extension of 16 bp, 
GTG CAC ATT ACC CAT T). This shifts the open reading frame and produces a 
STOP codon TGA in exon 5. The third transcript (5301 bp) encodes two putative 
truncated proteins. The first is a 464 aa sequence containing only the GESGAGKT 
conserved region from the P-loop of the myosin head domain. It does not contain the 
Switch-1 (NxxSSR) and Switch-2 (DxxGxE) regions which together with the P-loop 
have been implicating in the regulation of ATP hydrolysis. The second is a 864 aa 
putative protein, containing a large part of the head domain, two IQ motifs and a 
myosin tail domain. The head of this isoform contains only the Switch-2 (DFYGFE) 
conserved sequence, which prevents it from converting ATP, probably rendering the 
isoform inactive. Homology searches with the protein sequence for the head domain 
showed 33% identity (53% similarity) to vertebrate brush border class I myosins. 
Three ESTs were found for Myo95E . A search with them revealed up to 37% 
identity to vertebrate brush border myosins and less to other myosin classes. Analysis 
of Myosin 95E with domain scanning programs confirmed its structural similarity to 
class I myosins (Fig. 6.1.513). It was found to contain 2 IQ domains (928-974 aa) the 
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second being poorly conserved (Fig. 6.3.1C), and a Basic Tail domain (974-1278 aa 
for isoform I and 974-1258 aa for isoform II) (Fig.6.1.5, Table 6.3). The latter is 
thought to be involved in membrane binding. Recent studies have shown it is also 
able to bind to actin filaments (Lee et al. 1999) and (Liu et al. 2000). This changes 
the number of class I myosins in Drosophila to three, hence Myosin 95E was 
renamed Myosin IC. The Drosophila Myosin IC does differ from other class I 
myosins. The unusually long exon 3 results in a 281 amino acid insertion into the 
head domain. This insertion contains a partial AAA domain, a conserved region that 
contains an ATP-binding site. So far no other myosins from class I have been 





















80% 	-------- xQ --- Rx --- Rx------ 
50 - -----A--IQ---RG---RR------ 
Figure 5 Alignment of the IQ motifs for the five newly identified 
myosins from Drosophila melanogaster: Myosin IC (Myo95E), 
Myosin VIIB (Myo28B), Myosin XV (MyolOA), Myosin8913 (Mhc!), and 
Myosin 29D(Myo29D) 
The consensus sequence is shown below the alignment and the highly 
conservative positions are shaded. Residues in bold indicate similarity to the 
consensus. Myosin IC has two different variants (A and B) of its second IQ 
motif, a result of alternative splicing. 
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6.3.2 Myo28B (Myosin VIIB) 
The amino acid sequence of the Myosin 28B head showed 61% identity (74% 
similarity) to ck-Drosophila myosin VITA. It also exhibited a very high identity of 
58% (72% similarity) to Myosin VITA from zebrafish and other class VII myosins. 
Analysis of Myosin 28B revealed that it has four IQ motifs (753-845 aa), the third 
being poorly conserved (Figs 6.1.5 and 6.3.1C). Two MyTH4 (Myosin Tail 
Homology 4 domain) (1070-1246 aa and 1681-1826 aa), two FERM (1246-1454 aa 
and 1826-2039 aa), and one SH3 domain (1561-1626 aa) were identified (Fig. 
6.3.2A, B). 
The function of MyTH4 domains is unknown. The FERM domain, (the name 
stands for Band 4.1, ezrin, radixin, moesin-homology) is believed to be involved in 
linking cytoskeletal proteins to the membrane, as well as in dimerisation. Talin, 
merlin and philopodin are other major members of the FERM superfamily. These 
deserve mentioning, especially the talin, because the FERM domain exhibits highest 
homology to the FERM domain in talins (Fig. 6.3.3) and less homology to FERM 
domains from other members of the FERM family. 
The SH3 domain has been identified in many proteins involved in signal 
transduction. It is believed that SH3 domains mediate protein-protein interactions by 
binding to proline-rich domains. Other myosins such as IV, X and XV also contain 
this motif. A short coiled-coil domain (849-908 aa) was predicted by the Paircoil 
program (Fig. 6.3.4). 
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Figure 6.3.2 CLUSTAL W alignment of the predicted MyTH4 (A), SH3 
(B), and PDZ (C) domains in the tails of the newly identified Drosophila 
myosins 
The sequences were shaded on the BoxShade server and manipulated with 
Microsoft Word 98. The parameters set on BoxShade are as follows: output format: 
RTF New; Fraction of sequences: 0.5; Input sequence format: MSF (multi sequence 
format this is the output format of CLUSTAL W). Identical amino acids are shaded in 
black, similar residues are shaded in grey. Myosin VII has two MyTH4 domains. The 
first MyTH4 domain in HsM7a, DmCk. CeHp, and Myo28Bl contain an insert of 61-
88 aa (regions 1057-1144; 1048-1135; 971-1055; 1107-1168, respectively) that was 
not included in the alignment. Accession numbers and Abbreviation full terms: Ce-
Caenorhabditis elegans (Myosin VII-T25888), Hp-hypothetical protein, Dm-
Drosophila melanogaster (ck, VILk-AAF44915, Myo28B-AAF52536, PDZ Myosin-
AE00371 1), ck-crinkled, Hs-Homo sapiens (M7A-Q13402; Myosin XV-A59266, 
PDZ Myosin-AL080245 and Z98949), Dr- Danio rerio (Myosin VILA- CAC05418), 
Mm-Mus musculus (Myosin VIIA-P97479, Myosin XV-A5 9295, PDZ Myosin-
BAA93660). 
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6.3.3 MyolOA (Myosin XV) 
An RT-PCR analysis was used to verify the exon composition and exon 
length of MyolOA transcripts (See Appendix III). It was found that there are at least 
two transcripts which are expressed from the larval stage onwards (Fig 6.3.1Q. The 
longer transcript (7462 bp) consists of all the previously known 5 exons and 
represents no more than 5% of the total amount of mRNA for this myosin. The 
shorter transcript (7189 bp) lacks exon 2 and is expressed abundantly. The two 
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Figure 6.3.3 RT-PCR analysis of MyolOE transcripts 
mRNA was prepared from different developmental stages and reverse 
transcribed. Primers specific for MyolOA were used to generate PCR products. The 
latter were analysed by sequencing and assembled into full length mRNA using 
GeneJockey. 
PCR Expected Amplified! 
Primers product Sequenced 
product 
INF+ 	514 bp 	514 bp 
I OAR 
HYST + 	327 bp 	327 bp 
I OAR 
PI5F+ 	4703 bp 	4703 bp 
AR3 
MYTH4+ 	3194 bp 	3194 bp 
FERMIO 
MYTH4 + 	3746 bp 	3746 bp 
AR3 
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A BLAST search with the conserved head domain showed significant, 47% 
identity (64% similarity), to the mouse and human myosin XV. MyoIOA is also 
related to human and mouse myosin VITA with an identity of 42% (59% similarity). 
A specific N-terminal domain was identified in Myosin 1OA (1-149 aa). The latter 
showed low similarity to the characteristic N-terminal domain found in other class 
XV myosins. The shorter protein isoform lacks this N terminal domain. In the neck 
region three IQ domains (841-910 aa) were identified (Fig. 6.3.1C). Immediately 
after the IQ motifs there is a short coiled-coil region (919-946aa) (Fig. 6.3.4). 
Analysis of the tail revealed the presence of one MyTH4 domain (1014-1173 aa) 
(Fig. 6.3.2), a QPA-rich domain, a Proline rich domain (the borders of QPA and the 
Proline rich domain were not clearly defined), a short transmembrane motif (21 94aa) 
(Fig.6.1.5), and a FERM domain (2220-2424aa). The latter showed a very high 
identity of 40% (59% similarity) to the first and 13% identity (30% similarity) to the 
second FERM domain from mouse myosin XV and a limited similarity of 38% (17% 
identity) to Talin itself (Fig. 6.3.3). 
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Myosin XV (M. muscuhis,) 	 21; 53% 	 19; 34% 
Figure 6.3.3 Sequence comparison of the FERM domains found in 
Drosophila Myosin VII and XV 
These were aligned separately to the Talin domain from C. elegans Talin 
protein. Multiple alignment was not appropriate in this case because the similarity 
between FERM I and FERM 2 to the Talin domain (from the Talin protein) is very low 
and results in unordered alignment. The comparison was performed by CLUSTAL W 
(http://www2.ebi.ac.uk/clustalw/). In addition the FERM domains from M. musculus 
Myosin XV were included in the diagram. In general FERMI motifs from Myosin VII 
show 12% to 21% similarity to proteins from the FERM family and '-i6% to the band 
4.1 protein. FERM2 domains (Myosin VII), show a higher similarity of 17-18% to 
band 4.1 protein and 18-20% to proteins from the FERM family. FERM domains from 
Myosin XV show less similarity of 9%-17% to FERM proteins and '14% to the band 
4.1 protein. Accession numbers are: C. elegans (Talin)-AAA74747, D. ,nelanogaster 
(Myosin VITA)- CAC05418, (Myosin VIIB)-AAF52536, (Myosin IOA-XV)-
AAF47980, M. musculus (myosin XV)-AAF05 904. 
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6.3.4 Mhcl (Myosin XVIII) 
A partial sequence of this gene has been submitted to the Genbank Data Base 
by Biru (Biru 1999). It shows high similarity to the Mhc II type of myosins and was 
termed Myosin heavy chain like. Subsequently the full length (without the sequence 
encoding for PDZ domain) for this myosin was published by Celera (Adams et al. 
2000). RT-PCR analysis we have undertaken shows that Mhcl has a very complex 
structure and expresses multiple transcripts throughout the Drosophila life cycle (Fig 
6.3.IB). 
Data from the available ESTs for Mhcl, PCR analysis and a Promoter 
predicting program (http://www.frujtfly.org/seq_tools/promoter.html) suggest that 
the seven identified transcripts are transcribed from four putative promoters (See 
Appendix IV). Transcripts I (6603 bp) and III (6909 bp) are highly expressed. The 
other five identified transcripts are expressed at comparatively lower levels. 
Transcripts I and III are composed of 18 exons (the gene comprises 19 exons), 
lacking exon 15. The difference between them is that in transcript III the second 
intron is not spliced out which introduces a STOP codon in the open reading frame. 
One unusual feature of Mhcl is the fact it contains three other genes within it (Fig. 
6.3.113). The exons of these genes are not found in combination with any of the 
exons of the myosin gene. Importantly there are ESTs for each of the three genes. 
One of the genes has been previously identified as phosphatidylserine-specific 
phospholipase Al (CG4979). Its is located in the 91h  intron and its reading frame is in 
that opposite direction to the Mhcl reading frame (EST: GH15759). The other two 
genes have open reading frames in the same direction as the main (Mhcl) gene. The 
gene in intronlO (ESTs: RE41368, RE44374) is a novel gene and does not show any 
significant homology to previously characterised genes. The gene in intron 12 (ESTs: 
LP08646, LP05315) shows a limited identity of 35% (46% similarity) to bovine 
synaptojanine 1 protein (SYNAPTIC INOSITOL-1,4,5-TRISPHOSPHATE 5-
PHOSPHATASE 1). 
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PCR Primers Expected product Amplified/Sequenced 
product 
PDZFI + 89DR 848 bp 848 bp 
PDZF2 + 89DR 893 bp 893 bp 
NYP2+89DR 1264 bp 1264 bp 
EVEI+89DR 1852 bp 1852 bp 
CHF + ExR /202 bp? 300, 400, 600 and 1.0 kb * 
CHF + ml R /? 50,300, 600, and 1.0 kb * 
ln3F+In3Sp /(1841 bp)? /(1841 bp)? 
In2F + ln3R  
389F + ln3R  
389F + PrPDZR 2312 bp 2312 bp 
PrPDZF + PrPDZR 2281 bp 2281 bp 
In3F + PrPDZR  
lnlF+InlR 1585 bp 1585 bp 
ln2F+In2R 611 bp 611 bp 
In3F + ln3R 652 bp 652 bp 
Figure 6.3.1 RT-PCR analysis of MhcI transcripts 
mRNA was prepared from different developmental stages and reverse transcribed. 
An ovarian cDNA library was also used as a source of mRNA. Gene-specific primers were 
used to generate PCR products. The available ESTs for this gene were extensively analysed 
and some of them sequenced to determine the intron-exon structure of the gene. These date 
was used to assembled the full length Myo8913 mRNA. *Initial PCR experiment using CHF 
primer produced a multiple pattern on agarose gel because of mispriming. Subsequent PCRs 
produced two bands as expected, a 532 bp band and a 349 bp band that indicate the lacking 
of exon 10 in the produced transcripts (data not shown). 
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Mhcl transcripts translate into a set of protein isoforms: 1-2200 aa, 11-2139 aa, 
111-439 aa, IV-899 aa, V-730 aa, VI-512 aa and VII-479 aa. Only the isoforms 
produced by transcripts I and II contain the conserved motor domain. BLAST 
analysis showed that Myosin heavy chain-like is most closely related to mouse PDZ-
Myosin (41% identity) and human PDZ-Myosin (40% identity). It showed a limited 
identity of 28-29% to smooth muscle and non-muscle myosins and less than 25% to 
skeletal muscle myosin. BLAST searches revealed that the tail domain shows the 
highest similarity, 32%, to PDZ-containing myosins and less than 25% similarity to 
other types of myosins. Interestingly this myosin was not predicted to contain a PDZ 
domain. We used the DNA sequence encoding the mouse PDZ domain to search the 
genomic sequence (AE003711) surrounding Mhcl (approximately 10kb in each 
direction). This detected a PDZ domain 481 Obp upstream of the predicted start for 
Mhcl mRNA (the domain was found in the borders of the predicted genomic DNA 
for this gene but has not been previously included in its open reading frame (ORF)). 
The presence of the PDZ domain was verified by RT-PCR and the sequence 
submitted to the NCBI database (AF454347). A sequence alignment of the PDZ 
domains from Drosophila mouse and human is given on Fig. 6.3.2. Interestingly 
transcript III translates into a truncated protein containing only this PDZ domain 
(349-429 aa). PDZ domains are known to bind C-terminal or internal (non-C-
terminal) polypeptides. Two IQ domains were found in Mhcl (1379-1428 aa) (Fig. 
6.11C), although the second differed slightly from the consensus sequence. The 
Paircoil program predicted two coiled-coil domains, at 1439-1549 aa and 1616-2121 
aa (Fig. 6.3.4). 
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Figure 6.3.4 Predicted coiled-coil structures in the tails of the 
newly identified Drosophila myosins 
Only three of the five myosins are likely to form coiled-coils, these 
being Myosin 28B-VII3, Myosin 1OA-XV, and Mhcl-PDZ. Both myosin 
28B-VIIB and 10A-XV produced scores close to the lower threshold. 
Whether they form coiled-coils or not can only be determined experimentally. 
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6.3.5 Myo29D 
Database searches suggested that the first three exons of Myo29D are 
probably part of a gene adjacent to the myosin. Subsequent RT-PCR showed that 
they splice together with the other 3 myosin exons to produce at least two different 
transcripts (see Appendix V). Transcript I (4402 bp) contains all 6 exons, while 
transcript 11 (2530 bp) lacks exon 5. Transcript I and II are present during all stages 
of Drosophila development, with transcript I being expressed at higher levels. 
Transcript TI produces a truncated form of the protein lacking most of the motor head 
domain. 
Analysis of the conserved head domain revealed that Myosin 29D is not 
similar to any of the known classes of myosins. It showed 29% identity (45% 
similarity), to myosin VII, X, and V from different species, which is sufficient to be 
considered as a myosin, but not enough to be related to a given class. A search with 
the available ESTs for this myosin showed 36 to 39% identity to Myosin V from 
different species and 31-36% to vertebrate myosin heavy chains (Myosin TI). Motif 
search programs detected in Myosin 29D a specific N-terminal extension (1-338 aa), 
two IQ motifs (1089-1136 aa), the second being poorly conserved, and a short 
transmembrane motif in the tail (1144-1279 aa) (Fig. 6.1.5). 
The detailed search of the translated Drosophila genome sequence produced 
several low score hits. Close analysis of these (searches up and downstream of the 
respective sequences) revealed they are not true myosins. Despite exhibiting certain 
similarities to given parts of the myosins none of them showed high homology to a 
larger part of the head domain. AE003 112 showed similarity to the highly conserved 
region (GESGAGKT) from the P-loop of the head domain. Its polytene chromosome 
location remains undetermined. AE003614 (CG11199) showed homology to the 
myosin tail, containing coiled-coil and FERM domains. It is located on chromosome 
arm 2L (27E), next to the nina C gene. AE003495 (CG12047) also showed similarity 
to the myosin tail, containing coiled-coil and FERM domains. This is located on X 
chromosome (12E1), close to the newly identified MyolOA. 
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Figure 6.3.1 RT-PCR analysis of Mhc! transcripts 
mRNA was prepared from different developmental stages and reverse 
transcribed. Primers specific for Mhcl were used to generate PCR products. The 
latter were analysed by sequencing and assembled into full length mRNA using the 
program GeneJockey. The PCR amplification products denoted with * indicate an 
alternative splicing. 
PCR Primers Expected product Amplified/Sequenced 
product 
595F-A+529R 	 915 bp 	 915 bp 
SECF+529R 	 813 bp 	 813 bp 
TRIF + 529R 	 526 bp 	 526 bp 
595F-A+595R 	 1247 bp 	 1247 bp 
SECF+595R 	 1145 bp 	 1145 bp 
TRIF + 595R 	 858 bp 	 858 bp 
595F-B + 595R 	 496 bp 	 496 bp 
595F-C + LASR 	 703/2575 bp 	 764/2636 bp* 
PHex+LASR 	 1076 bp 	 1076 bp 
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The BLAST search retrieved one more myosin-like gene, CG15831 in the 
AE002795 genome scaffolding. This is single exon gene, 219 bp long. The 
chromosome position of AE002795 has not been previously determined. The 
program showed similarity to a highly conservative part of the myosin head domain 
(LGVLDIFGFENFSHNSFEQLCINYTNEKLHKFFNH). We found that the DNA 
surrounding the gene shows no similarity to the myosin genes (at DNA or protein 
level). This suggests that AE002795 is either incorrectly assembled in the genome, or 
the gene CG15831 is a partial duplication of a myosin gene (this might be either a 
part of Mhc (muscle myosin II) or diduni (Myosin V) which produced the highest 
score for this sequence, 59% and 54% identity respectively). 
6.4 Discussion 
The myosin family has grown significantly in the past decade to encompass 
more than 177 myosins. These myosins, with a few exceptions fall into 18 classes. 
Myosins are expressed in both prokaryotes (though these have not been well studied) 
and eukaryotes. 
The annotation of the genome sequences for S. cerevisiae, D. discoideum, A. 
thaliana, C. elegans, D. melanogaster and H. sapiens, made it possible to identify 
the complete sets of myosin genes in these organisms. It appears that all eukaryotes 
have an essential set of three myosin genes, these being from the classes I, II and V, 
as well as a number of species-specific myosins. In Drosophila 13 different myosin 
genes were identified. The fruitfly has three myosin I genes, two myosin II genes 
(one encoding for muscle and one for nonmuscle myosins), one myosin III, one V, 
one VI, two VII, one XV, one XVIII, and one myosin gene that remains to be 
classified. These classes of myosins have been found in wide range of invertebrate 
and vertebrate animals. It has been shown that they have a role in a variety of cell 
functions, including membrane trafficking, signal transduction and maintenance of 
the cell architecture. Several new myosin genes were identified in the fruitfly. The 
genome data provided eDNA sequences for four of them (Myo28B, MyolOA, Mhcl 
and Myo29D). The sequences and the open reading frames for these myosins (ORF) 
were verified by RT-PCR and sequencing. In addition a fifth myosin was found 
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(Myo95E). Using the fruitfly genomic sequence we were able to predict and 
subsequently isolate and sequence this gene. 
Only two of the five newly identified genes in Drosophila fell directly into 
previously known classes, these being Myosin VIIB (Myo28B) and Myosin heavy 
chain like (Mhcl). Myosin VIIB is from the well studied class VII myosins with role 
in the membrane trafficking and stereocilia function. 
Mhcl is a member of the recently defined class XVIII of myosins which 
consists of only two other members, mouse and human PDZ-containing myosins. 
The PDZ, domain also called DHR (Dlg homologous region), is known to bind either 
C-terminal or internal (non-C-terminal) polypeptides. These domains have been 
identified in a broad range of signalling proteins from bacteria, yeast, plants, insects 
and vertebrates. PDZ domains have been implicated in targeting signalling molecules 
to sub-membranous sites. 
Myosin IC (Myo95E) is the third member of class I myosins in Drosophila. It 
contains the Basic Tail domain (TB 1) specific to all class I myosins. It is thought that 
TH1 binds to acidic phospholipids and actin filaments. Interestingly this myosin 
contains an additional N-terminal insertion, which is similar to the AAA motif, a 
conserved region of about 220 amino acids that contains an ATP-binding site. This 
domain is inserted in the region of loop 1 of the motor domain, the other region 
associated with the hydrolysis site for ATP, and probably modulates its activity. 
MyolOA is closely related to class XV myosins. This myosin has a short N-
terminal extension which differs from the N-terminal domain characteristic for 
vertebrate myosins class XV. It also lacks the SH3 and the second MyTH4 domain 
found in other myosin XV tails. Instead the Drosophila Myosin XV tail contains 
three addition motifs, a GPQ-glycine/proline/glutamine rich domain, a Proline-rich 
domain and a small Transmembrane domain. The proline-rich sequences have been 
demonstrated to bind to SH3 (Src homology 3), a small 50 amino acids motif. SH3 
domains have been identified in a wide variety of intracellular and membrane-
associated proteins and are implicated in signal transduction, linking signals 
transmitted from the cell surface by protein tyrosine kinases to effector proteins 
located downstream of the hierarchical pathways. 
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Myosin 29D is a highly divergent member of the myosin superfamily. 
Presently it forms a class of its own. This myosin contains an unusual N-terminal 
extension which shows no homology to other proteins. It also has a small 
Transmembrane domain in its tail rich in proline residues. 
Drosophila inelanogaster expresses many myosins genes. Apart from the 
essential myosins (class I, II and V) it also has myosins from classes III, VI, VII, XV, 
XVIII, as well as a novel type of myosin. This new data should help to design 
experiments to investigate the roles of these newly identified myosins in the cell 
biology and development of Drosophila. 
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Chapter Seven: The function of the Broad-Complex 
during Drosophila melanogaster oogenesis 
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7.1 Introduction 
Drosophila oogenesis is an ideal system to study gene regulation during 
development as it is a comparatively short process with morphologically well defined 
stages. It takes approximately 3 days for the stage-1 egg chamber to develop into a 
mature egg. Further, egg chambers, the developmental units of oogenesis, contain 
only a few types of cells: the somatic follicle cells and the germline cells. The follicle 
cells perform multiple functions; they undergo dramatic morphogenetic movements 
and interact with the germline cells to establish both the anterior/posterior (A/P) and 
dorsal/ventral (D/V) axes of the egg and embryo, as well as producing yolk proteins 
for the developing oocyte and then chorion (the protective shell that enables the egg 
to survive in the environment). 
Pattern formation and cell fate specification during development require 
complex regulation of the multiple families of transcription factors to establish and 
coordinate transcriptional cascades. Transcription factors are expressed differentially 
in a temporally ordered manner governed by a genetically based hierarchical time 
table. They in turn activate or repress the tissue specific expression of structural 
genes, a critical process in morphogenesis. One way to regulate the temporal and 
spatial expression of developmental genes is by alternative splicing. Thus different 
messenger RNAs can be generated from identical pre-messenger RNA transcripts. 
This is the primary mechanism by which the Broad complex(BR-C), an early 
ecdysone response gene, is regulated. 
The Broad-Complex encodes a family of zinc-finger transcription factors 
(DiBello et al. 1991; Bayer et al. 1996a) and was shown to be expressed in the 
follicle cells in a dynamic pattern. The late pattern (stage lOB of oogenesis) is 
defined by two groups of dorsal-anterior follicle cells (Deng and Bownes 1997) and 
is specified by the epidermal growth factor receptor (EGFR) signalling pathway and 
further regulated by decapentaplegic (DPP) signalling pathway along the D/V axis. 
This localised expression is associated with the function of the BR-C in dorsal 
appendage formation. The involvement of BR-C in dorsal appendage morphogenesis 
was shown by mutational analysis of BR-C partial "loss-of-function" mutants, and 
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was supported by ectopic expression of BR-C transgenesu  during oogenesis. It is 
thought that the BR-C may provide a link between pattern formation and cell 
differentiation in morphogenesis (Deng and Bownes 1997). 
7.1.1 Molecular organisation of Broad complex gene 
The BR-C encodes a family of C2H2 zinc-finger proteins (Zi, Z2, Z3, and 
Z4), which share a common amino terminal (the BR-C "core") domain, but differ in 
zinc-finger domains (DiBello et al. 1991). The core is alternatively spliced to one of 
four pairs of zinc-finger encoding exons (Figure 7.1.1A, B), generating four classes 
of transcripts. Each transcript class is translated into a specific protein izoform: ZI, 
Z2, Z3 or Z4. In addition, three Zi isoforms have been identified: Q1 -Q2-Z1 encodes 
232 amino acids which are fused to the BR-C core domain (Q stands for glutamine 
rich region); Q2-Z1 lacks the first 17 amino acids from the glutamine-rich part of the 
ZI exon (this is due to alternative splicing, utilising a shorter version of the Zi exon, 
while preserving the same open reading frame); TNT-Q1 -Q2-Z1 contains a small 
threonine, asparagine rich (TNT) exon which is preceding the Zi exon but is not part 
of the BR-C core domain (DiBello et al. 1991; Tzolovsky et al. 1999). 
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Figure 7.1.1 Organisation of the BR-C gene 
Molecular organisation of the BR-C gene, which maps to the 2B5 region (adapted from 
(Chao and Guild 1986) and (Gonzy et al. 2002). For simplicity and clarity the first intron 
of the BR-C, is not shown on the figure. Coloured boxes represent open reading frames; 
black filled boxes represent untranslated regions of the BR-C transcripts. Four putative 
promoters have been previously described: P Distal at nucleotide 120; and P Proximal at 
nucleotides 163, 165 and 167 (DiBello et al. 1991; Bayer et al. 1996a). Zi and Z2 
transcripts can be synthesised from either P120, P165 or P167, while Z3 and Z4 only initiate at 
P165 and P167 (Bayer et al. 1996a). Z2 is the only transcript that uses P163 start site. 
Organisation of zinc-finger isoforms. Differentially spliced BR-C transcripts share a 
common Core domain linked to one of four (Z I -Z4) pairs of C2142 zinc-finger domains. 
Complementation map of the BR-C based on (Bayer et al. 1997; Gonzy et al. 2002). 
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7.1.2 The function of Broad complex 
Metamorphosis is a major developmental event during the life cycle of 
holometabolous insects. The relatively immobile larva transforms into a highly 
motile adult with systems specialised for dispersal and reproduction. Larval tissues 
undergo a controlled hystolysis as the imaginal disks differentiate and develop into 
adult structures. This sequence of tissue specific changes is driven and regulated by 
fluctuations in the titre of the steroid hormone 20-hydroxyecdysone (Buszczak and 
Segraves 2000). Ecdysone is released from the ring gland in pulses during 
development, and is converted to 20-hydroxyecdysone in the fat body and target 
tissues. Prior to each developmental event such as larval molting, pupariation, 
pupation and metamorphosis the concentration of the 20-hydroxyecdysone (hereafter 
referred as ecdysone) rises. 
At the end of larval development in Drosophila an ecdysone peak induces a 
small set of early polytene chromosome puffs. Puffing results from structural 
changes in the polytene chromosomes and indicate gene activity. The products of the 
genes located in the early puffs are necessary for the induction of a large number of 
late puffs and the repression of the early ones (Ashburner 1974). 
Ecdysteroids act by binding to receptors of the nuclear hormone receptor 
superfamily, which are ligand-dependent transcription factors (Henrich and Brown 
1995). The ecdysone receptor is a heterodirner composed of two nuclear receptors, 
the products of EcR (Ecdysone Receptor) and Usp (Ultraspiracle) (Homer et al. 
1995; Henrich et al. 1994; Yao et al. 1992; Grad et al. 2001). Usp is the Drosophila 
homologue of the mammalian retinoid X receptor (RXR) (Ghbeish et al. 2001; 
Zelhof et al. 1997). The EcR/Usp dimer can bind ecdysone-responsive regulatory 
DNA sequences, thus repressing transcription in the absence of hormone and vice 
versa. There is evidence that Usp is also able to dimerise with other steroid receptors 
(Sutherland et al. 1995; Zelhofet al. 1995). 
The Broad complex (BR-C) has been identified as an essential gene required 
for Drosophila metamorphosis (Karim et al. 1993). BR-C is located within the limits 
of the early ecdysone inducible puff 2B4-5 on the X chromosome. It is one of three 
early ecdysone responsive genes, including E74 and E75 (Burtis et al. 1990; 
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Segraves and Hogness 1990). These genes encode transcription factors, which are 
directly activated by the ecdysone receptor and co-ordinate the subsequent 
transcription of secondary effector genes (Ashburner 1974); and for reviews see 
(Bayer et al. 1996b; Kiss et al. 1988; Zhimulev et al. 1995; Karim et al. 1993). All 
three early genes are unusually long: BR-C - 80 kbp; E74 17 kbp, E75 108 kbp, 
and generate a large number of spatially and temporally regulated alternative 
transcripts. 
Genetically, the BR-C locus has three complementation groups, defined by 
mutations: br (shorter and wider wings), rbp (reduced bristle number on palpus), and 
2Bc (causes early pupal developmental arrest). An additional 2Bab group does not 
complement either the br and rbp mutations but does complement the 2Bc mutations. 
A group of mutations that do not complement any of the other mutations defines a 
non-pupariating (npr) class (Figure 7.1.1C) (Belyaeva et al. 1980; Kiss et al. 1988). 
Nonpuparating mutants are phenotypically indistinguishable from deletions of the 
BR-C locus (they correspond to a complete loss of function) and die as wandering 
third instar larvae, failing to puparate. Genetic analysis of BR-C has shown that the 
gene is essential for the morphogenesis of imaginal discs. The function of br is 
primarily required for the elongation and eversion of the imaginal discs into adult 
appendages as well as tanning and hardening of the larval cuticle. The rbp function, 
has been implicated in muscle and bristle development. In addition, both rbp and 
2Bc functions are essential for histolysis of the larval tissues and gut 
morphogenesis. It was found that 2Bc has important role in the fusion of the 
imaginal discs to form a continuous adult epidermis, (Kiss et al. 1988). All three 
functions are also required for the reorganisation of the CNS (Kiss et al. 1988; Emery 
etal. 1994). 
It was suggested there may be a one-to-one link between the genetic function 
of a given complementation group and a specific protein isoform (Z1-Z4) (DiBello et 
al. 1991). Current data shows that the relationships between the complementation 
groups and protein isoforms are more complicated. It several case it has been 
demonstrated that one isoform can provide a regulatory function opposite that of the 
other isoform (Hodgetts et al. 1995; von Kalm et al. 1994). Clearer data on these 
relationship were provided by Bayer et al. (1996a), who showed that the lethality 
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associated with each of the complementing groups was rescued using heat-inducible 
transgenes. This data was supported by (Gonzy et al. 2002) with the isolation of a 
number of novel mutations in the BR-C. It was found that br function is only 
provided by the Z2 isoform. Despite this, there may be functional redundancy or 
regulatory dependency associated with rbp and 2Bc functions (Bayer et al. 1996a). 
The Zi isoform was shown to provide full rbp function, while Z4 provides partial 
function. So far no mutants for Z4 have been identified and its function remains 
unclear. The 2Bc lethality is fully rescued by heatshock expression of a Z3 transgene, 
and partially rescued by a Z2 transgene. 
7.1.3 Functional domains in Broad Complex 
7.1.3.1 	BTB domain 
The BR-C core contains a highly conserved amino-terminal motif of 
approximately 115 amino acids called the BTB domain. In Drosophila there are at 
least 40 members of the BTB family which appear to be involved in protein-protein 
interactions (homodimerisation and heterodimerisation) and are widely distributed 
among metazoans (Bardwell and Treisman 1994; Zollman et al. 1994; Couderc et al. 
2002). The family was named after the first three genes in Drosophila found to 
contain BTB domain: BR-C, tramtrack and bric a brac (Figure 7.1.3A). The domain 
is also known as POZ (poxvirus and zinc finger). 
The Ttk protein (tramtrack) binds to the promoter of the pair-rule genesfushi 
tarazu and even-skipped (Harrison and Travers 1990; Brown and Wu 1993) and is 
responsible for the repression of these genes during embryogenesis. The gene is also 
expressed downstream of Notch with a function in the specification of daughter cell 
fates during the assyrnetric cell divisions in the peripheral nervous system (Guo et al. 
1995). Lai and Li (1999) have demonstrated a positive role of one of the Ttk 
isoforms (Ttk69) in the differentiation of the photoreceptor neurons at the later stages 
of Drosophila eye development. 
The gene bric a brac (BAB) is essential for pattern formation along the 
proximal-distal axis of the leg and antenna (Zollman et al. 1994). The gene was also 
found to have important function in the basal and interfollicular stalk development of 
the ovariole (Godt and Laski 1995). Null mutations in bab disrupt ovarian 
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Figure 7.1.3 Protein alignment of the BR-C domains 
The alignments were performed with CLUSTAL W (Thompson et al. 1994) 
available from the WEB-based package at http://www.ebi.ac.uklclustalw/. 
Subsequently, the multiple alignments were analysed and shaded on the BoxShade 
server (http://www.ch.embnet.org! 
software/BOX _form.html). The sequences were exported to Microsoft Word as RTF-
new files. The consensus sequence is given in red. 
BTB domain alignment. The sequence of the BR-C BTB domain is compared to 
BTB domains from Ttk (tramtrack) and Bab (bric a brac); NCBI accession numbers: 
BAB-I (CAB64385), BAB-11 (CAB64388), TTK (P42282), and BR-C (Q01295) 
Protein alignment of BR-C zing finger domains Zi (X54666), Z2 (X54665), Z3 
(X54664), Z4 (U51585), AZ2 (NP_6 10289), Ttk69 (NP_52491 1), and Hunchback 
(062537). 
7.1.3.2 Zinc finger domains 
Zinc finger motifs are small DNA binding domains. They exist as different 
types, depending on the positions of the cysteine residues. In BR-C the zinc fingers 
are from the C21-12 type, composed of --30 amino acids including two conserved 
Cystidine and two conserved Histidine residues that fold in a complex tertiary 
structure with a central Zn2 ion. This arrangement yields a finger-Re projection that 
protrudes from the zinc coordination site and is responsible for the nucleic acid 
binding properties of the domain. It was shown that C2H2 zinc fingers recognise 
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short, approximately 5 base pairs, G-rich nucleic acid sequences (DNA or RNA). 
Figure7. 1 .3B shows a protein alignment of the BR-C zinc finger domains compared 
to C2H2 fingers from several other Drosophila genes known to contain zing finger 
domains. 
r 	I' 
7.1.4 Chorion genes in Drosophila 
The somatic follicle cells synthesise endochorion and exochorion, the two 
outer layers of the Drosophila eggshell, during the last 6 hours of the oogenesis. Five 
chorion genes are clustered on two genetic loci, one on the X-chromosome (polytene 
position 7E9) encoding Cp36 and Cp38, and one on the Third chromosome (polytene 
position 66D14), producing Cp15, Cp16, Cp18 and Cp19 (Waring and Mahowald 
1979; Spradling and Mahowald 1980). The chorion proteins are transported and 
secreted at the inner surface of the follicle cells from where they are incorporated 
into the eggshell. 
During late oogenesis the two clusters of chorion genes are selectively 
amplified, above the level of the remainder of the follicle cell genome, which also 
endoreplicates to produce polyploid cells (Spradling and Mahowald 1980; Spradling 
et al. 1980; On-Weaver 1991). In response to developmental signals in the follicle 
cells the third chromosome cluster is amplified 60-80 fold and the X-chromosome 
set, 15-20 fold above the rest of the genome. This specific amplification depends on 
cis-acting sequences amongst the chorion genes (On-Weaver and Spradling 1986; 
Delidakis and Kafatos 1989). 
7.2 	Project aims 
Over the last several years a number of developmentally important questions 
about cell activity and function of the somatic follicle cells have been studied. The 
data suggests that a crucial role is played by the follicle cells in oocyte determination, 
maturation and in polarity establishment. However, there are many more questions 
that remain unanswered: how is the oocyte determined, what signals trigger follicle 
cell differentiation and what are the interactions between the subtypes of follicle cells 
and between the follicle cells and the germ line cells? 
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The aim of this work was to study the early function of Br-C, when it is 
expressed in all follicle cells at stage 6 of oogenesis. Its later expression in the 
dorsal-anterior follicle cells, is known to be related to its function in dorsal 
appendages morphogenesis (Deng and Bownes 1997). Since the chorion genes 
encode major eggshell components, and rbp+ function has been reported to be 
necessary for chorion gene amplification during oogenesis (On et al. 1989; Huang 
and On 1992), the purpose of this work is to investigate the relationship between the 
Br-C and chorion gene amplification and expression. 
7.3 	Project background 
7.3.1 Isolation and expression of the BR-C gene in oogenesis 
An extensive P[Gal-4] enhancer trap screen for genes involved in Drosophila 
oogenesis was carried out in our laboratory (Deng et al. 1997). Br-C was identified 
as the target gene in one of the lines. The reporter gene showed specific expression 
patterns in two sets of dorsal-anterior follicle cells at stage 10 of oogenesis. This 
finding prompted further investigations. 
In situ experiments revealed that Zi is the sole zinc-finger isoform expressed 
at detectable levels during oogenesis. The Br-C is initially expressed in all follicle 
cells at stage 6 (Figure 7.7.1A). Later at stage 10, Br-C forms a gradient of 
expression with the strongest signal localised to the dorsal-anterior follicle cells 
(Figure 7.7.1B). Shortly after that (stage lOb, 11) the Br-C transcripts are detected in 
just two sets of dorsal-anterior follicle cells (Figure 7.7.IC), which are thought to be 
the precursors of the chorionic appendages (Deng and Bownes 1997). 
Immunochemical analysis with antibodies for the Zi isoform showed that the 
BR-C protein distribution pattern is similar to that of Zi mRNA during stages 6-8 of 
oogenesis, when all follicle cells stain. The BR-C (Zi isoform) is then detected at 
stage 10 with staining in all columnar follicle cells except the dorsal anterior cells, a 
pattern similar to the mRNA distribution (Deng and Bownes 1997). However, the 
follicle cells at the posterior pole appear to be stained at this stage, which does not 
overlap completely with the mRNA distribution pattern. The late distribution pattern 
of the BR-C protein and mRNA differs. At stages 11-12 a strong signal is observed in 
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two groups of lateral-dorsal follicle cells but the posterior and ventral follicle cells 
are still stained. The signal in the posterior and ventral region gradually decreases 
and disappears at late stage 13, leaving only two patches of dorsal-anterior follicle 
cells stained. A likely reason for that difference is that the half-life of the protein is 
much longer than that of the mRNA. Thus, by the time when late BR-C transcription 
occurs in the lateral-dorsal-anterior follicle cells, the protein translated from the early 
BR-C transcripts are still present in the posterior and ventral follicle cells, while the 
mRNA has been degraded. This explains how the early and late protein distribution 
patterns overlap to form a gradient pattern at stages 11-12. This can also explain why 
the protein, but not the mRNA, is detected in the follicle cells at the posterior pole 
during stage 10. Antibodies that recognise the BR-C core domain produced similar a 
staining pattern to Zi antibodies, while Z3 antibodies did not generate any detectable 
staining during the oogenesis. Antibodies to Z2 and Z4 were not available at that 
time and their expression patterns have not been investigated. 
Deng and Bownes (1997) also showed that BR-C is expressed only in the 
nuclei of the follicle cells, which is consistent with the fact that the BR-C encodes a 
transcription factor. 
7.3.2 The function of Broad Complex during Drosophila oogenesis 
Genetical analysis of partial 'loss of function" mutants indicated that Br-C is 
required for dorsal appendage morphogenesis during oogenesis. Deng and Bownes 
(1997) showed that signals from both the germline and the somatic follicle cells are 
required to determine the correct BR-C expression pattern. First, the Grk (TGF-a 
homologue) signal from the oocyte binds to the epidermal growth factor receptor 
(EGFR) to activate a tyrosine kinase signalling pathway which establishes a dynamic 
pattern along the D/V (dorsal/ventral) axis in a dose dependant manner. The 
patterning along the AlP (anterior/posterior) axis is directed by TGF-/DPP 
(Decapentaplegic) signalling pathway. These two pathways (EGFR and DPP) 
cooperate to specify the expression of Br-C into two discrete groups of lateral-dorsal-
anterior follicle cells. These then differentiate and direct the formation of the dorsal 
appendages in the correct position on the eggshell (Deng and Bownes 1997). 
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A number of experiments were done by Wu Min Deng to determine which 
BR-C isoform is required for dorsal appendage formation (Deng, Thesis, 1997). The 
ZI zinc-finger is the only isoform expressed at levels detectable by in situ 
hybridisation and immunohystochemistry during oogenesis. Bayer et al. (1997) 
reported that Zi provides the full rbp function. To test whether the rbp (Zi 
isoform) function is responsible for the dorsal appendage formation, female 
homozygous viable rbp' and rbp2 mutants (escapers) (Table 7.4.1) were dissected 
and the eggshell phenotype examined. It was found that the dorsal appendages are 
shorter and irregular in shape compared to wild type suggesting that rbp is indeed 
involved in the dorsal appendage morphogenesis. 
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7.4 	Materials and fly strains used in the analysis of the Broad 
complex 
7.4.1 List of the Drosophila strains used to study Broad complex 
Oregon R and W 118 (the host strain used in the construction of the transgenic 
heatshock lines) were used as wild-type controls. The rbp2 and Br' alleles are viable 
and were maintained as homozygotes. All other BR-C mutations were maintained 
over Binsn, an X-chromosome balancer carrying the markers Bar and singed. Since 
all mutant and transgenic stocks showed slightly reduced viability they were 
maintained on standard corn meal food at 26°C 
Table 7.4.1 Drosophila strains 
Stock no Genotype Comments Reference 
br1  br1 deficiency line (Kiss et al. 1988) 
br5 I(1)t 5/Binsn deficiency line (Kiss et al. 1988) 
br6 I(I)t/Binsn deficiency line (Kiss et al. 1988) 
rbp1 br0h/Binsn deficiency line (Kiss et al. 1988) 
rbp2 6r 2/Binsn deficiency line (Kiss et al. 1988) 
2Bc1  br' 1/Binsn deficiency line (Kiss et al. 1988) 
2Bc2 br/Binsn deficiency line (Kiss et al. 1988) 
npr6 bt'/Binsn deficiency line (Kiss et al. 1988) 
brJk47 br44"/Binsn deficiency line (Deng and Bownes 1997) 
hsZl (527) w; P{BRcore-Q1-Z1} carries Q1-Q2-Z1 
transgene 
(Bayer et al. 1997) 
hsZl (708) w; P{hs-BRC-Z1} carries TNT-Q1-Q2-Z1 
transgene 
(Bayer et al. 1997) 
hsZ2 (CD5) w; P{hs-BRC-Z2] carries Z2 transgene (Bayer et al. 1997) 
hsZ3 (797) w; P{hs-BRC-Z3} carries Z3 transgene (Bayer et al. 1997) 
hsZ4 (28-I) w; P{hs-BRC-Z4] carries Z4 transgene (Bayer et al. 1997) 
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7.4.2 PCR analysis of Broad complex transcripts 
BR-C transcripts levels in ovaries were detected by RT-PCR as described 
previously (Hodgetts et al. 1995). Total RNA from ovaries and larvae (control RNA) 
was isolated using RNAeasy-Total RNA Kit (see methods, 2.5.12). The RNA (5 fig) 
was 	primed with Oligo-p(dT)15 and reverse transcribed using Superscript TM  II 
(methods, 2.5.10). For the subsequent DNA amplification, 5% of the first strand 
reaction mix was used. To amplify each of the zinc-finger domains, appropriate 
primer pairs (Table 7.4.2) were added to the PCR mixture: a common primer for the 
core domain was combined with one of the four primers for the respective zinc-
finger motif. The sequence data for the primers was obtained from (DiBello et al. 
1991; Hodgetts et al. 1995) (Table 7.4.2). In the PCR reaction QIAGEN Taq 
Polymerase and the protocol designed for use with Q-Solution was used. The PCR 
reaction was carried out as follows: one cycle at 94°C for 4 minutes; 35 cycles, step 
one - at 94 °C for 30 seconds, step two - 60 °C for 30 seconds, step three - 72°C for 
1.5 minutes; one cycle at 72°C for 7 minutes. 
Table 7.4.2 Broad complex PCR primers 




ZI TGC TGG TGC TGC TGG TGA TA 20 62 
Z2 TCA TCT CCA TTT CGC CGG GA 20 62 
Z3 GAT GGC GGT CGT CTT AAG CA 20 62 
Z4 GTG GTT GTT CAG CGA GTT CA 20 60 
CORE 3' ACA AGA TGT TCC ATG CAG CC 20 60 
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7.5 	rbp function is required for dorsal appendage formation 
To further test if rbp is the major functional domain involved in dorsal 
appendage formation we did a genetic analysis using the npr allele in crosses with br, 
rbp, and 2Bc alleles (Table 7.4.1). The cross between rbp' and npr6 produced only 
two males and no viable female heteroallelic mutants (Table 7.5). Two rbp2/npr6 
females were produced in the cross with rbp2 flies. They lived for two days without 
laying any eggs. Then they were dissected to examine the ovarian phenotype. It was 
found that the ovaries were not completely developed and the few late stage oocytes 
formed had no appendages (Wu Min Deng was also involved in these experiments). 
Thus we were unable to examine rbp function by this method. The combination 
2Bc/npr6 was found to be completely lethal, and as a result we could not establish if 
there is a function encoded by Z3 (213c) isoform (Table7.5). 
The function of Z2 was investigated further. The cross between br5 and npr6 
produced no viable heteroallelic flies, while the cross between br6 and npr6 generated 
22 heteroallelic males, but no females which could be examined. It was observed that 
eggs produced by br'/br'147 and br'/npr6 mothers have reduced dorsal appendages 
(Deng and Bownes 1997), suggesting that the br functional domain is likely to be 
required for dorsal appendage formation. In order to test this hypothesis, eggs 
produced by br5/br' and br6/br' females were examined, and found to have normal 
dorsal appendages. This observation, along with the fact that the br' 47 is actually an 
rhp allele (Huang and On 1992), suggests that the br functional domain, and hence 
Z2, is not involved in dorsal appendage formation. 
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Table 7.5 Survival frequencies of BR-C mutants 
Cross Progeny 
Heterozygotesa Heteroallelic mutantsc Lethal 
+Homozygous period 
Balancer b 
br 7 	x  npe 
Pr Binsn 
216 21 9 not observed 
158 0 0 III instar larva 
Binsn 	Binsn 
be 	Lxi1Pi 36 22 0 pupal 
Binsn Binsn 
rbp' xupi 140 2 0 pupal 
Binsn 	Binsn 
(12Q. 	x UQL 130 11 2 pupal 
rbp 2 Binsn 
x QQL 73 0 0 Il-Ill instar 
Binsn 	Binsn larva 
?cxuPL 215 0 0 pupal 
Binsn 	Binsn 
aHeterogotes  flies carrying a BR-C mutant chromosome and a balancer chromosome 
(br/Binsn, rbp/Binsn, 2BC/Binsn, and npr/Binsn). 
bnomozygous  balancer, flies homozygous with respect to the balancer chromosome 
(Binsn/Binsn). 
cHeteroallelic  mutants, flies carrying different combinations of BR-C alleles (br/npr, rbp/npr, 
and 2BC/npr). 
How can the phenotype of br'/br'447 and br'/npr6 eggshells be explained if hr 
is not the functional domain required for dorsal appendage formation? This could be 
understood if the bra' mutant not only affected hr function, but also affected rbp 
function. In order to test this possibility, the eggshell phenotype of eggs laid from 
br'/rbp' mutants was examined. It was shown that eggs produced by the br'/rbp' 
mothers have reduced dorsal appendages, similar to those produced by the br'/br' 47 
females. This indicates, therefore, that the br' is in fact a weak 2Bc or 2Bab allele, 
which fails to complement either rbp or hr function. This suggests that rbp (Zi and 
Z4 isoforms) is a functional domain involved in dorsal appendage formation during 
oogenesis, however, we cannot rule out the involvement of Z3 from these 
experiments due to the failure of these crosses to generate adult females due to early 
lethality. 
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7.6 	Ectopic BR-C expression induces ectopic dorsal appendage 
material 
Is BR-C function sufficient to direct the formation of the dorsal appendages? 
To address this, heat-inducible ZI transgenic flies (hsp70/Z1) were used to examine 
the effect of ectopic BR-C expression during oogenesis (Table 7.4.1). Following 
standard heatshock (37°C, 30mm) and incubation at 26°C for 2 to 48 hours, ovaries 
of the hsp70/Z1 females were analysed (Table 7.6). Flies were dissected to examine 
the effect of the heatshock at 2, 3, 5, 9, 24, and 48 hours after heat treatment. The 
first abnormalities in the egg chambers were observed 3 hours after the heatshock. 
The eggs laid during the first 3 hours following heatshock also have a very high 
hatch rate, presumably being sufficiently differentiated at the time of the heatshock 
for the ectopic BR-C expression to have any effect. The results over this period do 
not differ significantly for the control heatshocks (Table 7.6). The strongest effect 
was observed between 4 and 6 hours. It was observed that extra dorsal appendage 
material was produced in the dorsal-anterior region of the eggshells (Figure 7.613-17). 
In most cases, dorsal appendage material appeared in the dorsal gap between the two 
appendages. It condensed at the base of the dorsal appendages and less material was 
deposited in the appendages themselves. The dorsal appendages did not elongate 
properly (Figure 7.613-1)) presumably due to a failed migration of the follicle cells. 
Different phenotypes have been observed depending on the stage of the egg chamber 
at the time of heatshock. Heatshock at the time of dorsal appendage formation, stage 
11, leads to an 'appendageless" phenotype or to small fused appendages (Figure 
7.6B, Q. Appendages with abnormal shapes and/or different lengths have been 
observed on eggs staged 12-13 at the time of heatshock (Figure 7.61), E, F). These 
observations indicate that ectopic Zi can induce formation of ectopic dorsal 
appendage material. Nevertheless, the ectopic dorsal appendage material is restricted 
to the dorsal anterior eggshell, suggesting that the fate of the follicle cells is pre-
determined along the two major axes prior to the requirement for BR-C function in 
this process. It was hypothesised that the lack of BR-C expression in the dorsal-most 
follicle cells is due to high levels of expression of pointed (pnt) in those cells (Deng 
and Bownes 1997). The data shown here indirectly support this hypothesis. In the 
dorsal-most follicle cells, there could be competition between the expression of Pnt 
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and BR-C. When high levels of Pnt are expressed, BR-C expression is inhibited in 
these cells. However, in heat-shock lines, the BR-C expression would overcome the 
inhibition by Pnt. Thus, dorsal appendage material can be synthesised by these cells. 
Table 7.6 Effect of heatshock on ZI -Z4 transgenic flies 
Experiment Fly stock No of eggs laid Percentage of Percentage of 
abnormal eggs eggs hatched 
0-3h Zi 172 5.8 94 
Z2 144 2.3 96 
Z3 134 1.5 98 
Z4 80 5.0 96 
W 
1118 
364 1.6 98 
OrR 94 2.1 99 
3-5h Z1 27 74 2 
Z2 68 55 8 
Z3 4 0 25 
Z4 23 43 4 
W 
1118 
137 2.5 97 
OrR 117 2.7 96 
5-24h Zi 10 89 6 
Z2 361 78 12 
Z3 27 42 18 
Z4 186 77 15 
w1118  505 4.4 94 
OrR 363 3.6 98 
24-48h Z1 9 62 72 
Z2 670 33 93 
Z3 72 24 90 
Z4 390 18 97 
W 
1118 520 1.3 100 
OrR 370 1.1 99 
Note: Z1-Z4, transgenic flies carrying constructs to misexpress the various zinc-finger 
isoforms of the BR-C in response to heatshock; W" is the host line used for the construction 
of the transgenic lines used as a control. OrR (wild-type) flies were also used as a control. 
Approximately 100 flies (50 males and 50 females) from each stock were used in the 
heatshock experiments. 
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111007P, 	~Tvft- 
Figure 7.6 Ectopic expression of different BR-C zinc-finger isoforms 
during oogenesis 
A-F: dark field microscopy; 
A: Shows a wild type egg after heatshock treatment. 
B,C: Two distinctive hsp70/Z1 (527-5 and 708-1) transgenic lines exhibit a 
similar phenotype. Dorsal appendage materials are present in the dorsal-most 
region, resulting in fused, thickened and shortened dorsal appendages. 
fl-F: Shows a similar, but less severe eggshell phenotype in hsp70/Zl flies-see 
explanation in the text. Fused, thickened, and irregularly shaped appendages are 
also found in eggshells produced by the Z2, Z3 and Z4 transgenic lines. 
Although Zi seemed to be the sole BR-C zinc-finger isoform expressed at 
high levels during oogenesis when analysed by in situ hybridisation, we tested Z2, 
Z3 and Z4 to determine if they exhibit a similar phenotype when ectopically 
expressed during oogenesis. Thus, hsp70/Z2, hsp70/Z3 and hsp70/Z4 flies were heat-
shocked and the eggshell phenotype was examined (Table 7.6). It was found that 
ectopic dorsal appendage material is produced in the dorsal-anterior region of the 
eggshells by all three transgenic lines. This phenotype is similar to that exhibited by 
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eggs by the hsp70/Z1 flies after heatshock, suggesting that all of the four zinc-finger 
isoforms could be functional in dorsal appendage formation during oogenesis. 
It is apparent from Table 7.6 that heatshock has the strongest effect on 
chorion morphology and egg viability in hsp70/Zl flies. Z2-Z4 recovered viability to 
approximately 95% in two days, while Zi recovered only to 72% during that time 
period. It was also found that heatshocked Zi, Z2 and Z4 flies lay abnormal eggs 
(Table 7.6). The ectopic expression of BR-C in Z3 flies was found to disrupt the 
process of egg development soon after the heatshock. We observed that some 20% of 
all laid eggs have aberrant micropyles, due to excess chorion formation. This could 
prevent the sperm entering the egg and hence subsequent development would fail 
due to lack of fertilisation. Another possible explanation is that ectopic expression of 
BR-C can disrupt some other BTB containing protein that can dimerise with the BR-
C and thus modulate its function. 
Heatshock alone causes eggshell defects. The data of the control experiments 
with the heatshocked wild type OrR flies and w'118 the host line for the transgenic 
flies is presented in Table 7.6. We observed in the few abnormal eggs wide branched 
dorsal appendages of approximately normal length. It is quite clear that the results of 
misexpressing BR-C in oogenesis significantly affects the eggshell. 
7.7 	Other zinc finger isoforms are expressed in oogenesis 
Although only Zi expression was clearly detectable by in situ hybridisation 
we observed defects in chorion formation and morphology by overexpressing all four 
zinc finger isoforms available. It became essential, therefore, to establish if this was 
due to some degree of functional redundancy between the isoforms with respect to 
eggshell development or if the other zinc fingers are, in fact, expressed at lower 
levels in oogenesis. 
Firstly we repeated the in situ hybridisations to whole mount ovaries, 
following a modified protocol, using ssDNA probes labelled by PCR (see methods, 
2.5.14). We observed that Zi transcripts are expressed in a dynamic pattern (Figure 
7.7.1 A, B, and C) consistent with the previously reported data (Deng and Bownes 
1997). No transcripts for Z2 and Z3 isoform were detected by in situ hybridisation 
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(Figure 7.7.1D and E). We observed that Z4 is initially expressed in all follicle cells 
at late stage 5 to stage 6. Later at stage 10, low levels of Z4 transcripts were detected 
in the columnar follicle cells (Figure 7.7. IF). This showed that the expression pattern 
of Z4 is similar the expression pattern of Z I. However the transcripts for Z4 isoform 
did not localise specifically to the lateral-dorsal-anterior follicle cells to produce the 
characteristic pattern for the Z  isoform. 
A 	 D 
B 	 E 
C 	 F 
At, 	11,00  
Figure 7.7.1 BR-C expression pattern in wild-type ovaries 
BR-C transcripts (Zi isoform) are first detected in all follicle cells, at stage 6 
(black arrows). 
At stage 10A most of the columnar follicle cells express BR-C (Zi), except the 
dorsal anterior region and the cells at the posterior pole. 
At stage lOB The BR-C (Zi) staining is confined to two discrete patches of 
follicle cells lying symmetrically on either side of the dorsal midline. The distance 
between the stained patches is approximately 3 cell wide (blue arrow). 
D, E: No expression was detected using probes for Z2 and Z3 isoforms. 
F: In situ hybridisation with probe for Z4 transcripts produced a low level staining 
similar to the Ziexpression pattern. 
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RT-PCR was performed to detect low levels of BR-C transcriptional activity 
(for details see 7.4.2). To check the expression of the different transcripts we used 
primer pairs for the different isoforms and the common core domain (the 
organisation of the zinc finger isoforms in relation to the BR-C gene are shown in 
Figure 7.1.1). The position of the PCR primers on the BR-C map is illustrated on 
Figure 7.7.2, while their sequence is given in Table 7.4.2. 
The results clearly show that all 4 zinc fingers are expressed in oogenesis 
(Figure 7.7.3). The identity of the PCR generated products was confirmed with 
Southern blot analysis (Figure 7.7.4). 
CORE 	ZI Z4 Z2 Z3 
i am 
ZI (974J80, 728 bp) 
Z2 (320 bp) 
Z3 (784 bp) 
Z4 (1082 bp) 
Figure 7.7.2 Exon map of BR-C 
Simplified exon map of BR-C. The upstream half of gene, including the first 
exon is omitted from the figure. Arrows indicate the relative position of the primer 
pairs used in the RT-PCR analysis. All four PCR reactions were carried out with a 
common primer located at the 3' end of the core domain of BR-C. The other primers 
are located just within, or immediately 3' to the respective Zl-Z4 domain. The 
predicted sizes of the PCR amplification products are given beneath the map. The 
primers used should generate products of 974 bp, 780 bp, 728 bp (Z 1); 320 bp (Z2); 
784 bp (Z3); and 1082 bp (Z4) respectively, based on published data (Hodgetts et al. 
1995; Bayer et al. 1996a) (Figure 7.7.3). 
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Figure 7.7.3 PCR analysis of the BR-C transcripts in Drosophila 
melanogaster (wild-type, Oregon R) ovaries. 
Total RNA from ovaries was reverse transcribed and the subsequent cDNA 
PCR amplified using the primer pairs shown with arrows below the exon map (Figure 
7.7.2). M, marker-lkb ladder (Gibco BRL); Ov, ovaries; L, larvae (whole organism) 
used as a control. The primer sets generated the following products from transcribed 
larvae RNA: 974 bp, 780 bp (ZI); 320bp (Z2); 784bp (Z3); 1082 bp (Z4). The PCR 
did not generate the 728bp Zl product from transcribed ovarian RNA indicating the 
lack of this transcript during oogenesis. 
L0 kb 
0.5 kb 
0.3 kb 	. 	 * 
ZI 	Z2 	Z3 	Z4 
Figure 7.7.4 Southern analysis of BR-C transcripts 
The gel from the RT-PCR analysis of the BR-C transcripts was transferred to 
a nylon membrane and hybridised with a radio labelled probe for the BR-C core 
domain. The probe was prepared from the Bs-cD5 plasmid DNA provided by (Bayer 
et al. 1996a) (for details about the plasmid see Table 2.2.1; for probe preparation and 
hybridisation techniques, 2.5.13.2 chapter. 
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It seems likely, therefore, that, as in metamorphosis, all zinc finger isoforms 
are expressed and function to regulate downstream gene expression. However, only 
Zi and partially Z4 are expressed at a high enough levels to be detected by in situ 
and immunohystochemistry methods. 
7.8 	Ectopic BR-C expression during mid-oo genesis affects 
endoreplication and chorion gene amplification 
Ectopic BR-C expression appears to induce premature production of the 
chorion. Figures 7.8.1C and 7.8.11) show that the chorion is already present in the 
stage 11 egg chamber. This could isolate the oocyte from the nurse cells and 
physically prevent transferring of the nurse cell components into the oocyte. 
Alternatively this could result from an altered pattern of transcription and translation 
of the chorion genes, or from abnormalities in the amplification of the chorion genes, 
or both. We investigated, therefore, whether the alterations in BR-C expression 
affected the timing or pattern of chorion gene amplification. Since the chorion is 
synthesised by most follicle cells this function could be related to the earlier 
expression of the BR-C. To monitor amplification we investigated the incorporation 
of BrdU in the follicle cell nuclei of wild type ovaries and in ovaries misexpressing 
various isoforms of the BR-C (see methods,2.5.16). 
In wild type ovaries, after 8 mitotic cell divisions, the endoreplication phase 
of follicle cell development begins (stage 6 of oogenesis) and is completed by stage 
lOB; during this process the entire nucleus is labelled by BrdU. The endoreplication 
is asynchronous in wild type and w"18 (the host strain used to produce the transgenic 
lines) ovaries and occurs in both nurse cells and follicle cells (Figure 7.8.2A, Q. We 
observed a continuous endoreplication in the nurse cell associated follicle cells at 
stage lOB (Figure 7.8.2C). This is followed by the chorion gene amplification phase 
when 4 spots of incorporation are seen per nucleus in the follicle cells overlying the 
oocyte (Figure 7.8.2C, G, K). These 4 spots represent amplification of the two 
clusters of chorion genes (Figure 7.8.2G, K). Two are always larger, presumably due 
to the higher level of amplification of the cluster on chromosome 3 compared to the 
X chromosome cluster (Orr-Weaver and Spradling 1986; Delidakis and Kafatos 
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1989). This amplification was first observed at the border between the oocyte and 
nurse cells and it soon spread to the rest of the follicle cells. 
Figure 7.8.1 Ectopic BR-C expression affects the onset of chorion 
synthesis 
A, D: Hoechst staining; C1-D1, dark field microscopy 
Shows a wild type egg chamber at late stage 11. The oocyte is larger than 
the nurse cell complex due to the onset of nurse cell dumping into the oocyte. 
Wild type egg chamber, late stage 12. Dumping is complete. 
C-D: (late stage 11) and 
C1-D1: (late stage 12) show that transgenic Z 1 -Z4 also causes inappropriate 
chorion synthesis (arrows), and this blocks dumping of the nurse cell cytoplasm 
into the oocyte during stage 11-12 of oogenesis. 
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When the BR-C isoforms are misexpressed, there is prolonged and synchronised 
endoreplication until late stage lOB, followed by specific amplification of genes in 
each nucleus Figure 7.8.21), F, H, L). These results are observed from 3.5 - 4.5 hours 
after heatshock. We also observe extra spots of incorporated BrdU in the nuclei 
(Figure 7.8.2H, L). 
There were three possible explanations for this: either the heatshock could be 
responsible; or the homologues of the chromosomes could have separated due to a 
defect in the cell cycle; or there could be amplification of DNA at additional sites in 
the genome. The host flies used to produce the transgenic lines, w1118, were 
heatshocked and still showed 4 spots per nucleus, so heatshock itself was not 
responsible for the results. We counted the number of spots per nucleus and found 6 
or 12 spots in approximately 80% of the nuclei. Occasionally we observed up to 28 
spots. If the cell cycle was affected, and the homologues had separated, we would 
expect to see many more than 28 spots per nucleus due to the polyploidy of the 
follicle cells. If the amplification sites varied we could not predict the numbers, and 
indeed it may well be variable. This suggests that there are other sites in the genome 
induced to replicate by BR-C overexpression. We conclude that the endoreplication 
of DNA and the amplification of the chorion genes depends upon the BR-C encoded 
proteins or an unknown protein that is encoded by one of the downstream targets of 
the BR-C. This observation is consistent with the report that a mutation in the BR-C 
locus causes premature arrest of chorion gene amplification (Huang and On 1992). 
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Figure 7.8.2 Chorion gene amplification. BrdU incorporation associated with 
endoreplication and amplification 
BrdU incorporation in the nuclei of wild type Drosophila (Oregon R) ovaries and w1118, 
the host strain used for the production of the BR-C transgenic lines, stage bA. The 
endocycles are not synchronous. Thus, just some of the nuclei are positive (Calvi et al. 
1998). 
Overexpression of a BR-C (Zi) transgene in ovaries at stage bA. Most of the nuclei 
show synchronous endoreplication. 
Normal synchronised amplification in wild type and w"8 at stage lOB. By that time the 
endoreplication associated with the main body follicle cells is completed. 
BrdU incorporation in the nuclei of heatshocked BR-C (Z 1) transgenic ovaries, stage lOB. 
Strong BrdU incorporation is present in the nurse cells. 
BrdU incorporation in wild type nuclei at stage 12. 
BrdU incorporation in the nuclei of BR-C (Zi) expressing ovaries 3h after the heatshock, 
stage 12. Some of the nuclei contain extra spots of replication. 
Higher magnification of wild type and w"8 nuclei at stage lOB to show the four spots of 
amplification normally occurring in wild type ovaries. 
BrdU incorporation in the nuclei of BR-C (Zi) expressing ovaries 3h after the heatshock, 
stage lOB. Some of the nuclei contain extra spots of replication. The amplification pattern 
overlaps with the labelling due to continued endoreplication. 
E-K: The nuclei of heatshocked w"18 ovaries still show four spots of amplification. 
F-L: The nuclei of BR-C (Zi) transgenic ovaries 4.5 h after the heatshock exhibit a 
multispotted pattern. 
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Figure 78.2 Chorion gene amplification. BrdU incorporation associated 
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7.9 	Ectopic BR-C expression in relation to chorion gene 
expression 
The chorion is produced by the columnar follicle cells to provide a shell 
around the egg. Later in oogenesis, two groups of cells migrate anteriorly to produce 
the chorionic appendages and produce very large amounts of chorion material. 
Ectopic expression of the Zi isoforms lead to chorionic appendage deposition by 
extra cells lying at the anterior of the egg filling in the mid-dorsal gap observed in 
wild type eggs. Often the follicle cells fail to migrate anteriorly over the remaining 
nurse cells at stage 11 and they are present, therefore, at a more posterior position. 
The pattern of chorion gene expression was compared in wild type ovaries and those 
expressing the Zi isoform ectopically. In the wild type, we observe a high 
concentration of chorion transcripts in all follicle cells at stage 9, prior to their 
translation; they then become inactive and transcripts are again seen in stages 11-14 
(Figure 7.9A, C, E, G). In the ovaries with ectopic BR-C gene expression, examined 
3.5-4.5 hours after the heatshock, the same high concentration of chorion transcripts 
is observed in anterior follicle cells, even though their location in relation to the 
nurse cells is more posterior. This suggests the expression pattern is not dependent 
on the BR-C along the anterior-posterior axis (Figure 7.913, D, F, H). Moreover, 
posterior follicle cells do not produce substantially more chorion material even 
though they express Zi protein after heatshock. The fact that more dorsal cells 
produce appendage material and express the chorion genes means that BR-C 
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Figure 7.9 In situ hybridisation to chorion RNA in ovaries 
A, C, E, G: In situ hybridisation to wild type (Oregon R) Drosophila ovaries with a DIG-
labelled probe hybridising to chorion mRNA. The chorion probe, 7C8, was generated from 
cDNA encoding the c38 chorion protein, which maps to the X chromosome (see plasmid 
stocks, Table 2.2.1). Similar results were obtained using the alternative 7B7 probe (cDNA 
encoding 65 protein), which maps to a site on the third chromosome. For more 
information about the probes see Spradling et al. 1980. 
B: In situ hybridisation to heatshocked Drosophila BR-C (Z 1) transgenic ovaries with 7C8 
probe, stage 11. At that stage an increase in the amount of chorion mRNA is observed at 
the border between the nurse cells and the oocyte. The misexpression of the BR-C leads to 
abnormal migration of the anterior follicle cells. 
D: In situ pattern of chorion mRNA expression in heatshocked BR-C (Zi) transgenic 
ovaries, stage 12. A gap (arrows) is formed at the anterior pole as a result of failed 
migration of the follicle cells. 
F: Strong expression of the chorion gene clusters in heatshocked BR-C (Z 1) transgenic 
ovaries at stage 13. The variations in the egg chamber shape result from the heatshock 
induced misexpression of BR-C. 
H: Strong continuous expression of chorion mRNA in heatshocked BR-C (Z 1) transgenic 
ovaries, stage 14. The anterior gap is not present because the nurse cells have completed 
dumping and the follicle cells have migrated correctly by the time of heatshock. 
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In summary we observed two different effects. Initially the ectopic expression 
of BR-C prevents the migration of the dorsal follicle cells in an anterior direction. 
Then the midline cells which normally express chorion protein at that stage start 
depositing chorion material in the wrong location. This results in the production of 
aberrant dorsal appendages. It is possible that the BR-C activates downstream genes 
which, in turn, activate the chorion genes. In anterior cells high levels of BR-C 
expression "win" over trans-acting repressors, but in posterior cells they do not. The 
in situ hybridisation results and the observed characteristic phenotypes following 
ectopic BR-C expression are both consistent with this observation. Alternatively BR-
C could be essential for the cell migrations to position the follicle cells and 
endoreplication of the chorion genes but not in regulating chorion gene expression. 
7.10 DISCUSSION 
7.10.1 The BR-C complementing groups and zinc-finger isoforms 
It has been shown by genetic analysis that rbp function is required for dorsal 
appendage formation, and it was observed that Zi is the only zinc-finger isoform 
expressed at high levels in the appendage-producing cells. These observations are 
compatible with the report that Zi provides rbp function (Bayer et al. 1997). It was 
also found that rbp function is partially provided by Z4, but is not provided by Z2 
and Z3, (Bayer et al. 1997). However, heatshock-induced expression of all four zinc-
finger isoforms (Zi, Z2, Z3 and Z4) leads to a similar phenotype of extra dorsal 
appendage material production in the dorsal-gap, indicating that they may substitute 
for each other functionally in dorsal appendage formation. 
The homozygous viable mutant, br', was the first mutant identified in the BR 
C locus. hr' mutant flies have shorter and wider wings than in wild type and fail to 
complement other mutations which belong to the br complementation group. 
However, the results from the complementation analysis suggests that the br' 
mutations also partially remove rbp function. Therefore, it is in fact a 2Bab allele 
(Figure 7.1.1). It is known that 2Bab mutations cause reduction of both Zi and Z2 
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expression. Thus in the br'/brA47  and br'/npr6 females, both Zi and Z2 are reduced. 
The reduction of Zi levels results in the reduction of dorsal appendages, while no 
effect is produced by the reduction of Z2 levels. That is why no defects were 
observed in eggs produced by br'/br5 and br'/br6 females. 
The mutant phenotypes clearly show the need for the BR-C in dorsal 
appendage morphogenesis. PCR experiments have demonstrated that all zinc finger 
isoforms are expressed in oogenesis, but as yet we have no evidence that they 
perform different functions. We also do not know the spatial and temporal 
distribution of Z2-Z4, which are not present at sufficiently high levels for detection 
by in situ hybridisation. Overexpression studies using transgenic flies carrying 
heatshock-controlled Zi, Z2, Z3, and Z4 isoforms lead to a failure of proper 
migration of the follicle cells that will secrete the appendages, premature chorion 
deposition, and abnormal appendage formation. 
7.10.2 Relationship between the BR-C and chorion production 
We have shown here that the BR-C is important for controlled DNA 
replication in oogenesis. Overexpression does not affect the timing of the onset of 
endoreplication and amplification but, endoreplication is prolonged beyond that 
observed in wild type ovaries and it leads to additional replication loci in the 
genome. These additional sites presumably share sequence similarities with the cis-
acting sites regulating chorion gene amplification. This suggests that the BR-C is a 
key regulator of endoreplication and chorion gene amplification. The early BR-C 
expression pattern is in all the follicle cells and it is presumably at this stage that it is 
involved in this function. The expression of the BR-C is first observed in wild type 
flies at stage 6 and it is also at stage 6 that the endoreplication cycles begin. Since we 
do not observe premature endoreplication with BR-C overexpression, presumably 
other components essential for endoreplication are absent until stage 6 of oogenesis. 
The active role of the BR-C in endoreplication is also apparent from the fact that we 
observed prolonged incorporation of BrdU in the nurse cell nuclei when the BR-C is 
overexpressed. This presumably results in expression of the BR-C in the nurse cells, 
where it normally is not expressed. This shows that the proteins encoded by the BR-C 
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can function to prolong replication of DNA, even in cells where it is not normally 
used to control this process. It also suggests that an alternative regulator for DNA 
replication to the BR-C is used in the nurse cells. In normal development, the later 
BR-C expression, which is maintained in the dorsal-anterior cells making the 
appendages, is probably needed for cell migration, chorion deposition, and other 
follicle cell differentiation events. 
It is possible that the initial activation of the BR-C in all follicle cells is 
regulated by the ecdysone/USP heterodimer (Yao et al. 1992; Homer et al. 1995) as 
is observed in metamorphosis. There is some evidence that in intermoult puffs a 
second heterodimer with DHR38 (a nuclear receptor related to NGF1-13 from 
mammals) can compete for the same binding sites (Crispi et al. 1998). It is also 
possible that other DNA binding proteins besides the ecdysone receptor will be 
involved in BR-C expression. This would suggest a role for ecdysone during these 
stages of oogenesis. Later, the BR-C could be repressed in specific follicle cells by 
competitive and co-operative interactions with other gene products initiated by the 
grk and dpp signalling pathways. There is a significant amount of evidence that 
ecdysone and Juvenile Hormone (which binds to USP) are important for the progress 
of oogenesis (Bownes 1989) and we have recently shown that there is a check point 
in oogenesis that regulates whether egg chambers will proceed with development or 
undergo an apoptosis, which is regulated by the balance of Juvenile Hormone and 
ecdysone (Soller et al. 1999). However, there is little evidence as to precisely what is 
the role these hormones in regulating oocyte development and egg chamber 
differentiation. It has been shown (by antibody staining) that the Ecdysone Receptor 
is present in the follicle cells at the time when BR-C is activated (Mauchline, Deng 
and Bownes, unpublished). 
Once activated, as we have shown, the BR-C gene is involved in 
endoreplication, the selective amplification of the chorion genes, and in the 
subsequent morphogenesis of the chorionic appendages. Calvi et al. (1998) have 
recently shown that the selective amplification of the chorion genes is closely linked 
with the cell cycle and the cycles of endoreplication that occur earlier in the follicle 
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cells. Somehow the chorion genes escape the replication controls that influence other 
parts of the genome. Our BrdU labelling experiments confirm their results on the 
timing of endoreplication and chorion amplification and the close association 
between endoreplication and selective amplification. Using overexpression of the 
BR-C we see not only the two extra sites they mentioned that may represent another 
chorion gene amplified for a function in later oogenesis, but also a number of 
additional sites. These may be sites with sequence similarity to the cis-acting sites 
regulating amplification. (Calvi et al. 1998) propose that there are amplification 
complexes located at chorion genes. Whether the BR-C encoded proteins are 
associated with these complexes or regulate the synthesis of one or more of their 
components remains to be elucidated. We have confirmed the link between 
endoreplication and chorion amplification and shown that it involves the BR-C. This 
may, therefore, provide a crucial link between hormones and the control of the cell 
cycle, and hence differentiation of the egg chamber during oogenesis. 
In summary, our working model would be that the BR-C is activated by 
ecdysone in all follicle cells at stage 6 of oogenesis where its key function is the 
control of endoreplication, and then selective amplification. Later, when it is turned 
off in all but the anterior-dorsal follicle cells that will secrete the appendages, it has a 
second set of functions and is involved in the migration of cells and morphogenesis 
of the chorionic appendages. Recently this link between ecdysone (but not the 
ecdysone receptor), the BR-C, and morphogenesis has also been described for the 
progression of the furrow in the developing eye imaginal disc of Drosophila 
(Brennan et al. 1998; Brennan et al. 2001). 
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Appendix I Alignment of the conserved myosin head domains 
The head domains of Drosophila myosins (equivalent to amino acids 88-780 of 
chicken skeletal myosin) were compared to selected myosins representing phylogenetically 
diverse organisms. Some of the major structural features are colour shaded. 
Ac-lB VDDLVLMPKIT-EQDICANLEKRY-E'NDLIYTNIG--PVLISVNPFRRI DA--LLTDECL 54 
Ac-IC VDDMVMLTSIS-NDAINDNLKKRF-AADLIYTYIG--HVLISVNPYKQINN--LYTERTL 54 
ScMyo3-IA ISDLTLLSKIS-DESINENLKKRF-KNGIIYTYIG--HVLISVNPFRDLG --- IYTAVL 53 
ScMyo5-IB VSDLTLLSKIS-DEAINENLKKRE'-LNATIYTYIG--HVLISVNPFRDLG --- TYTDAVM 53 
Cehum5-IA VEDLVLLSTID-LKSVVQNLQLRE'-QKGRIYTYIG--EVLVAVNPYRQLG --- IYEKSTV 53 
Cehuml-IB VDDMVLLPKLT-EQSIVENLKKRL-QANSIFTYIG--PVLISVNPE'KQMP --- YFTEKEM 53 
Dm31D-IA vQDFvLLDQvs-MEKFMDNLRKRF-QNGSIYTYIG--VCVSMNPYRQMN --- IYGPETI 53 
Dm61 F-lB VQDFVLLENYQSEEAFIGNLKKRF-QEDLIYTYI--GQVLISVNPYKQLP --- IYTDNHV 54 
Dm95E TWDSVLLENLS-EDSFINNIHQRY-KRDHIYTYIG--TSVVALNPYHHIS --- EHSLDNV 53 
Rc-IB VQDEVLLENYTSEAAFIENLRKRF-KENLIYTYIFTGSVLVSVNPYKELE --- IYSKQF{M 56 
Gg-Bb VGDLVMLDFLS-EESLLRTLQERF-SRGEIYTYIGFTEVVISVNPYKPLP --- IYTPEKV 55 
Gg-IB VDDMVLLAKIS-EEAIVENLKKRF-MDDYIFTYIG--PVLISVNPE'KQMP --- YFTDRI 53 
Rnmyrl-IA VGDTVLLEPLN-EETFIDNLKKRE'-DHNEIYTYIG--SVVISVNPYRSLP --- IYS PEKV 53 
Rnmyr2-IB VQDFVLLENFTSEAAFIENLRRRE-RENLIYTYI--GPVLVSVNPYRDLQ --- IYTRQHN 54 
Rnmyr3-IC VDDMVLLSKIT-ESSIVENLKKRY-MDDYI FTYIG--SVLISVNPFKQMP---YFGEKEI 53 
Rnmyr4 -ID KADFVLMDTVS-MPE FMANLRLRF-EKGRIYTFIG--EVVVSVNPYKVLN---IYGRDTI 53 
ScMY01-IIA VENMSELTHFN-EPSVLYNLEKRY-DCDLIYTYSG--LE'LVAINPYHNLN --- LYSEDHI 53 
ScMYS1-IIB VENMSELTHLr'-EPSVLYNLEKRY-DCDLIYTYSG--LFLVAINPYHNLN---LYSEDHI 53 
Dd-nmII VEDMSELSYLN-EPAVFHNLRVRY-NQDLIYTYSG--LFLVAVNFFKRIF --- IYTQEMV 53 
Cemyo3-IIA TEDMANLTE'LN-EASVLGNLKDRY-KDLMIYTYSG--LFCVVINPYKRLF --- IYSESVI 53 
Cemyo4-IIB TEDMSt'TLSFLN-DASVLHNLRSRY-AAMLIYTYSG--LFCVVINPYKRLP --- IYTDSCA 53 
Cemyo2-IIC TEDMSNLTFLN-DASVLYNLKARY-AAMLIYTYSG--LFCWINPYKRLP --- IYTESVA 53 
Cemyol-IID TEDMSNLTFLN-DASVLWNLRSRY-AAMLIYTYSG--LFCVVINPYKRLP---IYTDSVA 53 
Dm-mhcll AEDMSNLTYLN-DASVLHNLRQRY-YNKLIYTYSG--LFCVAINPYKRYP --- VYTNRCA 53 
Dmzip-nmII VEDMAELTCLN-EASVLHNIKDRY-YSGLIYTYSG--LFCVVVNPYKKLP --- IYTEKIM 53 
X1-nmIIB VEDMAELTCLN-EASVLHNLKDRY-YSGLIYTYSG--LFCVVINPYFC1LP --- IYSENII 53 
Gq-E'SkII IEDIvIAMMTHLH_EPAVLYITLKERY-AAWMIYTYSG--LFCVTVNPYkWLP --- VYNPEVV 53 
Gg-nmII VEDMAELTCLN-EASVLHt'TLKERY-YSGLIYTYSG--LFCVVINPYKNLF --- IYSEEIV 53 
Gg-smII VEDMAELTCLN-EASVLHNLRERY-FSGLIYTYSG--LFCVVINPYKQLP --- IYSEKII 53 
Hs-FSkEII IEDMN4LTHLN-EPAVLYNLKDRY-TSWMIYTYSG--LFCVTVNPYKWLP --- VYNPEVV 53 
Hs-nml IA VEDMAELTCLN-EASVLHNLKERY-YSGLIYTYSG--LFCVVINPYKNLP --- IYSEEIV 53 
Hs-CaA IEDMAMLTFLH-EPAVLFNLKERY-AAWMIYTYSG--LFCVTVNPYKWLP --- VYNAEVV 53 
DrrjNinaC-III PEDLAALENPV-DENIIESLRHRI-LMGESYSFIG--DILLSLNSNEIKQ --- EFPQEFH 53 
Lp-III VDDLAFLDSpT-EEv'rLENLEQRy-RKGEIYTFAG--DVLLTLNPGKVLP---LYGDQTA 53 
HsMY03A VDDLATLEILD-ENTVSEQLEKCY-SRDQIYVYVG--DILIALNPFQSLG --- LYSTKHS 53 
ScMyo2p-Va TEDLTSLSYLN-EPAVLHAIKQRYSQLN-IYTYSG--IVLIATNPFDRVDQ--LYTQDMI 54 
ScMyo4p-Vb TDDLTTLSYLN-EPAVLHAIKKRYMNGQ-IYTYSG--IVLIAANPFDKVDH--LYSREMI 54 
Cehum2 -v KDDLTLLSYLH-E FAVLHNLQVRFVKGSSIYTYCG--IVLVAIMPYADCSH--IYGEEII 55 
SpMyo-Va ENDLTSLSYLH-EPAVLYNLNERFIRNTAIYTYCG--IVLVAIN PYESLP---LYGEDVI 54 
Dmdidum-Va QNDLTTLSYLH-EPGVLHNLRVRFCERQIIYTYCG--IILVAINPYAEMP --- LYGPSII 54 
Ggp190-Va ENDLTALSYLH-EPAVLHNLKVRFIDSKLIYTYCG--IVLVAINPYEQLP --- IYGEDII 54 
Mmdilute-Va ENDLTALSYLH-EPAVLHNLRVRFIDSKLIYTYCG--IVLVAINPYEQLP --- IYGEDII 54 
Rnmyo5-Va ENDLTALSYLH-EPAVLHNLRVRFIDSKLIYTYCG--IVLVAINPYEQLP --- IYGEDII 54 
Rrimyr6-Vb ENDLTALSHLH-EPAVLHNLKVRFLESNHIYTYCG--IVLVAINPYEQLP --- IYGQDVI 54 
HsMY05A ENDLTALSYLH-EPAVLHNLRVRFIDSKLIYTYCG--IVLVAINFYEQLP --- IYGEDII 54 
HsMY05C ENDLTALSYLH-EPAVLHNLRIRFAESKLIYTYSG--IILVAMNPYKQLP---IYGDAII 54 
SpMyoVI VDDNCSLMYLN-EATLLNNLRLRY-KKNSIYTYVA--NILIAVNPYKQMG--DLYTSSNI 54 
Cehum3-VI VEDNCALVHLN-EATLLNMCRLRY-ANGKIYTYVA--NILISIr'TPYQLID--GLYSPETI 54 
Dmj ar-VI HDDNCELMLLN-EATFLDNLKVRY-YKDKIYTYVA--NILIEAVNPYREIK--ELYAPDTI 54 
Ms-VIA VEDNCSLMYLN-EATLLNNVRVRY-SKDKIYTFVA--NILIAVNPYYDIPFTKLYSFETI 56 
Ms -VI B VDDNCSLMYLN-EATLLNNVRVRY-SKDHIYTYVA--NILIAVN PYYDI PFTKLYGFDSI 56 
GgMyoVI VEDNCSLMYLN-EATLLHNIKVRY-SKDRIYTYVA--NILIAVNPYFDIP--KFYSSDAI 54 
MmWaltzerVl VEDNCSLMYLM-EATLLHNVKVRY-SKDRIYTYVA--NILIAVNPYFDIP--KIYSSDTI 54 
HsMY06 VEDNCSLMYLN-EATLLHNIKVRY-SKDRIYTYVA--NILIAVNPYFDIP--KIYSSEAI 54 
Cehum6-VII VEDMCQLGDFH-ESAILRNLFIRY-REKLIYAYTG--SILIAVNPYMDIA --- IYTADEI 53 
Dmck-VIIA VEDMISLGDLH-EAGILRNLLIRY-KENLIYTYTG--SILVAVNPYQILP --- IYTGDQI 53 
Dm28B-VIIB VEDMITLGDLQ-EYTILRNLQNRY-AKQLIYTYTG--SMLVAINPYQILP --- IYTNREI 53 
DrMyo-VIIA VEDMIRLGDLN-EAGILRNLLIRY-RHLIYTYTG--SILVAVN2YQLL2 --- IYTADQI 53 
Mmshaker-VIIA VEDMIRLGDLN-EAGILRNRLIRY-RDHLIYTYTG--SILVAVNPYQLLS --- IYSPEHI 53 
HsUsherlb-VIIA VEDMIRLGDLN-EAGILRNLLIRY-RDHLIYTYTG--SILVAVNPYQLLS --- IYSPEHI 53 
Dm10A-XV VEDMTLLDDLH-EASLLWNLRLRY-DKGLIYTFAG--SILIAVNPYKMFPD--AYGLEVA 54 
Mm-MYO15 VEDMTQLEDLQ-ETTVLANLKTRF-ERNLIYTYIG--SILVSVNFYRMFA --- IYGPEQV 53 
Hs-MYO1 5 VEDMTQLEDLQ-ETTVL5NLKIRF-RNLIYTYIG--SILVSVNFYQMFG---IYGPEQV 53 
DmMhcl-PDZ VEDICELKYLN-EASVLHCLRQRY-ASNLIHTKAG--PTLLVVNPMAFLS---LYSEKVV 53 
Hs-PDZ -----------------------------------------------------------M 1 
Mm- PDZ LEDLASLVYLN-ESSVLHTLRQRY-GASLLHTYAG-- PSLLVLSTRGAPA 	\/YSEKVM 53 
Dm29D -QDLIHLSGPLTEHAVMRTLQARF-MERRYFTNVG--PILLSINPYLDVG ----- NPLTL 51 
CONSENSUS VEDM--L--LN-E-SVL-NLK-RY ---- LIYTY-G --- VLV VNPYK-LP --- IYS-D-I 
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ATP binding site 
Ac-lB HCYR-GR ----------- YQHEQPPHVIALAEAAYRGVKSENINQCVIIS---GESGAGKT 100 
Ac-IC KDYR-GFc ----------- YRYELPPHVYALADDMYRTMLSESEDQCVIIS--GESGAGKT 100 
ScMyo3-IA ESYK-RKK ---------- NRLEVPFHVFAIAESMYYNLKSYNENQCVIIS--GESGAGKT 100 
ScMy05-IB NEYK-GK ----------- NRLEV9PHVFAIAESMYYNMKSYNENQCVIIS--GESGAGKT 99 
Cehum5-IA DQYK-GR ----------- EIYERAPHVFAIADAAYRSMKRE'GRDSCIVIS--GESGAGKT 99 
Cehuml-IB LLYQ-GA ----------- AQYGNAPHIYALADNMYRNMLIDNESQCVIIS--GESGAGKT 99 
Dm31D-IA Rk1K-GR ----------- ELFENAPHLF'AIADSAYRVL}cQRQQDTCILIS--GESGAGK'r 99 
Dm61F-IB KAYR-NK-----------HFYEMPPHIFAVTDNAFRSLIEENRGQCVLIS--GESGSGKT 100 
Drri95E RNYG-DK ----------- GIEQLPPHIYGLTNLAYQSLFcDQSEDQCVLLT--GESGAGKT 99 
Rc-IB ERYR-GV ----------- SFYEVSPHIYAIAD4SYRSLRTERKDQCILISFTGESGAGKT 104 
Gg-Bb EEYH-NC ----------- NFE'AVKPHIYAIADDAYRSLRDRDRDQCILITGFTESGAGKT 103 
Gg-IB ELYQ-GA ----------- AQYENPPHIYALTDNMYRNMLIDGENQCVIIS--GESGAGKT 99 
Rnmyrl-IA EDYR-NR ----------- NFYELSPHIFALSDEAYRSLRDQDKDQCILITG--ESGAGKT 99 
Rnmyr2-IB ERYR-GV ----------- S FYEVPPHLFAVADTVYRALRTERRDQAVMIS--GESGAGKT 100 
Rnmyr3-IC EMYQ-GA ----------- AQYENPPHIYALADSMYRNMIIDRENQCVIIS--GESGAGKT 99 
Rrimyr4 -ID EQYK-GR ----------- ELYERPPHLE'AILDAAYKAMKRRSKDTCIMIS--GESGAGKT 99 
ScMY01-IIA NLYHNKHNRLSKSRLDENSHEKLPPHIFAIAEEAYENLLSEGKDQSILVT--GESGAGKT 111 
ScHYS1-IIB NLYHNKHNRLSKSRLDENSHEKLPPHIEAIAEEAYENLLSEGKDQSILVT--GESGAGKT 111 
Dd-nmII DIE'KGRR ------------ RNEVAPHIFAISDVAYRSMLDDRQNQSLLIT--GESGAGKT 99 
Cemyo3-I IA KHEMGKR ------------ RNEMPPHLE'AVSDEAYRNMVQDKENQSMLIT--GESGAGKT 99 
Cemyo4 -I lB RME'MGKR ------------ KTEMPPHLEAVSDEAYRNMLQDHENQSMLIT--GESGAGKT 99 
Cemyo2-I IC RMF'MGKR ------------ RTEMPPHLE'AVSDEAYRNMLQNHENQSMLIT--GBSGAGKT 99 
Cernyol-IID RMFMGKR------------RTEMPPHLFAVSDQAYRYMLQDHENQSMLIT--GESGAGKT 99 
Dm-mhcll KMYRGKR ------------ RNEVPPHIE'AISDGAYVDMLTNHVNQSMLIT--GESGAGKT 99 
Dmzip-nmII ERYKGIK ------------ RHEVPPHVFAITDSAYRNMLGDREDQSILCT--GESGAGF(T 99 
X1-nmIIB EMYRGKK ------------ RHEMPPHIYAISESAYRCMLQDREDQSILCT--GESGAGIKT 99 
Gg-FSkII LAYRGKK ------------ RQEAPPHIE'SISDNAYQFMLTDRENQSILIT--GESGAGKT 99 
Gg-nml I EMYKGKK------------RHEMPPHIYAITDTAYRSMMQDREDQSILCT--GESGAGKT 99 
Gg-smII DMYKGKK------------RHEMPPHIYAIADTAYRSMLQDREDQSILCT--GESGAGKT 99 
Hs-FSkEII EGYRGKK ------------ RQEAPP[-iI E'SISDNAYQFMLTDRENQSILIT--GESGAGKT 99 
Hs-nmIIA EMYKGKK------------RHEMPPHIYAITDTAYRSMMQDREDQSILCT--GESGAGKT 99 
Hs-CaA AAYRGKK------------RSEAPPHIFSISDNAYQYMLTDRENQSILIT--GESGAGKT 99 
DmNjnaC-II I AKYR-FK ----------- SRSENQPHI FSVADIAYQDMLHHKE PQHIVLS--GESYSGKS 99 
Lp-III VKYC-ER ----------- GRSDNPPHVFAVADRAYQQMLHHKSPQAVILS--GVSGSGKS 99 
HsMY03A KLYI-GS ----------- KRTASPPHIFPMADLGYQSIITYNSDQCIVIS--GESGAGKT 99 
ScMyo2p-Va QAYA--GK ---------- RRGELEPHLFAIAEEAYRLMKNDKQNQTIVVS--GESGAGFcT 100 
ScMyo4p-Vb QNYS--SK ---------- RKDELEPHLFAIAEEAYRFMVHEKANQTVVVS--GESGAGFcT 100 
Cehum2-V QVRGAGK ---------- SAREMDPHIFAVAEEAHFDMGAFGKSQSII\TS--GESGAGKT 103 
SpMyo-Va QAYH--GQ----------DMGAMDPHIFAVAEEAFKRMARFEQDQSIIVS--GESGAGKT 100 
Dmdidurn-Va RAYR--GH ---------- PMGDLEPHIFALAEEAYTKLERENCNLSIIVS--GESGAGKT 100 
Ggpl90-Va NAYS--GQ ---------- NMGDMDPHIFAVAEEAYKQMARDERNQSIIVS--GESGAGFcT 100 
Mmdilute-Va NAYS--GQ ---------- NMGDMDPHIFAVAEEAYKQMARDERNQSIIVS--GESGAGKT 100 
Rnmyo5-Va NAYS--GQ ---------- NMGDMDPHIFAVAEEAYKQMARDERNQSIIVS--GESGAGKT 100 
Rnmyr6-Vb YAYS--GQ----------NMGDMDPHIFAVAEEAYKQMARDEKNQSIIVS--GESGAGKT 100 
HsMY05A NAYS--GQ ---------- NMGDMDPHIFAVAEEAYKQMARDERNQSIIVS--GESGAGKT 100 
HsMY05C HAYS--GQ ---------- NMGDMDPHIFAVAEEAYKQMARNNRNQSIIVS--GESGAGKT 100 
SpMyoVI KKYQ--GK ---------- SLGTLPPHVFAIADK'SYREMITSKQSQAIIVS--GESGAGKT 100 
Cehum3-VI KEYR--GK ---------- SLGQME PHI FAIADKAYREMRRIKTSQSI IVS--GESGAGKT 100 
Dm1 ar-VI KKYN--GR----------SLGELPPHVFAIADKAIRDMRVYKLSQSIIVS--GESGAGKT 100 
Ms-VIA KQYR--GR----------SLGTLPPHVYAIADKAYRDMKVLKMSQSIIVS--GESGAGKT 102 
Ms-VIB KSYR--GK ---------- SLGTLPPHVFAIADKAYRDMKVLl1SQSIIVS--GCSGAGKT 102 
GgMy0VI KKYQ--GR ---------- SLGTLPPHVFAIADKAYRDMKVLKMSQSI IVS--GESGAGKT 100 
MmWaltzerVl }5YQ--GK ---------- SLGTMPPHVFGIADKAE'RDMKVLKMSQSIIVS--GESGAGKT 100 
HsMY06 KSYQ--GK ---------- SLGTRPPHVFAIADKAFRDMKVLKMSQSIIVS- -GE SGAGKT 100 
Cehum6-VII RMYK--RK ---------- RIGELPPHIE'AIADNAYTNMRREKKNQSVIIS--GESGAGKT 99 
Dmck-VIIA KLYK--ER ---------- KIGELPPHIFAIGDNAYAHMKRYRQDQCIVIS--GESGAGKT 99 
Dm28B-VIIB QLYR--NK ---------- SLAELPPHIFAISDHAE'QRLQRLKENQCVVIS--GESGAGKT 99 
DrMyo-VIIA RLYT--NK ---------- KIGEMPPHICAIADNCYFNMQRNNKDQCCIIS--GESGAGKT 99 
Mmshaker-VIIA RQYT--NK ---------- KIGEMPPHIFAIADHCYFNMKRNNRDQCCIIS--GESGAGKT 99 
HaUsherib-VIIA RQYT--NK----------KIGEMPPHIFAIADNCYFNMKRNSRDQCCIIS--GESGAGKT 99 
Dm1 OA-XV KQYA--GR ---------- PLGSLPPHLFAIGAAAHAALPSP --- QVVVIS--GESGSGKT 97 
Mm-MYO15 QQYS--GR ---------- ALGENPPHLFAIANLAE'AKMLDAKQNQCVIIS--GESGSGKT 99 
Hs-MY015 QQYN--GR ---------- ALGEHPPHLFAVANLAFAKMLDAKQNQCIIIS--GESGSGKT 99 
DmMhcl-PDZ SMFRGCKT ------------ EDMPPHVYSLAQTAYRSLVETRRDQSLI FM--GRSGSG-- 97 
Hs-PDZ HMFKGCRR ------------ EDMAPHIYAVAQTAYRPMLMSRQDQSI I LL--GSSGSGFT 47 
Mm-PDZ HMFKGCRR------------EDMAPHIYAVAQTAYRAMLMSRQDQSIVLL--GSSGSG-- 97 
Dm29D TSTR---------------AMPLAPQLQKIVQEAVRQQSETGYPQAIILS--GTSGAGKT 94 
CONSENSUS --YR ----------------- EMPPHIFALADAYR-M ------ QSIIIS--GESGAGKT 
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Drosophila non-muscle Myosin II Insert 
ATP k ,l  ulflulflg SIC 
Ac-IC EASKLV--MQYVAAVS--GNS---------------------------------------117 
Ac-IC EASKKI--MQYIAAVS--GAT --------------------------------------- 117 
ScMyo3-IA EAAKRI--MQYIAAASN-SHS --------------------------------------- 118 
ScMyo5-IB EAAKRI--MQYIAAASS-Tt-IT --------------------------------------- 117 
Cehum5-IA ETSKII--MKYLAAITNVRQQ---------------------------------------118 
Cehuml-IB VNAKE'I--MNYISRIS--GGG --------------------------------------- 116 
Dm31D-IA EASKII--MKYIAAVTNAQGQ---------------------------------------118 
Dm61F-IB EASKKV--LQFIAACSG--NQ --------------------------------------- 117 
Dm95E ETF}1I--VNFLTHIQD--HK --------------------------------------- 116 
Rc-IB EASKKI--LQYYAVTCP--VS --------------------------------------- 121 
Gg-Bb EASKLV--MSYVAAVSS--KG --------------------------------------- 120 
Gg-IB VAAKYI--MGYISKVS--GGG---------------------------------------116 
Rnmyrl-IA EASKLV--MSYVAAVCG--KG --------------------------------------- 116 






Cemyo3-IIA ENTKKV--ISYFAIVGATQAASG------------------------------------- 120 
Cemyo4-IIB ENTKKV--ICYFAAVGASQQEGG-------------------------------------120 
Cemyo2-IIC ENTKKV--ISYFAAVGAAQQETFGA-----------------------------------122 
Cemyol-IID ENTKKV--ICYE'ATVGASQK ---------------------------------------- 117 
Dm-mhcll EMTKKV--IAYFATVGAS ------------------------------------------ 115 
Dmzip-nmII ENTKKT--IQE'LAYVAASKPKGSGAVPHPAVLINFSVNTNKYIKVKIMAQNQNQTIEVVN 157 
X1-nmIIB ENTK}<V--IQYLAHVASSHK ----------------------------- GKKDHTI PTES 128 










ScMyo4p-Vb VSAKYI--MRYFASVQESNNR---EG ----------------------------------- 121 











Dm1 ar-VI ESTKYL--LKYLCYSHDSAG----------------------------------------118 
Ms-VIA ENTKFFTVLRYLTTSYGTGQ----------------------------------------122 
Ms-VIB ENTKFFTVLRYLTTTYGSGQ----------------------------------------122 
GgMyoVI ENTKFV--LRYLTESYGTGQ ---------------------------------------- 118 
MmWaltzerVl ENTKFG--SKIPDRILWTGQ----------------------------------------118 
HsMY06 ENTKFV--LRYLTESYGTGQ----------------------------------------118 
Cehum6-VII ESTKLV--LQE'LATISG ------------------------------------------- 114 
Dmck-VIIA ESTKLI--LQYLAAISG-------------------------------------------114 
Dm28B-VIIB ESTKLI--LQYLAAISG-------------------------------------------114 
DrMyo-VIIA ESTKLI--LQE'LAAISG ------------------------------------------- 114 
Mmshaker-VIIA ESTKLI--LQFLAAISG-------------------------------------------114 
HsUsherlb-VIIA ESTKLI--LQE'LAAISG ------------------------------------------- 114 
Dm1OA-XV ESTKLV--MQYLAAVVPGGG----------------------------------------115 
Mm-MYO15 EATKLI--LRCLAAMNQ-------------------------------------------114 
Hs-MY015 EATKLI--LRYLAAMNQ------------------------------------------- 114 




CONSENSUS E-TK-V--M-YLA-%7-G ------------------------------------------- 
253 
Appendix 
Loop 1 	 Switch 1 
Ac-lB GGV ---- DEVKHSNPLLEAEGNAKTLRNNNSSRE'G--KYE'EIHFNRLG-- 159 
Ac-IC G ------ DVMRVKDVILEAFGNAKTIRNNNSSRE'G--KYMEIQFDLKG-- 157 
ScMyo3-IA ESIGKIKDMVLAT-TLLESFGCAKTLRNNNSSRHG--KYLEIKFNSQF-- 163 
ScMyo5-IB ESIGKIKDMVLT\TNPLLESFGCAKTLRNNNSSRHG--KYLEIKFNNQF-- 163 
Cehum5-IA GEIERVKNVLLRSNCILEAFGCAKTTRNDNSSRE'G--KYMHItJE'DYDG-- 164 
Cehuml-IB QKVQHIKDVILQSNPLLEAFGNSATVRNWNSSRFG--KYVEIVFSRGG-- 162 
Dm310-IA NEIERVKNVLIQSNAILETFGNAKTNRNDNSSRFG--KYMDIEFDYKA-- 164 
Dm61 F-lB TTVGVKDKLLKSNPVLEAFGMAKTNRNDNSSRF--GKYMDIQFDFKG-- 163 
Dm95E SPTQRMRECVTCADVFLEAMGNACTLKNNNSSRYG--KLFDIEIDFKG 162 
Rc-IB DQVETVKDRLLQSNPVLEAFGNAKTLRNDNSSRFFTGKThDVQFDYKG 169 
Gg-Bb ECVDKVKEQLLQSNPVLEAFGNAKTIRNDNSSRFGFTKYMDVEFDFKG-- 168 
Gg-IB DKVQHVKDIILQSNPLLEAFGNAKTVRNNNSSRFG--KYFEIQFSRGG-- 162 
Rnmyrl-IA AEVNQVKEQLLQSTPVLEAFGNAKTVRNDNSSRFG--KYMDIEFDFKG-- 162 
Rnmyr2-IB ERGGAVRDRLLQSNPVLEAFGNAKTLRNDNSSRF--GKYMDVQFDFKG-- 163 
Rnmyr3-IC PKVQHVKDI ILQSNPLLEAFGNAKTVRNNNSSRFG--KYFEIQFSPGG-- 162 
Rnmyr4 -ID AEIERVKNMLLKSNCVLEAFGNAKTNRNDNSSRFG--KYMDINFDFKG-- 164 
ScMY01-IIA ---IAPVSGSSIVCSFEMKILQSNPILESFGNAQTVRNNNSSRFG--KFIKIEFNEHG-- 184 
ScMYS1-IIB ---IAPVSGSSIVESFEMKILQSNPILESFGNAQTVRNNNSSRFG--KFIKIEFNEHG-- 184 
Dd-nml I ANGSGVLEQQI:LQANPI LEAFGNAKTTRNNNSSRFG--KFIEIQFNNAG-- 164 
Cemyo3-IIA ----KFAKDGKKGGTLEEQIVQTNPVLEAFGNAKTVRNNNSSRFG--KFIRTHFSGSG-- 172 
Cemyo4-IIB ----AEVDPNKKKVTLEDQIVQTNPVLEAFGNAKTVRNNNSSRFG--KFIRIHFNKHG-- 172 
Cemyo2-TIC KKAATEEDKNKKKVTLEDQIVQTNPVLEAFGNAKTVRNNNSSRFG--KFIRIHFSKQG-- 178 
Cemyol-lID ----AALKEGE}KEVTLEDQIVQTNPVLEAFGNAKTVRNNNSSRFG--KFIRIHFNKHG-- 169 
Dm-mhcll ---KKTDEAAKSKGSLEDQVVQTNPVLEAFGNAKTVRNDNSSRFG--KFIRI}-IFGPTG-- 168 
Dmzip-nmII GLKMVEVNSNCQEGELEQQLLQANPILEAFGNAKTVKNDNSSRFG--KFIRIt'JPDASG-- 213 
X1-nmIIB PFZAIKHQSGSLLYGELERQLLQAN2ILESFGNAKTVKNDNSSRFG--KFIRINFDVTG-- 184 
Gg-FSkII ---KKFEQSGKMQGTLEDQIISANPLLEAFGNAKTVRNDNSSRFG--KFIRIHFGATG-- 171 
Gg-nml I GELERQLLQANPILEAFGNAKTVKNDNSSRFG--KFIRINFDVNG-- 165 
Gg-amII ---ASLKVHLFPYGELEKQLLQANPILEAFGNAKTVKNDNSSRFG-KFIRINFDVTG 175 
Hs-FSkEII ---AKKKDS-KMKGTLEDQIISANPLLEAFGBAKTVRNDNSSRFG--KFIRIHFGTTG-- 170 
Hs-nml IA GELERQLLQANPILEAFGNAKTVKNDNSSRFG--KFIRINFDVNG-- 165 
f-{s-CaA ---GKKDNANANKGTLEDQTIQANPALEAFGI'TAKTVRNDNSSRFG--KFIRIHFGATG-- 171 
DrnNinaC-III GNR-GATGRVESSIKAILMLVNAGTPVNNDSTRCV--LQYCLTFGKTG-- 159 
Lp-III QNKEGMREKLEYLCPLLDTLGNAYTSTNPNSSHFV--KILEVTFTKTG-- 160 
HsMY03A ANNRTLQEKILQVNNLVEAFGNACTIINDNSSRFG--KYLEMKFTSSG-- 160 
ScMyo2p-Va QVEMSETEQKILTNPIMEAFGNAKTTRNDNSSRFG--KYLEILFDKDT-- 170 
ScMyo4p-Vb EVEMSQIESQILATNPIMEAFGNAKTTRNDNSSRFG--KYLQILFDENT-- 168 
Cehum2-V NGGTTSIEARVLASNPIMESIGNAKTIRNDNSSRFG--KFIQINFCERGR- 170 
SpMyo-Va ETQVEKKVLASNPIMEAIGNAKTTRNDNSSRFG--KYIEIRFNRLH-- 162 
Dmdidum-Va ------------ETQVERKVLASSPIMEAFGNAKTTRNDNSSRFG--KFTKLLFRNQMGV 164 
Ggpl 90-Va EANVEEKVLASNPIMESIGNAKTTRNDNSSRFG--KYIEIGFDKRY-- 162 
Mmdilute-Va ------------EANVEEKVLASNPIMESIGNAKTTRNDNSSRFG--KYIEIGFDKRY-- 162 
Rnmyo5-Va EANVEEKVLASNPIMESIGNAKTTRNDNSSRFG--KYIEIGFDKRY-- 162 
Rnmyr6-Vb DTNIEEKVLASSPIMEAIGNAKTTRNONSSRFG--KYIEIGFDKKY-- 162 
HaMY05A EANVEEKVLTSNPIMESIGNAKTTRNDNSSRFG--KYIEIGFDKRY-- 162 
HaMY05C NAHVEDKVLASNFITFAVGNAKTTRNDNSSRFG--KYTEISFDEQN-- 162 
SpMyoVI II EQRIIEPNPLLEAFGNAKTVRNNNSSRFG--KFMEMHFGEKH-- 161 
Cehum3-VI --------------PIQQRLLETNPILEAFGNAKTLRNNNSSRFG--KFVQIHFSDNG-- 161 
Dmj ar-VI --------------PIETKILDANPVLEAFGNAKTTRNNNSSRFG--KFIEVHYDAKC-- 160 
Ma-VIA DIDERIVEPJ'PLLEAFGNAKTVRNNNSSRFG--KFVEIHE'NEKN-- 164 
Ma-VIB DIDERIVEANFLLEAFGNAKTVRNNNSSRFG--KFVEIHFDEKN-- 164 
GqMy0VI DIDDRIVEANPLLEAFGNAKTIRNNNSSRFG--KFVEIHFNEKN-- 160 
MmWaltzerVl --------------DIDDRIVEANPLLEAFGNAKTVRNNNSSRFG--KFVEIHFNEKS-- 160 
HsMY06 DI DDRIVFANPLLEAFGNAKTVRNNNSSRFG--KFVEIHFNEKS-- 160 
Cehum6-VII QHSWIEQQVLEANPVLEAFGNAKTIRNDNSSRFG--KIIDVHFNESG-- 159 
Dmck-VIIA KHSWIEQQILEANPILEAFGNAKTIRNDNSSRFG--KYIDIHFSANG-- 159 
Dm28B-VIIB KHSWIEQQIIEANPIMEAFGNAKTVRNDNSSRFG--KYIEIRFTPQG-- 159 
DrMyo-VI IA QHSMIEQQVLEANPILEAFGNAKTIRNDNSSRFG--KYIDIHFNKRG-- 159 
Mmshaker-VIIA -----------QHSWIEQQVLEATPILEAFGNAKTIRNDNSSRFG--KYIDIHFNKRG-- 159 
HsUsherlb-VIIA -----------QHSWIEQQVLEATPILEAFGNAKTIRNDNSSRFG--KYIDIHFNKRG-- 159 
Dm1 OA-XV SASAVITEQILEAAPLLEAFGNARTARNDNSSRFG--KYLEVYFKS-G-- 160 
Mm-M1015 RRDVMQQIKILEATPLLEAFGNAKTVRN0BSSRFG--KFVEIFLEG-G-- 159 
}-{a-MY015 KREVMQQIKILEATPLLESFGNAKTVRNDNSSRFG--KFVEIFLEG-G-- 159 
DrnNhcl -PDZ -------------FINAEKVNALCTILEAFGNTKTCLNSNATRMTQLLSL--DFDQTG-- 161 
Ha-PDZ VF'SVEKWQALYTLLEAFGNSPTIINGNATRESQILSLFTDFDQAG-- 114 
Mm-PDZ VFSVEKWQALSTLLEAFGNSPTIMNGSATRFSQILSL--DFDQAG-- 162 
Dm290 TDAFKHLPAAFTVLRSLGSAKTTTNSESSRIG--QFIEVQVTDGA-- 156 
CONSENSUS ---------------  Ei-IL-SNPILEAFGNAKTVPIDNSSRFG--KYIEI-F---G-- 
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Ac-lB --- EPCGGRITNYLLEKSRVTFQTRGERSFHIE'YQLLAGAS-DAEAQEMQLY --- APENF 212 
Ac-IC ---DPVGGRISNYLLEKSRVVQTNGERNFHIFYQLLAARA-RRPEAKFGLQ --- TPDYY 210 
ScMyo3-IA --- EPCAGNITNYLLEKQRVVGQIKNERNE'HIFYQFTKGAS-DTYKQMFGVQ --- MPEQY 216 
ScMy05-IB --- EPCAGNITNYLLEKQRVVSQIKNERNFHIFYQE'TKGAS-DAYRQTFGVQ --- KPEQY 216 
Cehum5-IA ---DPVGGNISNYLLEKSRVVRQQEGERNEHVEYQLVNGGD-DGLLRQFGLT--KDAKQY 218 
Cehurnl-IB --- EPIGGKLSNFLLEKSRVVHQNEGDRNFHVF'YQLCAGD--KNLRST'GIG --- ELQYY 214 
Dm31D-IA ---DPVGGIITNYLLEKSRVVQQQPGERNFHSEYQLLRGAN-DNELRQYELQ--KETGKY 218 
Dm61F-IB ---APIGGNILNYLLEKSRVVAQMGGERNFHIFYQLLAGAO-EALLQELGLE--RALDTY 217 
Dm95E --- DFMG ---------- TRITDPIIGERNFHI E'YQLLLGAD-LQLLKSLKLYR--NVEKY 206 
Rc-IB ---APVGGHILNYLLEKSRVVHQNHGERNFHIFYQLLEGGE-EDLLRRLGLFTDKNAQNY 225 
Gg-Bb ---DPLGGVISNYLLEKSRIVRHVKGERNFHIFYQLLAGGS-AQLLQQLKLRE'TPDCSHY 224 
Gy-IB ---EP0GGKISNFLLEKSRVVSQ'JEHERNFHVYYQLIEGAS-QEQRQNLGIM --- SPDYY 215 
Rnmyrl-IA ---DPLGGVISNYLLEKSRVVKQPRGERNFHVE'YQLLSGAS-EELLHKLKLER--DE'SRY 216 
Rnmyr2-IB ---APVGGHILSYLLEKSRVVHQNHGERNE'HVFYQLLEGGE-EEALRRLGLE--RNPQSY 217 
Rnmyr3-IC --- CPDGGKISNFLLEKSRVMRNPGERSFHIEYQLIEGASPEQKQSLGITSMDYY 215 
Rnmyr4-ID ---DPIGGHINNYLLEKSRVIVQQPGERSFHSFYQLLQGGS-EQMLHSLHLQ--KSLSSY 218 
ScMY01-IIA ---MINGAHIEWYLLEKSRIVHQNSKERNYHIFYQLLSGLDDSELKNLRLKSRN--VKDY 239 
ScMYS1-IIB ---MINGAHIEWILLEKSRIVHQNSKERNYHIE'YQLLSGLDDSELKNLRLKSRN"VKDY 239 
Dd-nrnll ---FISGASIQSYLLEKSRWFQSETERNYHIFYQLLAGAT-AEEKKALHLAGPESFN 218 
Cemyo3-IIA ---KLAGGDIEHYLLEKSRVVRQAPGERCYHIFYQIMSGND-PSLRGKLKLSND--ITYY 226 
Cemyo4-IIB ---RLASCDIEHYLLEKSRVIRQAPGERCYHIFYQIYSDFR-PELKKELLLDLF--IKDY 226 
Cemyo2-IIC ---RVASCDIEHYLLEKSRVIRQAPGERSYHIFYQVFSDYL-PNLKKDLLLNKP--VKDY 232 
Cernyol-IID ---TLASCDIEHYLLEKSRVIRQAPGERCYHIFYQIYSDFK-PQLRDELLLNHP--ISNY 223 
Dm-nihcll ---KLAGADIETYLLEKARVISQQSLERCYHIFYQIMSGSV-PGVKEMCFLSDN--IYDY 222 
Drnzjp-nmII --- FISGANIETYLLEKSRAIRQAKDERTE'HI FYQLLAGAT-PEQREKFILDD---VKSY 266 
X1-nrnIIB --- YIVGANIETYLLEKSRAVRQAKDERTFHIFYQLLAGSG-EHLKSDLLLDG --- FNNY 237 
Gg-FSkII --- KLASADIETYLLEKSRVTFQLPAERSYHI FYQIMSNKK-PELIDMLLITTN--PYDY 225 
Gg-nmII --- YIVGANIETYLLEKSRAI RQAKEERT FHI FYYLLSGAG-EHLKTDLLLE P --- YNKY 218 
Gg-smII --- YIVGANIETYLLEKSRAIRQAKDERTFHIFYYLIAGAS-EQMRNDLLLEG --- FNNY 228 
Hs-FSkEII ---KLASADIETYLLEKSRVTFQLKAERSYHIFYQILSNKK-PELIELLLITTN--PYDY 224 
Hs-nml IA --- YIVGANIETYLLEKSRAIRQAKEERTFHI FYYLLSGAG-EHLKTDLLLEP---YNKY 218 
Hs-CaA --- KLASADIETYLLEKSRVIFQLKAERNYHIFYQILSMKK-PELLDMLLVTNN--PYDY 225 
DrnNinaC-III ---KMSGAVFNNYMLEKLRVATTDGTQHNFHIFYYFYDFINQQNQLKEYNLKADRNYRYL 216 
Lp-III ---KITGAILFTFLLEARRLTDIPKGERNFHVFYYFYEGLRSEGRLKEFGLEEK-NYRYL 216 
HsMY03A ---AVVGAQISEYLLEKSRVIHQAIGEKNFI-iIFYYIYAGLAEKKKLAHYKLPENKFPRYL 217 
ScMyo2p-Va -SIIG--ARIRTYLLERSRLVYQPPIERNYHIFYQLMAGLP-AQTKEELHLT --- DASDY 223 
ScMyo4p-Vb -TIRG--SKIRTYLLEKSRLVYQPETERt'JYHIFYQILEGLP-EPVKQELHLS---SPKDY 221 
Cehum2 -v -RIVG--AEMKTYLLEKSRLVFQAPGERNYHI FYQLCAARN-HQVLKDLHLG--- PCESY 223 
SpMyo-Va -HIVG--ANMRTYLLEKSRVVFQAPEERNYHIFYQLCACCD-QPELKELALG --- HPDEF 215 
Drndidum-Va MFLQG--ATMHTYLLEKSRVVIQAQGERNYHI FYQLCAAR---SKYPELVLD---HQDKF 216 
Ggpl 90-Va -RI IG--ANMRTYLLEKSRVVFQAEEERNYHI FYQLCASAA-LPE FKTLRLG---NANYF 215 
Mmdilute-Va -RIIG--ANMRTYLLEKSRVVFQAEEERNYHIFYQLCASAK-LPEFKMLRLG --- NADSF 215 
Rnrnyo5-Va -RIIG--ANMRTYLLEKSRVVFQAEEERNYHIFYQLCASAK-LPEFFC1LRLG --- NADSF 215 
Rnmyr6-Vb -HIIG--ANMRTYLLEKSRVVFQADDERNYHIFYQLCAAAS-LPEFKELALT --- CAEDF 215 
HsMY05A -RI IG--ANNRTYLLEKSRVVFQAEEERNYHI FYQLCASAK-LPE F'KMLRLG---NADN F 215 
HsMY05C -QIIG--ANIISTYLLEKSRVVFQSENERNYHIFYQLCASAQ-QSEFKHLKLGSAEEF 215 
SpMyoVI -DVVG--GYVSHYLLEKPRVCWQNGEERNYHVFYYLCAGAP-DDLRTKLRIQ --- TFDDY 214 
Cehum3-VI -TVAG--GFVSHYLLETSRVCRQAAGERNYHIFYQLIAGSS-PDLYKKLRLD,-2ASSF 214 
Dmj ar-VI -QVVG--GYISHYLLEKSRICTQSAEERNYHVFYMLLAGAP-QQLRDKLSLG---KPDDY 213 
Ms-VIA -AVVGFTGF\TSHYLLEKSRICRQSSEERNYHIFYRLCAGAT-EDIRQKFHLS---SPDTF 219 
Ms-VIB -AVVGFTGFVSHYLLEKSRICMQSNDERNYHIFYRLCAGAS-EDIKKKLHLD---SPDSF 219 
GoMy0VI -SVVG--GFVSHYLLEKSRICVQGKEERNYHI FYRLCAGAP-EDIREKLYLS---SPDSF 213 
MinWaltzerVl -SVVG--GFVSHYLLEKSRICVQGKEERNHHIFYRLCAGAS-EDIREKLHLS --- SPDNF 213 
HsMY06 -SVVG--GFVSHYLLEKSRICVQGKECRNYHI FYRLCAGAS-EDIREKLHLS---S DONE' 213 
Cehum6-VII -SIEG--AKIEQYLLEKSRIVTQSENCRNYHI FYCLLAGLS-RFEKSELELG---TAADY 212 
Dmck-VIIA -VIEG--AKIEQYLLEKSRIVSQNHSERNYHVFYCILAGLS-ADEKSRLDLG --- MAADY 212 
Dm28B-VIIB -AIQG--ARIQQYLLEKSRIVFQSRDERNYHIFYCMLAGLS-TAERERLKLQE-QSPSQY 214 
DrMyo-VIIA -AIEG--AKIEQYLLEKSRVCRQARDERNYHIFYCMLKGMT-PDQKKQLGLS -'- KATDY 212 
Mrnshaker-VI IA -AIEG--AKIEQYLLSKSRVCRQAPDERNYHVFYCMLEGMN-EEEKF(KLGLG --- QAADY 212 
HsUsherlb-VIIA -AIEG--AKIEQYLLEKSRVCRQALDERNYHVFYCMLEGMS-EDQKKKLGLG --- QASDY 212 
Dm1 OA-XV -AIVG--AKITQYLLEKSRIVTQAPGERNYHVFYELLGGLS-ETERSKYGLL---EADKY 213 
Mm-MYO1 5 -VICG--AITSQYLLEKSRIVFQAKNERNYHI FYELLAGLP-AQLRQAFSLQ---EAETY 212 
Hs-MY015 -VISG--AITSQYLLEKSRIVFQAKNERNYHIFYELLAGLP-AQLRQAFSLQ--EAETY 212 
DmMhcl-FDZ ---QIASASLQVLLFERQRAGRRLGHEHSFHIMTRLLAGAA-GLLQKELHLE---NITSE 214 
Hs-PDZ --- QVASASIQTMLLEKLRVARR2ASEATFNVFYYLLACGD-GTLRTELHLN --- HLAEN 167 
Mm-PDZ --- QVASASIQTMLLEKLRVARRPASEATFVFYYLLACGDATLRTELHLNHLAEN 215 
Dm290 ----LYRTKIHCYFLDQTRVIRPLPKEKNYHIFYQLLAGLS-REERQKLHLDG-YSPANL 210 
CONSENSUS A-I--YLLEKSRVV-Q --- ERNYHIFYQLLGA ---- LK--L-L -------- '1 
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Class VI insert 
Ac-lB NYLNQSACYT----------------------------VDGIDDIKEFADTRNAINVMG- 243 
Ac-IC EYLNQGKTYT ---------------------------- VDGMDDNQEFQDTWNAMKVIG- 241 
ScMyo3-IA IYTAAAGCTT----------------------------ADTIDDVKDYEGTLEAMRTIG- 247 
ScMyo5-IB VYTAAAGCIS----------------------------AETIDDLQDYQETLKAMRVIG- 247 
Cehum5-IA YFLt1QGQSHK ---------------------------- VASINDSRDEAEVQTALRSIHT 250 
Cehuml-IB NYLNMSGVFK ---------------------------- ADDTDDGKEE'ESTLHAMKVVG- 245 
Dm31D-IA HYLNQGS-------------------------------MDILTEKSDYKGTCNAFKTLG- 246 
Dm61E'-IB SYLTDGLNGT ---------------------------- VTSINDADSE'KQVQQALTVID- 248 
Dm95E ELLRNTTAME ---------------------------- EDRMN ---- FHYTKRSLDVLG- 233 
Rc-IB QYLIKGQCAR----------------------------VSSINDKNDWKVVRRALSIIN- 256 
Gg-Bb GYLNH-EKSV----------------------------LPGMDDAANFRAMQDAMAIIG- 254 
Gg-IB YYLNQSDTYQ ---------------------------- VEGTDDRSDELETMNAMQVIG- 246 
Rnmyrl-IA NYLSL-DSAK----------------------------VNGVDDAANFRTVRNAMQIVG- 246 
Rnmyr2-IB LYLVKGQCAK----------------------------VSSINDKSDWKVVRKALSVID- 248 
Rnmyr3-IC YYLSLSGSYK ---------------------------- VDDIDDKRDE'QETLHAMNVIG- 246 
Rnmyr4-ID NYIRVGAQL ----------------------------- KSSINDAAEE'KVVADAMKVIG- 248 
ScMY01-IIA KILSNSNQDIIP ---------------------------- GI-DVENE'KELLSALSIIGE' 270 
ScMYS1-IIB KILSNSNQDIIP ---------------------------- GINDVENE'KELLSALNIIGE' 271 
Dd-nmII YLNQSG-YVDIK----------------------------GVSDSEEFKITRQAMDIVGF 249 
Cemyo3-IIA HFCSQA-ELTIE----------------------------GMDDKEEMRLTQEAFDIMGF 257 
Cemyo4-IIB WFVAQA-ELIID ---------------------------- GIDDVEEFQLTDEAFDILNE' 257 
Cemyo2-IIC WFIAQA-ELIID----------------------------GINDKEEHQLTDEAFDILKF 263 
Cemyol-IID WEVAQA-ELLID ---------------------------- GIDDTEEFQLTDEAFDVLKF 254 
Dm-mhcll YNVSQG-KVTVP ---------------------------- NMDDGEEFQLADQAE'DILGF 253 
Dmzip-nrnll AFLSNG-SLPVP----------------------------GVDDYAEFQATVKSMNIMGM 297 
X1-nmIIB REVSNG-YIPIP ---------------------------- GQQDKDNFQETMEAMHIMGF 268 
Gg-FSkII HYVSQG-EITVP ---------------------------- SIDDQEELMATDSAIDILGE' 256 
Gg-nmII RFLSNG-HVTIP ---------------------------- GQQDKDME'QETMEAMRIMGI 249 
Gg-smII TE'LSNG-HVPIP ---------------------------- AQQDDEMFQETLEAMTIMGF 259 
Hs-E'SkEII PE'ISQG-EILVA ---------------------------- SIDDREELLATDSAIDILGE' 255 
Hs-nrnIIA RFLSNG-HVTIP ---------------------------- GQQDKDMFQETMEPMRIMGI 249 
Hs-CaA AEVSQG-EVSVA ---------------------------- SIDDSEELMATDSAE'DVLGF 256 
DmNinaC-III RVPPEVPPSKLK-----------------------YRRDDPEGNVERYREFENILRDID- 252 
Lp-III --- PELKSS ------------------------------ NSPEYVKGYQQFLRALTSLA- 242 
HsMY03A QNDHLRTVQD --------------------------- IMNNSE'YKSQYELIEQCE'KVIG- 249 
ScMyo2p-Va FYMNQGGDTKI ---------------------------- NGIDDAKEYKITVDALTLVGI 255 
ScMyo4p-Vb HYTNQGGQPNI----------------------------AGIDEAREYKITTDALSLVGI 253 
Cehum2-V SYLTQGGDSRI----------------------------PGVDDKADFEALLKALQLLGF 255 
SpMyo-Va YYTSQGEAPTV----------------------------DGIDDKANLVETKEAFKLLGF 247 
Dmdidurn-Va QE'LNMGGAPEI ---------------------------- ERVSDAEQE'NETVQAMTVLGF 248 
Ggp190-Va HYTKQGGSPVI----------------------------DGIDDAKEMVNTRQACTLLGI 247 
Mmdilute-Va HYTKQGGSPMI----------------------------EGVDDAKEMAHTRQACTLLGI 247 
Rnniyo5-Va HYTKQGGSPMI ---------------------------- EGVDDAKEMAI-{TRQACTLLGI 247 
Rnmyr6-Vb FYTAHGGNTTI----------------------------EGVDDAEDFEKTRQALTLLGV 247 
HsMY05A NYTKQGGSPVI ---------------------------- EGVDDAKEMAI-{TRQACTLLGI 247 
HsMY05C NYTRMGGNTVI ---------------------------- EGVNDRAEMVETQKTE'TLLGF 247 
SpMyoVI QYLRNGITQYF--AGKESQKQVKADRQSKMYKKKGALHDIQVDDYRCYQRVVDALRKIGL 272 
Cehum3-VI NYLKHGATLFE--VNSKSSLKTDASRFSETr1 --- SSVSDSIISDIDDFAKLERALALSGV 269 
Dmj ar-VI RYLS-GCTQYF--ANAKTEQLIPGSQKSKNHQQKGFLKDPIIDDYQHFHNLDKALGRLGL 270 
Ms-VIA RYLNRGCTRFFTYASKDTDKQILQNRKSPEHMKSGPLKDPLLDDRGDFNRMSVAMKKIGL 279 
Ms-VIB RYLNRGCTRYFTFASKDSDKQIMQNRKSPEHLKVGALKDLLLDDQGDFNRMCVAMKKIGL 279 
GgMyoVI RYLNRGCTRYF--ATKETDKQILQNRKSPEYLKAGSLKDPLLDDHGDFNRMCTAMKKIGL 271 
MmWaltzerVl RYLNRGCTRFF--ANKETDKQILQNRKSPEYVKAGSLEGSSIRRPWRFYQDVHSHEKNWF 271 
HsMY06 RYLNRGCTRYF--ANKETDKQILQNRKSPEYLKAGSMKDPLLDDHGDFIRMCTANKKIGL 271 
Cehum6-VII YYLIQGKTLTA----------------------------EGRDDAADLAEIRSAMRVLMI 244 
Dmck-VII/\ KYLTGGNSITC ---------------------------- EGRDDAAEFSDIRSAMKVLLE 244 
Dm28B-VIIB HYLAQGGCFTL ---------------------------- PGRGDAKDE'ADIRAPMKVLSF 246 
DrMyo-VIIA TYLTIGNCTVC ---------------------------- DGRDDQKEYSNIRSPMK\ILMF 244 
Mmshaker-VIIA NYLAMGNCITC ---------------------------- EGRVDSQEYANIRSPJKVLMF 244 
HaUsherlb-VIIA NYLPMGNCITC ---------------------------- EGRVDSQEYANIRSAMKVLMF 244 
Dm10A-XV FYLNQGATDCA ---------------------------- SGR --- VDWESLQGAMQVLGV 242 
Mm-MYO15 YYLNQGGHCEI ---------------------------- AGKSDADDFRRLLAAMEVLGF 244 
Hs-MY015 YYLHQGGNCEI ---------------------------- AGKSDADDERRLLAAMEVLGE 244 
DmMhcl-PDZ --DSHPFISLSQ ------------------------ KLEDRHRAANDFMRTVQAFETLWI 248 
Hs-PDZ E'TNVFGIVPLA ------------------------- KPEEKQKAAQQFSKLQAAMKVLGI 202 
Mm-PDZ --NVFGIVPLS-------------------------KPEEKQKAAQQFSKLQAAMKVLAI 248 
Dm29D RYLRGDIGQNE------------------------------QEDAARFQAWKTCLGILG- 239 
CONSENSUS -YL-QG ---------------------------------- GIDD--EF ----- AW-VLG- 
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Ac-TB MTAEEQRQVEH--LVAGILHLG--NVAE'I-IDGGK --------- GTAAVHD ------- RTPF 283 
Ac-IC FTAEEQHEI FR--LVTAILYLG--NVQEVDDGK---------GGSTIAD-------SRPV 281 
ScMyo3-IA LVQEEQDQIFR--4LAAILWIG--NISFIENEE --------- GNAQVGDTSVTDFVAYLL 294 
ScMyo5-IB LGQEEQDQIFR--MLAAILWIG--NVSFINEE --------- GNAQVRDTSVTDEVAYLL 294 
Cehum5-IA FDKQDVESMWS--VIAGLIHLG--NVRFI DGENS-------SGAVHTAEKAALQNAARCL 299 
Cehuml-IB VNDQDQLEVLR--IVATVLHIG--NITFTEENN --------- E'AAVSGKD-YLEY PAE'LL 291 
Drn3lD-IA FSTDEVQTIWR--TIAAVLHLG--NVEFQTIED----------ELVISNKQHLKSTAKLL 292 
Dm61F-IB FGKEEQREIFG--IVASILHLG--NVGFTEVE --------- G-NAKVNSRDLVVTAARLL 294 
Dm95E LSCEESNSIFR--VIAVVLKLG--NFIFVPITNID --- G--TEGCQVSNVYEVQETAQLL 284 
Rc-IB E'NDDDIEELLS--IVASVLHLGNFTVQFATDE --------- HGHAQVTTENQIKYLARLL 305 
Gg-Bb FAPAEVTALLE--VTAVVLKLG--N\TKFTLSSCFQ --- ASGMEASSITEPRELQEISQLI 307 
Gg-IB IRGEDQQLVLQ--IVAGILHLG--NISFREEGN --------- YARVENAD-SLA'PAYLL 292 
Rnmyrl-IA FSDPEAESVLE--VVAAVLKLG--NIEFKPES--R --- MNGLDESKIKDKNELKEICELT 297 
Rnrnyr2-IB E'TEDEVEDLLS--IVASVLHLG--NIHFAADE --------- DSNAQVTTENQLKYLTRLL 295 
Rnmyr3-IC I FSEEQTLVLQ--IVAGILHLG--4INFKEVGN---------YAAVESEE-FLAEPAYLL 292 
Rnrnyr4 -ID FKPEEIQTVYK--ILAAILHLG--NLKFIVDGD----------TPLIENGKVVSVIAELL 294 
ScMY01-IIA SKDQI-RWI FQ--VVAIILLIG--NIEFVSDRAE--------QASFKN---DVSAICSNL 314 
ScMYS1-IIB SKDQI-RWIFQ--VVAIILLIG--NIEE'VSDRAE -------- QASFKN --- DVSAICSNL 315 
Dd-runll SQEEQ-MSIFK--IIAGILHLG--NIKE'EKGAG --------- EGAVLKDKTALNAASTVF 295 
Cemvo3-IIA EDNET-MDLYR--STAGIMHMG--EMKE'KQRPRE -------- EQAEFDGEEDALNAAANL 304 
Cernyo4 -IIB SAVEK-QDCYR--LMSAHMHMG--NMKFKQRPRE -------- EQAEFDGTVEAEKASNMY 304 
Cemyo2-IIC TPTEK-MECYR--LVAAMMHMG--MMKFKQRPRE -------- EQAEPDGTDDAERAAKCF 310 
Cemyol-TID SPTEK-MDCYR--LMSAHMHMG--NMKFKQRPRE -------- EQAEPDGQVEAERACMMY 301 
Dm-mhcll TKQEK-EDVYR--ITAAVMHMG--GMKFKQRGRE--------EQAEQDGEEEGGRVSKLF 300 
Dmzip-nmII TSEDF-NSIFR--IVSAVLLFG--SMKFRQERNN--------DQATLPDNTVAQKIAHLL 344 
X1-nmIIB SHEEI-LSMLK--VVSSVLQFG--NIVFKKERNT--------DQASMPENTAAQKLCHLL 315 
Gg-FSkII SADEK-TAIYK--LTGAVMHYG--NLKFKQKQRE--------EQAEPDGTEVADKAAYLM 303 
Gg-nmII PDEEQ-IGLLK--VISGVLQLG--NIVFKKERNT--------DQASMPDNTAAQKVSHLL 296 
Gg-smII TEEEQ-TSILR--VVSSVLQLG--NIVFKKERNT -------- DQASMPDNTAAQKVCHLM 306 
Hs-E'SkEII TPEEK-SGLYK--LTGAVMHYG--NMKE'KQFKQRE -------- EQAEPDGTEVADKTAYLM 302 
Hs-nmIIA 0EEEQ-MGLLR--VISGVLQLG--NIVEKKERNT -------- DQASMPDNTAAQKVSHLL 296 
Hs-CaA TSEEK-AGVYK--LTGAIMHYG--MMKE'KQKQRE -------- EQAEPDGTEDADKSAYLM 303 
DrnNjriaC-III F'NHKQLETVRK--VLAAILNIG--NIRFRQNGKYA --- E--VENTDIV-----SRIAELL 298 
Lp-III FTEEEIFAIQK--VLAAILLLG--ETEIQN------------------------------268 
HsMY03A FTMEQLGSIYS--ILAAILNVG--NIEFSSVATEH --- Q--IDKSHISNHTALENCVSLL 300 
ScMyo2p-Va TKETQ-HQI FK--ILAALLHIG--NIEIKKT---------RNDASLSADE PNLKLACELL 301 
ScMyo4p-Vb NHETQ-LGIFK--ILAGLLHIG--t1IEMKMT --------- RNDASLSSEEQNLQIACELL 299 
Cehum2-V DEKQM-SDVFR--LLAGLLLLG--NVHFENG-------EGSSAVSASSCQEISRLCREFW 303 
SpMyo-Va KDDMM-KQIFR--IIGAVLHFG--NVEIQP--------DQHESCKIEVESESLPILCSLL 294 
Dmdidum-Va SIQQI-ADIVK--ILAGILHLG--NIQVSKKFNEGSEEEDSDSCDIFHNDIHLQITADLL 303 
Gqpl90-Va SDSYQ-MGIFR--ILAGILHLG--NVEFAS--------RDSDSCAIPPKHDPLTIFCDLM 294 
Mmdilute-Va SESYQ-MGIFR--ILAGILHLG--NVGFAS--------RDSDSCTIPPKHEPLTIFCDLM 294 
Rnmyo5-Va SESYQ-MGIFR--ILAGILf-iLG--NVGFAS -------- RDSDSCTIPPKHEPLIIFCDLM 294 
Rrimyr6-Vb RESHQ-ISIFK--IIASILHLG--SVEIQAE-------RDGDSCSISPQDEHLSNFCRLL 295 
HsMY05A SESHQ-MGI FR--ILAGILHLG--NVGFTS--------RDADSCTI PPKHEPLCI FCDLM 294 
HsMY05C KEDFQ-MDVFK--ILAAILHLG--NVQITA--------VGNERSSVSEDDSHLKVFCELL 294 
SpMyoVI KPQEE-YDI LR--IVACVLHLG--NIAFTGN-----DSQEGGCGVS PDAQDSLKFVADLI 322 
Cehum3-VI SDDEK-MFIWS--TVAGILHLG--NIEFEENA ---- SDSRGGCMITSGTENSLMAAAELL 320 
Dmj er-VT SDTEK-LGIYS--LVAAVLHLG--NIAFEEIP ---- DDVRGGCQVSEASEQSLTITSGLL 321 
Ms-VIA DDTEK-LDLFRGFTVAGVLHLG--NI DFEEA-----GSTSGGCAIKNQSIQTLEHCAELL 331 
Ms-VIB DDTEK-LDLFRVFTVAGVLHLG--NIDFEET-----GSSSGGCVLKNQSGQTLEYCADLL 331 
GgNyoVI DDAEK-LDLFR--VVAGVLHLG--NI DFEEA-----GSTSGGCTLKAQSQPALECCAALL 321 
MmWaltzerVl GMMKKNFDLFR--VVAG\rLHLG--NIDLEEA ----- GSTSGGCNLKNKSAPSLEYCAELL 322 
HsMY06 DDEEK-LDL FR--VVAGVLHLG---NI DFEEA-----GSTSGGCNLKNKSAQSLEYCAELL 321 
Cehum6-VI I NEQEI-GSI FK--LLASLLHIG--NIRFRQNTN------DNMESVDVADPSTLVRIAKLL 293 
Dmck-VIIA SDQEI-WEIIK--LLAALLHCG--NIKYKATVV ------ DNLDATEIOEF{INVERVAGLL 293 
Dm28B-VIIB KPEEV-WSILS--LLAAILHLG--NLRFTATEV------ANLATAEIDDTPNLQRVAQLL 295 
DrMyo-VIIA TDKEN-WEI SK--LLAAILHMG--NLRYEARTY------DNLDACEVVRCSALTTAAVLL 293 
Minshaker-VIIA TDTEN-NEISK--LLAAILHMG--NLQYEARTF ------ ENLDACEVLFSPSLATAASLL 293 
HsUsherlb-VIIA TDTEN-WEISK--LLAAILHLG--NLQYEARTF ------ ENLDACEVLFSPSLATAASLL 293 
Dm1 OA-XV SEGER-EGIVR--VLAAVLHLG--NVYFHRRQLR-----HGQEGVEVGSDAEIKWAAHLL 292 
Mm-MY015 TSEDQ-DSIFR--ILASILHLG--NVYFEKHET------DAQEVASVVSAREIQAVAELL 293 
Hs-MY015 SSEDQ-DSIFR--ILASILHLG--NVYFEKYET------DAQEVASVVSAREIQAVAELL 293 
DmMhcT-PDZ DAKAV-RGTWS--ILAAIYHLG--IAGVTKLG ------ TGSTARTQFANPTAARKASGLL 297 
Ks - PDZ S PDEQ-KACWF--ILAAIYHLG--AAGATKE FT-----AAEAGRKQFARHEWAQKPAYLL 252 
Mm-PDZ S PEEQ-KTCWL--ILASIYHLG--AAGATKE-------AAEAGRKQFARHEWAQKAAYLL 296 
Dm290 ---I PFLDVVR--VLAAVLLLG--NVQFIDGGG---------LEVDVKGETELNSVASLL 283 
CONSENSUS --- E ---- IFR--ILAAILHLG--NI-F ------------------------ L---A-LL 
257 
Appendix 
Ac-ID ALKNALLFRVLNTGGAG---AK4S-TYNVPQNVEQA --------- AS--ARDALAKTIY 328 
Ac-IC AVETALLYRTITTGEQG --- RGRSS-VYSCPQDPLGA --------- IY--SRDALSKALY 326 
ScMyo3-IA QVDASLLVKCLVERIMQTSHGMKRGSVYHVFLNPVQA --------- TA--VRDALAKAIY 343 
ScMyo5-IB QIDSQLLIKSLVERIMETNHGMKRGSVYHVPLNIVQA --------- DA--VRDALAKAIY 343 
Cehum5-IA NVTPDELAKSLSSQVVAAHGDIVKK-----QHDVNAA---------YY--TRDALAKALY 343 
Cehuml-IB GLTSADIEAKLTGRKMESKWGTQKE-EIDMKLNVEQA --------- SY--TRDAWVKAIY 339 
Dm310-IA QVTETELSTALTKRVIAAGGNVMQK-----DHNATQA---------EY--GKDALAKAIY 336 
Dm61E-IB GVNASELEAALTHRTIDARGDVVTS ----- FLNQELA --------- IY--ARDALAKAVY 338 
Dm95E NMEAQILINCLTRANSTNSAQEDVG ---- CEMDARQA --------- AT--NRNTLCRTLY 329 
Rc-IB SVDSTVLRESLIHKKIIAKGEELNS ----- PLNLEQA --------- AFTYARDALAKAIY 351 
Gg-Bb GLDPSTLEQALCSRTVKVRDESVLT ----- ALSVSQF --------- TGYYGRDALAKt'JIY 353 
Gg-IB GIDRDRLNDKITSRPC1DSKWGGRSE-SITVTLI'WEQA --------- AY--TROALAKGLY 340 
Rnmyrl-IA SIDQVVLERAE'SFRTVEAKQEKVST ----- TLNVAQ ----------- AYYARDALAKNLY 341 
Rnmyr2-IB GVEGTTLREALTHRKIIAKGEELLS ----- PLNLEQA --------- AY--AROALAKAVY 339 
Rnmyr3-IC GIt'QDRLKEKLTSRQMDSKWGGKSE-SIHVTLNVEQA --------- CY--TRDALAKALH 340 
Rnmyr4 -ID STKADMVEKALLYRTVATGRDI 10K-----QHTEQEA---------SY--GRDAFAKAIY 338 
ScMY01-I IA GVDEKDFQTAILRPRSKAGK ------- EWVSQSKNST --------- KLSSLLNALSRNLY 358 
ScMYS1-I lB GVDEKDFQTAILRPRSKAGK ------- EWVSQSKNSQ --------- QAKE'ILNALSRNLY 359 
Dd-nmII GVNPSVLEKALMEPRILAGR-------DLVAQHLNVE---------KSSSSRDALVKALY 339 
Cemyo3-IIA GIQAEEKLK/ALTKPRVRVGT ------- EWVNKGQNLE --------- QVNWAVSGLAKAIY 348 
Cemyo4 -IIB GIGCEE ELKALTKPRVKVGT-------EMVSKGQNCE---------QVNWAVGAMAKGLY 348 
Cemyo2-IIC GIDSEEFLKALTRPRVKVGN-------EWVNKGQKIE---------QVNWAVGAMAKGLY 354 
Cemyol-IID GIDVVQFLKALVSPRVKVGT ------- EMVSKGQNVD --------- QVHWAIGPJ'4AKGLY 345 
Dm-mhcll GCDTAELYKNLLKPRIKVGN ------- EFVQGRNVQ --------- QVTNSIGALCKGVF 344 
Dmzip-nmII GLSVTDMTRAFLTPRIKVGR ------- DF\PIKAQTKE --------- QVEFAVEAIAKACY 388 
X1-nml lB GLNIME KTRAILTPRIKVGR-------DYVQKQTKE---------QADFAVEALRKATY 359 
Gg-FSkII GLNSAELLKALCYPRVKVGN-------EFVTKGQTVS---------QVHNSVGALAKAVY 347 
Gg-nmII GINVTDE'TRGILTPRIKVGR ------- DYVQKAQTKE --------- QADFAIEALAKATY 340 
Gg-smII GINVTDE'TRSILTPRIKVGR ------- DVVQKAQTKE --------- QADE'AIEALAKAKF 350 
Hs-FSkEII GLNSSDLLKALCE'PRVKVGN ------- EYVTKGQTVD --------- QVHHAVNALSKSVY 346 
Hs-nmIIA GINVTDFTRGILTDRIKVGR ------- DYVQKAQTKE --------- QADFAIEALAKATY 340 
Hs-CaA GLNSADLLKGLCHFRVKVGN ------- EYVTKGQSVQ --------- QVYYSIGALAKAVY 347 
DmNinaC-I II RVDEKKFMWSLTNFIMVKGGIAERR ----- QYTTEFA --------- RD--ARDAVASTLY 342 
Lp-III SAAFKLLGAESSEL-----ENTLTQD---------VN--ARDVYARAMY 301 
HsMY03A CIRADELQEALTSHCVVTRGETI IR-----PNTVEKA---------TD--VRDAMAKTLY 344 
ScMyo2p-Va DI DAYNFAKWVTKKQI ITRS-------EKIVSNLNYS---------QALVAKDSVAKFIY 345 
ScMvo4p-Vb GIDPFNFAKWIVKKQIVTRS ------- EKIVTNLNYN --------- QLIARDSVAKFIY 343 
Cehum2-V KISESDLRIWLTRREIRAVN ------- EIVTKPLTKN --------- EAVRSRDALTPC1LY 347 
SpMyo-Va GIEEDAMRKWLCNRKIVTVQ ------- EVLTKPLRRD --------- -MAVFSRDALAKHIY 338 
Dmdidum-Va RVSADDLRRWLLMRKIESVN-------EYVLIPNSIE---------AAQAARDALAKHIY 347 
Ggpl 90-Va GVDYEEMAHWLCHRKLATAT ------- ETYIKFISKL --------- HAINARDALAKHIY 338 
Mmdilute-Va GVDYEEMCHWLCHRKLATAT-------ETYIKPISKL---------QATNARDALAKHIY 338 
Rnmyo5-Va GVDYEEMCHWLCHRKLATAT ------- ETYIKPISKL --------- QATNARDALAEC-IY 338 
Rnmyr6-Vb GIEHSQMEHWLCHRKLVTTS ------- ETYVKTMSLQ --------- QVVNARNALAKHIY 339 
HsMY05A GVDYEEMCHWLCHRKLATAT-------ETYIKPISKL---------QATNARDALAKHIY 338 
HsMY05C GLESGRVAQMLCNRKIVTSS ------- ETVVKPMTRP --------- QAVNARDALAKKIY 338 
SpMyoVI KVDAKELEQSLTSRTMQARG ------- TVIKV2LKKE --------- QASt'JARDALAKAVY 366 
Cehum3-VI GLEPEEMKLGLCARIMQTTK--GGVKGTLIRVPLKAH---------EASAGRDALAKAIY 369 
Dmj ar-VI GVDQTELRTALVSRVMQSKG--GGFKGTVIMVPLKIY---------EASNARDALAKAIY 370 
Ma-VIA GLEEGDLRVSLTTRVMLTTAFTGGAKGTLIKVPLKVE---------QANNSRDALAKAVY 382 
Ma-VIB GLDQDDLRVSLTTRIMLTTAE'TGGAKGTVIKVPLKVE --------- QAMNARDALAKAVY 382 
GgMyoVI GLDEEDLRVSLTTRVMLTTA--GGAKGTVIKVPLKVE --------- QANMARDALAKTVY 370 
MmWaltzerVl GLDQDDLRVSLTTRVMLTTA--GGTKGTVIKVPLKVE---------QANNARDALAKTVY 371 
HsMY06 GLDQDDLRVSLTTRVMLTTA--GGTKGTVIKVPLKVE---------QANNARDALAKTVY 370 
Cehum6-VII QLHEQNLLDAITTKSLVTRE-------ERVISRLNGQ---------QAVDARDALAKAIY 337 
Dmck-VIIA GLFIQPLIDALTRRTLFAHG ------- ETVVSTLSRD --------- QSVDVRDAFVKGIY 337 
Dm28B-VIIB GIPISTALNAALTQRTIFVHG ------- EHVTTSLSKE --------- AAIEGRDAFVKSLY 339 
DrMyo-VIIA EVDLKDLMNCLTSRTI ITRG-------ETVSTPLSTE---------QALDVRDAFVKGIY 337 
Mmsha ker-VI IA EVNPPDLMSCLTSRTLITRG ------- ETYST PLSRE---------QALDVRDAFVKGIY 337 
HaUsherib-VIIA EVNPPDLMSCLTSRTLITRG ------- ETVST PLSRE---------QALDVRDAFVKGIY 337 
Dm1OA-XV HISADGLHRALTSRTTEARA-------ERLHTPLGID---------QALDARDAFAKALY 336 
Mm-MY015 QVS PEGLQKAITFKVTETIR-------EKI FTPLTVE---------SAVDARDAIAKVLY 337 
Hs-M1015 QISPEGLQKAIT FKVTETMR-------EKI FT PLTVE---------SAVDARDAIAKVLY 337 
DmMhcl-FDZ G\/NLEDLSSAAFGLTQPN-APNGGLSPSKSP-TSDTG ------- HEWAWECLEALVIGLY 348 
Hs-PDZ GCSLEELSSAI FKHQHKGGTLQRSTSFRQGPEESGLGFTDGTGPKLSALECLEGMAAGLY 312 
Mm-PDZ GCSLEELSSAIFKHQLKGGTLQRSTSFRQGPEESGLG ---- EGTKLSALECLEGMASGLY 352 
Dm290 GVPPAALFRGLTTRTHNVRC'- -------- QLVKSVCGDG -------- DANMTRDCLAKALY 327 
CONSENSUS GV---DL --- LT--R--I ----------- E-V --- L ------------- A--ARDALAKAIY 
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Appendix 
Drosophila Myo29D Insert 
Ac-lB SRMFDWIVSKVNEALQKQGGSGD-------------------------------------351 
Ac-IC SRMFDYIIQRVNDAMYID ---- D ------------------------------------- 345 
ScMyo3-IA NNLFDWIVDRVNVSLQAE'P ----------------------------------------- 362 
ScMyo5-IB NMLFDWIVSRVNKSLQAFP ----------------------------------------- 362 
Cehum5-IA ERLESWMVSKVNEAISVQNSSRYS ------------------------------------ 367 
Cehuml-IB ARLFDYLVKKVNDAMMITS-QST ------------------------------------- 361 
Dm31D-IA DRLFTWIISRINRAILFRGSKTQA------------------------------------360 
Dm61 F-ID DRLFSWLVQRLNISLQAKETRAS-------------------------------------361 
Dm95E SRLFTWLVNKINESLKSTQREKN-------------------------------------352 
Rc-IB GRTFSWLVSKINKSLAYKGTDMHK ------------------------------------ 375 
Gg-Bb SRLFDWLVNRINTSIQVKPGKQR-------------------------------------376 
Gg-IB ARVFDFLVESINRPM ----- QKP ------------------------------------- 358 
Rnmyrl-IA SRLFSWLVNRINESIKAQTKVRK-------------------------------------364 








Cemyo2-IIC SRIFNWLVKKCMQTLDQKG ----------------------------------------- 373 
Cemyol-IID ARVFHWLVKKCNLTLDQKG-----------------------------------------364 
Dm-mhcll DRLFKWLVKKCNETLDTQ------------------------------------------362 
Dmzip-nmII ERME'KWLVNRINRSLDRTK ----------------------------------------- 407 
X1-nmIIB ERLFRWLVIRINKALDRTK ----------------------------------------- 378 




Hs-nmIIA ERMFRNLVLRINKALDKTK ----------------------------------------- 359 




ScMyo2p-Va SALFDWLVENINTVLCNP ---- AVN ----------------------------------- 366 
ScMyo4p-Vb STLE'DWLVDNINKTLYDP ---- ELD ----------------------------------- 364 
Cehum2-V SHLE'GWLVDKINEALNEKDKLDGTN ----------------------------------- 372 
SpMyo-Va SQLE'TWIVEQINTKAMD -------------------------------------------- 354 
Dmdidum-Va AKLE'QYIVGVLNKSLN -------------------------------------------- 363 
Ggpl90-Va ANLFNWIVDMVNKALH -------------------------------------------- 354 
Mmdilute-Va AKLFNWIVDHVNQALH--------------------------------------------354 









GgMyoVI SHLFDHVVNRVMQCFP -------------------------------------------- 386 
MmWaltzerVl SHLFDHVVNRVNQCFP--------------------------------------------387 
HsMY06 SHLFDHVVNRVNQCFP--------------------------------------------386 
Cehurn6-VII GKLFIHIVRRVNDAIYKPSQ---------------------------------------- 357  
Dmck-VIIA GRNEVHIVRKINTAIFKPRG ---------------------------------------- 357 
Dm28B-VIIB DGIFVRIVRRINETINKQVD----------------------------------------359 
DrMyo-VIIA GRLF\TWIVEKINAAIYKFBSL --------------------------------------- 358 
Mmshaker-VIIA GRLFVWIVEKINAAIYKPPPL --------------------------------------- 358 






Mm-PDZ SELFTLLISLVNRALKSSQ ----------------------------------------- 371 
Dm2 9D CRTVATIVRRANSLKRLGSTLGTLSSDSNESVHNQADVASQHASTIGGGNAGSKSMAALN 387 




Ac-lB HNNNMIGVLDI F--GFEI FE------QNGFE--QFCINYVNEKLQQYFIELTLT< 395 
Ac-IC PEALTTGILDIY--GFEI FG------KNGFE--QLCINFVNEKLQQI FIQLTLK 389 
ScMyo3-IA GADKSIGILDIY--GFEI FE------HNS FE--QICINYVNEKLQQI FIQLTLK 406 
ScMy05-IB GAEKSIGILDIY--GFEIFE------HNSFE--QICINYVNEKLQQIFIQLTLK 406 
Cehum5-IA K--SKVIGVLDIY--GFEIFG ------ TNSFE--QLCINYCNEKLQQLFIELVLK 410 
Cehuml-IB SDNFSVGILDIY--GFEIFN------NNGFE--QFCINFVNEKLQQIFIELTLK 405 
Dm31 0-IA R-FNSVIGVLDIY--GFEI FD------SNS FE--QFCINYCNEKLQQLFIELVLK 404 
Dm61F-IB RNNVMGILDIY--GFEIFQ------KNSFE--QFCINFCNEKLQQLFIELTLK 404 
Dm95E LALLDFY--GFEALD------HNSFE--QFAINYSAEKIHQNFVFHVLR 391 
Rc-IB LGSASVIGLLDIY--GFEVFQ ------ HNSFE FTQFCINFCNEKLQQLFIELTLK 422 
Gg-Bb KVMGVLDIY--GFEI FQ------DNGFEQFIFTINYCNEKLQQI FILNTLK 419 
Gg-IB YEEYSIGVLDIY--GFEI FQ------KNGFE--QFCINFVNEKLQQI FIELTLK 402 
Rnmyrl-IA KVMGVLDIY--GFEI FE------DNS FEQFI--INYCNEKLQQI FIELTLK 405 
Rnmyr2-IB WRSTTVLGLLDIY--GFEVFQ------HNSFE--QFCINYCNEKLQQLFIELTLK 408 
Rrimyr3-IC HEEYNIGVLDIY--GFEI FQ------FcNGFE--QFCINFVNEKLQQI FIELTLK 402 
Rnmyr4 -ID HGKNTVIGVLDIY--GFEI FD------NNSFE--QFCINYCNEKLQQLFIQLVLK 407 
ScMYO1-IIA SATLNYIGLLDIA--GFEI FE------NNSFE--QLCINYTNEKLQQFFNNHMFV 421 
ScMYS1-IIB SATLNYIGLLDIA--GFEIFE ------ tJNSFE--QLCINYTNEKLQQFFNNHMFV 422 
Dd-nmII RKAYFIGVLDIS--GFEIFK ------ VNSFE--QLCINYTNEKLQQFFNHHNFK 401 
Cemyo3-IIA IERKHFIGVLDIA--GFEIFD------LNSFE--QLWINFVNERLQQFFNHHMFV 412 
Cemyo4 -I lB I DRDYFIGVLDIA--GFEI FD------FNSFE--QLWINFVNEKLQQFFNHHMFV 412 
Cemyo2-IIC ISRDHFIGVLDIA--GFEIFD ------ FNSFE--QLWINFVNEKLQQFFNHHMFV 418 
Cemyol-IID IDRDYFIGVLDIA--GFEIFD ------ FNSFE--QLWINFVNEKLQQFFNHHMFV 409 
Dm-mhcll QKRQHFIGVLDIA--GFEI FE------YNGFE--QLCINFTNEKLQQFFNHHMFV 407 
Dmzip-nrnl I RQGASFIGILDMA--GFEIFE ------ LNSFE--QLCINYTNEKLQQLFNHTMFI 452 
X1-nml ID RQGASFIGILDIA--GFEI FE------LNSFE--QLCINYTNEKLQQLFNHTMFI 423 
Gg-FSkI I QPRQYFIGVLDIA--GFEI FD------FNSFE--QLCINFTNEKLQQFFNHHMFV 410 
Gg-nmII RQGASFIGILDIA--GFEIFE------LNSFE--QLCINYTNEKLQQLFNHTMFI 404 
Gg-sml I RQGASFLGILDIA--GFEI FE------INS FE--QLCINYTNEKLQQLFNHTMFI 414 
Hs-FSkEII LPRQHFIGVLDIA--GFEIFE ------ YNSLE--QLCINFTNEKLQQFFNHHMFV 409 
Hs-nml IA RQGASFIGILDIA--GFEI FD------LNSFE--QLCINYTNEKLQQLFNHTMFI 404 
Hs-CaA QPRQYFIGVTLDIA--GFEIFD ------ FNSFE--QLCINFTNEKLQQFFNHHMFV 410 
OmNinaC-Ill DTNAIIIHDMF--GFECFN------RNGLE--QLMINTLNEQMQYHYNQRIFI 408 
Lp-III DVYSVTVIDSP--GFENGL------HNSLH--QLCANVISDNLQNYIQQIIFF 367 
HsMY03A GDELSIGILDI F--GFENFK------KNSFE--QLCINIANEQIQYYYNQHVFA 412 
ScMyo2p-Va DQISSFIGVLDIY--GFEHFE------KNSFE--QFCINYANEKLQQEFNQHVFK 411 
ScMyo4p-Vb --- QQDHVFSFIGILDIY--GFEHFE ------ KNSFE--QFCINYANEKLQQEFNQHVFK 411 
Cehum2-V --- QKKRPDRFIGVLDIY--GFETFD ------ VNSFE--QFSINYANEKLQQQFNQI-{VFK 419 
SpMyo-Va --- TQAKTTNFIGVLDIY--GFEMFE ------ INS FE--QFCINYANEKLQQQFTQHVFK 401 
Dmdidum-Va --- NGSKQCS FIGVLDIY--GFETFE------VNS FE--QFCINYANEKLQQQFNQHVFK 410 
Gqpl 90-Va --- STVKQHSFIGVLDIY--GFETFE ------ INSFE--QFCINYANEKLQQQFNMHVFK 401 
Mmdi lute-Va ---SAVKQHS FIGVLDIY--GFET FE------INS FE--QFCINYANEKLQQQFNMHVFK 401 
Rnmyo5-Va --- SAVKQHSFIGVLDIY--GFETFE ------ INSFE--QFCINYANEKLQQQFNMHVFK 401 
Rnrnyr6-Vb --- TSLKQHSFIGVLDIY--GFETFE ------ INS FE--QFCINYANEKLQQQFNSHVFK 402 
HsMY05A --- SAVKQHS FIGVLDIY--GFETFE------INSFE--QFCINYANEKLQQQFNMHVFK 401 
HsMY05C --- FSGKQHTFIGVLDIY--GFET FD------VNSFE--QFCINYANEKLQQQFNMHVFK 401 
SpMyoVI ---- FKTSANFIGLLDIA--GFEFFT ------ LNSYE--QFCINYCNEKLQQFFNLRVLK 428 
Cehum3-VI ---- FEKSTGYIGVLDVA--GFEYFA------VNSFE--QFCINFCNEKLQHFFNERILK 431 
Cml a r-VI ---- FQASNFYIGVLDIA--G FEY FT ------ VNSFE--QFCINYCNEKLQKFFNDNILK 432 
Ms-VIA ---- FDSSANFIGVLDIAFTGFEYFE------HNSFE--QFCINYCNEKLQQFFNERILK 446 
Ms-VIB ---- FETSSNFIGVLDIAFTGFEYFE ------ HNSFE--QFCINYCNEKLQQFFNERILK 446 
GgMy0VI ---- FETSSFFIGVLDIA--GFEYFE------HNSFE--QFCINYCNEKLQQFFNERILK 432 
MmwaltzerVl ---- FETSSYFIGVLDIA--GFEYFE ------ HNSFE--QFCINYCNEKLQQFFNERILK 433 
I-{sMY06 ---- FETSSYFIGVLDIA--GFEYFE ------ HNSFE--QFCINYCNEKLQQFFNERILK 432 
Cehum6-VII SRRTSIGILDI F--GFENFE------SNSFE--QLCINFANETLQQFFVHHVFK 401 
Dmck-VIIA TSRNAIGVLDI F--GFENFD------QNSFE--QFCINYANENLQQFFVQHI FK 401 
Dm2 8B-VI lB QPMNSIGVLDI F--GFENFD------NNSFE--QLCINYANENLQQFEVGHI FK 403 
DrMyo-VIIA --- ELKAVRRSIGLLDI F--GFENFM------VNSFE--QLCINFANENLQQFFVRHVFK 405 
Mmshaker-VIIA --- EVKNSRRSIGLLDIF--GFENFT ------ VNSFE--QLCINFANEHLQQFFVRHVFK 405 
HsUsherlb-VIIA --- DVKNSRRSIGLLDI F--GFENFA------VNSFE--QLCINFANEHLQQFFVRHVFK 405 
Dm1OA-XV THDAHRISILDIF--GFEDLA------ENSFE--QLCINYANENLQLYFNKHVFK 400 
Mm-MY01 5 NQDTLSIAILDIY--GFEDLS ------ FNSFE--QLCINYANENLQYLFNKIVFQ 399 
Hs-MY01 5 RQDTLSIAILDIY--GFEDLS------FNSFE--QLCINYANENLQYLFNKIVFQ 399 
DmMhcl-PDZ HTIASIMLIDTP--GFQNPA--SCGQQVGATLADLRHNYLQERLQMLFHHTTLV 417 
Hs-PDZ HSLCSMMIVDTP--GFQNOEQFTGGSARGASFEELCHNYTQDRLQRLFHERTFV 383 
Mm-PDZ HSLCSMMIVDTP--GFQNPE--WGGSARGASFEELCHNYAQDRLQRLFHERTFL 421 
Dm29D NAVRJ-IATSDGFIGILDMF--GFEEFS ------- FHAHLEHLCINLCAETMQHFYNTHIFK 438 




Ac-lB AEQEEYVNEGIQW--TPIKYE'NNKVVCELIEGKR-PPGI SLLD 	 DICE 440 
Ac-IC AEQEEYGAEGIQW--ENIDYFNNKICCDLIEEKR-PPGLMTILD------------DVCN 434 
ScMyo3-IA AEQETYEREKIKW--TPIKYEDNKVVCDLIEAKN-PPGILAAMN ------------ DSIA 451 
ScMy05-IB SEQETYEREKIQW--T PIKYFDNKVVCDLIEARR-PPGI EAAMN------------DSVA 451 
Cehum5-IA QEQEEYEREGIK1--VKIEYFNNKVICDLVEI PR--TGILSILD------------EACA 454 
Cehuml-IB AEQEEYVREGIKW--TEI DYFDNKIVCDLIETKR-PPGIMSLLD------------DTCA 450 
Dm31D-IA QEQEEYQREGIEW--TNIEYFNNKIICDLVEQPH--KGIIAIMD ------------ EACL 448 
Dm61 E'-IB SEQDEYRREGIEW--I FVEYEDNKVICNLIEEKH--KGII SIL------------DCCCL 448 
Dm95E SEQELYIREGLEW--SRIDYFDNCSICELIDKPS--YGILSLIf1 ---------------- 431 
Rc-IB SEQDEYESEGIAW--C PVQY FNNKIICDLVEEKF--KGIISI ETL ---------- DEECL 468 
Gg-Bb EEQEEYVRCGIQW--TPVEFFDNSIICDLIENSkVGILAMLDC ---------- FTECL 465 
Gg-IB AEQEEQEGIKW--TQIQYFNNKVVCDLICNKLNPPGIMSVLD ------------ DVCA 448 
Rnmyrl-IA ECQEEYIREDICW--THI DYENNAIICDLIEr'JNT--NGILAMLDE------------CCL 449 
Rnmyr2-IB SEQEEYEAEGIAW--E PVQYFNNKIICDLVEEKE--KGIISIL------------DCCCL 452 
Rnmyr3-IC AEQEEYVQEGIRW--TPICYFNNKIVCDLIESKVNPPGIMSILD ------------ DVCA 448 
Rnmyr4-ID QCQEEYQREGIPW--KHIDYFNNQIIVDLVEQQH-KGIIAILD ------------ DACM 451 
ScMY01-IIA LEQSEYLKENIQWD-YISYGKDLQLTIDLIEARG-HDRVLPLLV---------------- 463 
ScMYS1-IIB LEQSEYLKENIQWD-YIDYGKDLQLTIDLIESKGPPTGVLPLLD---------------- 465 
Dd-nmII LEQEEYLKEKINWT-FIDFGLDSQATIDLI DGRQ-PFGILALLD----------------443 
Cemyo3-IIA LEQEEYKREGIAWT-FIDFGLDLQACICLICKPL-GIISILD ---------------- 452 
Cemyo4-IIB LEQEEYAREGIQWV-FIDEGLDLQACICLIEKPLGIISMLD ---------------- 452 
Cemyo2-IIC LEQCEYAREGIQWT-FIDFGLDLQACIELIEKPLGIIPMLD ---------------- 458 
Cemyol-IID LEQEEYAREGIQWT-FIDFGLDLQACIELIEKPL --- GIISMLD ---------------- 449 
Dm-mhcll LEQEEYKREGIDWA-FIDFGMDLLACIDLICKPMGILSILE ---------------- 447 
Dmzip-nmII LCQCEYQREGIEWK-FIDFGLDLQFTIDLIDKPG --- GIMALLD ---------------- 492 
X1-nml ID LEQEEYQREGICWN-FIDFGLDLQPCIDLIERPANSPGVLALLD ---------------- 466 
Gg-FSkII LEQEEYKKEGICWC-EIDFGMDLAACIELIEKPM --- GIESILE ---------------- 450 
Gg-nmII LEQEEYQNEGIEWN-FI DFGLDLQPCI DLIEKPAGPPGILALLD----------------447 
Gg-smII LEQEEYQREGIEWN-E'I DE'GLDLQPCIELIERPTNPPGVLALLD----------------457 
Hs-E'SkEII LEQEEYKKEGIEWT-FIDFGMDLAACIELIEKPM --- GIFSILE ---------------- 449 
Hs-nmIIA LEQCCYQRCGICMN-FIDFGLDLQPCIDLIEKPAGPPGILPLLD ---------------- 447 
Hs-CaA LCQCEYKkEGICMT-FIDFGMDLQACIDLICKPMGIMSILE ---------------- 450 
DmNinaC-III SEMLEMEAEDIDT-II4LN-FYDNKTALDNLLTKP--DGLEYII 0----------------448 
Lp-III KELEEYGEEGVNVPFNLEGGVDHRTLVNKLMDSG--QGLLTAIS---------------- 409 
HsMY03A WEQNEYLNCDVDA--RVIEYEDNWPLLDMFLQK2MGLLSLLD ---------------- 452 
ScMyo2p-Va LEQEEYVKEEIEWS--FIEFNDNQPCIDL--IENK-LGILSLLD ---------------- 450 
ScMyo4p-Vb LCQEEYVKCEICWS--FIEFSDNQPCIDL--IENK-LGILSLLD ---------------- 450 
Cehum2-V LCQECYIREEIEMV--RVDFHDNQPAIDLIEGPVGMINLLD ---------------- 458 
SpMyo-Va LEQEEYVKEQIEWS--E'IDYYDNQPCIDM--IESK-LGILDLLD ---------------- 440 
Dmdidum-Va LEQEEYLKEGITWT--MIDFYDNQPCIDL--IESRLGVLDLLD ---------------- 449 
Ggpl 90-Va LEQEEYMKEQIPWT--LIDFYDNQPCINL--IEAKMGVLDLLD ---------------- 440 
Mmdilute-Va LEQECYMKEQIPWT--LIDFYDNQPCINL--IESK-LGILDLLD ---------------- 440 
Rnmyo5-Va LEQCCYMKCQIPWT--LIDFYDNQPCINL--IESK-LGILDLLD ---------------- 440 
Rnmyr6-Vb LEQEEYMKEQI PWT--LIDFYDNQPCIDL--IEAK-LGILDLLD----------------441 
HsMY05A LEQEEYMKEQIPWT--LIDE'YDNQPCINL--ICSK-LGILDLLD ---------------- 440 
HsMY05C LEQEEYMKEDIPWT--LIDFYDNQPVIDL--ICAK-MGILELLD ---------------- 440 
SpMyoVI CEQCLYERESLGVN--TVNYVDNQDCIDL--VCLKPNGILDLLD ---------------- 468 
Cehum3-VI QEQEMYCAEGLNIQ--KICFTDNLDCIEL--E'EKKASGLFDLLD ---------------- 471 
Dm1 ar-VI NEQELYKRCGLNVP--CITFTDNQDIIEL--IEAKSNGIFTLLD ---------------- 472 
Ma-VIA CCQELYQREGLGVN--CVWfVDNQDCIDLFTVEAKLVGILDILD ---------------- 488 
Ma-VIB EEQCLYQREGLGVN--EVHYVDNQDCIDLFTVEVKLVGVLDILD ---------------- 488 
GgMy0VI EEQELYQKEGLGVN--EVRYVDNQDCIDL--ICAKLIGVLDILD ---------------- 472 
MmWaltzerVl EEQELYQKEGLGVN--EVHYVDNQDCICL--IEVKLVGILDILD ---------------- 473 
HsMY06 EEQELYQKEGLGVN--EVHYVDNQDCIDL--IEAKLVGILDILD---------------- 472 
Cehum6-VII MEQKEYDCEHINWR--MIKFVDNQATVDL--IAQRPLNILSLID ---------------- 441 
Dmck-VIIA LEQECYNHEAINWQ--I4IEFVDNQDALDL--IAIKQLNIMALID ---------------- 441 
Dm28B-VIIB MEQDEYQNEHINWQ--HIEFQDNQQILDL--IGMKPMNLMSLID---------------- 443 
DrMyo-VIIA LEQEEYNLCNINWQ--HIEFTDNQDALDM--IAIKPMNIISLID ---------------- 445 
Mmshaker-VIIA LEQCEYDLESIDWL--HIEFTDNQEALDM--IANRPMNVISLID ---------------- 445 
HsUsherlb-VIIA LEQEEYDLESIDWL--HIEFTDNQDALDM--IANKPMNIISLID ---------------- 445 
Dm1 OA-XV LEQAEYARERLEWT--PLAWDDNLPVIHL--LAKKPVGICHLLD---------------- 440 
Mm-MY015 EEQEEYIREQMDWR--EIAEADNQPCINL--ISLKPYGILRILD ---------------- 439 
Ha-MY015 EEQEEYIREQIDWQ--EITFADNQPRINL--ISLKPYGILRILD---------------- 439 
DmMhcl-PDZ APRDRYAQCLVEIEMDLASECHPGPLIS-LIDKAPQNHVVRSSQRDLREHDRRGMLWLLD 476 
Hs-PDZ QCLERYKECNIELAFDDLEPPTDDSVAAFTVDQASHQSLVRSLAR --- TDEARGLLWLLE 440 
Mm- PDZ QELERYKEDNIELAEDDLE PVADDSVAA--VDQASH--LVRSLAHADEARGLLWLLC 474 
Dm2 9D SSVESCRDEGIVCD-TEVDYVDNVPCIDLISSLR--TGLLSMLD---------------- 479 




Ac-TB TMHAQSDGMDGKFLQKCQGGFPSHLHFRGMN -------------- NAE'SIKHYAGEV--T 484 
Ac-IC ---- FPKGTDDKE'REKLLGAFPTHAHLPATSQ ------------ PDEFVIKHYAGDV--V 476 
ScMyo3-IA TAHADSNAADQAFAQRLN-LFNSNPYFELRA -------------- NKE'VIKHYAGDV--T 494 
ScMyo5-IB TAHADSNAADQAFAQRLN-LFTTN PHFDLRS--------------NKFVIKHYAGDV--T 494 
Cehum5-IA SI --- GNVTDKVE'LGELDKKLKSHKHYTSRNLKQSD --- KSMGE'-EEFKITHYAGDV--T 505 
Cehuml-IB QNHGQREGVDRQLLTTLSKSFAGHPHE'GPGS -------------- DSFVIKHYAGDV--T 494 
Dm31D-IA SV --- GKVTDDTLLGAMDKNLSKHPHYTSRQLKPTD --- KELKHREDFRITHYAGDV--I 500 
Dm61F-IB RP --- GEPTDKTELEKLTQKLAQHHHYVCHEKAPAH--IKKIMLRDEFRLVHYAGEV--T 501 
Dm956 --- EPHLNSNDALLLRVQQCCAGHPNFMTTGSNS ----------- MCFQIRHYASVVN-- 475 
Rc-IB RP --- GEATDMTFLEKLEDTVKNHFHFVTHKLGDQK--TRKVLGRDEFRLLHYAGEVNFT 523 
Gg-Bb RP --- GTVNEDTFITKLNQIFASHKRYESKETLNAKHVTDVSLPLRCFRIHHYAGKVTYF 522 
Gg-IB TMHATGEGADQTLLQKLQAAVGTHEHFNSWS -------------- SGF'VIHHYAGKV--S 492 
Rnmyrl-IA R2 --- GTVTDETE'LEKLNQVCATHQHFESRMSKCSRFLNDTTLPHSCFRIQHYAGKVLY- 505 
Rnmyr2-IB R2 --- GBATDLTE'LEKLEDTIKHHPHFLTHKLADQK--TRKSLDRGEFRLLHYAGEV--T 505 
Rnmyr3-IC TMHAVGEGADQTLLQKLQMQIGSHEHFNS9N -------------- QGFIIHHYAGKV--S 492 
Rnmyr4-ID NV --- GKVTDGMFLEALNSKLGKHGHFSSRKTCASD --- KILEFDRDFRIRHYAGDV--V 503 
ScMY01-IIA EEAVLPKSLMESE'YSKLISTWDQNSSKFKRSALKN ----------- GFILKDYAG--DVN 510 
ScMYS1-IIB EEAVLPKSTDESFYSKLISTWDQNSSKFKRSRLKN-----------GFILKHYAG--DVE 512 
Dd-nml I EQSVFPNATDNTLITKLHSHFSKKNAKYEEPRFSK ---------- TEFGVTHYAG--QVM 491 
Cemyo3-IIA EFCIVPKATDMTYAQKLLDQHLGKHPNFQKPKPPKGKQ ----- GDAHFAIVHYAG--TVR 505 
Cemyo4-IIB EECIVPKATDLTLASKLVDQHLGKHPNE'EKPKPPKGKQ-----GEAHFAMRHYAG--TVR 505 
Cemyo2-IIC EECIVPKATDLTLAQKLIDQHLGKHPNFEKFKPEKGKQ ----- AEAHFAMRHYAG--TVR 511 
Cemyol-IID EECIVPKATDMTLAQKLTDQHLGKHPNFEKFKFPKGKQ-----GEAI-ILAMRHYAG--TVR 502 
Dm-mhcll EESMFPKATDQTFSEKLTNTHLGKSAPFQKPKPPKPGQ-----QAAHFAIAHYAG--CVS 500 
Dmzip-nmII EECWFPKATDKTF'VDKLVSAH-SMHPKFMKT-DFR -------- GVADFAIVHYAG--RVD 540 
X1-nmIIB EECWE'PKATDKTFVDKLVQEQ-GTHSKFQKPRQLK -------- DKADFCIIHYAG--RVD 515 
Gg-FSkII EECMFPKATDTSFKNKLYDQHLGKSNNFQKPKPAK-GK ----- AEAHFSLVHYAG--TVD 502 
Gg-nmII EECWFPKATDKSFVEKVVQEQ-GTHFKFQKPKQLK -------- DKADFCIIHYAG--KVD 496 
Gg-sml I EECWFPKATDTS EVEKLIQEQ-GNHAKE'QKSKQLK--------DKTEFCILHYAG--K\TT 506 
Rs-FSkEII EECMFPKATDTSFKNKLYDQHLGKSNNFQKPKVVK-GR-----AEAHFSLIHYAG--TVD 501 
Hs-nml IA EECWFPKATDKS EVEKVMQEQ-GTHPKFQKPKQLK--------DKADFCIIHYAG--KVD 496 
Hs-CaA EECMFPKATDMTFKAKLYDNHLGKSNBFQKPRNIK-GK ----- PEAHFSLIHYAG--TVD 502 
DmNinaC-III DASRSCQD-----QNLIMDRVSEKHSQFVKKHTA-----------TEISVAHYTGRII-- 490 
Lp-III KATQYQRKGESGWMESLQEADSEELVEFSNVNGK-----------PIVSVKHIFRKVS-- 456 
HsMY03A EESRFPKATDQTLVEKFEGN-LKSQYFWRPKRME-----------LSFGIHHYAGKVL-- 498 
ScMyo2p-Va EESRLPAGSDESWTQKLYQTLDKSPTNKVFSKPRFGQT---------KFIVSHYA-LDVA 500 
ScMyo4p-Vb EESRLPSGSDESWASKLYSAFNKPPSNEVFSKPRFGQT---------KFIVSHYA-VDVE 500 
Cehum2-V EQCKRLNGSDADWLSQLQNST-ELKRNPQLAFPKVRSN---------DFIVRHFA-ADVT 507 
SpMyo-Va EECMLPKGSDENWCNKLYN --- KLTAHGHFSKPRTSRT --------- AFLVHHFA-DKVE 487 
Dmdidum-Va EECRMPKGSDESWAGKLIG --- KCNKFPHFEKPRFGTT --------- SFFIKHFS-DTVE 496 
Ggpl90-Va EECKMPKGSDDTWAQKLYNT--HLNKCALFEKPRLSNK---------AFIIKHFA-DKVE 488 
Mmdilute-Va EECKMPKGTDDTWAQKLYNT--HLNKCALFEKPRMSNK---------AFIIKHFA-DKVE 488 
Rnmyo5-Va EECKMPKGTDDTWAQKLYNT--HLNKCALFEKPRMSNK --------- AFT IKHFA-DKVE 488 
Rnmyr6-Vb EECKVPKGTDQNWAQKLYER--HSN-SQHFQKFRMSNT --------- AFIVIHFA-DKVE 488 
l-IsMY05A EECKMPKGTDDTWI\QKLYNT--HLNKCALFEKPRLSNK --------- AFIIQHFA-DKVE 488 
HsMY05C EECLLPHGTDENWPQKLYNN--FVNRNPLFEKPRMSNT --------- SEVIQHFA-DKVE 488 
SpMyoVI EESKLPKASJANNFTHNVHQKHKTHFRLAIPRKSKLTAHRI1LRDDEG--ILIKHFA-GAVC 525 
Cehum3-VI EEAKLPRATFQHFTQRAHESNKNHFRLDAPRKSKVKSHREMRDDEG--LLIRHYA-GTVC 528 
Dm1 ar-VT EESKLPKPSYSHFTAEVHKSNANHYRLGLPRSSRLKAHRTLRDEEG--FLVRHFA-GAVC 529 
Ms-VIA EEBRLPQPTDQHFTDTVHNKHKNHFRLTIPRKSKLAVHRNVRDDEGFTFIIRHFA-GAVC 547 
Ms-VIB EENRLPQPSDQHFALAVJ-iNKHKDHFRLTVPRKSKLTIHRNLRDDEGFTFIIRHFA-GAVC 547 
GgMyoVI EENRLPQPSDQHFTSVVHQKHKDHFRLSIPRKSKLAVHRNVRDDEG--FIIRHFA-GAVC 529 
MmWaltzerVl EENRLPQPSDQHFTSVVHQKHKDHFRLTIPRKSKLAVHRNLRDDEG--FIIRQLCRGRVL 531 
HsMY06 EENRLPQPSDQHFTSAVHQKHKDHFRLTIPRKSKLAVHRNIRDDEG--FIIRHFA-GAVC 529 
Cehum6-VII EESIFPKGTDKTMLLKLHST --- HGRNELYLQPKSELQR -------- AFGVTHFA-GNVF 489 
Dmck-VIIA EEARFPKGTDQTMLAKLHKT --- HGSHKNYLKPKSDINT -------- SFGLNHFA-GVVF 489 
Dm28B-VIIB EESKFPKGTDQTLLEKLHVQ --- I-{GNRSIYVKGKTTQTS -------- LFGIRHYA-GVVM 491 
DrMyo-VI IA EESKFPKGTDTTMLNKLNSQ --- HKLNTNYI PPKNTYET--------QFGIQI-TFA-GVVY 493 
Mmshaker-VIIA EESKFPKGTDATMLHKLNSQ --- HKLNANYVPPKNSHET -------- QFGINHFA-GVVY 493 
HsUsherlb-VI IA EESKFPKGTDTTMLHKLNSQ --- HKLNANYI FPKNNHET--------QFGINHFA-GIVY 493 
Dm1OA-XV DESNFPRATDLSFLEKCHYN --- HALSELYARPRIGAQ --------- EFGVTHYA-GQVW 487 
Mm-MYO15 DQCCFPQATDHTFLQKCHYH --- I-iGANPLYSKPKMPLP --------- EE'TIKHYA-GKVT 486 
Hs-MY015 DQCCFPQATDHTFLQKCHYH---HGANPLYSKPKMPLP---------EFTIKHYA-GKVT 486 
DmMhcl-PDZ EEAIYPNSNDDTFLERLFSHYGDREHH ------ SLLRKCA --- GPRQE'VLHHLQGTrJPVL 527 
Hs-PDZ EEALVPGASEDTLLERLFSYYGPQEGDKKGQSFTPLLHSS---KPHHFLLGHSHGTNWVE 497 
Mm-PDZ EEALVPGATEDALLDRLFSYYGPQEGDKKGQ--SPLLRSS --- KPRHFLLGHSHGTNWVE 529 
Dm29D -AECSVRGTAESYVTKLKVQHRSSTRLETKPTAEPHDP ------- RMFLIRHFAG--RVE 529 




Ac-IS YEAEGE'CE-KNKDTLFDDLIAVIQESE--NRLLVSWE'P-EDTKQLQ -------------- 526 
Ac-IC YNVDGE'CD-KNKDLLFKDLIGLAECTS--STFE'AGL'P-EAKEVATS ------------- 519 
ScMyo3-IA YDINGITD-KNKDQLQKDLIELIGTTT--NTFLSTI FP-DDVDKDS--------------536 




Dm61F-IB YSVNGE'LD-KNNDLLFRDLKETLSKAG--NGIVRSCFPEKELR --- S ------------- 542 
Dm95E YSIHRE'LE-KNSDMLPKYISAAFYQSK--LSLVQSLE'PEGNPRR-QV ------------- 518 
Rc-IB YSVAGFLD-KNNDLLFRNLKEVMCDSG--NPIAHQCFNRSELT---D ------------- 564 
Gg-Bb TNVTGFIE-KNNDLLE'RDLSQAMWAAR--HTLLRSLFPEGDPQR- PS-------------565 
Gg-IB YDVNGFCE-RNRDVLE'TOLIELMQSSE--YAFIRMLE'P-EKLDADK -------------- 534 
Rrcnyrl-IA -QVEGFVD-KNNDLLYRDLSQPMWKAG--HALIKSLFPEGNPAK-VN ------------- 547 
Rnmyr2-IB YSVTGFLD-KNNDLLFRNLKETMCSST--NPIMAQCFDKSELS --- D ------------- 546 
Rnmyr3-IC YDMDGFCE-RNRDVLFMDLIELMQSSE--LPFIKSLFP-ENLQADK--------------534 
Rnmyr4-I D YSVIGFID-KNKDTLFQDFKRLMYNSS--NPVLKNMWPEGKLSITEV-------------547 
ScMY01-IIA TLWKAGYP-KT-DPLNDNLLSLLSSSQ--NDIISKLFQPEGGKNLLVCGVEANISNQEV 565 
ScMYS1-IIB YTVEGWLS-KNKDPLNDNLLSLLSSSQ--NDIISKLFQPEGEK-SSSAGVEANISNQEV 567 
Dd-rimll YEIQDWLE-KNKDPLQQDLELCFKDSS--DMVVTKLENDPNIASRAKKGPN --------- 539 
Cemyo3-IIA YNATNFLE-KNKDPLNDTAVALLKHSTD-NSLMLDIWQDYQTQEEAAEAAKAGQTAGG- 561 
Cemyo4-IIB YNCLNWLE-KNKDPLtJDTWSAMKQSKG-NDLLVEIWQDYTTQEEAAAKAKEGGGGGK 561 
Cernyo2 -I IC YNCLNWLE-KNKDPLNDTWrVMKASKE-HALIVEVWQDYTTQEEAAAAAAKGTAGAK 567 
Cernyol-IID YNVLNWLE-KNKDPLNDTVVSVMKASKK-MDLLVEIWQDYTTQEEAAAAAKAGGG--R 556 
Dm-mhcll YNITGWLE-KNKDPLNDTVVDQFKKSQ--NKLLIEIFADHAGQSGGGEQAKGGRG ----- 552 
Drnzip-nml I YSAAKWLM-KNMDPLNENIVSLLQGSQ--DP E'VVNIWKDAE-IVGMAQQA-LT DTQFG 593 
Xl -nmIIB YKADEWLL-KNMDPLNDNVATLLHQSS--DKFVSELWKDVDRIVGLDQVAGMAETAFGA 571 
Gg-FSkII YNISGWLE-KNKDPLNETVIGLYQKSS--VKTLALLFATYGGEAEG-GGGKKGGK ----- 553 
Gg-nmII YKADEWLM-KNMDPLNDNIATLLHQSS--DKE'VSELWKDVDRIVGLDQVAGMSETALPG- 552 
Gg-smII YNASAWLT-KNMDPLNDNVTSLLNQSS--DKFVADLWKDVDRIVGLDQMAKMTESSLPS- 562 
Hs-E'SkEII YSVSGWLE-KNKDPLNETVVGLYQKSS--NRLLAHLYATFATADAD-SGKKKVAK-----552 
Hs-nmIIA YKADEWLM-KNMDPLNDNIATLLHQSS--DKFVSELWKDVDRIIGLDQVAGMSETALPG- 552 
Hs-CaA YNILGWLE-KNKDPLNETVVGLYQKSS--LKLMATLFSSYATADTGDSGKSKGGK ----- 554 
DmNinaC-III YDTRAETD-INRDFVPPEMIETFRSSL--DESIMLMETNQLTKAGNLTMPFEAVQHKDES 547 
Lp-III YDATDLVK-KNVEDKTRALTSTMQRSC--DPRIRAI ESSENPSP-----------FLSSP 502 
HsMY03A YNASGFLA-KNKTLVPTDIVLLLRSSD--NSVI RQLVNH PLTKTGN--LPHSKLKMLNYQ 553 
ScMyo2p-Va YDVEGFIE-KNRDTVSDGHLEVLKAST--NETLINILEGLEKAAKKLEEAKKL-------550 
ScMyo4p-Vb YEVEGFIE-KNRDSVSLGHLDVFKATT--NPIFKQILD ----- NRELRSDDAP ------- 545 
Cehum2-V YSTDGFVE-KNRDAIGEQLLDVVVASK--FPFIRTVIGST--------------------544 
SpMyo-Va YESEGFVQ-KNRDQVNDEHLNILMASQ--YE E'VAELFRPK-----PEAPKHNHK------533 
Dmdidum-Va YDVNGFLE-KNRDTVSKELTQVLSESN--MSLAKQVMTLEEIDTLCVDSAKSSTLG-- 549 
Ggpl90-Va YQCEGFLE-KNKDTVYEEQIKVLKSSKK-FKLLPELFQDEEKAISPTSATPSGRVPL--- 543 
Mmdilute-Va YQCEGFLE-KNKDTVFEEQIKVLKSSK--FKMLPELFQDDEKAISPTSATSSGRTPL--- 542 
Rnmyo5-Va YQCEGFLE-}cNKDTVFEEQIKVLKSSK--FKMLPELFQDDEKAISPTSATSSGRTPL--- 542 
Rnniyr6-Vb YLSDGFLE-KNRDTVYEEQINILKASK--FPLVADLFRDDEDSVPATNTAKSRSS ----- 540 
HsMY05A YQCEGE'LE-KNKDTVFEEQIKVLKSSK--FKMLPELFQDDEKAISPTSATSSGRTPL--- 542 
HsMY05C YKCEGFLE-KNRDTVYDMLVEILRASK-- EHLCPNFE'QEN-----PTPPSPPG-------533 
SpMy0VI YQTSEFIE-KNNDALHASLEVVIRDCK--DPFITSLFPKNDKEPSKGRGGQNVQ ------ 576 
Cehum3-VI YETRYEVE-KNSDQLHNSLEMLIEQSS--FPLVVSLFTSEATGAVKTGG ----------- 574 
Dmj ar-VI YNTEQEIE-KNNDALHASLEGLVQECD--NPLLQTLFPSGSSTSVRG ------------- 573 
Ms-VIA YETTNFVE-KNNDALHMSLECLVSESK--DREVRELFE-NSNNSKDVKQKPEET ------ 597 
Ma-VIB YETCRFVE-KNNDALHMSLESLVCESK--DKEVRELFE-NSNTTKDSKQKAGFT ------ 597 
GgMyoVI YETTQFVE-KNNDALHMSLESLICESK--DKEVRQLFESNTNNNKDPKQKAG -------- 578 





DrMyo-VIIA YETRGFLE-KNRDTLHGDIIQLVHSSK--NKFIKQIFQADVF\MGAETRKRS --------- 541 
Mmshaker-VIIA YESQGELE-KNRDTLHGDIIQLVHSSR--NKEVKQIFQADVAMGAETRKRS --------- 541 
HsUsherlb-VIIA YETQGEIE-KNRDTLHGDIIQLVHSSR--NKFIKQIFQADVAMGAETRKRS --------- 541 
DrnlOA-XV yCVDGFLD-RDALRGDVLELLASSR--LPLVGELTKQLRAQRDAGKTLPKGSMG 540 
Mm-MYO1 5 YQVHKFLD-KNHDQVRQDVLDLFVHSR--TRVVAHLFSSHAAQTAP-PRLGKSSS ----- 537 
Hs-MY015 YQVHKFLD-KNHDQVRQDVLDLFVRSR--TRVVAHLFSSHAPQAAP-QRLGKSSS ----- 537 
DrnMhcl-PDZ YAVDGWVRHSREHPGIRNAVSLLQDSSR-EEINRLYIGSLTRGSGAMVFC&SFAGLEG 584 
Hs-PDZ YNVTGWLWYTKQNPATQNVPRLLQDSQK-KIISMLFLFTGRAGS-ATVLSGSIAGLEGGS 555 
Mm- PDZ YNVAGWLNYTKQNPATQNAPRLLQDSQK-KIISNLFL--GRAGS-ATVLSGSIAGLEGGS 585 
Dm29D YDTTDE'LD-TNRDVVPDDLVGVFYKHTCNFGFATHLE'GSELKALYAQQQAPRGLSFRIS 587 
CONSENSUS Y --- GFLE-1-L --- LI-LL--S ----- L --- LF------------------------- 
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Appendix 
Class V insert 
-, 	Actin contact helix 
Ac-lB ------------------- KKRPTTAGE'KLKT ------- SCDALMEALSRCSPHYIRCIK 560 
Ac-IC -------------------KKKPTTAGFKIKE-------SINILVATLSKCTPHYIRCIK 553 
ScMyo3-IA -------------------KRRPPTAGDKIIK-------SANELVETLSKAEPSYIRTIK 570 
ScMy05-IB ------------------- KRRPPTAGDKIIK ------- SANDLVETLSKAQPSYIRTIK 570 
Cehum5-IA -------------------NRRPPTAGFLFKN-------SMSELVKQLAQKEPHYIRCIK 583 
Cehuml-IB -------------------GKRPTTFSTKIRT-------QANTLVESLMKCSPHYVRCIK 570 
Dm31D-IA ------------------- TKRPLTAGTLFQR ------- SMADLVVTLLKKEPFYVRCIK 578 
Dm61E-IB -------------------LKRPETAITQFR--A-----SLNNLMDILMCKEPSYIRCIK 576 
Dm95E ------------------- TKKPSTLSSNIRT ------- QLQTLLAIVKHRRSHYVE'CIK 552 
Rc-IB -------------------KKRPETAATQFKNSL-----SKLFTMEILMSKQPSYVRCIK 600 
Gg-Bb ------------------- LKLPPTTGSQFKASV ----- ATE'TLMKNLYSKNPNYIRCIK 601 
Gg-IB -------------------KGRPTTAGSKIKK-------QANDLVNTLMKCTPHYIRCIK 568 
Rnmyrl-IA ------------------- LKRPPTAGSQFKASV ----- A--TLMKNLQTKNPNYIRCIK 581 
Rrimyr2-IB ------------------- KKRPETVATQE'K--M ----- SLLQLVEILRSKEPAYIRCIK 580 
Rnmyr3-IC -------------------KGRPTTAGSKIKK-------QANDLVSTLMKCTPHYIRCIK 568 
Rnmyr4-ID ------------------- TKRPLTAATLFKN ------- SMIALVDNLASKEPYYVRCIK 581 
ScMY01-IIA -------------- KKSARTSTFKTTSSRHREQQI ------- TLLNQLASTI-IPHE'VRCII 604 
ScMYS1-IIB -------------- KKSARTSTFKTTSSRHREQQI ------- TLLt'TQLASTHPHEVRCII 606 
Dd-nmII ---------------------- E'ITVAAQYKEQLA ------- SLMATLETTNPHE'VRCII 570 
Cemyo3-IIA --------------- KRGKSSSEATVSMIYRESLN ------- NLMNMLYQTHPHEIRCII 599 
Cemyo4-IIB --------------- KKGKSGSFMTVSMLYRESLN ------- NLMTMLNKTHPHE'IRCII 599 
Cemyo2-IIC --------------- KKGKSGSFMTVSMLYRESLN ------- KLMTMLHSTHPHFIRCII 605 
Cemyol-IID --------------- KGGKSGSFMTVSMMYRESLN ------- KLMTMLHKTHPHFIRCII 594 
Dm-mhcll --------------- KKG--GGFATVSSAYKEQLN ------- SLMTTLRSTQPI-{F\TRCII 588 
Drnzip-nmII --------------- ARTRKGMFRTVSHLYKEQLA ------- KLMDTLRNTNPNFVRCII 631 
X1-nmIIB -------------- AYKTKKGMFRTVGQLYKESLA ------- KLMATLRNTNPNE'VRCII 610 
Gg-FSkII --------------- KKG--SSE'QTVSALFRENLN ------- KLMANLRSTHPHF'VRCII 589 
Gg-nmII AFKTRKGMFRTVGQLYKEQLA-------KLMATLRNTNPNFVRCII 591 
Gg-srnhI ASKTKKGMFRTVGQLYKEQLT ------- KLMTTLRNTN9NFVRCII 601 
Hs-FSkEII --------------- KKG--SSF'QTVSALFRENLN ------- KLMSNLRTTHPHFVRCII 588 
Hs-nmIIA -------------- AFKTRKGMFRTVGQLYKEQLA ------- KLMATLRI'TTNPNFVRCII 591 
Hs-CaA KKG--SSFQTVSALHRENLt1 ------- KLMTNLRTTHPHFVRCII 590 
DmNinaC-III ERKSYALNTLSAGCISQVNNLRTLAANFRE'TCLT ------ LLKMLSQNANLGVHFVRCIR 601 
Lp-III RRSSIQENMLLP--------ERTVTDSLHSALSS------VLNLASTEDPP--HLILCMR 546 
HsMY03A MRTSEKLINLAKGDTGEATRHARETTNMKTQTVASYFRYSLMDLLSKMVVGQPHFVRCIK 613 
ScMyo2p-Va ---- ELEQAGSKKPGPIRTVNRKPTLGSMFKQSLI ------ ELMNTTN-STNVHYIRCIK 599 
ScMyo4p-Vb ---- EEQNTEKKIMIPARLSQKKDTLGSMFKKSLG ------ ELMAIIN-STNVHYIRCIK 594 
Cehurn2-V --- APTSVSSSSSSSTPGKRTIKKTVASQFRDSLK ------ ELMSVLC-STRPHYVRCIK 594 
SpMyo-Va ---- RGSVKPMVAPVSR-TKTFKRSVGSQRDS--  ------ YLMMKLN-STTPH'IVRCIK 581 
Dmdidum-Va ---- GRVVISAGRKQVVPSKQHRKTVGSQFQESLA ------ SLISTLH-ATTPHYVRCIK 598 
Ggp190-Va --- SRTPVKFAKARPGQTSKEHKKTVGHQFRNSLH ------ LLMETLN-ATTPHYVRCIK 593 
Mmdilute-Va --- TRVE'VKPTKGRPGQTITKEHKKTVGHQFRNSLH ------ LLMETLN-ATTPHYVRCI}( 592 
Rnmyo5-Va --- TRVPVKPTKGRPGQTAKEHKKTVGLQFRNSLH ------ LLMETLN-ATTPHYVRCIK 592 
Rnmyr6-Vb --- SKINVRSSRPLMKAPNKEHKKSVGYQFRTSLN ------ LLMETLN-ATTPHYVRCIK 590 
HsMY05A --- TRTPAKPTKGRPGQMAKEHKKTVGHQFRNSLH ------ LLMETLM-ATTPHYVRCIK 592 
HsMY05C --- SMITVKSAKQVIKFNSIKH ERTTVGSKFRSSLY------LLMETLI'J-ATTPHYVRCIK 583 
SpMyoVI ------------------- KLAFDSVGNKFKVQLN ------ QLMEKLR-STGSSEVRCIK 610 
Cehurn3-VI -------------------RLKAVSVGAKFKSQLS------SLLDKLN-NTGTHFVRCVK 608 
Dmj ar-VT -------------------KLNFISVGSKFKTQLG------ELMEKLE-QNGTNFIRCIK 607 
Ms-VIA ------------------- KLSFISVGNKFKTQLN ------ ILLEQARCSTGSSFIRCIK 632 
Ms-VIB -------------------KLGFISVGNKFKTQLN------LLLEKLR-STGSSFIRCVK 631 
GgMyoVI -------------------KLSFISVGNKFKTQLN------LLLEKLH-STGSSFIRCIF 612 
MmwaltzerVl -------------------KLSFISVGNKFKTQLN------LLLDKLR-STGASFIRCIK 615 
HsMY06 -------------------KLSFISVGNKFKTQLN------LLLDKLR-STGASFIRCIK 612 
Cehurn6-VII ----------------------- VTVGNQERRSLE ------ QLMSQLT-QTHPE'FIRCIK 565 
Dmck-VIIA ----------------------- PTLSTQERKSLD ------ ALMKTLS-SCQPETIRCIK 567 
Dm28B-VIIB ----------------------- PTLCVKE'RNSLD ------ MLMRTLS-QAHPYE'IRCIK 567 
DrMyo-VIIA ----------------------- 9TLSSQFKRSLE ------ LLMRTLS-VCQPE'E'VRCIK 571 
Mmshaker-VIIA ----------------------- PTLSSQFKRSLE ------ LLMRTLG-ACQPETVRCIK 571 
HaUsherib-VIIA ----------------------- PTLSSQFKRSLE ------ LLMRTLG-ACQPFFVRCIK 571 
Dm10A-XV --------------RFVTMKPRTPTVAARFADSLQ------QLLQSMG-RCHPWFVRCIK 579 
Mm-MY015 ---------------- ITRLYKAHTVAAKFQQSLL ------ DLVEKME-RCN2LFVRCLK 574 
Hs-MY015 ---------------- VTRLYKAHTVAAKFQQSLL ------ DLVEKNE-RCNPLFMRCLK 574 
DrnMhcl-PDZ TQSLRRVSSIRRSFTT--AGVKRNSIMLQVKFTVD ----- GIID--TLRRTGTHFVHCYL 635 
Hs-PDZ QLALRRATSMRKTFTTGMVAVKKKSLCIQMKLQVD ----- ALIDFTTIKKSKLHFVHCFL 610 
Mm-PDZ QLLRRATSMRKTFTTGMAAVKKKSLCIQIKLQVD ----- ALID--TIKRSKMHFVHCFL 638 
Dm29D PTSHSDLLNGDEPVSTLTQDFHTRLDN-------LLRTLVHARPHFVRCIR 631 
CONSENSUS ----- 	- •-LL--T-PHFVRCIK 
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Appendix 
Class XVIII insert 
Ac-ID PNDNKAYHDWDATRTKHQVQYLGLL ------------------------------- ENVA 589 
Ac-IC PNEKKAANAFNNSLVLHQVKYLGLL-------------------------------ENVR 582 
ScNyo3-IA PNQTKSPNDYDDHQVLHQVKYLGLQ-------------------------------ENVR 599 
ScMy05-IB PNETKSPNDYDDRQVLHQIKYLGLQ-------------------------------ENVR 599 
Cehum5-IA PNEEKNSNVFDLERVEHQVRYLGLL ------------------------------- ENYR 612 
Cehuml-IB PNETKRPNDWEESRVKHQVEYLGLR-------------------------------ENIR 599 
Dm31D-IA PNDLKSSTVFDEERVEHQVRYLGLL-------------------------------ENLR 607 
Dm61 F-ID PNDLQTANVFNDELVLHQVKYLGLM-------------------------------ENLR 605 
Dm95E PNEGKQPHQFDMALVQHQVRYMSLM-------------------------------PLVH 581 
Rc-IB PNDAKQPARFDEVLIRHQVKYLGLI-------------------------------ENVR 629 
Gg-Bb PNDTKTAMLFTPDLVLAQVRYLGLM-------------------------------ENVR 630 
Gg-IB PNETKKPRDWEESRVKHQVEYLGLK-------------------------------ENIR 597 
Rnrnyrl-IA PNDKKAA}-iIFSESLVCHQIRYLGLL ------------------------------- ENVR 610 
Rnmyr2-IB PNDAKQPGRFDEVLIRHQVKYLGLM-------------------------------ENLR 609 
Rnmyr3-IC PNETKKPKDWEESRVKHQVEYLGLK-------------------------------ENIR 597 
Rnmyr4-ID PNDKKSPQIFDDERCRHQVEYLGLL-------------------------------ENVR 610 
ScMY01-IIA PNNVKKVKTFNRSLILDQLRCNGVL-------------------------------EGIR 633 
ScHYS1-IIB FNNVKKVKTFNRRLILDQLRCNGVL-------------------------------EGIR 635 
Dd-nmII PNNKQLPAKLEDKVVLDQLRCNGVL-------------------------------EGIR 599 
Cemyo3-IIA PNEKKASGVIDSALVLNQLTCNGVL-------------------------------EGIR 628 
Cemyo4-IIB PNEKKQSGMIDAALVLNQLTCNGVL-------------------------------EGIR 628 
Cemyo2-IIC PNEKKASGVIDAGLVLNQLTCNGVL-------------------------------EGIR 634 
Cemyol-IID PIEKKQSGMIDAALVLNQLTCNGVL-------------------------------EGIR 623 
Dm-mhcll PNEMKQPGVVDAHLVMHQLTCNGVL-------------------------------EGIR 617 
Dmzip-nmII PNHEKRAGKIDAPLVLDQLRCNGVL-------------------------------EGIR 660 
X1-nmIIB PNHEKRAGKLDPHLVLDQLRCNGVL-------------------------------EGIR 639 
Gg-FSkII PNETKTPGANEHELVLHQLRCNGVL ------------------------------- EGIR 618 
Gg-nmII PNHEKKAGKLDPHLVLDQLRCNGVL-------------------------------EGIR 620 
Gq-smII PNHEKRAGKLDANLVLEQLRCNGVL ------------------------------- EGIR 630 
Hs-FSkEII PNETKTPGA?IEHSLVLHQLRCNGVL ------------------------------- EGIR 617 
Hs-nmIIA PNHEKKAGKLDPHLVTLDQLRCNGVL ------------------------------- EGIR 620 
He-CeA PNERKAPGVMDNFLVMHQLRCNGVL ------------------------------- EGIR 619 
DmNinaC-III ADLEYKPRSFHSDVVQQQMKALGVL-------------------------------DTVI 630 
Lp-III PQKKELINDYDSKSVQIQLHALNVL-------------------------------ETIL 575 
HsMY03A PNSERQARKYDKEKVLLQLRYTGIL-------------------------------ETAR 642 
ScMyo2p-Va PNADKEAWQFDNLMVLSQLRACGVL ------------------------------- STIR 628 
ScMyo4p-Vb PNSEKKPWEFDNLMVLSQLRACGVL-------------------------------ETIR 623 
Cehum2-V PNDSKISFDFEPKRAIQQLRACGVL-------------------------------ETVR 623 
SpMyo-Va PNDYKLPFTFEPKRAVEQLRACGVL ------------------------------- STIR 610 
Dmdidum-Va PNDDKVAFKWETAKIIQQLRACGVL-------------------------------ETVR 627 
Ggp190-Va PNDFKFEFTFDEKRAVQQLRACGVL ------------------------------- ETIR 622 
Mrndilute-Va PNDFKFPFTFDEKRAVQQLRACGVL-------------------------------ETIR 621 
Rnmyo5-Va PNDFKFPFTFDEKRAVQQLRACGVL-------------------------------ETIR 621 
Rnmyr6-Vb PNDEKLPFHFDPKRAVQQLRACGVL-------------------------------ETIR 619 
HsMY05A PEDFKFPFTFDEKRAVQQLRACGVL ------------------------------- STIR 621 
HsMY05C PNDEKLPFEFDSKRIVQQLRACGVL ------------------------------- STIR 612 
SpMy0VI 2NGFC1VDSLFEGGQILSQLQCSGMV ------------------------------- TVLD 639 
Cehum3-VI PNSQNKAWHFDGSAILGQLQCAGMA ------------------------------- SVLR 637 
Dmjar-VI PNSKMIDRQFEGSLALAQLKCSGTI ------------------------------- SVLE 636 
Ms-VIA PNLF01VSHQEEGAQILSQLQCSGMFT ----------------------------- VSVLD 663 
Ms-VIB PNLKMVSHQFEGALILSQLQCSGMVF ----------------------------- TSVLD 662 
GgMy0VI FNL1C1TSHHFEGGQILSQLQCSGMV ------------------------------- SVLD 641 
MmWaltzerVl PNLKMASHHFEGAQILSQLQCSGMV-------------------------------SVLD 644 
HsMY06 PNLF1TSHHFEGAQILSQLQCSGMV ------------------------------- SVLD 641 
Cehurn6-VII PNEMKRALVMDRDLVLRQLRYSGMM-------------------------------ETIK 594 
Dmck-VIIA PNELKKPMMFDRGLCCRQLRYSGMM ------------------------------- STIR 596 
Dm28B-VIIB PNEYKEPKNFDKELCVRQLRYSGMM ------------------------------- STAR 596 
DrMyo-VIIA PNEYKKPMLFDRELCVRQLRYSGB4 ------------------------------- STIR 600 
Mmshaker-VIIA PNEFKKPMLFDRHLCVRQLRYSGMM-------------------------------ETIR 600 
HsUsherlb-VIIA PNEFKKPMLFDRHLCVRQLRYSGMM ------------------------------- STIR 600 
Dm10A-XV PNQEKHALRMDMPCVLQQLRYLGML-------------------------------DTIQ 608 
Mm-MY015 PNHKKEPGLFEPDVMMAQLRYSGVL-------------------------------ETVR 603 
Hs-MY015 PNHKKEBGLFEEDVVMAQLRYSGVL ------------------------------- ETVR 603 
DrnMhcl - PDZ LQHN--AGKHTKYTANGS PSSAAGQVSSEE------EMVNVPLLR--SQLRGSQVLEAAR 685 
Hs-PDZ PVAEGWAGEPRSASSRRVSSSSELDLPSGDHCEAGLLQLDVPLLRFTTQLRGSRLLDAMR 670 
Mm-PDZ PVARGWPGEPRSASSRRVSSSSELDLPPGDPCEAGLLQLDVSLLR--AQLRGSRLLDPI1R 696 
Dm29D SNGTEAARSFDRATVVRQIRSLQVL-------------------------------ETVN 660 




Ac-lB VRRAGFAYRAEFDR ---- FLRRYKKLSP-KTWGIWGES-GAPKDGCQTLLNDLGLDT-S 642 
Ac-IC IRRAGYAYRQSYDK ---- F'FYRYRVVCP-KTW --- SGWN-GDMVSGAEAILNHVGMSLGK 633 
ScMyo3-IA IRRAGFAYRQTFEK ---- FVERFYLLSPDCSYAGDYTWD-GDTLEAVKLILRDAMIPE-K 653 
ScHyo5-IB IRRAGE'AYRQVFEK ---- FVERFYLLSPHCSYAGDYTWQ-GDTLDAVKYILQDSSIPQ-Q 653 
Cehum5-IA VRRAGFAHRMPYDRF ---- VNRYKLICA-STWP-NPRRG-QQLKDSCMQILESAGLA--Q 663 
Cehuml-IB VRRAGFAYRRAFDK ---- FAQRYAIVSP-QTBF --- CE'Q-GDQQRACEIICDSVHMEK-N 649 
Dm310-IA VRRAGFVHRQRYDKF ---- LLRYKMISQ-YTWP-NFRAG-SD-RDGVRVLIEEKKFA--Q 657 
Om6lF-IB VRRAGFAYRRTYE--LF--LERYKSLSK-STWP-NYKGP-GGPKAGVQQLVKDLGWDE-E 657 
Dm95E LCRTGHCYHLLHVK ---- FFHRYKLLNS-LTP--HFHG-GSQVEGIALIIRNLPL2S-A 632 
Rc-IB VRRAGFAYRRKYE--IFTFLQRYKSLCP-DTWP-N4DG --- RAMDGVAVLVKSLGYKP-E 681 
Gg-Bb VRRAGYAFRQLYQ--FTPFLERYKMLSR-KTWP-RWTG --- GDREGAEVLLAELKFPP-E 682 
Gg-IB VRRAGAYRRIFHK ---- FLQRYAILTP-ETWP --- SWR-GDERQGVQHLLRSVNMD2-D 647 
Rnmyrl-IA VRRAGYAFRQAY ---- EPCLERYKMLC(-QTW-HWKG --- PARSGVEVLFNELEIPV-E 660 
Rnmyr2-IB VRRAGEAYRRKYE--AF--LQRYKSLCO-ETWP-VWTG --- RPQDGVAVLVRHLGYKP-E 659 
Rnmyr3-IC VRRAGYAYRRVFQK ---- E'LQRYAILTK-ATWP --- VWR-GDEKQGVLHLLQSVNMDS-D 647 
Rnmyr4-ID VRRAGFAFRQTYEKF ---- LHRYKMISE-FTWP-NHDLP-SD-KEAVKKLIERCGFQ--D 660 
ScMY01-IIA LAREGYPNRIAE'QEFFQRYRILYPBNSTTTTFSSKLKASTKQNCRFLLTSLQ ---- LDTK 689 
ScMYS1-IIB LAREGYPNRIAFQEFFQRYRILYPENSTTTTE'SSKLKASTKQNCEFLLTSLQ ---- LDTK 691 
Dd-nmII ITRKGFPNRIIYADFVKRYYLLAPNVPRDA--EDSQKA ----- TDAVLKHLN ---- IDPE 648 
Cemyo3-IIA ICRKGFPNRMLYPDFKHRYAILAADAAKE---SDPKKA ----- SVGILDKISVDGNLTDE 680 
Cemyo4-IIB ICRKGFPNRTLHPDFVQRYAILAAKEAKS--DDDKKKC ----- AEAIMSKLVNDGSLSEE 681 
Cemyo2-IIC ICRKGFFNRTLI-IPDFVQRYALLAADESIIG-KTDAKKG ----- SALMLARLVKEKKLEEE 688 
Cemyol-IID ICRKG'PNRTQHPDE'VQRYAILAAkEAKS--SDDMKTC ----- AGAILQALIMQKQLNDE 676 
Dm-mhcll ICRKGFPNRITh4YPDFFCIRYQILNPAGIVG--VDD2KKC ----- GSIILESTA ---- LDPD 666 
Dmzip-nmII ICRQGFPMRIPFQEERQRYELLTPNVIPKG-FMDGKKA ----- CEKMIQALE ---- LDSN 710 
X1-nmIIB ICRQGE'PNRIVFQEFRQRYEILTPNSIPRG-FMDGKQA ----- CERMIRSLE ---- LDPN 689 
Gg-FSkII ICRKGFPSRVLYADE'KQRYRVLNASAIPEGQFMDSKKA ----- SEKLLGSID ---- VDHT 669 
Gg-nmII ICRQGEPNRVVFQEFRQRYEILTPNAIPKG-FMDGKQA-----CVLMIKALE ---- LDSN 670 
Gg-smII ICRQGE'PNRIVFQEFRQRYEILAANAIPKG-FMDGKQA ----- CILMIKLE ---- LDPN 680 
Hs-FSkEII ICRKGEPNRILYGDFKQRYRVLNASAILEGQFIDSKK ----- CEMLLASID ---- IDHT 668 
Hs-nmIIA ICRQGE'PNRVVFQEFRQRYEILTPNSI PKG-FMDGIKQA-----CVLMIKALE----LDSN 670 
Hs-CaA ICRKGFFNRILYGDFRQRYRILNPVAIPEGQFIDSRKG ----- AEKLLSSLD ---- IDHM 670 
DmNinaC-III ARQKGFSSRLPFDE ---- FLRRYQFLAFDE'DE P-----V-EMTKDI'JCRLLE'LRLKMEG-- 678 
Lp-I II IRQFGE'ARRISFVD ---- FLNRYQYLAFDE'NEN ----- V-ELTKENCRLLLLRLKMDG-- 623 
HsMY03A IRRLGFSHRILFAN ---- FIKRYYLLCYKSSEE ----- P-RMSPDTCATILEKAGLDN-- 690 
ScMyo2p-Va ISCAGFPSRWTFEEFVLRYYILIPHEQWDLIEKKKETTE-EDIISWKMILDATVKDK-S 686 
ScMyo4p-Vb ISCAGFPSRWTFDEFVQRYELLTDYSLWSGILYt'TPDLPK-EAIVNFCQSILDATISDS-A 681 
Cehum2-V ISAAGFPSRYPYEEFARRYRVIYTKEAALWR ---------- DKPKQFAELACQQCLEE-G 672 
SpMyo-Va ISAAGYPSRWSYSEFFTRYRVLMVRKEINKK ---------- DVRGTSEKTLKRLIVDP-D 659 
Dmdidum-Va ISAAGFPSRWLYPDFYMRYQLLVYRSKLDKN ---------- DMKLSCRNIVMKWIQDE-D 676 
GgplOO-Va ISAAGFPSRWTYQEFFSRYRVLMKQKDVLS ----------- DRKQTCKNVLEKLILDK-D 670 
Mmdilute-Va ISARGFPSRWTYQEFFSRYRVLMKQKDVLG ----------- DRKQTCKNVLEKLILDK-D 669 
Rnmyo5-Va ISAAGFPSRWTYQEFFSRYRVLMKQKDVLG ----------- DRKQTCQNVLCKLILDK-D 669 
Rnmyr6-Vb ISAAGYPSRWTYHDFFNRYRVLMKKRELPNTT --------- DKKNICF(SVLESLIKDP-D 669 
HsMY05A ISAAGFPSRWTYQEFFSRYRVLMKQKDVLS ----------- DRKQTCKNVLEKLILDK-D 669 
HsMY05C ISAQSYPSRWTYIEFYSRYGILMTKQELSFS ---------- DKKEVCKVVLHRLIQDS-N 661 
SpMyoVI LMQGGFPSRTQE'LDLYNMYKQYMPPELVRLDP ----------- RLFCJKALFBALGLDE-N 687 
Cehum3-VI LMQEGFPSRTSFADLYAMYEKNLPPSLARLDP ----------- RLFSKCLFHALGLDQN 685 
Dm1 ar-VI LMEHGYPSRVLFADLYSMYKSVLPPELVSLPA ----------- RTFCEPMFQSLNLSA-K 684 
Ms-VIA LMQGGFPSRAPE'HELYNMYQKYMPPKPTRLDP ----------- CLFCKALFKALGLNE-N 711 
Ms-VIB LMQGGFPSRASFHELYNMYKQYMPDKLTRLNP ----------- RLFCKALFKALGLND-S 710 
GgMyoVI LMQGGFPSRAS FHELYMMYKKYLPEKLARLDP-----------RLFCKALFKALGLNE-I 689 
MmWaltzerVl LMQGGFPSRASFHELYNMYKKYMPEKLPRLDP ----------- RLFCKELFKALGLNE-V 692 
HsMY06 LMQGGYPSRAS FHELYMMYKKYMPDKLARLDP-----------RLFCKALFKALGLME-N 689 
Cehum6-VII IRRSGYPIRHDYYPFVFRYRVLVSSIQG-PVNR ------- IDLHDAAKKICHMILGTN-A 645 
Dmck-VITA IRRAGYPIRHGFREEVERYRE'LIPGVPP-AHR -------- TDCQAATSRICAVVLGK--S 645 
Dm28B-VIIB IRRAGYPIRHAYRAEVERYRLLVPPVGP-LEQ -------- CDCRKLARQICEVALPAD-S 646 
DrMyo-VIIA IRRAGYPIRYTFVEFVDRYRVLMPGVKP-AYKQ ------- EDLRGTCQRIAEAVLGRD-D 651 
Mmshaker-VIIA IRHAGYPIRYSFVEE'GERYRVLLPGVKP-AYKQ ------- GDLRGTCQRMAEAVLGTH-D 651 
HsUsherlb-VIIA IRRAGYPIRYSFVEFVERYRVLLPGVKP-AY}KQ ------- GDLRGTCQRMAEAVLGTH-D 651 
Dm1 OA-XV IRQRGYPVRLRFQHFVERYRHLLPSPLARGTPY ------- RELCRALLEAMPRTGVEG-P 660 
Mm-MY015 IRKEGFPVRLPFQVE'IDRYRCLVALKLN-VPAD ------- GDMCVSLLSRLCT--VTP-D 652 
Hs-MY015 IRKEGFPVRLPFQGE'IDRYCCLVALKHD-LPAN ------- GDMCVSVLSRLCK--VMP-N 652 
DmMhcl-PDZ LHRLGE'PESVPLLEEVRRFGLLAGDLASMKDVSVEQILAVNELDVASYRIGPSQMWSDKS 745 
Hs-PDZ MYRQGYPDHMVFSEFRRRFDVLAPHLTKKI-iGR --- NYIVVDERRAVEELFTLECLDLEKS 727 
Mm-PDZ MYRQGYPDHMVFSEFRRRFDVLAPHLTKKHGR---NYIVVDEKRAVEEL--LESLDLEKS 751 
Dm290 LMASGFPHRMRE'KQFNARYRMLAPFRLLRRSED-KALEDCQLIL}cYAMEQPPVLDGSVTL 719 
CONSENSUS I-RAGFP-R--F--EF--RY-IL --------------------------- LL --- L----- 
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Drosophila Mhcl (class XVIII) insert 
Ac-lB QWQLGK-----------------------------------------------SKVFIRY 655 
Ac-IC EYQKGK-----------------------------------------------TKIFIRQ 646 
ScMyo3-IA EFQLGV-----------------------------------------------TSVFIKT 666 
ScMy05-IB EYQLGV ----------------------------------------------- TSVE'IKT 666 
Cehum5-IA DCVQGR ----------------------------------------------- TKIE'IRS 676 
Cehuml-IB QYQMGK ----------------------------------------------- TKIEVKN 662 
Dm31D-IA DVKYGH-----------------------------------------------TKIFIRS 670 
Dm61E'-IB KYRVGE-----------------------------------------------TKLFIRW 670 
Dm95E EE'TIGT ----------------------------------------------- KNVE'VRS 645 
Rc-IB EYKMGR-----------------------------------------------TKIFIRF 694 
Gg-Bb ELAYGH-----------------------------------------------TKIFIRS 695 
Gg-IB QYQMGR ----------------------------------------------- SKVFVKN 660 
Rnmyrl-IA EYSE'GR ----------------------------------------------- SKIFIRN 673 
Rnrnyr2-IB EYKMGR-----------------------------------------------TKIFIRF 672 
Rnrnyr3-IC QFQLGR-----------------------------------------------SKVFIKA 660 
Rnmyr4-ID DVAYGK-----------------------------------------------TKIFIRT 673 
ScMY01-IIA VYKIGI ----------------------------------------------- LTVFQKL 702 
ScMYS1-IIB VIKIGN ----------------------------------------------- TKLFFKA 704 
Dd-nmII QYRE'GI ----------------------------------------------- TKIFFRA 661 
Cemyo3-IIA EFKVGE ----------------------------------------------- TKIE'FKA 693 
Cemyo4-IIB MFRIGL ----------------------------------------------- TKVFE'KA 694 
Cemyo2-IIC NFRVGL-----------------------------------------------TKVFFKA 701 
Cemyol-IID QFRIGH-----------------------------------------------TKVFFKA 689 
Dm-mhcII MYRIGH ----------------------------------------------- TKVFFPA 679 
Dmzip-nrnll LYRVGQ ----------------------------------------------- SKIFFRA 723 
X1-nmIIB LYRIGQ ----------------------------------------------- SKIFFRA 702 
Gg-FSkII QYRFGH ----------------------------------------------- TKVE'FKA 682 
Gg-nmII LYRIGQ-----------------------------------------------SKVFFRA 683 
Gg-smII LYRIGQ-----------------------------------------------SKIFFRT 693 
Hs-E'SkEII QYKFGH-----------------------------------------------TKVFFKA 681 
Hs-nmIIA LYRIGQ ----------------------------------------------- SKVFE'RA 683 
Hs-CaA QYKFGH-----------------------------------------------TKVFFKA 683 
DmNinaC-III -WALGK-----------------------------------------------TKVFLRY 690 
Lp-III -WTLGK-----------------------------------------------NKVFLKY 635 
HsMY03A -WALGK-----------------------------------------------TKVFLKY 702 
ScMyo2p-Va KYQIGN-----------------------------------------------TKIFFKA 699 
ScMyo4p-Vb KYQIGN-----------------------------------------------TKIFFKA 694 
Cehum2-V KYAVGK-----------------------------------------------TKIFLRT 685 
SpMyo-Va KYQFGK-----------------------------------------------TKIFFRA 672 
Dmdidum-Va KYRFGN-----------------------------------------------TQIFFRA 689 
Ggp190-Va KYQFGK-----------------------------------------------TKIFFRA 683 
Mmdilute-Va KYQFGK-----------------------------------------------TKIFFRA 682 
Rnmyo5-Va KYQFGK-----------------------------------------------TKIFFRA 682 
Rnmyr6-Vb KFQFGR-----------------------------------------------TKIFFRA 682 
HsMY05A KYQFGK-----------------------------------------------TKIFFRA 682 
HsMY05C QYQFGK-----------------------------------------------TKIFFRA 674 
SpMyoVI DYQFGL ----------------------------------------------- TKVFFRP 700 
Cehum3-VI DFQE'GN ----------------------------------------------- TKVFFTA 698 
Dmjar-VI DFKFGI-----------------------------------------------TKVFFRP 697 
Ms-VIA DYKFGLFT---------------------------------------------TIVFFRP 726 
Ms-VIB DFKFGLTF---------------------------------------------TRVFFRP 725 
GgMyoVI DYKFGL-----------------------------------------------TKVFFRP 702 
MmwaltzerVl DYKFGL-----------------------------------------------TQVFFRP 705 
HsMY06 DYKFGL-----------------------------------------------TKVFFRP 702 
Cehum6-VII DYQLGK-----------------------------------------------TKVFLKD 658 
Drnck-VIIA DYQLGH-----------------------------------------------TKVFLKD 658 
Drn28B-VIIB DRQYGK-----------------------------------------------TKLFLRD 659 
DrMyo-VIIA DWQMGK ----------------------------------------------- TKI E'LKD 664 
Mmshaker-VIIA DWQIGK-----------------------------------------------TKIFLKD 664 
HsUsherlb-VIIA DWQIGK-----------------------------------------------TKIFLKD 664 
Drn10A-XV DYQLGA-----------------------------------------------TRVFLRE 673 
Mm-MY015 MYRVGI-----------------------------------------------SKLFLKE 665 
Hs-MY015 MYRVGV-----------------------------------------------SKLFLKE 665 
DrriMhcl-PDZ AVCLPLSGNASVAASFRNSAQILNLFYGEGHEDFVVPQPILGLLTIGCAIACVRIILFRS 805 
Hs-PDZ SCCMGLSR-----------------------------------------------VFFRA 740 
Mm-PDZ SCCLGLSR-----------------------------------------------VFFRA 764 
Dm29D AWAPGK ----------------------------------------------- RHVE'LSE 732 
CONSENSUS --Y-IG ------------------------------------------------ TKVFFR 
267 
Appendix 
Ac-lB PETLE'HLEECLD 667 
Ac-IC PESVFSLEELRD----------658 
ScMyo3-IA FESLFALEDMRD----------678 
ScMyo5-IB PETLE'ALEHMRD ---------- 678 
Cehum5-IA PQTVFRLEELRT----------688 
Cehuml-IB PESLE'LLEETRB ---------- 674 
Dm31D-IA PRTLFALEHQRt't ---------- 682 
Dm61F-IB PRTLFDTEDAYQ----------682 







































Cehum3-VI GKFAEDQMMKQD --------- 711 
Dmjar-VI GKFVEFDRIMRSD---------710 
Ms-VIA GKFAEFDHIMKSD---------739 
Ms-VIB GKFAEFDQIMRSD --------- 738 


















Appendix II 	 Myo95E mRTJA 
Translated sequence is shown in black. Untranslated sequences (5'UTR and 3'UTR) 
are coloured in red. The promoter sequences are given in blue and the cutoff scores are 
shown above the sites. The transcription start sites are underlined and coloured in blue. The 
polyadenilation signals (AATAAA) and the subsequent cleavage sites (AAGA) are coloured 
in purple. The PCR primers used in the analysis of the gene are shown with arrows. The 
exon borders are indicated with vertical arrows. 
Predicted promoters: 
Score 0.78 
1 	TAATACI;C 	/4JC 1A]C 	:GFAGA.6GG4 	AG TC 
Score 0.86 
6 GAA G GCCGAC LCTATC TAT C CGGAATATA'I GAGTC2 ACAC GACcT::GA6; cTGTTiCTCG 
101 CCAGCACATG AAAATCAATA ATTGPATCAG AAAATCAAAA CACGGATTCG CCCAGATGCA 
Myo95E mRNA sequence: 
Exi 	TGTTGCTCGC CAGCACAGA AAATCAATAA TTGAATCAGA AAATCAAAPC ACGGATTCGC 
EFI (ST95F) 
41 CCAGATGCAT GCAGGCCCCC GATAAATTAT GAATTGTTG GAGCCATTAA CAACCCCCCT 
121 TACCCTTCCC ATCGTTCCCG TTCTTGTTTT GGCCCCGTTT GCAGTTGATG TATTCAAATT 
181 CAAATGGTGA ACTCGATTTT G2C:GTTiTC GTTGTTGTC7 CTT\CTGCCGT GCACGTTC-TA 
Start Codon 
241 ATTGGAGCTG GGAATCGUGA TGGAGCAGGA AATCGGCPCC TGGGACTCGG TACT GTTGGA 
IBR 	 EF2(46F) 
301 GAACCTGTCC GAGGATAGTT TCATAAACAA CATCCACCAG CGCTATAAGC GCGATCACAT 
361 ATATACCTAC ATTGGAACAT CTGTTGTGGC TCTGPATCCA TATC.ATCACA TATCCGAGCA 
Ex2 
421 CTCTCTGGAC AATGTCCGCA ACTATGGCGA TAAGGGCATT TTCCAGCTGC CGCCCCACAT 
481 ATATGGTCTC ACAAATCTGG CTTATCAATC GCTCAAAGAT CAGAGCGAGG ATCPGTGTGT 
Ex3 
541 TCTGCTCACC GGTGAGAGCG GAGCGGGCAA AACGG7GACT TTTAAAATGA TCGTGAACTT 
601 TCTGACCCAC ATACAAGATC GCTCCCACTG CCCCCCAACA CCGAATGTTT TGCGCAAGCA 
661 ATCCTCAACT AGCTCGGCCA GCGGATTGGT GATGCACGCC CACAGGCGAG CCTCCAGCAG 
721 CTGCTCCGGC ACTGCCAP.TT TTATTATATG CAAAAACCGG GCGGAAAATC CGTCAGGCAG 
781 TGTTTCACGG CGCAAAGTC CATCGCCAGG ACCATCGCAG CGATCGCGGA CGCGGGCCGA 
841 GAGCATCGAG CGCCAAAGCA GGCGCCACAT GCGGGAGPAA ATTGTCGACT TTGATTTCTC 
901 ACACCACAAG AGTAGCGAAA ACATCAGCGG CCTTCCTGAA TCGCACGCCC ACCACATGCA 
EF3 (3FOR) 
961 TCCGACCAAG TCGTGCTTCA AGCACCAGCA GACCCAAGTC AGCGCCTGCA CTGCAATGCC 
1021 CGCAGCAGCC AAGGGATCGC CCAATACGC GGTACCCACC GTGTACGGCG GTTGCCGCCA 
1081 GTGCGGACAC AGCAAGTGTG TCCGTGCTCA GAGCCTGGAA AAGGAGGAGC GGGATGATCT 
1141 ACGAGGCAGC AACTGCCGCC TGTCTACCAT AGCCACTGCC ACCACCAATC CGGCACATCC 
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1201 GCTCGCGGT AGTTGCTCCA ACCTGATGCG CCAGCACTCG ACAGAG1GTC AGCCGGAGCG 
1261 GGPGCGGGAT CGAPGCTCCC TTATGGGGTC CACGCAACGT ATATCGCTGT ACGATGCACA 
1321 CAAGCTGAGT AAGGTTCTGG GCGATCTGCC GCCGCCTCCG CCTAGTTCTG TTTCGCCCAC 
1381 GCCATCGGCC AGCTCTTCGC TGCACAGGCG TCATWTCG CCCACGCAAC GAATGCGAGA 
1441 GTGCGTCACC TGTGCGGATG TGTTCCTGGA GGCCATGGGC AATGCCTGCA CCCTGAAAAA 
Ex 4 1501 TAATAACTCT AGTCGATATG GAAAGCTATT TGJ½TATCGAA ATTGATTTTA AGGGAGATCC 
1561 AATGGGAACC CGTATAACGG ACCCTATCAT TGAGPGCGP AATTTTCACA TCTTTTACCA 
Ex5 	 *1 1621 ATTACTATTA GGAGCTGATC TCCAGTTGCT AAAATCGCTC AAGCTGTATC GAAATGTGGA 
Ex6 1681 AAAGTACGAG CTGCTCCGCA ACACAACTGC CATGGAGGAG GACCGCATGA ATTTTCATTA 
1741 TACGAAGA TCCTTGGATG TGCTGGGACT TAGTTGTGAA GAGAGCAACT CCATCTTTCG 
Ex7 1801 GTCATCGCA GTGGTTCTAA AGTTGGGTAP CTTTATTTTC GTACCCATTA CTAACATTGA 
4BAK 
1861 TGGAACTGAG GGTTGTCJGG TGTCCAATGT ATACGPAGTT CAAGTAACAG CACAGCTTCT 
Ex8 1921 TAATATGGAA GCCCAAATTC TCATAAATTG CTTAACCAGA GCGAATAGCA CGAACAGCGC 
1981 TCAAGAGGAT GTGGGTTGCG AAATGGPTGC ACGACAAGCA GCTACCAJ\CC GAAACACGCT 
2041 GTGTCGCACT CTTTATAGCC GTCTCTTCAC GTGGCTGGTG AACAAAATTA ATGAGTCCCT 
2101 GAAGTCAJ\CA CAGCGCGAAA AGAACCTAGC ATTGCTAGAT TTTTATGGAT TCGAAGCGCT 
2161 GGACCACAAC TCATTTGAGC AATTTGCCAT TAACTACAGC GCGGAAAAGA TCCACCAGA1 
Ex9 2221 TTTTGTGTTT CATGTGCTGC GTTCGGGCA AGPGCTCTAT ATTCGCGAGG GATTGGAATG 
2281 GTCTCGCATT GACTATTTCG ACAACGAGTC TATTTGCGAG TTAATAGACA AACCCAGCTA 
2341 TGGTATATTG AGCTTGATTA ATGAACCCCA TTTAAATAGC AACGACGCTT TGCTTTTGCG 
2401 AGTTCAGCAA TGTTGTGCGG GGCATCCCAA CTTTATGACC ACCGGCAGCA ATTCCATGTG 
2461 CTTTCAGATT CGTCATTATG CPAGTGTAGT G2\ACTACTCA ATACATCGGT TTCTCGAAAA 
2521 GAACTCCGAC ATGCTGCCGA AGTACATAAG CGCTGCCTTT TATCAG1GCA AACTTTCTTT 
ExI 0 	 ERI (ESR) 	 EM (ESF) 
2581 GGTGCAAAGC CTATTCCCCG AGGGGAATCC CCGTCGACAG GTTACCAAAA AGCCCAGCAC 
2641 GTTGPGTTCG PATATCCGCA CCCAATTGCA GACGCTGCTG GCCATCGTTA AGCATCGCCG 
2701 CTCCCACTAT GTGTTCTGTA TTAAGCCCAA CGAGGGCAAG CAGCCGCACC AGTTCGATAT 
2761 GGCTCTAGTG CAACATCAGG TGCGCTACAT GTCGCTCATG CCGCTGGTCC ACCTGTGTCG 
2821 CACTGGCCAT TGCTACCACC TGTTGCACGT TAAGTTTTTT CATCGCTATA AGTTGCTCAA 
2881 CAGCCTGACG TGGCCCCACT TTCATGGCGG CAGTCAGGTA GAGGGTATCG CCCTCATAAT 
2941 CCGTAACCTA CCGCTGCCCT CAGCGGAGTT CACGATCGGC ACCAAAAATG TGTTCGTGCG 
3001 TAGTCCCCGC ACCGTATATG AGTTGGAACA GTTTCGCCGC CTGCGTATTA GCGPGCTGGC 
PIEF 
3061 CGTGCTTATT CAAACCATGT TCCGAATGTA TCACGCAAGG AAGCGCTTTC AGCGCATGCG 
Eli X 	3121 ACACAGCCAG ATGATCATAT CGAGTGCCTG GCGCACGTGG CGGGAATGCC GATTTGGCAT 
3181 TCCCTTCACT GGTCGTAGGC ATTTGTGGAG TTTATATCGT GTCGCCCGCG AGGAGTATCG 
Ex12 3241 GTCCTTGAAG TACAAACGAC AGGTGAGATG GGCCATCGAT ATTATAGGCC GCTACTACCG 
3301 CCAGTGGAAG ATCAGACAGT TCCTTCTGC AATTCCCTTG CGACTGCCAC CGAACACGCT 
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3361 AAGCCCGCTC TCCACCGAAT GGCCAGTGGC TCCCGCATTT CTGGCAGATG CCTCTCGTCA 
9512R 
3421 TCTTAGGTCC ATATACCATC GTTGGAAGTG CTACATCTAC CAACTCCT TTGATCAAC 
3481 GGCGCGTAT CGAATGCGGG AGAAGGTCAC AGCCAGCATT ATCTTCAAGG ATCGAPAAGC 
3541 TTCATATGGA CGAJTGTGG GTCATCCTTT TGTGGGGGAC TACGTGCGAC TGCGACACAA 
Ex13 3601 CCAGCAGTGG AAAAAGATCT GCGCCGAGAC CAACGATCAG TATGTTGTAT TCGCAGACAT 
3661 AATCAACAAG ATAGCGCGCT CCAGTGGC)A G TTGTGCCC ATTTTGCTGG TGCTATCCAC 
Ex14 3721 GTCATCGCTT TTGCTGTTGG ACCAACGAAC GCTGCAAATT A7GTACAGAG TGCCTGCATC 
3781 GGGATTTAC CGAATGTCTC TGPGCCCCTA CCTAGATGAC ATTGCTGTGT TTCACGTAAA 
Ex15 3841 AGCGTCTGAA TTTGG1CGGA AGAGGGTGA TTTCGTTTTT CAAACGGGTC ATGTGATTG 
3901 APTTGTTACC AAAATGTTTC TGGTCATACA AAATGCCACA GGCAAACCCC CGGAGATACA 
Ex16 3961 CATAAGCACT GA1TTTGAAG CGAPCTTCGG CCAGCAGPCT GTCATCTTTT CGTTCAATA 
4021 CGGCGGCATG TCGGACTTAG CACAGGCCC ACCCAAGGTC ACACGCAAGG CGAACCGCAT 
13F 	I StOD Codon 
4081 GAG1TAATT GTGTGAFCG CG7CAGAATC GAAACCTGAT CGFGG(:AGCT CTTT:T;FC 
ER2 (46R) 
4111 GcT;cT:i!:. TTTCTTCGC CTTAGGCAGA ACTCGTGTTC GGCGGACGT ATCCAAAAT 
4201 TGTCGCCAGT CATCATGCA1 TTGCAATTAC CATTGCTTTT TGCGGTGGCC GGGGTCAGTC 
4261 GACTTTTATA TGGTCCCAGG GATCAN\ATA CAATTTTAGC AATATATTCA TACAGTCACA 
4321 CTTACAATTT AGTTTCGTTC ACAAGTGACA ATCAG1GTAA CCAATTTGTT GTCAGGATTG 
4381 TGCCAA7AGC AGAPAACTAG AATTGTACCA ATGGTAAAAG AAAAAAGAGC GAGCTAATTT 
4441 TAAAATGCAC CGTTTTTATT TAACTATGTA APGTTAAACG AAAJkGAAACT APCGAAGTGA 
4501 ACAACTGAAT TTATTCATCT AATTTGTCGA ACTAGGTTTA AGTGTAAATC GTGCACCAI\G 
4561 TCGATTAGCA TTGCAACAAT AAGTATGTAC TGCAAATAAG CACTGGTAGC AGCGCAGCTC 
4621 G1.AAGATTG GAAGCAGGAT TTTGACGGGG GTGCGCCTGT GCTGGATGAG CAGTATTTAG 
4681 GATTTTACAC AAACTATG1T ATTTCCGTTA TAGMACCAA GGCATTTCTC TTACATTTAP 
4741 GGTTTCATAC AC?ATATTA GTAAACTAAT GCTAGAGACA GACATATAAA CCTCTTTATA 
4801 TACTGGAAAC ACAAATGAAC CCAATATATG CAATTTGCTG CGACAAPGCA AGATAGAAAC 
4861 TTTTCCCAAG CAAAACPAAA AATGTTAAAC AACTATTTAC AAAGCAGAGC AGATGPGTAG 
4921 TTAAATATTT CAAATAAATA TMAAATATA TGTATACACC ATACGAATT AATAATGAGT 
4981 CTATATAAI½A GCGJCAACAA TATGGAAAPA ATACATGTTT GTTACAPGTT GAGAACGAAT 
5041 GTATGTAGTT GTTTATATAT AACTTGTTAT TGATAGTTCA GGCATCTACG TAATTAAAGC 
ER2(46R) 
5101 TGGAGTTGAG TTCTAGAGCT TCAGCGATGT CACATGCTAT CTG-CGACATG GAPATCCATC 
5161 AGTTTTTATT TGTATTTAAG TTTTAAGCGA ATACTTCGAA AGAAPJGCCA AATATGAGTA 
5221 AATCGAAACC CAACCAGTTG GTAGTTTATA AAACAAGTT TAGCAATAAT AAAACATACA 





Appendix III 	 MyolOA mRNA 
Predicted promoters: 
Score 0.61 
I TATAATGCAP AAGACTGAGG I½ATTTTTATA GAAAGGCACC GTAATTAIAC GAATTTTTTT 
51 TTAATTTTGT TGGGTGTTGA TAGAGAAAAA TTGTAAATTT TACTTAGTAA ATTCCCATTT 
Score 0.4 
101 CGTATATTTA TTGCAGCAAT GAATCA1CCG GTTTGAAGAC CACATCCATA CCGCACCACT 
MyolOA mRNA sequence: 
1 Gc:YATGA ATCAACCGGT TTG2TC]\CA CAICATACC GCACCATCC CATCAGTAGT 
Exi 	 AF1(tNF) 
61 GAGTTCCACA GJTTGTCAC ACTAAAGAGG AAGCGCCGGA GAGGAAGATC GGGAAGAGTA 
121 TCGTTGCCI\C A:Yr GJ\.1TGA CCGGAGC4ATA GTGAGTCCAG ACAGG]C G-CTAACTTAG 
Start Codon 
181 CGGAGCCATG GACTGGGCCG AGGGTGATCT GGTCTGGTTC GACCGGGCA TGGGACATCC 
AF2 (HYST) 
241 CATTCCCGGC GAGTTCAGG AGGTGCACCG CGCTGCCCAG GTGATTGTCG TGCAGGCGCT 
301 CATCAAAGGC AAcLGCGCA TCGTACGGTT TCATTTGGAG CCGTGGCAC GCGGCGGCGG 
361 AGGATCGGTG ACTCCCAGTC CAGCCCAATC GCCCTCTCTG GCACTCCTCT CGCCGCACGT 
Ex2 
421 CCTGCGTCGT CAGCGTCCCG CCAGTCTCGA GGATTTCGAA GATCTTCCAA ATCTGTCGGC 
481 CAAACATCCG GCTCTGCCCT CCAGTCGCCT GCGTCGCCTC AGTGTCGAT ATCCACAAGT 
541 GGTCAAGCGA CTGTCCACGC TCTGCAGCGA TGTGATAGCA CGCCATCCAC AAACATTCGC 
Ex3 601 CCTGCAACCA GGAGAAGGCA GCCTGCGCGC TCGCCAGGAT CTGGGCAGCA GCGGTGTGGA 
ME 
661 GGACATGACC CTGCTGGICG ATCTGCACGA GGCGTCGCTG CTGTGGAATC TTCGTCTGCG 
51 OR 
721 TTACGACAG GGTCTAATCT ACACPTTCGC CGGCAGCATC CTGATCGCGG TGAPTCCGTA 
10-AR 
781 CAAGATGTTC CCGGATGCCT ACGGATTGGA GGTGGCCAG CAGTATGCCG GCCGACCACT 
841 TGGATCCCTG CCGCCGC1TC TGTTTGCTAT CGGAGCGGCT GCACATGCCG CATTACCATC 
901 GCCGCAGGTG GTAGTCATCT CCGGTGAGAG TGGCTCCGGC AAAACGGAGT CCACCAAATT 
961 GGTGATGCAG TACCTGGCGG CCGTGGTGCC CGGCGGTGGA TCCGCCTCAG CAGTCPTCAC 
1021 CGAGCAGATC CTGGAGGCTG CTCCGCTTCT TGAGGCCTTT GGCAATGCCC GCACCGCGCG 
1081 CAACGACAPT AGTTCGCGGT TTGGAAAGTA TCTGGAGGTG TACTTCAAGA GTGGCGCCAT 
1141 CGTGGGCGCC AAGATTACGC AGTACCTGCT GGAGAAGTCG CGTATCGTGA CACAGGCGCC 
1201 GGGCGAACGG AACTACCATG TGTTTTACGA ACTCCTAGGC GGACTATCCG AAACGGAGAG 
1261 ATCCAPLGTAC GGTCTGCTGG AGGCGGACAA GTACTTCTAT CTGACCAGG GCGCCZCCGPL 
1321 CTGTGCCAGT GGTCGAGTGG ACTGGGPGTC ACTGCAAGGG GCCATGCAGG TTCTTGGAGT 
1381 CTCCGAGGGC GAGCGAGAGG GCPTCGTGCG TGTCCTGGCG GCAGTTCTTC ATCTGGGAAA 
1441 CGTGTACTTC CATCGCCGGC AATTGAGACA CGGCCAGGAG GGCGTGGAGG TCGGTTCCGA 
1501 TGCAGAGM'C AAPTGGGCCG CCCACCTGCT GCACATTAGC GCGGATGGAC TGCTCGGGC 
1561 ATTAACCAGT CGCACCACCG AAGCTCGAGC GGAACGATTG CACACGCCAC TTGGCATCGA 
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1621 TCAGGCATTG GATGCCCGAG ATGCCTTCGC CAAGGCTCTC TATGCGGGAC TCTTCAATTG 
1681 GCTGGTCTCG CGGPTCAATT CGTTGTTCA GAAGGGCGGA ACCCACGATG CCCTCGCAT 
1741 CAGCATCCTG GACATCTTTG GGTTCGPGGA TTTGGCGGAG AACAGCTTCG AGCAGCTGTG 
1801 CAT CAAC TAT GCG1ATGAGA ACCTGCAGCT GTACTTCAAT AAGCATGTCT TTAACCTGGP 
1861 GCAGGCGGAG TATGCCCGCG AGCGTCTGGA GTGGACTCCG CTGGCCTGGG ACGPTAATCT 
1921 GCCGGTGATC CATCTACTGG CCAAGAAGCC GGTGGGCATT TGCCATCTGT TGGACGACGA 
1981 GTCCAATTTC CCGCGTGCCA CCGATCTGAG TTTCCTGGAG APGTGCCACT ACAPTCATGC 
2041 GCTGAGCGAG CTATACGCTC GTCCGCGGAT CGGTGCCCAG GAGTTTGGGG TGACCCACTA 
2101 TGCGGGTCAG GTGTGGTACT GTGTGGACGG TTTCTTGGAC AAGAATCGCG ATGCGCTGAG 
2161 GGGTGATGTC CTGGAGCTAT TGGCCTCCAG CCGGCTGCCC TTGGTGGGTG AGTTGACCAA 
2221 ACAGCTTCGT GCCCAGAGAG ACGCTGGAAA APLCTTTGCCA AAGGGCAGCA ATGGAAGATT 
2281 CGTCACGATG AAGCCGCGAA CCCCPCGGT AGCAGCCAGL TTTGCGGACT CACTGCAGCA 
2341 GTTGCTCCAA TCGJTGGGCA GGTGTCATCC ATCGTTCGTG CGTTGCATCA AACCGAATCA 
2401 GG2GAAGCAC GCCCTCCGCA TGGATATGCC GTGTGTGCTG CAACAACTTC GTTACTTGGG 
2461 CATGCTGGAC ACCATCCAGP TCCGGCAGCG AGGCTATCCG GTGCGCTTGC GCTTCCAGCA 
2521 CTTTGTGGAG CGTTATCGTC ACCTGCTGCC ATCGCCTCTG GCCAGAGGTA CACCCTACCG 
2581 CGAGCTGTGC CGAGCTCTGC TGGAGGCCAT GCCGCGI\ACT GGTGTGGAAG GTCCGGATTA 
2641 TCAATTGGGA GCTACGCGGG TTTTCCTGCG CGAGGCATTG CATCGGGCTC TGGAAAGTGG 
2701 ACGAACCGAG CGTCTGCGCC GAGCGGCGGT CAGTGTCCAG AGGCATGT,GC GTGGTATGCT 
AF3 (PI5F) 
2761 TGTCCGCCGG CAATTGGCGC GTCGCCAGGC GGCCGCCACC CGTCTCCAGG CCCGTTGGCG 
2821 AGGTCAGAGG GCACAGCAAC GGTACGAGCG TCTCCGCA2LG GGAGCACTCA CTGCCCAGCG 
2881 ATTGTGGCGA GGACGCCAGG CGPLGGAGG/G AGTCCAACAA CTGCGATCCG ATCACCGPCG 
2941 CAGGCAGGAG GCCPLGGGAGG CAGCTCAGCG AGCTCGCGAG GCACGGGAGG CCAAGCAGGC 
3001 CGTGCTGGAG AGAAGTCAAC TTAGCTACCT GGACATACCA GCCGPATTGG CATTCATCTA 
3061 CTCCNACTG CAGGGCTGGT CACCGCCGCA CGGTGJ½TCGT CATCTGGTCA AGGTATTGGG 
3121 CACAGTTCCC GGTCCACCGT CGTCGGCAGT TCAGCTGCCC GAGGATTTGG GTCAGTTTTC 
3181 GTTTGGAAAA TTCAGCAGCG TGTACTGCAA TGGCTTGAGA TTGCAGCCGC GGAGGGAACC 
3241 CATCACTGCT CCCCTGCTA1 CAAGAGCTGC CTCGAGGGAT CAGGACTTCC AGGATGCATT 
3301 GGCCGTGTTC AAGCTTATCC TTCGCTGG1G TAACGATAAA GCATTGGAAG GCGCCAAGGA 
3361 A7\AGCTATTG GCCGACTATA TTGTGCACAA GGCTTTGAGC TCCAGAGGPT TGCGGGATGA  
3421 GATTCTGGTG CAGTTGTGCA ACCAGTTCA TGGCCTGCCG CCCAATTCCG GAGPGGCPJC 
3481 TCGACTGTGG CAPCTTTTGG GACAGTGTCT GTGCTGCTTC CAGCCCAGTG CTGCCTTCAG 
3541 CAAATATCTG ATGAGATTCG TGGACGATGA GGCTCCAGAG TCACTGCGTC CACTACTGCT 
3601 GCGCCAGTTG CTACGCCAGC AGGGCGGTGG AACGTCGAGC GGCGCAGTGG GCGCTGGCGC 
3661 CTGTCGGAGC TTCGTGCCCG CCTGGCTGGA GTGGCGTGCC TGCCAGG G1TGCGACAT 
AR (MYTH4) 
3721 GGCACTACCG CTAACTCTGC CGGACG1GGC CAGTCAAACG GTCGCCGTCG ATTCGTGGAC 
3781 CAGTTGCGAG GAGGCCGCAG CTTTAGCTGT TTCATCTTTG GGCGTGGCCA GTCGTGGATG 
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3841 GACCCTGGTG CTGGACGATG GCCAACAGCT CACCGATAGC TGTGGACTAG ACTACGTGAT 
3901 GGATTTGATT GCAGAGAAGG AGCTGTGCCC CGCATTTCCT GCTCCCAGGA GTGATCTATT 
3961 GCGTTCTCGC CCCAAGTTTG CAAGAACCAC TCTGCCGGAT GCTGTTAZ\AC GTCCAGCGGT 
4021 TCCGCCACCA GCTCCACCCA CTTCCAGTGG CAAGGAGGAT GTGCCGCGGG AACGAAGAAG 
4081 CAGCCGGGAG CTACTCTCCA GAAGCTCGGC GCTCAATGAA CGCTATTTCG AACGTGAGCC 
4141 CAGTCCGGGA CCGGGTCAGG GATCGAGTAC GGGTCAGGCG AAGTCGCGAT CCAAGTCACT 
4201 GGATGACCTG CTCGCCGGTG ATATTGTTCC CGTGCCAACG G1\TTGCGATT CCCAGGAGCC 
4261 GTTGCACACA CTGGGTCTGT CGGAGAGTCG CCTGAACGAT CGCTATCACT CGGCGGAGCG 
4321 GCTGGCTCCA GTCGGCAAGG ACACGGGTCC TCGTTACCAG AAGTCCCAGC ACGCAGGACG 
4381 CCGATCCCAT GCTGCCTCCC ATGGTTCGCA TTCCAGTAAA TATGCGGACA AGGCCGAGTA 
4441 TGCCACCAGG TCCTCGGCCA TGTCCGATAC GAGTGGGCT CCATCCTTGG CTTCCCATGT 
4501 GAGGAGGGTA AGGGTCCCAT CGCAGGCATC AGATGTGGAT CAGTTCCTGG ACGTCTATT 
4561 TAGTCCAGTG CTGGATGGTT CCTTGGATGA GCTATCTGAT GCCAGATCCT TGGCAGCGAG 
4621 CATCCGAGGA GGCAGCTATG AACAAGPAAA TGAAGCGGAA TCGGAAATCG ATGACTTGGA 
4681 TGACTACATC AACGATATAT TCCAACCGAT ACCACTCGTC CAGAACTTGG AGAAGCTGAC 
4741 CAGCAAGGT CAGTTGGCGG CTATCATCAA GGGTGGAGGA GTGGCCAGTA AACCCGAGGA 
4801 GAGGGATGAG GAATCGGA2A TCGAGGATCT AGATGACTAC ATTAATGAGC TCTTTGAACC 
4861 TATTCCAGTG GCCGAGGGAT TAGACAAACT GACCAGCAAG GAGCACC TAG CTGTTAGCAT 
4921 CCGTGGAGGC GGCAGCACGG ACAGTAATGG AGCCGATCCG CTGCTCCACC AACTGATGCA 
4981 GCTGCCCGGC GAGACGGAGT CAGGTCCAGC ACTGTATCAG CAGCAGGTGC AGCGCGCCTT 
5041 CCTGCAGTCT GCAATGGCCC AGAACCTGCA GATCCAGCAG CAACTGCTCG CCCAGAATCA 
5101 AGCTCTGCAG ACGCTGCTTA GTCAGCAGGC GGCAGCGGCG GCGGCCAATA ACTCCACTTC 
5161 GCCGCCACCA GCTCCTCCGA TCCTGAGTAG CCTTTCTATA TCGCCACCGC CACCGCAIkTC 
5221 CCCPATGCGC ATGAAGGCCA CCCGGAGTAG TTTGGTGGAT CCCTCGGAGA CGCGACACTT 
EM 5281 CCTGGATCCC TACGGCAGGG CCAAGACCGT GCGTATCGGC AAGTGGCGCT GGCCACCGCC 
5341 CCAGGATGAG CCCCAGTTCC AGACCGAAGA GGATTTCTTC GCCTTCAAGA TGCGCCAGCA 
5401 CCAGCGCAAG ACGACGCCAC AGGCTCAGCA TCATCAGATG ACCAGCAATG GAGGTATGAT 
5461 GGAGTCGGGT CCTGGAGCAC GTGGTGCCTC GGCCACGGCC ATCGAGTGGG AGGAGTTCGA 
5521 GATCGAGAGT CCCACACCGC CGCCCATGPLG TGGTCAGCTA ATGAGGAGTA GCATCCGACT 
5581 GGAGAGAACC ACAPLCGACAA CCACATCGGC GGTGAATAAC AGGGACAGAG ACCGCGAAC 
5641 CCAGGATGTG GGACAACCGA TGCAGAGTGT GGTCACCACA AAGCTGGCCA AGAAGAGTTT 
5701 CGAGATCGGT GCGGATCGTC CGCCGCCGGG CAGTGTGGGT AAACTTAAGC TCAGTTCCGA 
5761 GATGCGACAG CGGTTGGAGC AAGTAACTGC TGGCCATTCG GTTAGATCAA CCGTTTCCAC 
5821 CAAGTCGGAG CAAAGAGCTC CGGCCAACT GGAGGACACA CGGAAGCTTA TGTTGCAGCA 
5881 GCAGCTGGGT GGACTCTTTG CCAGCGTGTC TGGTGGAAAT TCCGGCCCTG GTGGAGTAGT 
5941 CGPTTCCCAT GCAACGGTGC GCACACAGAT CGAGCGGATG GAGGGCAAAC TATCGCCACC 
6001 ACCAGCTCCG CCGTCGGGCG GCTGGCCTGG AGTGCTACTG CCACCGGCTC CAAGTGTGCC 
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6061 GGCTCCGCCG CCACCCATCA GACCACCCJG CATGGCGCCP CCTGCCCCGC CGCCAGCTCC 
6121 CCAGAGTCCG CCAACGGCTA GGAGTCCCGA ACCGGAGCCC GACTATCGCA CCTCGAGCAG 
6181 TCAGGTGGTC AAGGAGCATG TGCCCGCCTT TATTCAGCGC CAGGAGCGCG ACACATTCGG 
6241 TGCAGTGCGT CAGCAGCAGA TGATCAGCPG TCACCATCTG CATCTGGAGG ACCACTCAGC 
6301 CTCCTCCTCA CCGGCGGTGG CCGCCTGGGA GCAGGCGGAP CGGGAAAGAT CTCGCAGCCG 
6361 AGCAGGAGT CGCGATCGTG AGGATTACTC GGAGTCGGTG TGGGATCGGG CGGI\AGTGGA 
6421 GGGACCCGCC TCCGGAAGTG GCAGTGWA GGAGCGCGAG AAGCGGGAGC GTGi4.ACGCGA 
6481 GCGTCTCTAC GAGATTCGCC AAGTGG2ACG GGAGCGGGA7k AGCCATAAGG TCTACCAGCC 
6541 GGCGCCGCCG CGTGTCATCC AGGCTAGCAT GGACACCACC GGTGGCCATC GCCGGGAGGA 
6601 CCGCACCGGC GGATTGGCCA CCTTCCGCAC CCACATGGCC CAGAAGTACG AACACGAGCG 
6661 GAAGCGCAAG AGCTCGGCCA GCTCCGGAAT GCGCGAGGAG CTGGACTCGA TGCACATGAC 
6721 CACGCCGCCG CCCGTTATTG TGCCGGCTCC GGTGCCACCG CCTTCGTCGA CCAGCCCGGG 
6781 ATTGGGTGTG GTGTCTGGCG TTCTGATGGG ATCGGGTTCC GGGGGCAGCA CTGCATGCCT 
6841 GACCTACAAC CGGGTGCCGT GGAAGTTGCG CGTGCGGAPG GAGGTCTTCC AGCCACACGA 
AR2(FERM-10) 	 30 FERM-12R 
6901 ACCCATCGGT CCACCGGTGG CGCTGGACTT GCTCTTTGCC CAGGTGCTGG GCGACGTTTT 
6961 CGGGGTGACT CCCTGCCTGC GAATTACGCC GCAGGAGAAG AGCTCCGCCC TGAACATGCT 
7021 GCACGGGCAT GGCGTGAGTG TGGACACGCT GTCCAATCGA AP,CGGATCGG GAGCCGGCGG 
7081 TGGAGGAAAT GGAGGACAGG TGCGTGCCCT GGTCAAGCGG CATCTGGTGG ATATGGCTCG 
7141 CGATTGGCCG CTGTATTTCG CTCGACTGTT CGCCGTACAA GGAGCGCCGC TCTATCCGGP 
7201 TGTTAGCATC ATGGGCGTCT CGCACAGTGG ACTCTACCTG GCTCGTCGAG ATGCCGACTA 
7261 TCTGATCGTG GTGCAGGCCA TCTCCTTTGG CG7½AATCCAG AGTGCAGTCA CCCTGCCGCG 
7321 TCCTGCTGCA CTGCAGCTCA ATCTGAGGAA TGGAAAGCAT CTGGCACTCC ATGCAGCCCG 
7381 CGCCGCCGCC ATCCAGTCGA TGGTCACCAC TTTTGTCCAG GAGTTCCGCA AGTCACAATC 
AR3 
7441 GPAGGCCTCC ACTTTGTCGT CGGGTGCCCG AGCCGCCGCC CAGACATTGA ATGTGCCGCT 
7501 GGAGCGCCTG GAATCCCGCC AGGCGCACGC CCAGCGCI\AC GAGCACGGCG TGGATGGCGG 
7561 ATCACGACAG AATGAGCAGC TGCAGCAGTC GGAACTGCAT CAT CACCTGC AGCAACAGCA 
7621 GCAGCAGCAG CAGCAGCAGC AGCACCATCA GCAGCAGCAG CAACAGCAGC AGTTGGAGGA 
7681 CGCTATGGG GAGCAGCACA TGGCCACCGA TCACCAGCAG CAGCAGCAGC AGCAGTTGGG 
7741 TCAGCAGCAG GGTCAACAGC AGCGCTTCCT CAAGCAGCAG AGCTACCTGC ACTCCGCCCG 
7801 AA1AATCGAAT GCTGGCCAAC AGCCCTCCTC GCTGACCAAC GGACAGGTGC ACCACCAGGA 
7861 GCAGATGCTG CAGCAGCAAC AGCAGCAATC ACAGTCCCTA CCGCATCACG ACCTGGATGC 
7921 CAACTATCTG CAGGACGAGA GTAATGGTGG CACTCCACCG TCGGTCACCA AGTACTCGCT 
'$1 
7881 GCTCCAGTTC GCCATGCAGC ACTTCCGCAA TGACCAACTG AGGGACGCTG ACCGCCACCA 
Ex5 8041 CGAGCGGCAC CPLGTCCGCCG CGAACCGCTC CTATGCGGAA CTGGTC1AGT GGCAGGGCCA 
8101 CGCCATACGC CTGCCGCTCC TCCGACTTCC APATGATTTG GCGCCACTGG CGCTCGAGTG 
8161 CTTCGACTGC ATCCTGCGCT ACTGCGGTGA TATACCGCTG GATCCCGACC TCACCGAGGT 
8221 CAAGTGCGTC TACACTGTGC TCATG 
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Appendix IV 	 Mite! mRNA 
Predicted promoters: 
Score 0.39 
1 AAPTCACATA AATACCGTAC TTTJWCTAT TCAGTGAATT AAAATTGTGT TACTGATTTT 
Score.0.43 
61 AAAAATGTAP GTTGTAATTT CAAGTTTGGA AATGAACGGT ATGCCCTGCA CGTTTGTCTA 
121 GATCCACCCC TGGATAGPGC GCAGCAAAGP GAACAGTGCA AATCGAATTA GTCCAGACTT 
Mitel mRNA sequence: 
Start Codon 
ExI 	1 ATGTTCAACT TTATG?AG?A GAGCTGGG GATGAGGACA AGGAGCGTCG CAAGCGCGAA 
MFI (EVEI) 
61 AAAAAACTGC GCAAAGAGGC TAAGGGCACC TCTGGTGGCC CGGGAATGGG AGGCGTGACT 
121 GGCGTCACCG GCAGCATGAG CACCGACGAG CTGCTCCGCC TGGACGAGGT GCGCCGATCG 
181 CTTAAAATCC GAGGGCGACG CAAGGAGA7LG GAAAAGTTGC CGAGCGGAAT TACGGCGGAC 
241 TATAGCGCAG ACTTCTTTGC CGCCCTCAAT GCAGATGCAA ACGGCGGAAG CAACGGGGA 
301 GCAGTGGGAG CTGCAGATCC CGAGCAGGAT CGTGGCAATG AGGAGATTGT AGCATCTGTG 
361 ATGACGCACA TCGPGAGCCG AGCGTCCAAT GGCGCCGGCG TGPLGTGTCAA CTACAGCGAG 
Ex2 
421 GTCACACATT CTCTCCTCTC TGGAGGGCTC AAGTCGCT TTCTTCCACC TATACCCCCA 
481 AAACCACCCA AGCGTGGCAT TCTGAAGGC TCCCCCAGTA ATATGACCAA TGTCCACGAG 
541 GAGATTAGCT TTGCGGGTAG TGCCGGAGGA GCAGGTGGCA CGCCIGAGAT GCTATTGC 
NYP2 
601 AACACCTTTC AGAATGAATC CCTTTACGAG GG2GCTGCCA GGGGAGCTGG TTCGATCGGC 
661 TCGAACTCCA GTCAGCATGG AACCTCGTTC ACTTCCGTGG AGAGCCTGCG CAGCGATGGA 
721 GAGCAG/\CAG GAGGTCAACA ACGGGCCATG ACCCTGCCGG CCI\ACGCCCG CTATGGAGCT 
781 TTACCCCAGG GCAACAGTCA AGGATCGCAC CTCCATGTGC TCACCTCGCC GTCGCCCAGC 
841 GCCGACGTC TCACAGATAC CACAAACTCC TCTTTCGCCA CACCCCCATT TTCGCTGNT 
901 CCCGTCGGCG AGTCCCAAGG CATCGACCGT TGGGCCCGCG TCCATGCCTT CGAGGATGTG 
961 GAGCTGCCGC TGCCGCCAGT GCAGCTAGTA AAACTTCCCC CACCGGCA GCTAGTGATC 
MF2 (PDZ-1 new) 
1021 AGGCGACAGA AGTCTCCGCG CCAGGACTTC GGCTTTAGCC TGCGCAGGC CATCTGTTTG 
30 
1081 GACAGAACAG AGTCCCTGAC TTCGCCCATT TTCAGGCCGG TTATATTCGC CGAGCCAGGT 
1141 GCTGGTGGCG GAGCCAC1GG TCTTTTGCCT GGCGATCGCC TAATCAGGT CAACGGCACG 
1201 CCGGTTGGGG AACTGCCGCG GGAGATCATA ATTGAATGA TACGGAACAG CGGAGAGGCT 
PDZ2 
1261 GTCACCGTGG AGGTCCAACC AGTCGCTGAG TTGGTGGAGC TGAGCAAGCG ATGCATGGCC 
Ex31321 CCCAGCACAG CCACCGTGGA GGAGATCGT CATTCCATTA CCACGGCAA CTGCAATACC 
1381 CTGCGACGCA GTGCCAGCAA GCGCTTCAAG CGTCAGCC GCCATG1GAA TGGCAATGGC 
Ex4 1441 GGAGGAGAAG AGGGAGGAGC CAAAGGAGTG GGCCACGATC TGGAGGCGGA TGTTGCGGAT 
1501 GCCAGTCAGC CGGAGCGCGT ATGGCTGGTG CACCGCGGTG GTTTCACTGC CGCCATCCGT 
1561 CTGCCGACTG CGTCTTCTGG CCGGGATGIG GAG1½ACAPGC TAGCCTGCG CCTCCTGCAT 
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1621. AATGGGGAGC AGCTGACCGT CGPLCGAGGC GATGTCGAGA AGCAGAPCAG CCCCCCCCTG 
1681 GACCTTGTCG AGGACATCTG CGAGCTGAAG TATCTGPACG AGGCGTCCGT GCTCCATTGC 
MRI (589R) 
1741 CTGCGTCAGC GATACGCCAG CAATCTCATC CACPLCCAAGG CGGGGCCCAC GCTGCTCGTG 
1801 GTCAATCCCA TGGCACCGCT GTCCCTGTAC TCGAGAAGG TTGTCTCCAT GTTCCGCGGC 
MR2(89R) 
Ex5 1861 TGCAGACGG AGGATATGCC GCCCCACGTC TATTCACTGG CCCAGACCGC CTACAGGAGC 
1921 CTGGTCGAGA CGCGGCGCGA CCAGAGCTTG ATATTCATGG GCCGPTCTGG TTCTGGCAAA 
1981 TCCACTAGCT TCAAGCATGC ACTCACTAC CTGGCGTTGG CAGCTTGC CTATAATAAT 
Ex6 2041 TTTATAAACG CGGAGAAGGT CAPTGCCCTG TGCACCATTC TGGAGGCTTT TGGAAATACG 
2101 AAAACTTGCC TAAACTCGAA TGCCACGCGG ATGACGCAGC TGTTAAGCCT GGATTTCGAT 
Ex7 2161 CAAACCGGCC AGATTGCATC TGCCTCATTG CATTCTCC TCCCAGAAAG ACAACGAGCT 
2221 GGCCGACGAC TTGGTCATGA ACATAGCTTC CACATCATGA CGAGACTTTT GGCTGGCGCT 
2281 GCTGGCTTGC TACAGAAGGA GCTGCACCTG GAGAACATAA CCTCTGAGGA CAGCCATCCT 
2341 TTTATATCGT TATCCCA2AA GCTGGAAGAT CGGCATCGAG CTGCCAATGA CTTTATGCGC 
2401 ACTGTTCAGG CCTTTGAGAC GCTGAACATT GATGCGAAGG CGGTACGTGG GATCTGGAGC 
2461 ATTTTGGCGG CCATTTACCA TCTGGGCATT GCTGGCGTCA CPAAACTGGG CACTGGCTCC 
2521 ACAGCCCGAA CTCAGTTTGC CAATCCCACG GCCGCCCGAA AGGCCTCGGG CTTGTTGGGC 
2581 GTGAATCTGG AGGATCTGTC ATCAGCTGCC TTTGGTCTTA CCCAACCAAA CGCCCCCAAT 
2641 GGCGGTCTGA GTCCATCGAA ATCGCCCACC TCGGACACTG GACACGAATG GGCCTGGGAA 
2701 TGTCTCGAGG CGTTGGTCAT TGGTCTATAT TCGGAGGCCT TGGCTGCAGT GGTGGCATTG 
2761 ATCAATCGTC AGATCTGCAC ATCGTCCCAC ACCATAGCCT CAATTATGCT ATTGACACG 
2821 CCCGGCTTCC AAAATCCAGC CAGCTGTGGC CAGCAAGTGG GTGCTACTCT AGCGGATCTG 
2881 CGTCACAACT ATCTACAGGA GCGTCTACAG ATGCTCTTCC ATCACACCAC ACTGGTGGCT 
2941 CCCCGCGATC GCTACGCCCA GGAGCTGGTA GAAATCGAGA TGGACCTGGC ATCGGAGTGT 
3001 CATCCGGGAC CGTTGATCTC GCTTATCGAC AAGGCACCTC AGAATCATGT AGTGCGCTCG 
3061 TCCCAGCGAG ATTTGCGAGA GCATGATCGT CGAGGAATGT TGTCTACT GGATGAGGAA 
Ex8 3121 GCTATCTACC CCAACTCCPA CGATGACACA TTCCTTGAAC GTTTGTTCTC CCACTACGGT 
3181 GACCGGGAAC ATCATAGCCT GCTGCGCAAA TGTGCAGGTC CGCGACAATT TGTACTCCAC 
3241 CATCTGCAAG GCACCAATCC CGTTCTCTAC GCTGTCGATG GATGGGTGCG TCATAGCCGG 
3301 GAGCACC GAG GTATTCGGAA TGCTGTATCC CTACTACAGG ACAGCAGTCG GGAGGAGATC 
3361 AATCGCCTAT ATATCGGCTC ACTGACTCGA GGATCGGGAG CAATGGTGTT TTGTGGCTCT 
3421 TTTGCTGGAC TGGAAGGCAC TCAGTCACTT CGTCGCGTGT CCAGTATTCG CCGCTCCTTC 
3481 ACAACGGCCG GAGTAAAGCG AAACTCCATA ATGCTGCAGG TGAAGTTCAC AGTGGATGGA 
3541 ATTATCGACA CTTTGCGCCG CACTGGAACT CACTTTGTGC ACTGCTATCT GCTGCAACAT 
3601 AACGCAGGCA AACATACCAA GTACACCGCC AATGGATCGC CCAGCTCAGC TGCCGGTCAG 
3661 GTGTCCAGCG AGGAGGAAAT GGTCAACGTG CCACTGTTAA GGAGTCJT ACGTGGTTC 
Ex9 3721 CAAGTCCTAG AAGCGGCTCG CTTGCATCGC CTTGGTTTTC CCGAATCAGT GCCATTGTTG 
899F 	
30 
3781 GAATTTGTCA GGCGTTTCGG GCTTTTGGCC GGGGATTTGG CTAGCAATAA GGATGTGAGC 
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3841 GTGG2GCAGA TATTAGCTGT CALTGAACTG GATGTGGCCL GCTATCGCiAT AGGACCCAGC 
MF3(CHF) 	
30 
3901 CAGATGTGGT CGGATAAAPG TGCAGTTTGT TTGCCGTTGA GTGGCAACGC GAGTGTCGCC 
ExlQ 3961 GCATCATTTC 
MF4(ExF) 	 30 
GCAACAGTGC TCAAATCCTG AACCTATTCT ATGGCGAGGG GCATGAGGAT 
4021 TTTGTGGTGC CGCAGCCAAT CCTGGGACTG CTGACCATCG GCTGTGCTAT CGCCTGCGTC 
NE 	
MR3(ExR) 
4081 CGTATTCC TCTTCCGCTC AGGAGTTCTT AGTGAACTGG AAGCCAAGCG CGATGTCCTG 
389F 	 10 
ExIl 4141 CTCTCAGATC GCATTATACA GCTGCAAGCA TTTTGCCGCG GCTACTTGGC ACGCAAGAAG 
MF5 (PRPD) 
4201 ATGTCCCAAC GAAGGGTCCA GGAACTGGCA GTGCGTTGCA TTCAACGCAA TGTGAAGGCA 
Ex12 4261 TTCCTTGCCG TTCGCGACTG GCCGTGGTGG CGTCTCCTGG TGCGGGTCAC TCCCCTGCTC 
4321 AACGTTCATC GCACCGAGGA GCAGCTGAAG ACGGCTAACG AGGAGCTCCT AATGCTGCGA 
4381 GCCAAGCTGG AGAAGATCGA GTGTGATCGC AGTGAGGTCA AGGCAGAAAA CCAAAAGCTG 
*1  8912R 
ExI 3 4441 GAAGCCAAGC TATCCGAGCT GACGGTGGAC CTGGCCGAGG AGCGATCCAC GGCTCATATA 
4501 GCTACCGAGC GGCTGGAGGC GGAAACCGCC GAACGCTTGA AGCTGGAGAA GGAGCTGGGC 
4561 GATCAAACCA AC?ACGTGAA GAACCTTCAG GPtGACGACGG AGAAGCTGGA AATGGAGCTG 
4621 ATATGCGCCA AGTCCGATCT GAATGGCATC TCTGAGGACG AGGATGCAGA GPACGAGGAT 
4681 GGGGTCGGCG GCGGCGTCTA CAAGCTTAAG TACGAGCGGG TGGCCAGGGA GCTGGAGTTC 
4741 ACCAAAAGGC GGTTACACAC GCAGCATGAG CACGATCTGG AACAGCTGGT CGCGCTCAAG 
4801 AAGCATTTGG AGATGAAT TTCCGATGCC TACGAAGAAG TTGTGGAACA ACGTCAGGTT 
Ex14 
4861 GTGGGCCAAT GGAAGCGCAA GGCACAGAAG ATGACCACG AGATGAACGA TCTGCGCATG 
8914R 
4921 CTGCTCGAGG AGCAA2ATGC GCGCAACAAT TTGCTCGAGA AGAAGCAGCG CAAGTTCGAC 
4981 GCCGAGTGCC AGTCCCTGCA GGATGCAGTG CGTCAGGAGC GACAGGCCAA AGAGCGCTAC 
AAGTTCACAC TGGAGCAAAC GCTGGCJGAC 5041 GGTCGCGAAA AGGACGTCCT GCAGGCC GAG 
8914F 
5101 ACCCGTCTGG ATCTTG.AATT CAAGGAGGAG AAACTTGCAT CGCTACAGCG CGAGCTGGAG 
ExI 6 
5161 GAGATGACCT TTGGTGGCGG CACCGAGGAG GAGTTCGCCC AACTGCGGCG CTCCAAAAAT 
5221 GAAACAGAGC GTCGGGCCAA GGAACAGGAG GAAGAACTGG ACGAGATGGC CGGTCAGATA 
5281 CAGCTGCTCG AACAAGCCAA GCTTCGCCTG GAGATGACCC TGGAAACAAT GCGCAAAGAA 
5341 GCGCGCCGTG AGTCCCAGCA GCGCGACAA GAGCTGGAAG AAGTACGCGG TAACGGCTAC 
8916R 
5401 AAGAAGATTA AAGCCCTTGA ATGCCAGCTG GAAACTGAGC ACGAGGAGCG GACTCTGCTG 
5461 CTGCGCGAGA AGCACGAGCT AGAGCGACGT CTCTCCTCCA TGGAGGATCG CGATCGGCC 
Ex17 5521 CTGCTCAAGG ACGCCCAGAC ACAGTTGGAG CGGCTTAAGG CTGACACGCC TGGCAAGACG 
5581 CTTATAAGAC AACTGCGTAA TCAACTGGAG GATGCCGAAT CTGCTCGTTC GCTGGCTATG 
5641 AAAGCGCGAC AAACTGCGGA AGCCGAACTT ACTGAAGTGC AGGCCATGTT CGATGAGTCG 
5701 CATCGAGCTA GGAATGACGC GGAGGAGCGA GCCAATGCCG CACACAGAGA TCGGGCTGAG 
5761 CTGCAGGCCC AGATCGAGGA GAACGAGGAG GAGCTGGGCG AGCTGATGAA GAAGTACAGC 
5821 GCCACGGTAA AGCAACTAAA TACAGAGCAA ATCAACGTAT CCGAGGCTGA GTTTAAACTC 
5881 AATGAAATGG AAGCAGAGCG CAATAACCTC AAGGAGCAGG TGGCCGAGCT GCAGCACCGA 
'sq 
5941 CTGGACAACG TTGAGAACTT GGGGGATCCA TCTATGGCCA TGATGTCCAA GCGACTGGAG 
Ex18 6001 CTGCGCACCA AGGAATTAGA GTCTCGACTG GAACTAGAGC AGGCCACTCG GGCTCGCCTT 
279 
Appendix 
6061 GA1LGTGCAGG TGAACCGTCA CAAPLGAGGCT CTGGAAAAAC TGCAGAJCGA GGTGCGCAG 
6121 TCAAAGATGC GTGAGATGCP GGCCCAGGAT GTA2TCAAPJL AATCGCAAAA GAGTCTGCGC 
6181 GACATGCGCG AAGAGTTCCA CGCTGTCTCC AGCCGCGAGC AGGAGTCGCT CLCAAGGCGC 
6241 AAGGACCTGG AGAAGPJGGT GGAGCAAATG GAGTCGGAGG GAGCGGCGCT TAAAACGAT 
6301 CTACGACTGG CTTTACAGCG AATAGCTGAT CTACAGCAGG CAATGGAGGA AGAGGGCGAG 
6361 GAGGAGCTGA GCGAAGGA TGAAAGCCTC AGTTCGGTGG GCTCTATCAG TGATCTGGAA 
MR4 (PRPDZR) 
Ex19 6421 GATCGACTTC GGCCAGTTCA TGTAWCGC AGCTCCAGC AGTCCTTGAA CGGCAGCATC 
6481 GGCGGCGGAG GCGGAAGCGT TGTCAGCTCC ACCCGCACCG TGGTGTTCGA AAAGGACGAC 
6541 AACAGCCCGA GGTACGCTGP TAACGAAGTC AACTCGAACA GCAGAA2GCA GCACAAGCAT 
-L Stop Codon 
6601 TAAAGGCCCA AGCACACAc4C GTAGACTCAC TCACCCTCTA ATTATCTGAC TTTTAATATG 
6661 CCTATCGCTA GTTAGCTAGT CTGTAGGTC TGTTGCTATT TGCCGGCTTA TCTAATTTAA 
6721 ATAATTAAAC CATACATGCA AACCATCCGC CTCAATCCAC ATCCACCAAC GACCCCAAAA 
6781 ACCAPCTCAA CAACCCCTGC CGACACTTAP ACGCTGCAAT TCTCGAACGA CTACCGCCAA 
6841 TTCAAACAAA ATCATAAGAA CCGAAACGAA ACGCCCCAAA ACAAACGATG CGTGTAAATA 
6901 TGTTAATGCG TATGTGACAA AAACCAAAPC ACACAAA1TT TCCTAACTCC GCTCCGCTCT 
6961 GATCCGCTGT ACCGCCCCCG CTCCGCTCCG CAACAACAAC AACAACAACC CGACCCTCCC 
7021 AATCCGCGTG TGTGTGCGTG TAAACAATTA GCTTTTTCTT ATTGTAGAAT AACAGTGACG 
7081 TCGCCATCGT CGCCACACAT TCATAAGCTG GCACTGGCGG CCAAAGCCAT ACCGGCCAAC 
7141 AAACCGGACA CAAJ½ACCTGC AGCGTCTACT AGGATGGAGT TAACAGTGCC AGCGGGCCAG 
7201 CATAPTGGTC ATAPTGCCTA GCTGGCCAAG CAGTAGATCC ATCCATTGTA CGGGGCATGT 
7261 CCATCTGGGG CTGCAGCTTG TAATTTGT?A TTTTTATTTT TTGGPTATTT ATTAGTTGTT 
7321 TATGATTATT ATTTTATTAC TGTTTAGTTC AATACGTTTA ACTATTTATT ATCGAATAT 
7381 AGCTACATGA T?ATATTTAA TATAAAACCC AATAGGCATT TGAAAIkCAAT GCTGAGTTGT 
7441 AGTTAATTTA ATTTGCGCGA CAGTCCCTAT ACAAAAAGTG ATTAACATGT TTTATCTCTC 
7501 TCAAAAACA1 AWACAAAA ACGAAACTGA ACTAPCACCT ATAGAATATA GTCCATTATC 
7561 CTATAGCAAA CTTAAATAAA ATTAGTTAAA CGCGTTTCAA AATCATAGGC AAGTGTATGC 
7621 AATACAATA AATTGAACCT TTA1TCAAAT TAAAACCCAC AAATTCGAGT ATTTTACAAA 
7681 TAACTCATAT TCTTATACGA ATCATCATCC CATTCACAAC ATCAGTATT GAACATCATT 
7741 AGCTTCATTC ATCATTAAAA TTAAA1LCCAT AAATAATATT TGAATACGAA ATTTTGCAGA 
7801 J\ATJACGCCA AGTAPCGGGA AAGATTCATA AAAPCCTTTA TAAAAACTM CAAAACGAAT 
7861 ATAAACAAAT AAATATATTG TTATAAA?\CT TAAGAAA 
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Appendix V 	 Myo29D mRNA 
Predicted promoters: 
Score 0.59 
1 TTAC1TATAT GAGCTAJ\I' GIAAGGAA1T ATCCCTCTC CCCGACC4G24G A2TTG1\ACCC 
Score 0.28 
61 CGGTCTCCCG CGTGACAG(IC GGGGATACTT AACCACTATA CTATCGGAGG ATGTTGCGCG 
121 CCGATTGCA ATAGTTCTAT TTCAGATTCT TCGGTGCTCT CAGTGCIAAT TATTGTGCTA 
Score 087 
181 AGAATTCAAG GAAACATAA, TACCTATTT TTGGAAAATT TCT TAAATAG CCCAJ'CTTAT 
301 CAAAACCACC CAAATATTTG AAGGTGTCTT TATTTGAACC TTCTAATTTA TCACACTTTC 
Myo29D mRNA sequence: 
1 ATGGTGGCCA AAAACGCGGA GGTTCATCGA CGAGGCATTT TGGGTTTTGC TCCCCGGTC 
ExI 61 GGATTGGTCA ATGTTGACTA CGACGATCTG GACAGGATTG ACALCTTCTA TTTGGAGPCC 
121 CAGAGGTATC GGGACTATTA CCGCGATCCG CACAACATTC TGCACAAGCC GGAGCGTTTT 
DFI (595F-A) 
181 CGGCAACATC AGGGAJ\AATG CTCAPTTAAPL CTGGACACCA GTGTCCAAA CTTGACCJGG 
E x 241 CCGATCCATG CATCTTCATC CAACGGGCA GTTCATCTGC AGCAGCGGCT CAAAAGCCTG DF2 (SECF) 
301 AGCACCGAAT TGGTGACTCT GCGAAACCGC CTGCATGTGG GTCATGGACC GGGTCAGGGT 
361 CAGAGCCAGG GAAPTGGCGC GCAGCCCGTC GCCCCAGCTC CCAATGCGGG TCCCAAGGCC 
421 AACAACTTTG ACCTAAACGC ATCCAGTCCG AATCTCAATC TGAGTTCCAG CGGCGCAGGA 
481 CTTTCAGCCA GTGCAGTTCA GCAACACACC AATGGACATC ACACGACATC GAAATCAC 
541 AGCTTCAGCC ACACATTGCC CGCAACTCG GGCTCTGGTG GAGGGGAGG CGCTGGAGGA 
Ex3 DF3 (TRIF) 	30 
601 GGCGCCGTTG TGTCGGCGAG GAACACGTCG ATTCCACATC CACTTCCGCA TCAGTTGGCC 
661 GAGAAGCCGG GCCTGTCGCA TCAGCAGAGT GGCAGCGGAC ATGGTCAGTC CACCGGGACA 
721 CTGCCACATA TGAGCGGCAT GGGAAGTATC CTGGGGCAA1 ATTCCCATTC CCATGCACCG 
781 GTCAACAPCA ACAGCAACAA CTCCAACACG CTGCCCATGC GCACCTCCAA CTCCGGACAC 
841 CTGGGCATCA ATGGCGGAGG CGTTGGCCAC CATCTCAGCC ACGCCCACAG CCAGCAATTG 
901 CCATTCATCC CGCAGTCGAA GCACACGAAT CCCTGCCAGA GTGTGAAGPC TCTGCCCTTT 
595F -B 
961 GGATTCGGT TCTCCAAAG TCAGCAGAAG ATGCAACPGC AGCAGCAACA GGGCAPCTCC 
1021 TCGCCCAAGG ACATGCAGGA TCTGATCCAC TTGTCGGGAC CGCTCACCGA ACATGCCGTG 
DRI (529R) 
1081 ATGCGAACGC TCCAGGCCCG ATTCAACGAG CGGCGGTACT TTACGAACGT GGGTCCAATC 
Ex41141 TTGCTCTCCA TCAPTCCGTA CCTGGACGTG GGCAACCCGC TGACCCTCAC CTCCACCCGC 
1201 GCCATGCCGC TGGCCCCGCA GCTGCAGAAG ATCGTCCAGG AGGCAGTGCG TCAGCAGGC 
1261 GAGACGGGCT ATCCGCAGGC CATCATTCTC TCGGGAACAT CGGGCGCTGG AAAGACGGCC 
1321 AATGCGATGC TGATGCTGCG CCPGCTCTTC GCCATCGCCG GCGGAGGTCC AGAGACTGAT 
DRZ(595R-R) 
1381 GCCTTCAAGC ACCTGGCAGC TGCATTCACA GTACTTCGAT CCCTGGGATC CGCCAAAACT 
0F4(595F-C) 
1441 ACGACCAACT CGGAGTCCAG TCGCATTGGC CAGTTCATCG AGGTGCAGGT CACGGPTGGG 
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1501 GCACTCTACC GCACCAAGAT ACACTGCTAC TTCCTGGPCC AGACTCGCGT CATTCGTCCP 
1561 CTGCCGAAGG AGAAGAACTA TCAC2TCTTC TATCAATTAC TGGCTGGTCT CAGCCGGGAG 
1621 GAGCGCCAGA AGCTACACCT GGATGGCTAC TCGCCGGCCA ATCTGCGCTA CCTGCGAGGT 
1681 GACATTGGCC AGAATGAGCJ GGAGGATGCG GCGCGCTTTC AGGC-ATGGAA GACCTGCCTC 
1741 GGCATCCTGG GCATCCCATT CCTGGACGTC GTTCGTGTCC TGGCCGCCGT TTTGCTGCTG 
1801 GGAAATGTTC AGTTTATTGA TGGAGGcLGT CTCGAGGTGG ATGTGAAGGG TGAAACGGAG 
Ex5 1861 CTGJACTCTG TGGCCAGTCT ACTTGGCGTT CCGCCGGCGG CCCTCTTCCG TGG2TTGPCC 
1921 ACCCGTACCC ACAACGTTCG TGGCCAGCTG GTGAGTCCG TGTGCGGCGA TGGCGATGCC 
1981 AATATGACGC GGGACTGCCT GGCAAAGGCG CTCTACTGCC GCACGGTGGC CACTATTGTG 
2041 CGGCGGGCCA ACAGCCTGAA GCGCCTGGGA TCCACGTTGG GCACCCTCAG CTCGGACTCA 
2101 AACGAATCGG TGCACAACCA GGCGGATGTC GCCTCTCGC ACGCCTCCAC CATTGGCGGT 
2161 GGCAATGCGG GCTCCAAGTC GATGGCGGCA CTCALTAATG CAGTGCGCCA TGCCACCTCC 
2221 GATGGCTTCA TTGGAATCCT GGACATGTTC GGTTTCGAGG AGCCCTCGCC ACATGCCCAT 
2281 CTGGAGCACT TGTGCATCAA CCTGTGCGCC GAGACCATGC AGCACTTCTA CAACACGCAC 
2341 ATCTTCAAGT CCTCCGTGGA ATCCTGTCGC GACGAGGGCA TCGTTTGCGA CACCGGGTG 
2401 GACTATGTGG ACAATGTGCC CTGCATCGAT CTGATATCCT CGCTGCGAAC CGGTCTGCTC 
2461 AGCATGCTGG ATGCAGAGTG TTCGGTTAGG GGCACTGCCG AGAGTTATGT GPCCAAGTTG 
2521 AAGGTGCAGC ATCGCAGCTC CACTCGCTTG GAGI\CGAA7\C CCACAGCCGA ACCACACGAT 
2581 CCACGCATGT TTCTCATCCG TCACTTTGCC GGTCGGGTGG AGTACGATAC CACGGACTTT 
2641 CTGG1CACCA ACCGTGATGT GGTGCCCGAC GATCTGGTGG GTGTCTTCTA CAAGCACACC 
2701 TGCAACTTTG GCTTCGCCAC CCATCTCTTT GGATCCGGC TGAAAGCCCT GTATGCTCAG 
2761 CAACAGGCTC CAAGGGGTCT GAGCTTCCGG ATCTCGCCCA CATCACACTC GGATCTGCTG 
2821 AACGGGGACG AGCCGGTGTC CACGCTGACC CAAGACTTCC ACCCAGGCT AGACAATTTG 
2881 CTGAGAACCC TGGTGCACGC CAGGCCGCAC TTTGTGCGCT GCATCCGAAG CAPTGGAACC 
DF-5 (PHox) 	 P29F 
2941 GAGGCGGCTC GCAGCTTTGA TAGGGCTACG GTGGTGCGCC AGATTAGATC CCTGCAGGTC 
3001 CTGGAGACGG TCAATCTAAT GGCCAGTGGG TTCCCGCATC GCATGCGCTT TAAGCAGTTC 
3061 AATGCCCGCT ACCGTATGCT AGCCCCATTC CGCCTCTTGC GCCGCAGCGA GGACAAGGCT 
3121 CTGGAGGATT GCCAGTTGAT TCTGAAGTAC GCAATGGAGC AGCCGCCAGT GCTGGITGGC 
3181 TCGGTGCCC TGGCCTGGGC ACCTGGCAAG CGTCATGTCT TCCTTAGCGA GGGCATTCGC 
3241 CAGCACTTGG AGCACTTGCG CACCGAGATC AGGCACAAGA GCGCCACCCT GATGCAGGCC 
3301 ACCTGGCGAG GCTGGTGGTG GCGCAAGAAG ATGGGCAATG GCGGGGCGAA GCGCTCCAAA 
3361 ATCCCAGGTC TTCAJ\CAGGC GCCACTGCCG AACAPCAAGA CCACGCCGPA CTCCGCCGCA 
3421 CAGAACAAGG CCGCATCCTC CACAATGGCC GCCCTTGCCG CTGTGGCAGC TGCTGCTCCC 
3481 ATTTCTGGTG AGATTCCCCC ACGGGTATAC CCATTCTCCG CCCATCTAAT CCCCAAACTC 
3541 TATGATGCAG TACCACGCCT CTCGGCCAPG ACAACGAGCC TGGGCATTGG AGGCACTGTG 
3601 GCCAGACCAA GGCCACAGCC CATTGCTGGG ACTCCTCCGC CGGATCCGCA GGAGAPGTGC 
Ex6 3661 GACCAGAAGA TCATTCAGCA GACCTGTAAC CTGTTTGGAG GAACGTCCGC CGCCAGTTCC 
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3721 GCCGTCTCGT TCCTACACGA TCACCGGGAA TTCGAAAATA AGCTATCCCC AAAACCGGGT 
3781 CATGAAGATG AACTTTCCAG AGGAGGGACA GTCGG1GGCG CCGCAGCTGA AGAAGGGCGA 
3841 AGCGGTGACC GTAGTGGGGG CCTCCACCGT TCGGGGTCAC CTGATGGTGG AGCPCAAGGG 
3901 GCAGAGCTTC CACGTTCCCT TCCAGTTCAT GACGCTCAGT AAATAAc4GAC TACTGTGGA 
3961 PCAICTGG TTATGATTCC ATTCATTCCA TCTGTTCAAC TCTTCCTGT TTTAGCATC 
4021 CCATTTCTAA AAGACTGTAA ATATTCCATT TGGTAGATTA AATAACAAGC ATTCTGTCTA 
4081 CGAAGCGCAT GCTAPLCTGAG GTGCTCTAAT TGGCCCCTAA CTTACGTAGT ATTATTATTG 
4141 TCGCGTTAAT AAATAAACGC CAATCGATAG GTTGTAGCTT CAATTACATA CCCACAAGTG 
4201 CCAATCAAAT AAGTTCTTCC ACCTAATTCA TAAGTATTTT ACATGTTACT GAGATTACJF 
4261 TATTCGCCGT TAAGTATTA GTTAAGTAAG TTTCACAAC GACATTCATT TTTTATTTTT 
4321 GAGTTCACTT AAGAATTGTG AATTTTATTA GACTAAGGTT CATTTTGTCA TTCAAATAAA 
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ABSTRACT 
The Broad-Complex (BR-C') is an early ecdysone response gene that functions during metamorphosis and 
encodesaftiniIv of iinc-litiger transcription factors. It is expressed in a dynamic pattern during oogenesis. 
Its late expression in the lateral-dorsal-anterior fdllicle cells is related to the niorphogenesis of the choiioiiic 
appendages. All four tine-linger isofonits are expressed in oogenesis, which is Consistent with the ahiioniial 
appendage phieitotvpes resulting from their ectopic expression. We investigated the mechanism by which 
the BR-C' afi'cts chorion deposition by using BrdU to follow the effects of BR-C miseXpreSsion on DNA 
replication and in .11/il hybridization to ovarian mRNA to evaluate chorion gene expression. Ectopic 
BR-C expression leads to prolonged endoreplication and to additional amplification of genes, besides the 
chorion genes, at other sites in the genome. The pattern of chorion gene expression is not affected along 
the aittenor-posterior axis, but the follicle cells at the anterior of the oocvte fail to migrate correctly iii 
an anterior direction when BR-C is misexpressed. We conclude that the target genes of the BR-C in 
oogenesis include a protein essential for endoreplication and chorion gene amplification. This may provide 
a link between steroid hormones and the control of DNA replication during oogenesis. 
THE regulation o!tbe expression ofstructi.tral genes is critical in morphogenesis. This requires differen-
tial expression of transcription factors, which in turn 
regulate the tissue-specific expression of structural 
genes. Drosophila oogenesis is ideal for the study of 
developmental gene regulation as it takes a fairly short 
time to develop from a stage-i egg chamber to a mature 
egg and all the stages are morphologically well defined. 
Further, egg chambers, the developmental units of oo-
genesis, contain only the somatically derived follicle 
cells and the germline cells. The former undergo dra-
matic morphogenetic movements and eventually syn-
thesize the yolk and then the eggshell, as well as interact 
with the germnline cells to generate the two major axes 
of the egg and embryo. 
The Broad-Complex (BR-C), a gene encoding a family 
of zinc-finger transcription factors (DtBei.i.o ci al. 1991; 
BAYER ci at. 1996), has been shown to be expressed in 
the follicle cells in a dynamic pattern, the late pattern 
being defined by two groups of dorsal-anterior follicle 
cells at stage lOB of oogenesis (DEN(; and BowNes 1997; 
for the staging of oogenesis, refer to SPIADI.ING 1993). 
This dorsal-anterior expression pattern is specified by 
Cons'spondittg (till/it,,: Maui tl()\VISCS, Instil tiic of Cell and Motecutar 
Biology, University of Edinburgh, Danvnt Bldg., King's Blttgs., Ma'-
field Rd., Ertiulangli EH9 3JR, United Kingdom. 
E-mail: marv.hownes©cd.ac.ttk 
fhesc authors contnhuicrt ecjiiatty to this work. 
2 I'reseiti at/tIn',.,: Depart went of Biochemistry, Box 3.I7350, Univer-
sity of \Vasttiugton. Seattle. WA 98195. 
Present address: ('.enetiscttes Institut ncr Jusitis-1 ichig-U niveisitaef, 
Heinrich-Buti-Riug 58-62, D-35392, (;iess'u, (;eniti,iu,'. 
(;enetins 153: 1371-1383 (November tttott) 
the (;rk-DER and decapentaplegic (DPP) signaling 
1th\v21y's along the two major axes, and is associated with 
the function of the BR-Cin dorsal appendage Formation. 
The involvement of BR-C in dorsal appendage morpho-
genesis was shown by mutational analysis of BR-C partial 
"loss-of-function mutants, and was supported by ectopic 
expression of BR-C "transgenes" during oogenesis. It is 
proposed that the 13R-C may provide a link between 
pattern formation and cell behavior in morphogenesis 
(DF:NG and BOWNES 1997). 
The BR-C has been previously identified as  key gene 
required for Drosophila metamorphosis. It is'among 
the early ecdysone responsive genes, which are directly 
activated by the ecdysone receptor and coordinate the 
subsequent transcription of the tissue-specific "late 
genes" (A5HBuRNI':R 1974; and for reviews see Kiss ci 
cii. 1988; K.RIrvI ci cii. 1993; Zi-iirsiui.ev ci al. 1995; BAYER 
el. at. 1996a). The BR-C is located at chromosomal region 
2115. Genetically, the BR-C loctis has three fully comple-
menting functions: br (broad), rhp (reduced bristle nttm-
her on palpus), and 2Bc, as well as a noncoinplementing 
npr (nonptipariating) class (Figure 1C; BELYAEVA ci at. 
1980). Additionally, a ni.tmher of BR-C alleles have been 
categorized to the 2Bab group. These alleles do not 
complement br or rbp mutations, but do complement 
2Bc mutations (Bt:tXAEvA ci cii. 1980). The nonpupar-
iating mutations are probably null mutations, because 
alleles in this class fail to complement mutations in each 
of the three complementing groups. These mutants are 
also phenotypically indistinguishable from deletions of 
the loctis. It has been shown by genetic analysis that 
BR-C is essential for the morphogenesis of imaginal 
discs. br' function is primarily required in the elonga- 
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tion and eversion of appendages from imaginal discs as 
well as tanning and hardening of the larval cuticle. rbJf 
function, oil the oilier hand, is essential for muscle and 
bristle developiiicnt. Additionally, both rbjf and 2Bc 
lunctions are vital for histolysis of the larval tissues and 
gut iiiorpluogenesis. 2& function was shown to be es-
sential in the fusion of discs to form a cmiii iuous adult 
epidermis (Kiss et al. 1988) All three functions are also 
required for the reorganization of the central nervous 
system (CNS) (Kiss p1 al. 1988; EMERY el al. 1994). 
The BR-Ccncodes a family oU(,,h I zinc-finger proteins 
(Z I, i2, Z3, and Z4) , which share a common aminoter-
minal (the /111-C "core") domain but differ in zinc-finger  
domains (DiBi:ii.o et al. 1991; BAYER ci al. 19961)). The 
core contains a highly conserved amino-terminal motif, 
called the BIB or POZ (Ioiiiaiiu, which appears to be 
involved in prowin-prolcin interactions and is widely 
(listrihttic'd among nietazoans (DiBi:i.i.o el al. 1991; 
RARDWEI ,i. and Tlu:lsruA N 1994; Zo1.t.MAN ci (11. 1994). 
The core is alternatively spliced to one of thc huir zinc-
linger domains (Figure 1), generating four classes of 
proteins, the Zi, Z2, Z3, and Z4 isoforms. Additionally, 
three variants of the Zi isoform have been identified. 
They differ in the linker region between the core motif 
and the zinc-finger domain. 
Some genetic studies suggest a one-to-one link he- 
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FIGURE 1.—Organization of the BR-C gene. (A) Molecular organization of the BR-C gene, which maps to the 2B5 region 
(adaptec! from Ciuo and Gtn.i) 1986). For simplicity and clarity the upstream half of BR-c, including the first exon, is not 
shown in the figure. Shaded boxes represent open reading 	solid boxes represent untranslated regions of the BR-C' 
transcripts. Two putative promoters have been previously described: P distal at nucleotide 120; and P proximal at nucleotides 
163, 165, and 167 (DJBrILo ci at. 1991; BAYER ci (1L 199Gb). The Z1—Z2 transcripts can be synthesized from either Pus or P, 
while Z2 and Z4 initiate only at P165  and 	respectively (BAYER (Ii at. 1996b).  The linker regions for Z I and Z3 domains are 
contiguous in the respective exon. (B) Organization of zinc-huger isofonns. Dilii'rentiahly spliced lIlt-C transcripts slia reaconi-
loon core cloniam linked to one of the four (ZI—Z4) different pairs of (2I 12 zinc-finger domains. The TNT, Q, and O linker 
seq iei ices found in Z I transcripts arc contiguous in the Z I exon, and gel lerat e by al teniatively splicing three Z I isotornis (BAYER 
ci at. 1997). Arnnvs indicate the punier pairs tisecl in RT-PCR analysis. (C) ( oniplenientation map of the BR-C based on BAYER 
ci al. (1997). 
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tween the specific complementing genetic functions 
and protein isoforms. However, other data suggest that 
the relationships between the complementing groups 
and protein isoforms are more complicated. For exam-
ple, in the In 2' mutant, Z3 transcripts and protein levels 
are reduced and all Zi isoforms are truncated. Clearer 
data on these relationships were provided by BAYER et 
al. (1997), who showed that lethality associated with 
each of the complementing groups was rescued using 
heat-inducible transgenes. It was found that br ,  function 
is only provided by the Z2 isoform. Despite this, there 
may, he functional redundancy or regulatory depen-
dcncv associated with rbp±  and 2Bc functions. It was 
found that Z 1 transgenes provide full ib/f function, 
while Z4 provides partial function. The 2Bc lethality is 
fully rescued by Z3 protein expression, and partially 
rescued by Z2 protein expression. 
The two clusters of chorion genes on the X-chromo-
some and third chromosome, which are responsible for 
the production of large amounts of chorion protein in 
the follicle cells at very precisely defined points in late 
oogenesis, are selectively amplified above the level of 
the remainder of the follicle cell genome, which also 
encloreplicates to produce polyploid cells (Sl'RA 1)11 NC 
and MAHOWAI,D 1980; Omu-WrAvm] 1991). The third 
chromosome cluster is amplified 60- to 80-fold and the 
X-chromosome group 15- to 20-fold above the rest of 
the genome. This specific amplification depends on cis -
acting sequences among the chorion genes (ORR-
WEAVER and SPRADI.ING 1986; Dl:l,i)AiKls and KAFAI'os 
1989). 
We know that the BR-Cexpression in the lateral-dorsal-
anterior follicle cells dttring oogenesis is related to its 
function in dorsal appendage formation. However, we 
do not know what the early function of the BR-C is, 
when it is expressed in all follicle cells at stage 6 of 
oogenesis. Since the chorion genes encode major egg-
shell components, and rh/t function has been reported 
to he necessary for chorion gene amplification during 
oogenesis (ORR et al. 1989; HUAN(. and ORR 1992), we 
investigate in this article the relationship between the 
BR-C and chorion gene amplification and expression. 
MATERIALS AND METHODS 
Drosophila strains: The Ihilowing Drosophila melanogaster 
strains were used: Oregon R, hi', br', br', 	', rbp2, 2B(,', 2B r', 
npr (Kiss ci al. 1988); lie'" (DFNC and BOWNES 1997); w'''', 
hs.ZI (527-5; 708-1). hs.Z2 (CD5-l), hs.73 (797-3), hs.Z4 (Z4- 
11) (BAYER el al. 1997). The rbp2 and Br' alleles are viable and 
were maintained as homozygotes. All other BR-C mutations 
were maintained over Binsn, an X-chromosome balancer car-
lying the markers Bar and singed. All stocks were maintained 
on standard cornmeal food at 26°. 
Antibody staining of ovaries: Ovaries were dissected from 
yeasted flies in Ringer's solution. The anterior parts of the 
ovaries were torn apart to facilitate antibody penetration. The 
ovaries were transferred to it microftige tube containing 2% 
/fornialdel'cle (in 1 X PBS) and fixed for 30 min at room  
temperature. The fixative was carefully removed and ovaries 
were washed in 1 ml of PTW [1.5% (v/v) Tween-20 in PBS] 
for 5 mm. Then the ovaries were incubated in 1% (w/v) 
bovine serum albumin (Sigma, St. Lotus) in PTW for  hr. 
Blocking was accomplished by incubation of the ovaries in 
PTW-NGS [5% (v/v) normal goat serum in PT\'] for 2 hr 
at room temperature. The first antibody was added at 1:200 
(liltiti011 in PT\ and the incubation was carried out overnight 
at 4°. Residual antibody was washed away with three changes 
of P1W with 30 mm of incubation per change. The HRP-
conjugated secondar'amitibodv (Proniega. Madison, WI) was 
then added to the ovaries at 1:500 (libation and i unabated for 
2 hr at room temnperanire or overnight at 4°. Excess secondary 
antibody was removed with three PTW washes at 30-mm inter-
vals. Diaminobenzidine (DAB) staining solution (Sigma) was 
added and the staining was allowed to proceed for 10-30 
min before washing with several changes of PBS to stop the 
reaction. Stained ovaries were mounted in PBS/glycerol (1:4) 
to allow )W In icr( )sc( 
Hoechst staining: Ovaries were dissected in PBS and fixed 
in 4% p-fio-nialdchvde (w/v in I X PBS) for 20 mm. This was 
followed by washing in I X NIT [1% (v/v) Triton-NI 00 in 
PBS] for 30 ml. The ovaries were then washed for 30 mm 
in PBS and stained for 5 inin in 1 ig/ml Hoechst 33258 
(Sigma; dissolved in PBS). After washing in PBS for 2 fir to 
overnight, the ovaries were mounted in PBS/glycerol (1:4) 
and examined tinder a fluorescent microscope. 
Preparation of the eggshell for dark-field microscopy: 
Freshly laid eggs were collected from tlieiupple juice plate 
and placed in it (li_Op of I loyer's motmntant (1-foyer's mounting 
mu cdiii iii: lactic acid = I : 1) on a glass slide and covered by it 
coveislip. After an overnight incubation at 65° the slides were 
ready for (lark-held microscopy. 
RNA extraction and RT-PCR: The BR-C transcript levels in 
ovaries were detected by reverse transcriptase (RT)-I'CR its 
described previously (Hor)(;m1rrs ci al. 1995). Total RNA from 
ovaries and larvae (control RNA) was isolated tmsing RNAeasy-
Total RNA Kit (QIAGEN, Chatsworth, CA, no. 7-1104). The 
RNA (5 p.g) was primed with ohigo-p((IT) 1 , and reverse tran-
scribed using Superscript II (Gihco BRI,, Gaitliersbtng, MD) 
following the supplier's protocol. For the stmhsequemit DNA 
amplification, 5% of the first-strand reaction mix was used. 
To amplify each of the zinc-finger domains, appropriate 
primer pairs were added to the PCR mixture: a common 
primer for the core domain was combined with one of the 
four primers for the respective zinc-finger motif. The sequence 
data for the primers were obtained from DIBI-;iLo ci al. (199 1) 
and HoDd;EtTs ci al. (1995): core, 5'-ACAACATGTTCCATG 
CAGCC-3'; ZI, 5'-TGCTGGTGcTGCT(;(;T(;ATA-3' Z2, 5'-
TcATcTcc&TTTCGCCGC;GA-3'; Z3, s'-(;AT(;Gc(;c;TCGT 
CTTAAG(A-3'; Z4, 5'-GTGC;TTGTTCA(;CGAGTTCA-3'. In 
the PCR reaction QIAGEN Taq Polymerase and the protocol 
designed for use with Q-Solution was used. The PCR reaction 
was carried out as follows: one cycle at 94° for 4 mm; 35 cycles, 
step one at 94° for 30 sec, step two at 60° for 30 see, step three 
at 72° for 1.5 mm; one cycle at 72° for 7 mm. 
BrdU labeling: Ovaries were dissected at room temperature 
in I x (;m-ace's medium (Flow Laboratories, no. 2700049) and 
incubated for 1 hr in 15 tIM BrdU (Signam) in Grace's medium 
(LILLY and SPRADLINCm 1996). After washing in EBR (Ephrtissi 
Beadle Ringer) the ovaries were fixed for 20 inin in 37% 
formaldehyde/buffer B/dH2O (1:1:4; LIN and SPtsDLINd; 
1993), followed by 1 hr denaturing in 2 N HCI and neutralizing 
for 2 min in 100 msm Na tetraborate. The tissue was rinsed 
several times in PBT (PBS + 0.1% Triton X-100) and blocked 
for 1 hr in 5% NGS in PBT. After overnight incubation in 
1:20 dilution of anti-BrdU antibody (Becton-Dickinson, San 
Jose, CA, no. 347580) detection was carried out with HRP- 
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conjugated secondary antibody (1:25 dilution). Sigma Fast 
DAB peroxidase substrate (no. zf  I 68) was used ill the peroXi-
(lase color reaction. the latter was enhanced with 10 fd 1 Ni 
Ni SO per I nil staining solution. 
In situ hybridization to mRNA in ovaries: 'the protocol is 
based oil the procedure previously described (Tr\ti'iZ and 
Pvi:ivii: 1998) and modified as billows. the ovaries were dis-
sected in Ringers solution and fixed for 20 miii in 4% /)-form-
aldehyde in PBS. Alter rinsing the tissue in ITT it was treated 
for 10 nun ill niethaiiol/0.5 Ni EG.TA, lAI 8 (9:1). The ovaries 
can then be stored in methanol at —20° for several iiionilis. 
The stored ovaries were rehiydraiecl ill l'P,T. The prehbridiza-
tin ii Was carried omit for I Ill- at 45° in DNA 1-lybrix (50% 
deion ifcd 6 )rni1nnide, 5 X SS( , 100 ig/ nil snuicated salnn m 
sperni DNA. SI) p.g/uil I leparin, 0.1% Tweeu 20). The ovaries 
were hiyhridiied I ivern i(hi i at 45° in DNA I b brix containing 
digoxigenin-labeled probe (DIG DNA labeling and detection 
kit, Boeli ii ngcr Man ii h ci ni , Indianapolis). For detection a 
1:1000 dilution of anti-l)lG-AP-conjngated Ab was used. The 
staining reaction was pertormiied in 100 HIM Tris pI-I 9.5, 50 
mM MgCl, 10 niM NaCI, 0.2% Tween 20. 8 mM levamisnle, 4.5 
ii.1/iul N BT, and 3.5 p.1/mI X-pliosphiate (Boehringer M:snn-
hems). Anti-DIG-AP conjugate was preabsorbed with postlixed 
wild-type (Oregon R) ovaries at 4° overnight. The ovaries were 
mounted in a mixture of PBS/glycerol (1:4) for microscopy. 
RESULTS 
The BR-C protein distribution pattern during oogen- 
esis: In a previous article (DEN(; and ROWNI,S 1997), we 
reported that BR-C inRNA is expressed in follicle cells 
in a dynamic pattern. Its expression is first detected in 
all follicle cells at stage 6. During stage bA, all the 
columnar cells, except the dorsal anterior follicle cells, 
contain the BR-C transcript. However, only two groups 
of dorsal-lateral-anterior follicle cells express the BR-C 
mRNA during stage lOB, marking the dorsal appendage 
secreting cells. 
To investigate the function of' the BR-C we need to 
establish whether or not the protein is disfribtited in a 
similar pattern to the mRNA (luring oogenesis. Antibod-
ies that recognize the BR-core, ZI, or Z3 cloniaiiis, re-
spectively, were used to stain the whole-niouiit ovaries. 
Antibodies to the Z2 and Z4 isoforms have not been 
generated, SO we were tunable to check their expression 
pattern. Both the ZI and BR-core antibodies exhibited 
similar staining patterns, while the Z3 antibody showed 
no staining (luring oogenesis. These observations are 
consistent with the results shown by RNA in silo hybrid-
ization; ZI is the only zinc-linger isolbrm with expres-
sion at levels significantly high to be detected by in silo 
hybridization techniques during oogenesis. 
The distribution pattern of the BIM protein appears 
to he similar to that of its mRNA during stages 6-8 of 
oogenesis, when all follicle cells stain (Figure 2, Al). 
The protein is also detected in all columnar follicle cells 
except the dorsal anterior cells at stage 10 (Figure 2, 
Al—A3), similar to the pattern of mRNA distribution 
(Dt':Nu and BowNis 1997). However, the follicle cells 
at the posterior pole appear to be stained at this stage 
(Figure 2, Al), which differs front the mRNA distribu-
tion pattern. The late distribution pattern of the BR-C 
protein and mRNA differs. A very strong signal is oh-
served in two groups of the lateral-dorsal follicle cells 
at stages 11 and 12, but the posterior and ventral follicle 
cells are still stained (Figure 2B). The signal in the 
posterior and ventral region disappears around late 
stage 13, leaving only the dorsal-appendage-associated 
1-ic; ui is i: 2 .—'l'h c distribution pat tem'i i of 
the B1? -C protein during oogencsis. (A I) 
Using BR-core antibody to staimi the ova-
lies, signals ai'e initially detected ill all 101-
licle cells at around stage 6 (arrowhead). 
Staining is also observed in all follicle cells 
at stage 7. During stage 10, columnar folli-
cle cells over the oocyte are stained. How-
ever, staining is not seems at the dorsal an-
terior region. (i\2) A closer look at the 
dorsal regioii . 1-h ie dorsal gap is mnarked by 
a do umbl c-li eaded arrow, while the am ii e rio r 
g;uj is labeled by two curved lines. (A3) A 
ventral view of, the sanie egg cli an ml )(' i. It 
appc;im's that all ventral coluitn tam' cells are 
stained. (B) During stage 12, two grouips 
of lateral-dorsal-anterior 6 dlicle cells are 
heavily stained, while the posterior and 
the ventral follicle cells are weakly stained. 
'I'hie dorsal gap between the two groups of 
the lateral-dorsal cells still exists (arrow). 
Expression ill the posterior follicle cells 
becomes gradually weaker (C), until it dis-
appears at 111)1)  m'( tx iii i at ely s( age 1") (1)) 
Expression is only detectable in the dorsal-
appendage-ass iciat ed loll ide cells. '[lie 
arrow shows a growimig dorsal appendage. 
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follicle cells stained (Figure 2, C and D). The differences 
between the distribution patterns of the protein and 
mRNA presumably reflect the fact that the half-life of 
the protein is much longer than that of the niRNA. By 
the time late BR-C transcription occurs at the lateral-
dorsal-anterior follicle cells, the protein translated from 
the early BR-C transcripts remains at the posterior and 
ventral side, while the mRNA has been degraded. Thus, 
the early and late Protein  distribution patterns overlap 
to form a gradient-like pattern at stages 11 and 12. The 
same reasoning could also he used to explain why the 
protein, but not the mRNA, is detected in the follicle 
cells at the posterior pole during stage 10. 
Another feature of the BR-C protein distribution is 
that it only appears in the nuclei of the follicle cells (Fig-
ure 2), which is consistent with the fact that the BR-C 
encodes transcription factors. 
rbp function is required for dorsal appendage forma-
tion: The genetic organization of the BR-c: is shown in 
Figure 1. BAv1:I el al. (1997) reported that ZI provides 
the full th/i function. Since the ZI zinc-finger isoform 
is expressed during oogenesis and is detectable by in 
si/u hybridization, it is predicted that the rhp functional 
domain will he required. To test this, female homozy- 
gous viable rbp' and 	mutants were dissected to exam- 
inc the eggshell phenotype. It was 1'01111(1 that the dorsal 
appendages were abnormal, being shorter and rougher 
than the wild type, and the eggshells were much more 
fragile (Figure 3). Shortening of the dorsal appendages 
was observed in rb/r homozygous mutants. 
To test if i-151) is the major functional domain involved 
in dorsal appendage formation we did a genetic analysis 
using the apr allele in crosses with br, rbp, and 2& alleles 
(Table 1). The cross between rbp' and npr produced 
only two males and no viable female heteroallelic mu-
tants. Two 1_1)p2/ npr' females were produced in the cross 
with rbp2 flies. They lived for 2 clays without laying any 
eggs. Then they were dissected to examine the ovarian 
phenotype. It was found that the ovaries were not com-
pletely developed and the few late stage oocytes formed 
had no appendages. Thus we were unable to examine 
rbp function by this method. The combination 2Bc/npr" 
was found to be completely lethal, and as a result we 
could not establish if there is a function encoded by 
the Z3 (211c) isoform. 
The function ofZ2 was investigated by further genetic 
crosses. The cross between hr and npr" produced no 
viable heteroallelic flies, while the cross between hr6 and 
npr6 generated 22 heteroallelic males, but no females 
that could be examined. It was observed that eggs pro-
duced by &,I/ W1 and bi/npr6 mothers have reduced dor-
sal appendages (DENG and BOWNES 1997), suggesting 
that the hr functional domain is likely to he required 
for dorsal appendage formation. To test this hypothesis, 
eggs produced by b1_ 5/ br' and br1'/ hr' females were exam-
ined, and found to have normal dorsal appendages 
(data not shown). This observation, along with the fact  
that the fjy2  is actually an rbp allele (HUANG and ORJ 
1992), suggests that the brfunctional domain, and hence 
Z2, is not involved in dorsal appendage formation. 
How can the phenotype of hr 1/br'' 7 and br'/ np' egg-
shells he explained if hr is not the functional domain 
required for dorsal appendage formation? This could 
he understood if the hr' mutant not only affected hr 
function, but also affected 'hp function. To test this 
possibility, the eggshell phenotype of eggs laid from 
III—VI—N), mutants was examined. It was shown that eggs 
produced by the bi/ ihp' mothers have reduced dorsal 
appendages, similar to those produced by the 1n/ hc1  17 
females. This indicates, therefore, that the bi is in fact 
a weak 2Br or 2Bah allele, which fails to complement 
either rbp or In function. This suggests that rLb (which 
encodes ZI and Z4) is a functional domain involved in 
dorsal appendage formation during oogenesis; how-
ever, we cannot rule out the involvement of Z3 from 
these experiments due to the failure of these crosses to 
generate adult females clue to early lethality. 
Ectopic BR-C expression induces ectopic dorsal ap-
pendage material: Is BR-C function sufficient to direct 
FIGURE 3.—Ch)rion defects in rhp mutants. (A) Wild-type 
chorionic appendages. (B) Appendages that are shorter and 
irregular in shape, produced by 	females. 
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TABLE 1 
Survival frequencies of BR-C mutants 
ProgcliV 
I Ieteroi.ygotes': 	 Fleeioallelic 
initial) is 
+ I loiuozygous 
Cross balancer' 	 4 Lethal period 
be' lip).,
X 216 	 21 	 9 Not observed 
hr ' Bi nsa 
l,r - x i/) 158 	 0 	 0 111 05512ff laiva 
Biisn Bisii 
hr 
>< 36 	 22 	 0 Pupal 
Binsn Binsn 
X 140 	 2 	 0 Pupal 
Binsn Binsii 
>< PPI 	 130 	 1 I 	 2 	 Pupal 
slip2 	Binsti  
2Bc' 	nJYr 
X 	 73 	 0 	0 	 Il—Ill instar larva 
Binsn Binsn 
2&2 X '— 	 215 	 0 	 0 	 Pupal 
Binsn Binsn 
Ileterozygotes, flies carrying a i-C mutant chromosome and it balancer chromosome ic ( bij Bins ii, ilsp/ Bi ii.n, 
213c/ Bins,i, and npr/Binsn) 
E-Ioiiioiygous balancer, flies lmlu( n'vgolis wit Ii respect to the balancer chromosome ( Biiisn/ Binsit) 
H cter( nil lelic nit nan Is, flies carrying different combinations of 13cC alleles ( lir/ n/); rbp/ n/n; and 2&l Qt).  
the formation of the dorsal appendages? To address 
this, heat-inducible Zi transgenic flies (Irs170/Z1) were 
used to examine the effect of ectopic BR-C expression 
during oogenesis. Following standard heatshock (37°, 
30 mm) and incubation at 26° Ru 2-48 hr, ovaries of 
the lisp 70/Z I females were analyzed (Table 2). Flies 
were dissected to examine the effect of the heatshock 
at 2, 3, 5, 9, 24, and 48 hr after heat treatment. The 
first abnormalities in the egg chambers were observed 
3 hr after the heatshock. The eggs laid during the first 
3 hr following heatshock also have a very high hatch 
rate, presumably being sufficiently differentiated at the 
time of the heatshock for ectopic BR-C expression to 
have no effect. The results over this period do not differ 
significantly for the control heatshocks (Table 2). The 
strongest effect was observed between 4 and 6 hr. It 
was observed that extra dorsal appendage material was 
produced in the dorsal-anterior region of the eggshells 
(Figure 4, B—F). In most cases, dorsal appendage mate-
rial appeared in the dorsal gap between the two append-
ages. It condensed at the base of the dorsal appendages 
and less material was deposited in the appendages them-
selves. The dorsal appendages did not elongate properly 
(Figure 4, B—D) , presumably clue to it failed migration 
of the follicle cells. Different phenotypes have been 
observed, depending on the stage of the egg chamber 
at the time of heatshock (Figures 4 and 5). I-Ieatshock 
at the time of dorsal appendage formation, stage 11, 
leads to the "appenclageless" phenotype or to small 
fused appendages (Figure 4, B and Q. Appendages with 
abnormal shapes and/or different lengths have been 
observed on eggs at stages 12 and 13 at the time of 
heatshock (Figure 4, 1)—F). These observations indicate 
Him ectopic ZI can induce formation of ectopic dorsal 
appendage material. Nevertheless, the ectopic dorsal 
appendage material is restricted to the dorsal anterior 
eggshell, suggesting that the fate of the follicle cells is 
predetermined along the two major axes prior to the 
requirement for BR-C function in this process. It was 
hypothesized that the lack of BR-C expression in the 
dorsal-most follicle cells is clue to high levels of expres-
sion of pointed (pot) in those cells (DENC and BowNes 
1997). The data shown here indirectly support this hy-
pothesis. In the dorsalmost follicle cells, there could he 
competition between the expression of Pni and BR-C. 
When high levels of Put are expressed, BR-C expression 
is inhibited in these cells. However, in heatshock lines, 
the BR-C expression would overcome the inhibition by 
Pnt. Thus, dorsal appendage material can he synthe-
sized by these cells. 
Although Zi seemed to be the sole BR-C zinc-finger 
isoform expressed at high levels during oogenesis when 
analyzed by in situ hybridization, we tested Z2, Z3, and 
Z4 to determine if they exhibit it similar phenotype 
when ectopically expressed during oogenesis. Thus, 
hsp70/Z2, hsp76/Z3, and hsp70/Z1 flies were heat- 
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TABLE 2 
Effect of heatshock on Z1-Z4 transgenic flies 
No. of 
Fly eggs Abnormal Eggs 
Experiment 	stock 	laid 	eggs (%) 	hatched (%) 
0-3 hr ZI 172 5.8 94 
Z2 144 2.3 96 
Z3 134 1.5 98 
Z4 80 5.0 96 
w"°  364 1.6 98 
OrR 94 2.1 99 
3-5 hr Zi 27 74 2 
Z2 68 55 8 
Z3 4 0 25 
Z4 23 43 4 
w"°  137 2.5 97 
OrR 117 2.7 96 
5-24 hr ZI 10 89 6 
Z2 361 78 12 
Z3 27 42 18 
Z4 186 77 15 
I!!X 505 4.4 94 
OrR 363 3.6 98 
24-48 hr Zi 9 62 72 
Z2 670 33 93 
Z3 72 24 90 
Z4 390 18 97 
50 1.3 100 
OrR 370 1.1 99 
Z1-Z4, transgenic flies carrying constructs to miseXpleSS 
the various zinc-linger isoforms of the BR-C in response to 
heatshock; w''' 5, the host line user! for the cnilStruCtiofl of the 
transgenic lines used as a control. OrR (wild-type) flies were 
also used as a control. Approximately 100 flies (50 males 
and 50 females) from each stock were used in the heatshock 
experiments. 
shocked and the eggshell phenotype was examined 
(Table 2). It was found that ectopic dorsal appendage 
material is produced in the dorsal-anterior region of the 
eggshells by all three transgenic lines. This phenotype is 
similar to that exhibited by eggs of the hsp70/Z1 flies 
after heatshock, suggesting that all of the four zinc-
finger isoforms could be functional in dorsal appendage 
formation during oogenesis. 
It is apparent from Table 2 that heatshock has the 
strongest effect on chorion morphology and egg viabil-
ity in /isp70/Z1 flies. Z2-Z4 recovered viability to 95% 
in 2 clays, while ZIE recovered only to 72% during that 
time period. It was also found that heatshocked Zi, Z2, 
and Z4 flies lay abnormal eggs (Table 2). The ectopic 
expression of BR-C in Z3 flies was found to disrupt the 
process of egg development soon after the heatshock. 
We observed that some 20% of all laid eggs have aber-
rant micropyles, due to excess chorion formation. This 
could prevent the sperm entering the egg and hence 
subsequent development would fail clue to lack of fertil- 
ization. Another possible explanation is that ectopic 
expression of BR-C can disrupt some other Bric-a-brac/ 
Tramtrack/Broad Complex (BTB)-containing protein 
that can climerize with the BR-C and thus modulate its 
function. 
I-Ieatshock alone causes eggshell defects. The data of 
the control experiments with the heatshockecl wild-type 
OrR flies and zo''', the host line for the transgenic flies, 
is presented in Table 2. We observed in the few abnor-
mal eggs wide-branched dorsal appendages of approxi-
mately normal length. it is quite clear that the results 
of misexpressing BR-C in oogenesis significantly affects 
the eggshell. 
Other zinc-finger isoforms are expressed in oogen-
esis: Although only Zl expression was clearly observed 
by in situ hybridization we observed defects in chorion 
formation and morphology by overexpressing all four 
zinc-finger isofortns available. It became essential, there-
fore, to establish if this was due to some degree of 
functional redundancy between the isoforms with re-
spect to eggshell development or if the other zinc fingers 
are, in fact, expressed at lower levels in oogenesis. To 
check this we used RT-PCR using primers for Zi, Z2, 
Z3, and Z4 and the core DNA binding domain. The 
organization of the zinc-finger isoforms in relation to 
the BR-C is shown in Figure 1. The primers used are 
illustrated in Figure lB and should generate products 
of 974 hp, 780 hp, 728 hp (Zi); 320 h1) (Z2); 784 hp 
(Z3); and 1082 bp (M), respectively, based on published 
data (HoDG11- rs et at. 1995; BAYER et al. 1996b). The 
results clearly show that all four zinc fingers are ex-
pressed in oogenesis (Figure 6). The identity of the PCR-
generated products was confirmed with Southern Not 
analysis. 
It seems likely therefore that, as in metamorphosis, 
all zinc-finger isoforms are expressed and function to 
regulate downstream gene expression. However, only 
Zi is expressed at a high-enough level to detect the 
spatial distribution of the RNA and protein in oogenesis. 
Ectopic BR-C expression during mid-oogenesis affects 
endoreplication and chorion gene amplification: Er-
topic BR-Cexpression appears to induce premature pro-
duction of the chorion. Figure 5, C and D, shows that 
the chorion is already present in stage-i 1 egg chamber. 
This could isolate the oocyte from the nurse cells and 
physically prevent dumping of the nurse cell compo-
nents into the oocyte. This could result from an altered 
pattern of transcription and translation of the chorion 
genes, or from abnormalities in amplification of the 
chorion genes, or both. We investigated, therefore, 
whether the alterations in BR-C expression affected the 
timing or pattern of chorion gene amplification. Since 
the chorion is synthesized by most follicle cells, this 
function could he related to the earlier expression of 
the BR-C. To monitor amplification we investigated the 
incorporation of BrdU in the follicle cell nuclei of wild- 
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I'icuRi: 4.—Flctopic expression of different 
BR-C zinc-finger isofoims (luring oogenesis. 
A—F, dark-field microscopy. (A) A wild-type egg 
after heatshock treatment. (B and C) Two distinc-
tive hs1570/Z] (527-5 and 708-1) transgenic lines 
exhibit a similar phenotype. Dorsal appendage 
materials are presem in the dorsalmost region, 
resulting in fused, thickened, and shortened dor-
sal appendages. (D-F) A similar, brit less severe, 
eggshell phenotype in hs1)70/Z1 tlics; see cxplana-
6011 in the text. Fused, thickened, and irregularly 
slialxdl appendages are also found in eggshells 
produced by the Z2, Z3, and Z4 transgenic lines. 
type ovaries and in ovaries misexpressing various iso-
li)rmS of the BR-C. 
In wild-type ovaries, after eight mitotic cell divisions, 
the endoreplication phase of the follicle cell develop-
ment of oogenesis begins (stage 6), and is completed 
by stage lOB; during this process the entire nucleus is 
labeled by BrclU. The endoreplication is asynchronous 
in wild-type and w"' (the host strain used to produce 
the transgenic lines) ovaries and occurs in both nurse 
cells and follicle cells (Figure 7, A and Q. We observed a 
continuous endoreplication in the nurse-cell-associated 
follicle cells at stage lOB (Figure 7C). This is followed 
by the chorion gene amplification phase when 4 spots 
of incorporation are seen per nucleus in the follicle  
;ells overlying the oocyte (Figure 7, C, G, and K). These 
4 spots represent amplification of the two clusters of 
chorion genes (Figure 7, G and K). Two are always 
larger, presumably due to the higher level of amplifica-
tion of the cluster on chromosome 3 compared to the 
X-chromosome cluster (OlR-WEAVER and SPRADI,ING 
1986; DF:1,IDAKIS and KAFAFOS 1989). This amplification 
was first observed at the border between the oocyte and 
nurse cells and it soon spread to the rest of the follicle 
cells. When the BR-C isoforms are misexpressed, there 
is prolonged and synchronized endoreplication until 
late stage lOB, followed by specific amplification of 
genes in each nucleus (Figure 7, D, F, H, and L). These 
results are observed from 3.5 to 4.5 hr after heatshock. 
Fu;utr 5.—Ectopic BR-C expression affects the 
onset of chorion synthesis. A-D, Floechst staining; 
Cl —Dl , dark-field nucroscopy. (A) A wild-type egg 
chamber at late-stage I I . The oocyte is larger than 
the nurse cell complex due to the ouset oh nurse 
cell dumping into the oocyte. (B) Wild-type egg 
chamber, late stage 12. Dumping is complete. 
C—Cl (late stage 11) and D—D 1 (late stage 12) 
show that transgenic Z1—Z4 also causes inappro-
priate chorion synthesis (arrows), and this blocks 
clumping of the nurse cell cytoplasm into the oo-
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FIc;UISE 6.—PCR analysis of the BR-C 
transcripts in Drosophila melanogasler 
(wild -type, Oregon R) ovaries. Total 
RNA from ovaries was reverse tran-
scribed and the subsequent cDNA PCR 
amplified using the primer pairs shown 
with arrows below the exon map (Fig-
ure 111). All four PCR reactions were 
carried out with a common primer lo-
cated at the 3' end of the core do-
main of BR-C. The other primers are 
I ( catecl just within, or immediately 3' 
to, the respective Zl-Z4 domain. M, 
marker-1-kh ladder (Gibco [WI.); Ov. 
ovaries: I., larvae (whole organism) 
med as a control. The primer sets geim-
erate the Il lowing products from Iran-
scribed larvae RNA: 974 hp. 7$)) hp, 
72$bp (Zi ): 320hp (Z2); 7841)9 (Z3); 
1082 bp (Z4). The PCR does not getter-
ate the 728-bp ZI product Ir()nm I Ian-
scrihed ovarian RNA, indicating the 
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We also observe extra spots of incorporated BrcIU in the 
nuclei (Figure 7, H and L). There were three possible 
explanations for this: either the heatshock could he 
responsible, the homologues of- the chromosomes could 
have separated due to a defect in the cell cycle, or there 
could he amplification of DNA at additional sites in the 
genotne. The host flies used to produce the transgenic 
lines, w''' 5, were heatshockecl and still showed 4 spots 
per nucleus, so heatshock itself was not responsible for 
the results. We counted the number of spots per nucleus 
and found 6 or 12 spots in '80% of the nuclei. Occa-
sionally we observed up to 28 spots. If the cell cycle was 
affected, and the homologues had separated, we would 
expect to see many more than 28 spots per nucleus clue 
to the polyploidy of the follicle cells. If the amplification 
sites varied we could not predict the numbers, and in-
(eed it may well be variable. This suggests that there 
are other sites in the genome induced to replicate by 
BR-C overexpression. We conclude that the encloreplica-
tion of DNA and the amplification of the chorion genes 
depends upon the BR-C encoded proteins or an un-
known protein that is encoded by one of the clown-
stream targets of the BR-C. This observation is consistent 
with the report that a mutation in the BR-C locus causes 
premature arrest of chorion gene amplification (HUANG 
and ORR 1992). 
Ectopic BR-C expression in relation to chorion gene 
expression: The chorion is produced by the columnar 
follicle cells to provide a shell around the egg. Later in 
oogenesis, two groups of cells migrate anteriorly to pro-
duce the chorionic appendages and very large amounts 
of chorion material. Ectopic expression of the ZI isoforms 
leads to chorionic appendage deposition by extra cells 
lying at the anterior of the egg filling in the micldorsal 
gal) observed in wild-type eggs. Often the follicle cells 
fail to migrate anteriorly over the remaining nurse cells  
at stage 11 and they are present, therefore, at a more 
posterior position. The pattern of diorion gene expres-
sion was compared in wild-type ovaries and in those 
expressing the ZI isoform ectopically. In the wild type, 
we observe a high concentration of chorion transcripts 
in all follicle cells at stage 9, prior to their translation; 
they then become inactive and transcripts are again 
seen its stages 11-11 (Figure 8, A, C, E, and G). In the 
ovaries with ectopic BR-C' gene expression, examined 
3.5-4.5 hr after the heatshock, the same high concentra-
tion of chorion transcripts is observed in anterior follicle 
cells, even though their location in relation to the nurse 
cells is more posterior. This suggests the expression 
pattern is not dependent on the BR-C along the ante-
rior-posterior axis (Figure 8, B, D, F, and H). Moreover, 
posterior follicle cells do not produce substantially more 
chorion material even though they express ZI protein 
after heatshock. The fact that more dorsal cells produce 
appendage material and express the chorion genes 
means that BR-C expression in the most dorsal anterior 
cells does induce additional chorion production. Thus 
we observed two different effects. initially the ectopic 
expression of BR-C prevents the migration of the dorsal 
follicle cells in an anterior direction. Then the midline 
cells that normally express chorion protein at that stage 
start depositing chorion material in the wrong location. 
This results in the production of aberrant dorsal ap-
pendages. It is possible that the BR-C activates down-
stream genes which, in turn, activate the chorion genes. 
Its anterior cells high levels of BR-C expression "win" 
over trans-acting repressors, but in posterior cells they 
do not. The in situ hybridization results and the oh-
served characteristic phenotypes following ectopic BR-C 
expression are both consistent with this observation. 
Alternatively, BR-C could he essential for the cell migra-
tions to position the follicle cells and encloreplication 
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Fu;urE 7.—Cliorioti gene amplification. Bidi.] 
incorporation associated with eiitlorepiication 
and amplification. (A) Brd 1) incorporation in the 
nuclei of wild-type Drosophila (Oregon R) ovaries 
and w' °, the host strain used for the produclion 
of the BR-C' transgenic lines at stage bA. The 
cnclocvcles are not synchronized. Thus, just some 
of the nuclei are positive. (C.uxi ri (1!. 1998). 
(B) Overexpression of a Jfk-C (Z I) lransge'tte in 
ovaries at stage I OA. Most of the' nuclei show svn-
chronized cud aeplicat iOfl. (C) Normal svttcliro-
tiii.ed amplification in wild type and w''° at stage 
lOB. By that time the etidore'plication associated 
with the main body follicle cells is completed. (I)) 
Brd Ii incorporation in t I te t I ttele i of he-atsia cke'd 
BR-C (Z I) trauisgeitic ovaries, stage 10B. Strong 
BrelU incorporation is present in the nurse cells. 
(U) Higher magnification of is iIeI-typc and w''° 
nuclei at stage lOB to show the four spots of anipli-
fication normally occurring in wild -type ovaries. 
(II) BrclLf incorporation in the nuclei of BR-C 
(ZI ) cxpressing ovaries 3 hr :ofui-'r thu licalshock, 
stage 10B. Some of the n nclei ci in tail I extra spots 
(If replicatl()u1. 1 lie amplification pattern overlaps 
with the labeling due to coiitiuitted eitdoueplica-
tion. (F—K) lbc nuclei of heatsliocked ''° ova-
ries still show fottr spots of amplification. (F—I-) 
The nuclei of BR-C (7.1) transgeiiic ovaries 4.5 lit 




of the chorion genes bitt not in regttlating chorion gene 
expression. 
DISCUSSION 
The BR-C complementing groups and zinc-finger iso-
forms: It has been shown by genetic analysis that i-hp 
function is required for dorsal appendage formation, 
and it was observed that Zl is the sole zinc-finger isoform 
expressed at high levels in the appendage-prodttciiig 
cells. These observations are compatible with the report 
that 7.1 provides ibp function (ftvi-;t et (If. 1997). It 
was also found that )-bp Junction is partially provided 
by Z4, bctt is not provided by 7.2 and Z3 (BAYER et (f. 
1997). However, heatshock-induced expression of all 
four zinc-Finger isoforms (Zi Z2, Z3, and Z4) leads to 
a similar phenotype of extra dorsal appendage tisttetial 
production in the' dorsal gap, indicating that the differ-
ent transcripts may stibstitute fOr eat-h other functionally 
in dorsal appendage fonnatiots. 
The hounotygotts viable nstttant hr'wts the first tilutant  
identified in the BR-C locus. It exhibits a broad wing 
phenotype and fails to complement other imitations 
that are categorized in the hr cotsipiementation group. 
However, the complementation analysis presented in 
this article suggests that the hr' mutations also partially 
remove clip function. Therefore, it is in fact a 2Bah allele. 
It is known the 2Bah mutations cause reduction of both 
Z I and Z2 expression. Thus in the br'Ibr 117  and br'/ opt 6 
females, both ZI and 7.2 are reduced. The reduction of 
7.1 levels results in the re'eltie- tion of dorsal appendages, 
while no effect is proclitcecl by the reduction of 7.2 levels. 
This is \vli)' no defects were observed in eggs ptDelttceel 
by hr'/b)` and hr'/ hr' females. 
The mutant phenotypes clearly show the need for the 
BR-C in chorionic appendage formation. PCR experi-
nients have shown that all zinc-finger isoforuns are its 
fitct expressed in oogenesis, but as yet we have no evi-
dence that they perform different Functions. Neither 
do we 1(110W the spatial and temporal clistribtution of 
7.2-1.4, which are' 1101 present at sttfliciently high levels 
for detection by in si/u hybridization. Ovetexpression 
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Wild-type ovaries 	 Zi transgenic ovaries (heatshocked) 
Fi.i Ri 	.—In sila hvhi idiiatioti 10 chorion 
l.'s\ in 0\dtI(S. (\.(.F..() Iasi/Ii li\I)ri(li/1iiII)li 
-eg 
 (	ih l (11)1 ((hI hybridizing iii chorion tuRN 
Y 
Il wld tsp (( )i 
DIG-labeled 	
..,oti It) Drosophila Ovaries with t 
The chorion probe. 7C5, was generated ruin 
fl\.\ encudini. the 18 (110111)15 jWntCiil, which 
lt11S to the \ cliii ((ill (SI line. Similar results were 
A 	 stIl 	B 	 stil 	OhiJitiC(l using the alternative 7117 probe It DNA 
encoding c15 protein), wltieli mi)s to a site on 
j
the third C1lInii)0S(liiit. For illOiC information 
about the pwhes see SPR\ni i's, t ii/. (1980). (B) 
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stage l 	.i 
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 ill 51 (.,( Itt 1il(i 	
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I unoumi 
- 	 (1) chorion tttR\\ is observed 111 the border he- 
stl2 	D 	" 	 stl2 	1oct11 the itUlse tells and the o0C\iC. The iitiSCX- 
1111SSIIIII I>! lie l'/'-( Iei1 Is to ibio >ntnil 01 glut oil 
- 	 of the anterior 111110 Ic cells. (1)) in sila l)iitCbu 
of* chorion inRNA expi 
rmvS) is forilled at the anterior pole as a ITSUlt Of' 
-ation of' the l'ollicle cells. (F) Strong failed nii,n 
BR-C (Zl) transgenic ovaries, stage 12 A gal) (in-- 
E 	 stl3 	F 	 st13 	hocked BI?-( (1.1) I ralisgi l eie ovaries It siige 
I I The sn-iiiiinits in the egg chamber shape re-
stilt fsiiii the heaishn( k-inhliiee(l iilise\ltl essioti 
of' BR-C. (II) Sttont., continuous expression of 
ieJ 
 
chorion niRNA in dHi( ( I)  
I 	 is 
not 91(5(111 because 1iI5C ilii_ nurse cells have eoiii- 
H 	 - 	
liipi ii . t ileted dii 	and the bIllu -le ells have till- 
G 	 stI4 	 stl4 	gi:ued 0(0(1 us hs the nine ol lieui',liotls. 
studies using transgenic flies carrying heatshock-con-
trollecl Zi and Z4 isoforms lead a failure of proper 
migration of the follicle cells that will secrete the ap-
pendages, premature chorion deposition, and abnor-
mal appendage Formation. 
Relationship between the BR-C and chorion produc-
tion: We have shown here that the BR-C is important 
For controlled DNA replication in oogenesis. Overex-
pression does not affect the timing of the onset of endo-
replication and amplification, but endoreplication is 
prolonged beyond that observed in wild-type ovaries 
and it leads to additional replication sites in the genome. 
These additional sites presumably share sequence simi-
larities with the cis-acting sites regulating chorion gene 
amplification. This suggests that the BR-Cis a key regula-
tor of endoreplication and chorion gene amplification. 
The early BR-C expression pattern is in all the follicle 
cells and it is presumably at this stage that it is involved 
in this function. The expression of the BR-C is first 
observed in wild-type flies at stage 6 and it is also at 
stage 6 that the endoreplication cycles begin. Since we 
did not observe premature endoreplication with BR-C 
overexpression, presumably other components essential 
for endoreplication are absent until stage 6 of oogenesis. 
The active role of the BR-C in endoreplication is also 
apparent from the fact that we observed prolonged in-
corporation of BrclU in the nurse cell nuclei when the 
BR-C is overexpressed. This presumably results in ex- 
pression of the BR-C in the nurse cells, where it is nor-
mall)' not expressed. This shows that the proteins en-
coded by the BR-C can function to prolong replication 
of DNA even in cells where it is not normally used to 
control this process. It also suggests that an alternative 
regulator for DNA replication to the BR-C is used in 
the nurse cells. In normal development, the later BR-C 
expression, which is maintained in the dorsal-anterior 
cells making the appendages, is probably needed for cell 
migration, chorion deposition, and other follicle cell 
differentiation events. 
It is possible that the initial activation of the BR-C 
in all follicle cells is regulated by the ecdysone/USP 
heterodimer (YA0 et al 1992; HORNER ci at. 1995) as is 
observed in metamorphosis. There is also some evi-
dence that in intermoult puffs a second heterodimer 
with DHR38 (a nuclear receptor related to NGFI-B from 
mammals) can compete for the same binding sites 
(CRIsPi et al. 1998), so it is also possible that other DNA 
binding proteins, besides the ecclysone receptor, will be 
involved in BR-C expression. This would suggest a role 
for ecdysone clueing these stages of oogenesis. Later, 
the BR-C could be repressed in specific follicle cells 
by competitive and cooperative interactions with other 
gene products initiated by the grk and dpp signaling 
pathways. There is  significant amount of evidence that 
ecclysone and juvenile hormone [which hinds to ultra 
spiracle proteins (USP)] are important for the progress 
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Of oogenesis (WilsoN 1982; BowNrs 1989, 1994) and 
we have recently shown that there is  control point 
in oogencsis that regulates whether egg chambers will 
proceed with development or undergo apoptosis, which 
is regulated by time balance of juvenile hormone and 
ecdysone (Sor.ri,az et al. 1999). However, there is little 
evidence as to precisely what role these hormones have 
in regulating oocytc development and egg chamber dif-
ferentiation. We have shown that the ecdysone receptor 
is present in the follicle cells at the time BR-Cis activated 
D. M,u(;HuNi;, W.-M. DeN(; and M. BowNt';s, unpub-
lished results) by antibody staining. 
Once activated, as we have shown, the BR-C gene is 
involved in encloreplication, the selective amplification 
of the chorion genes, and in the subsequent mnorpho-
genesis of the chorionic appendages. (Al,vm em' al. (1998) 
have recently shown that the selective amplification of 
the chorion genes is closely linked with the cell cycle 
and the cycles of endoreplication that occur in the folli-
cle cells earlier. Somehow the chorion genes escape the 
rereplication controls that influence other parts of the 
genome. Our BrdU labeling experiments confirm their 
results on the timing of endoreplication and chorion 
amplification and the close association between endore-
plication and selective amplification. Using overcxprcs-
sion of the BR-C we see not only the two extra sites they 
mentioned that may represent another chorion gene 
amplified for a function in later oogeuesis, but also a 
number of additional sites. These may be sites with se-
quence similarity to the cis-acting sites regulating ampli-
fication. CAEvI em' al. (1998) propose that there are ampli-
fication complexes located at chorion genes. Whether 
the BR-C encoded proteins are associated with these 
complexes or regulate the synthesis of one or more of 
their components remains to be elucidated. We have con-
firmed the link between endoreplication and chorion 
amplification and shown that it involves the BR-C. This 
may therefore provide a crucial link between hormones 
and the control of the cell cycle, and hence of clifhrenti-
ation, of the egg chamber during oogenesis. 
In summary, our working model would he that the 
BR-C is activated by ecdysone in all follicle cells at stage 
6 of oogenesis where its key function is the control 
of' endoreplication, and then selective amplification. 
Later, when it is turned off in all but the anterior-dorsal 
follicle cells that will secrete the appendages it has a 
second set of functions and is involved in the migration 
of cells and morphogenesis of the chorionic append-
ages. Recently this link between ecdysone, the BR-C, 
and morphogenesis has also been described for the 
progression of the furrow in the developing eye imaginal 
disc of Drosophila (BRENNAN em' (1!. 1998). 
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Identification and Phylogenetic Analysis of Drosophila inelanogaster Myosins 
George Tzolovsky, Hadas Millo, Stephen Pathirana, Timothy Wood, and Mary Bownes 
Institute of Cell and Molecular Biology, University of Edinburgh 
Myosins constitute a superfamily of motor proteins that convert energy from ATP hydrolysis into mechanical 
movement along the actin filaments. Phylogenetic analysis currently places myosins into 17 classes based on class-
specific features of their conserved motor domain. Traditionally. the myosins have been divided into two classes 
depending on whether they form monomers or dirners. The conventional myosin of muscle and nonmuscie cells 
forms class II myosins. They are complex molecules of four light chains bound to two heavy chains that form 
bipolar filaments via interactions between their coiled-coil tails (type 11). Class I myosins are smaller monomeric 
myosins referred to as unconventional myosins. Now, at least 15 other classes of unconventional myosins are known. 
How many myosins are needed to ensure the proper development and function of eukaryotic organisms? Thus far, 
three types of myosins were found in budding yeast. six in the nematode Ccie,,orhobditis elegans, and at least 12 
in human. Here, we report on the identification and classification of Drosophila inelanogaster myosins. Analysis 
of the Drosophila genome sequence identified 13 myosin genes. Phylogenetic analysis based on the sequence 
comparison of the myosin motor domains, as well as the presence of the class-specific domains. suggests that 
Drosophila myosins can be divided into nine major classes. Myosins belonging to previously described classes I. 
it, III, V, VI. and VII are present. Molecular and phylogenetic analysis indicates that the fruitfiy genome contains 
at least five new myosins. Three of them lull into previously described myosin classes I. VII, and XV. Another 
myosin is a homolog of the mouse and human PDZ-containing myosins, forming the recently defined class XVIII 
myosins. PDZ domains are named after the postsynaptic density. disc-large. ZO- 1 proteins in which they were first 
described. The fifth myosin shows a unique domain composition and a low homology to any of the existing classes. 
We propose that this is classified when similar myosins are identified in other species. 
Introduction 
The past decade has seen a significant increase in 
research on myosins. A major effort has been put into 
finding novel members of this family of actin-based mo-
tor proteins. More than 16 classes of myosins have been 
discovered and characterized, and this number is still 
rising (Hodge and Cope 2000; Sellers 2000). These my-
osins are often referred to as unconventional (Mooseker 
and Cheney 1995). The total number of known myosins 
is 17 if the conventional two-headed filament forming 
myosin II is included in the classification. Myosins have 
been identified in a wide variety of eukaryotic organ-
isms. Some myosin classes are found in phylogeneti-
cally diverse organisms, whereas others, which have 
arisen later in evolution, have been found in only a sin-
gle organism (Hodge and Cope 2000). 
Current research concentrates on the functional 
analysis of these new types of myosins. A number of 
studies suggest that these motors play important roles in 
a variety of cellular functions, including organelle, RNA 
and protein transport, maintenance of the cell architec-
ture, cell movements, and signal transduction (table 1). 
All known myosins comprise an N-terminal head 
domain, a neck regulatory domain, and a specific car-
boxy-terminal tail domain (fig. I) (Mooseker and Che-
ney 1995). The head or motor domain contains ATP-
and actin-binding sites and is responsible for the mech-
anochemical properties of the protein (Gilbert and 
Mackey 2000). Myosins show an actin-stimulated Mg2  
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ATPase activity, thus converting the energy stored in 
ATP into mechanical force (Volkmann and Hanein 
2000). The latter is used to move the myosin molecules 
along the actin filaments or to translocate other mole-
cules (Hasson and Mooseker 1995; Langford 1995). 
The neck domain contains regulatory sites, com-
posed of IQ (isoleucine-glutamine) motifs, repeats of 
23-30 aa (Mercer et al. 1991: Rhoads and Friedberg 
1997). Each IQ motif provides a binding site for a cal-
modulin or a related protein of the EF-hand family (Ka-
wasaki, Nakayma, and Kretsinger 1998). EF proteins 
have helix-loop-helix motifs in which the loop contains 
highly conserved residues that bind Ca2 ions. The size 
of the neck domain varies from one to seven IQ tandem 
repeats. In addition, the neck is often the site of alter-
native splicing. This produces necks with variable 
lengths (variable number of IQ repeats), which are as-
sociated with the regulatory function. In general, cal-
modulin activates a diverse group of target cellular pro-
teins when bound to Ca2 . Interestingly, most of the 
unconventional myosins carry IQ motifs that bind cal-
modulin with higher affinity in the absence of Ca 2+. 
After the neck domain, each myosin has a highly 
divergent tail domain. A subset of myosin tails has pre-
dicted coil-coil cr-helical domains, which promote the 
formation of dimmers, a typical example being the two-
headed conventional myosin II. Some other myosins 
lack coiled-coil domains but contain structural domains 
found in other proteins (table I). 
The classification of myosins is based on the se-
quence comparison of their core motor domains (myosin 
head), equivalent to amino acids 88-780 of chicken 
skeletal myosin II (Cope et al. 1996). The motor domain 
is highly conserved among all myosins. reflecting the 
high conservation of its function. However, they have a 
number of class-specific features (characteristic inserts 
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1 (monomer) TH I, GPA or GPQ, and SH3 Vesicle transport, cell growth, 
and cell motility 
I (monomer) THI Function in the microvilli of the 
brush border 
1 (monomer) TH 1 Epithelial morphogenesis and 
hair cells function 
I (monomer) TH I Epithelial morphogenesis 
CC Smooth or skeletal muscle con- 
traction 
CC Maintainance of the cell archi- 
tecture, cell motility, and 
phagocytosis 
N-terminal protein kinase Role in prototransduction 
MyTH4 and SH3 7 (Only in Ac'onthwnoebo spe- 
cies) 
CC, transmembrane, specific C- Membrane trafficking, polarized 
terminal globular domain cell growth, vesicle, protein 
and/or mRNA transport 
CC, reverse -car, specific C-tar- Vesicle transport, epithelial 
minal globular domain morphogenesis, and stereocil- 
ia function. Spermatid indi- 
vidualization. Moves toward 
the "-" end of actin fila- 
ments 
CC, MyTH4, FERM. and SH3 Membrane trafficking, hair and 
photoreceptor cells function 
CC, serine rich domain, specific Cell wall function in plants. in- 
C-terminal domain tracellular transport 
N-terminal extension, zinc bind- Signaling (GTPase activating) 
ing. and Rho-GAP domains 
CC. PH, MyTH4, FERM Localized to regions of dynamic 
actin. Signal transduction 
CC 
	
Vesicular transport in plants 
CC, N-terminal extension, and 
	
(In C. elegons only) 
MyTH4 domains 
7 (In plants only). 
(In To.voplasioo and Plasmo-
dium species) 
N-terminal extension MyTH4, 	Hair cell function 
FERM. and SH3 
Ankyri ii repeats 
	
Neuronal cell migration 
Chitin synthase domain 
	
7 (In Pv,'iculario and Eu,iricella 
species) 
CC, KE, and PDZ domain 
	







2 (dimer) ? 
2 (diner) ? 
2 (dimer) ? 
1 (monomer) 
2 (dimer) 7 
2 (dimer) 7 






2 (dimer) 7 
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Table I 
Domain Structure and Function of Myosin Classes 
Class 	 Number of 	 Number of Heavy 	Other (N- and C-terminal) 
Myosins IQ Motifs Chains 	 Domains 	 Function 
Subclass I ......One or two IQ 
Subclass 2 ......Three to six IQ 
Subclass 3 ......Three IQ 
Subclass 4 ......Two IQ 
II 
Muscle .........Two IQ 
Nonmuscle ...... Two IQ 
III ...............One or two IQ 
IV ...............One IQ 
V................Six IQ 
VI ............... 	One lQ 
VII 	..............Four or five IQ 
VIII 	.............Three or four IQ 
IX ...............Four to six IQ 
X................Three IQ 
XI ...............Five to six IQ 
XII 	..............IQ? 
XIII 	.............Four to seven IQ 
XIV .............IQ'? 
XV ..............Two to three IQ 
XVI 	.............Two IQ 
XVII ............. IQ ? 
XVIII ............One or two IQ 
NoTI:.—The number of heavy chains reflects their ability to dimerize (based on coiled-coil predictions). Key to doiutain abbreviations: IH I . Tail Homology 
Basic I domain: GPA, giycine-piotinc-alanine---rich domain: GPQ, gtycinc-proline-glutaminc—rich domain: S1-13. 'l'ail l-tonuology 3 domain (hinds to pioiiie-rich 
motifs): CC, coiled-coil; MyTH4, Myosin Tail Hontology 4 domain: Rho-GAP domain (activates siuiatt GTPases of the Rho family): Pt-I, Pteckstrin Homology 
domain: KE. tysimue-glutammute—rictu domain PDZ or DI-IR (Dig homologous region). For recent reviews on the structure and properties of the unconventional myosins 
see Wu, Jung, and Hammer (2000), Oliver, Berg, and Cheney (1 999), Baker and Titus (19911). and Mermall, Post, and Mooseker (19911). In the construction ot this 
table, data were used from these reviews, the ntyosin home page, and Cope et at. (1 996). 
or substitutions), which might be important in defining 
the precise function of a given myosin. For further in-
formation see the Myosin home page at http://www. 
rnrc-lmb.cam.ac.uk/myosin/myosin.html (Hodge and 
Cope 2000). Phylogenetic analysis of the tail domain 
sequences produces similar results, indicating that heads 
and tails have coevolved (Korn 2000). 
Five myosin genes have been identified in yeast 
(Saccharomvces ceret'isiae), falling into three classes: 
two class I myosins, one class 11 myosin, and two class 
V myosins (Brown 1997). It was suggested that the 
whole yeast genome had undergone a duplication in an-
cient times, followed by a number of modifications. As 
a result, a small fraction of the genes were retained in 
duplicate (most of them being deleted), thus explaining 
the loss of the second myosin I]gene (Wolfe and Shields 
1997). Sacc'haromyces cerevisiae is the organism with 
the lowest known number of myosin genes. This dem-
onstrates that a eukaryote can function with a set of only 
three types of myosins. 
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FIG. 1—Schematic diagram of the domain structure of Drosophila myosins. (A) The previously described Drosophila myosins. Their sequence 
and structure have been studied and confirmed. For DNA and protein accession numbers see table 2. (B) The live new or previously unchar-
acterized Drosophila myosins. Their domain structure is based on the predicted cDNAs for these myosins (see table 2). The presence of sonic 
domains (e.g., the PDZ domain in Mhcl myosin) was verified with RT-PCR. A color key to the domain nanics is given on the left. Some of 
the names are abbreviated: MyTH4, Myosin Tail Homology 4 doniain; FERM Band 4. 1 . eirin, radi sin, moesin-homology domain; QPA, 
glutamine-proline-alanine—rich domain; PDZ, a domain with potential for targeting membrane sites. 
Multicellular organisms have the ability to express 
some 10-40 myosin genes encoding at least six types 
of myosins. It seems that multicellular organisms require 
a multitude of specialized myosins. This has raised the 
question of what is the degree of functional redundancy 
between the classes and between the members of a given 
myosin class. 
So fat; II myosin genes have been identified in the 
slime mould Dictvosteliu,n di,rcoideum. Despite the fact 
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FIG. 2.—Polytene chromosome position of D. inelanoga.ster my-
osin genes (based on the data provided by the Berkeley Drosophila 
Genonie Project). The figure presents all myosin genes, new and pre-
viously identified. in relation to their chromosomal locations. So far, 
no myosin genes have been found on the fourth chromosome. 
that this is one of the simplest multicellular organisms, 
it expresses a diverse set of myosin genes (Soldati. Geis-
sler, and Schwarz 1999). They encode at least six dif-
ferent classes of highly specific myosins. There are six 
class I myosins (MyoA, B, C, D. E, K, and probably 
MyoF) and one member each of class 11 (MhcA), class 
VII (Myol) (Titus 1999), and class XI (MyoJ) (Hammer 
and Jung 1996). The highly divergent MyoM is still to 
be classified (Schwarz, Geissler, and Soldati 1999). 
Fourteen myosin genes have been identified in the 
nematode Caenorhahditis elegan.v (Baker and Titus 
1997). They encode two structurally distinct class I, six 
class II, one class V, two class VI, one class Vii, and 
one class IX myosins. It was found that C. elegans has 
a highly divergent type of nlyosin, which is the founding 
and only member of class Xli myosins. 
The situation with vertebrates appears even more 
complex. They express some 40 myosin genes grouped 
into 12 classes, hi humans, there are 8 class I, 16 class II, 
2 class III, 3 class V. I class Vi, 2 class VII, 2 class IX, 
I class X, 2 class XV, and I class XVI myosins (Hasson 
et al. 1996; Berg et al. 2000; Berg, Powell. and Cheney 
2001). Recent studies have discovered two PDZ-contain-
ing myosins (Furusawa et al. 2000), as well as a novel 
unclassified myosin (Berg. Powell. and Cheney 2001). 
PDZ domains are named after the postsynaptic, disc-large, 
ZO-1 proteins in which they were first described. 
In Drosophila eight different myosin genes have 
been described thus far (figs. IA, 2, and table 2). There 
are two class I myosins, members of subclass 3 (myosin 
IB) and subclass 4 (myosin IA) (Morgan et al. 1994: 
Mooseker and Cheney 1995; Morgan. Heinzelman, and 
Mooseker 1995). Only a single muscle myosin 11 gene 
was found in Drosophila (Hastings and Emerson 1991; 
Bernstein and Milligan 1997). It encodes more than 13 
protein isoforms with complex temporal and spatial ex- 
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Table 2 
A List of Drosophila inelanogaster Myosins 
Chromosome C,enom ic DNA 	m RN A 	 Protein 
Gcnc-Protein 	Class 	Position 	Length (hp) Length (bp) Length (as) 	 EST 
Myo$IDE I 	2L (31E3-6) 	AE003628 
(CG743 8) (15,084) 
Myosin IA . 
M'oóIE I 	3L (61F6-7) 	AE003471, 
(CG9155) 5 AC005847 
Myosin lB . . . . (5,057) 
Mvo95E I 	3R (95EL4) 	AE003746 
(CG550 I) (4.604) 
Myosin IC .... 
zip (zipper) II 2R (60E7-8) AE003465 
(CGl5792) 5 (21,711) 
Non muscle 
myosin-11 ..... 
Mvo (CC 17927) II 2L (36A8-9) M61229, 
Myosin heavy AE003652, 
chain AC005 119 
(22,663) 
ninoC (CG5 I 25) III 2L (27F5-6) AE0036 17, 
(Nina C J03131 
Protein) ....... (7,220) 
ditht,n (CG2146)5  V 2R (43Dl-3) AC004280, 
Myosin V AE003841 
(8,217) 
1(11 (jaguar) VI 31Z (95F1-2) AE003747 
(CG5695 5 (6,312) 
Myosin VI . 




Mvo28/31 VII 2L (28B3- AE003618, 
(CG6976) Cl) AC005834 
Myosin VIIB . . (10,519) 
MvolOA XV X (IA!) AE003484 
(CG2 174) (10,235) 
Myosin XV 
Mh(-1 (CGI0218) XVII! 3R (89137) AE00371 I 




Mro29/) 2L (29D!) AE003621 






































Nore.—Myosins denoted with * have been previously identified and characterized. The others resulted from the analysis of published genomie sequence or 
Drosophila nu'/anogaOe,- and molecular studies undertaken in this study. The classification is based on domain and phylogenelic analysis of the predicted niRNAs 
For these myosins. In several cases the presence or absence of* certain motifs was verified by RT-PCR (for detailed explanation of this, see text). The accession 
numbers show the most recent and complete sequence reports on the presented myosins. ESTs lilr all of the predicted genes have been identified and partially 
sequenced. In the case of Mhc/ the presented mRNA sequences were combined and the three longest transcripts shown. 
pression patterns (Bernstein and Milligan 1997; Zhang minal tails and show differential expression patterns (Por-
and Bernstein 2001). Drosophila has a second myosin 11 ter et al. 1992; Li, Porter, and Montell 1998). A single 
gene that encodes a cytoplasmic nonmuscie myosin (Kie- myosin V gene, with at least two different splice forms, 
hart and Feghali 1986: Mansfield ci al. 1996). The found- was identified in Drosophila (Bonafe and Sellers 1998: 
in- member of' class Ill myosins was discovered in Dro- Maclver et al. 1998). Kellerman and Miller (1992) cloned 
sophila (Montell and Rubin 1988). The ninaC-Ill gene a novel unconventional myosin from Drosophila—the 
encodes two isoforms resulting from alternative RNA first member of class VI myosins. The gene produces 
splicing. These differ in the composition of their C-ter- multiple protein isot'orms, which are present throughout 
Myosins of Drosophila Ine/c1nooste!- 1045 
Drosophila development (Kellerman and Miller 1992; 
Mermall and Miller 1995: Deng, Leaper. and Bownes 
1999; Hicks et al. 1999). Drosophila myosin VItA was 
the first member of this class to be described (Cheney. 
Riley. and Mooseker 1993: Kiehart et al. 1998). 
While this manuscript was in preparation, another 
paper dealing with Drosophila myosins was published 
(Yarnashita. Sellers, and Anderson 2000). The data from 
both research groups is complementary, with our man-
uscript focusing in detail on the molecular analysis and 
domain structure of the myosins. 
Materials and Methods 
Analysis of the Drosophila Genome—Analysis and 
Manipulation of Sequences 
We have used the completed D. inelanogaster Ge-
nome Project to determine the number of myosin-en-
coding genes in this species and to classify them. The 
new myosin genes were identified by comparing the 
Drosophila genome sequence with the conserved head 
(equivalent to amino acids 88-780) of the chicken skel-
etal myosin El. Comparison with the GenBank Data Base 
was done using the BLASTP algorithm of the National 
Center for Biotechnology Information (NCB 1) (http:// 
www.ncbi.nlni.nih.gov/BLAST/). the Pole Bio-Infor-
niatique Lyonnaism server (http://phil.univ-lyon I .fr/ 
BLAST/blast.html). and The Berkeley Drosophila Ge-
nome Project BLAST (http://www.fruitfly.org/blast/). 
This search retrieved the eight previously described my-
osin genes as well as three new genes: Mvo 28B1 
(AAF52536), MyoIOA (AAF47980). and Mhcl (or 
Mvo89B) (AAF5527 I). Subsequent detailed analysis 
was done using the conserved head or specific tails from 
all known classes of myosins to search the translated 
Drosophila genome sequence (TBLASTN on the NCBI 
server). These searches identified two other sequences 
highly similar to myosins: Mvo29D (AAF52683. 
AF454348) and Mv05E (AAF56246, AF454350). 
Domain Analysis—Multiple Sequence Alignment 
The domain structure was predicted with the Simple 
Modular Architecture Research Tool (SMART) server 
at http://smart.embl-heidelberg.de/ (Schultz et al. 1998). 
the Pfam HMM database at http://pfam.wustl.edu/ 
hmrnsearch.shtml or http://www.sanger.ac.uk/Software/ 
Pfamlsearch.shtml (The Sanger Centre), and the ProFile 
Scan Server of ISREC (Swiss Institute for Experimental 
Cancer Research) at http://www.isrec.isbsib.chlsoftware/ 
PFSCAN_form.html. Alignments of the detected do-
mains were performed with CLUSTAL W (Thompson, 
Higgins. and Gibson 1994) available from the Gene 
Jockey H software package distributed by Biosoft or 
from the WEB-based package at http://www2.ebi.ac.uk/ 
clustalw/. Subsequently, the sequences were run on 
WEB-based BoxShade Server (http://ludwig-sun I .unil. 
ch:8080/software/BOX_form.html) and manually adjust-
ed in Microsoft Word 98. 
Coiled-coil regions were predicted with the Paircoil 
program developed by Berger and coworkers (Berger et 
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FtG. 3.—Molecu!ar organization of MVo95E, MroIOA, MhcI. and 
Mvo29D myosin genes. The exon structure of the myosin genes is 
represented by gray boxes. Arrows indicate the primers used in the 
RT-PCR analysis of the gene structure. The length of the predicted 
niRNAs is noted on the left side of the transcript maps .,Shaded boxes 
represent ORFs-, solid boxes represent untranslated sequences (S'UTR 
or 3'UTR): dotted boxes represent the intron sequence in the spliced 
mRNA: wave pattern boxes represent exons from genes located within 
the myosin gene. The gene depicted by IF] and IRl primers is atleast 
a three-exon gene, but for simplicity it is presented with a single box 
here (for more information see text). 
RNA Extraction and RT-PCR 
Total RNA from larvae and adult flies was isolated 
using RNAeasy-Total RNA Kit (QIAGEN, Cat #: 74104). 
The RNA (4 p.g) was primed with Oligo-p(dT)18 and re-
verse transcribed by Superscript II (GIBCO BRL), fol-
lowing the supplier's protocol. For subsequent DNA am-
plification, 2 l out of 20 pA of the first-strand reaction 
mix was used. The PCRs were carried out with appro-
priate pail's of forward and reverse pruners. The position 
of the primers is indicated in figure 3. Primers for 
Mvo95E: EFI (TGT TGC TCG CCA GCA CAT G). EF2 
(ATG GAG CAG GAA ATC GGC AC), EF3 (CAT CAG 
CGG CCT TCC TGA AT). EF4 (GAA GTA CAT AAG 
CGC TGC CT). ER  (AGG CAG CGC TTA TGT ACT 
TC). ER2 (ACA ATT ATC TCC ATG CGG TTC G), 
ER3 (ACG TAG ATG CCT GAA CTA TC). Primers for 
MvoIOA: AFI (GCA GCA ATG AAT CAA CCG GT), 
AF2 (TGA TCT GGT CTG OTT CGA TC), AF3 (TCA 
GTG TCC AGA GGC ATG TG), AF4 (TGG AGT GGC 
GTG CCT GGA). AR  (CAT CTT GTA CGG ATFF CAC 
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CG), AR2 (TCC GCA CGC GCA ACT TCC A), AR3 
(CTT GCG GAA CTC CTG GAC A). Primers for Mhcl: 
MFI (CAA CTT TAT GAA GAA GAG CGC), MF2 
(AAG GCA GCT AGT GAT CAG GC), MF3 (TCG 
CAT AGG ACC CAG CCA G), MF4 (ATG TGG TCG 
GAT AAA AGT GCA), MF5 (GCT CTC AGA TCG 
CAT TAT ACA G), MR  (AGC TCG CAG ATG TCC 
TCG A), MR2 (ACA TGG AGA CAA CCT TCT CG), 
MR3 (TAT ACG GAC GCA GGC GAT AG), MR4 
(TCT TCC AGA TCA CTG ATA GAG). Primers for 
M"o29D: DFI (ATC CGC ACA ACA TTC TGC AC), 
DF2 (ATG CAT CTT CAT CCA ACG AG), DF3 (AAT 
CAC AGC TTC AGC CAC AC), DF4 (GAG ACT GAT 
GCC TTC AAG CAC), DF5 (ACT TTG TGC GCT 
GCA TCC G), DR  (GTC CCG ACA AGT GGA TCA 
6), DR2 (GTG CTT GAA GGC ATC AGT CTC), DR3 
(AGG AAG AGT TGA ACA GAT GGA). Primers for 
genes in the Mhcl gene: IF] (TTA CCT CCA TAA ACC 
TGC GO), 1F2 (GTC GCC GAG CCC GAA GAG). 1F3 
(AAC GTC GCG TTC GCA AGA GG), IRI (AAC GAT 
TCG GAG GTG CAC G), 1R2 (CTA GCT CTG CGA 
AGA TCT CA), 1R3 (COT TCA TGG CTG CTA GTA 
CG). QIAGEN Taq and Stratagene Pfu Turbo Polymer-
ase in a 3:1 ratio were used in the PCR reactions. The 
QIAGEN PCR protocol designed to work with Q-Solu-
tion was followed. The PCR reactions were carried out 
as follows: one cycle at 94°C for 4 mm: 35 cycles, step 
one-94°C for 40 s, step two-60°C for 40 s, step 
three-72°C for 1.8 min per expected kilcbase pair of the 
PCR product: and one cycle at 72°C for 10 mm. The 
obtained PCR products were isolated from Tris-acetate! 
Ethylenediaminetetra-acetate (TAE) gels, purified, and se-
quenced on a 373A automated DNA sequencer (ABI). 
Results 
The BLASTP and BLASTN searches with the con-
servative chicken skeletal myosin II head, against the 
completed Drosophila genome sequence, retrieved the 
previously identified genes and five new myosin genes 
(fig. 1). We selected a limit of 30%-40% identity for a 
myosin to fall into a given myosin class, and 25%-30% 
was considered as the lower threshold for a protein to be 
classified as a myosin. The new myosins (fig. lB) were 
named according to their chromosome position (fig. 2). 
Interestingly, half of the myosin genes are located be-
tween polytene bands 27F-36A, thus forming a myosin 
hot spot on the left arm of the second chromosome. 
In the cases of Mvo 95E, MvoJOA, Mhcl, and 
Mvo29D, we did a detailed analysis of the molecular 
structure of the genes and the transcripts they produced. 
The main reason for this was that the predicted sequenc-
es for these genes encode proteins that produced low 
homology scores to other myosins. They were obviously 
myosins, containing all the conserved sequences and 
structural parts defining them as myosins and at the 
same time showing no more than 15%-29% identity to 
other myosins. This implied either incorrectly predicted 
genes or incorrectly predicted splicing of the transcripts. 
Open reading frames (ORF), S'untranslated regions 
(UTRs), 3'UTRs, and the presence or absence of given  
motifs were tested by RT-PCR and subsequent sequenc-
ing of the products obtained. In these experiments we 
employed an ovarian Uni-ZAP XR library produced in 
our lab, along with cDNAs produced by reverse tran-
scription of RNAs from larvae and adult flies (see Ma-
terials and Methods). As a result, we determined a num-
ber of new myosin sequences and submitted them to the 
MEDLINE Database. The accession numbers for these 
are—Myo95E: AF454350, AF454351, and AF454352; 
MvoIOA: AF454346 (presents a part of the first three 
exons including the 5'UTR); Mhcl: AF454347 (presents 
a part of the first four exons including the sequence 
encoding the PDZ domain); Mvo29D: AF454348 and 
AF454349. Myo28B was not subjected to detailed anal-
ysis because it was found to be almost identical to the 
other myosin VII (crinkled) from Drosophila at both the 
DNA and protein levels. 
To examine the evolutionary relationships between 
members of the myosin family in Drosophila and other 
phylogenetically diverse species, we used two different 
phylogenetic methods. We applied Distant-matrix and 
Maximum-Parsimony methods (PROTDIST and PROT-
PARS from the PHYLIP package) to compare the con-
served head domains. These methods were chosen because 
they tend to outperform other methods (i.e., lower vari-
ance), such as the Maximum Likelihood, when dealing 
with large data sets. The two programs produced trees with 
similar topology (see the unrooted consensus tree in fig. 
4). Multiple sequence alignments were performed with 
CLUSTAL W without corrections for gaps or multiple 
substitutions. Excluding the positions with gaps would 
have omitted a significant proportion of the data, a prob-
lem that occurs when large amounts of input sequences 
are dealt with. CLUSTAL W (GCG software package) is 
provided by the Human Genome Mapping Project Re-
source Centre, Cambridge, at http:!/www.hgmp.mrc.ac.ukl 
(Thompson, Higgins, and Gibson 1994). The reliability of 
the tree structure was checked by bootstrapping (1 .000 tri-
als) and reordering the alignments randomly (bootstrap-
ping was performed with SEQBOOT from the PHYLIP 
package). The tests produced trees with similar branching 
order. A consensus tree was produced by the CONSENSE 
program of the PHYLIP package and graphically drawn 
with the TREEVIEW program (Page 1996), and was then 
transferred to and manipulated with PowerPoint. 
The protein sequences for the new Drosophila my-
osins are theoretical predictions. Myosins are large mul-
tiexon genes and are difficult to assemble with 100% 
accuracy from sequence data. There are also various iso-
forms of some myosins, which can lead to some mis-
alignments; hence, it is unlikely that the tree shown per-
fectly reflects the evolution of the Drosophila myosins. 
It is possible that some of the new Drosophila my-
osins could be pseudogenes. However, we found that the 
probability for this was low. Pseudogenes generally lack 
introns and are not transcribed into mRNA. We identified 
expressed sequence tags (ESTs) for all the myosin genes 
we predicted (the accession numbers for these are given 
in table 2), which confirmed their in vivo expression. The 
new myosins are described in detail subsequently. 
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FIG. 4.-Phylogenetic analysis of the myosin superfamily in D. tile-
Iaoogaster. The head domains of Drosophila myosins (equivalent to 
amino acids 88-780 of chicken skeletal myosin) were compared with 
selected myosins representing phylogcnetically diverse organisms. 
The alignment of 67 myosins (performed with the CLUSTAL W 
package) was used to generate data for an unrooted tree to scale 
based on sequence divergence (for details see text). Each myosin 
class is defined by the first node represented in >95% of the boot-
strap trials (starting from the tree center) and is color coded. The 
accession numbers for the myosins used in the alignment are given 
subsequently. These ale produced for the protein sequences, except 
in the case of Dm95E (M)'o95E gene) and Dm29D (Mt-o29D gene). 
where the cDNA accession numbers are given. Myosin class I: Ac-
113 (AAA27708). Ac-ICy (AAA27707), ScMyo3-IA (AAB34124), 
ScMyo5-IB (CAA89745). Cehum54A (CAA53244). Cehuml-113,1 
Dm3ID- IA (AAA19590). Dm6lF-1B (AAAI959I), Drn95E 
(AF454350). Re-113 (AAA57192), G--Bb (AAB38373). Gg-IB 
(CAA49850), Rnmyrl-IA (CAA48287), Rnmyr2-IB (CAA52807). 
Rnrnyr3-IC (CAA52815). Rnmyr4-ID (CAA50871). Myosin class II: 
ScMYOI-11A (CAA37894), ScMYSI-IIB (P08964), Dd-nmII 
(AAA33227), Ce myo3-11A (CAA30856). Cemyo4-II13 
(AAA28124). Cernyo2-11C (CAA30855). Cemyol-11D (CAA30854), 
Dm-mhcll (AAA28686). Dmzip-nnill (AAF473 II). XI-nmllb 
(AAA49915), G,, -FSkII (P13538), Gg-nmII (AAA48974). Gg-smIl 
(CAA29793), Hs-FSkEII (CAA32167). Hs-CaA (BAA00791). Hs 
nmIlA (AAA59888). Myosin class III: Lp-III (AAC16332), Dm-
NinaC-IlI (AAA28718). I-IsMY03A (AAF7086I). Myosin class V: 
ScMyo2p-Va (AAA34810), ScMyo4p-Vb (AAC37409), Cehum2 
(AAA97926). SpMyo-Va (AAF789I0). Dmdidum-Va (AAC99496). 
Ggp 190-Va (CAA77782). Mmdilute-Va (CAA4065 I), Rnrnyo5-Va 
4AA88350). Rnmyr6-Vb (AAB38840). HsMY05A (AAD00702). 
HsMY05C (AAF78783). Myosin class VI: SpMyo-VI (AAF72176). 
Cehum3 (AAC67447), Dmjar-VI (CAA47462), Ms-VIA 
(AAD52005). Ms-VIB (AAD52006). GgMyoVl (CAB96536). 
MmWaltzerVl (AABOOI94), HsMY06 (AAC51654). Myosin class 
VII: Cehum6-VlI (AAB37988). Dmck-11A (AAF53435), Dm28B-
VII13 (AAF52536). DrMyo-VIIA (CAC054I8). Mmshaker-VIIA 
(AAB40708). HsUsherlh-VIIA (AAB03679). Myosin class XV: 
Dm1 OA-XV (AAF47980). Mm-Myo 15 (AAF05904). HsMYO 15 
(AAF05903). Myosin class XVIII: Dm89B-PDZ (AAF55271). Mm-
PDZ (BAA93660). Hs-PDZ (BAA13206).2 Myosin class 7: Dm29D 
(AF454348). 
Myo95E (Myosin IC) 
This myosin was not found during the initial searches 
of the fly genome. It was subsequently identified in the 
AE003746 genome scaffolding. The predicted sequence 
for this gene is unusually short, resulting in only a 59-aa 
protein (accession number AAF56246). Detailed analysis 
showed that the gene was not predicted correctly by the 
Genome Project. The sequence for Mv05E was manually 
assembled, taking into account the reported sequence for 
this gene along with the identified ESTs (table 2), as well 
as the homology of the translated genomic DNA to other 
myosins (preserving the exon-intron spacing). To test out-
theoretical 
r
tical predictions, we used two splice-site prediction 
programs: The Neural Network at http://www.fruitfly.org/ 
seq_tools!splice.html and the GENSCAN Server at MIT-
http://genes.mit.edu/GENSCAN.htmI. Using the artificially 
assembled sequence, we were able to design primers, am-
plify a PCR product, and hence sequence the cDNA for 
Mvo95E (see Materials and Methods). The resulting se-
quence differed from the predicted sequence, showing the 
presence of an unusually long exon 3 and variations in 
exon 4. RT-PCR analysis showed that the gene produces 
at least three different transcripts expressed during oogen-
esis, and larval and adult stages (fig. 3). Two of the tran-
scripts (I-AF454350 and I1-AF45435 I), which represent 
5%-10% of the total amount of Mvo95E transcripts, trans-
late into two protein isoforms of 1,278 and 1.258 aa, re-
spectively. Transcript 1 (5,285 bp) comprises all 16 exons 
of the gene. Transcript 11(5,225 bp) lacks exon 12. The 
major third transcript (III-AF454352) has a longer exon 4 
(a downstream extension of 16 bp. GTG CAC ATT ACC 
CAT T). This shifts the ORF and produces a stop codon 
TGA in exon 5. The third transcript (5301 bp) encodes 
two putative truncated proteins. The first is a 464 aa se-
quence containing only the GESGAGKT conserved region 
from the P-loop of the myosin head domain. It does not 
contain the Switch-1 (NxxSSR) and Switch-2 (DxxGxE) 
regions which together with the P-loop have been impli-
cated as having a role in the hydrolysis of ATP. The second 
is an 864 aa protein containing a large part of the head 
domain, two IQ motifs and a myosin tail domain. The head 
of this myosin form contains only the Switch-2 (DFYGFE) 
conserved sequence, which prevents it from converting 
ATP, probably rendering the form inactive. Homology 
searches with the protein sequence for the head domain 
showed 33% identity (53% similarity) to vertebrate brush 
border class I myosins. Three ESTs were found for 
Mv05E. A search with them revealed up to 37% identity 
to vertebrate brush border myosins and less to other my-
osin classes. Analysis of Myosin 95E with domain-scan-
fling programs confirmed its structural similarity to class I 
myosins (fig. lB). It was found to contain two IQ domains 
(928-974 aa), the second being poorly conserved (fig. 5), 
This is a joint sequence from the first 72 amino acids of T2 1544 
and from the 11th amino acid to the end of AAA97925. 
2 The sequence for the human PDZ-containing myosin is truncat-
ed. This does not seem to affect its evolutionary position in the phy-
Iogenetic tree. 





















80% 	-------- xQ --- Rx --- Rx------ 
50% ----- A--IQ --- RG --- RR------ 
Fio. 5.—Ahgnment of the IQ motifs for the live newly identified 
myosins from D. Ine/000goster: Myosin IC (Mvo95E), Myosin VI1B 
(Mvo2S'B), Myosin XV (MvoIOA), Myosin 119B (MhcI). and Myosin 29D 
(Mvo29D). The consensus sequence is shown below the alignment, and 
the highly conservative positions are shaded. Residues in bold indicate 
similarity to the consensus sequence. Myosin IC has two different var-
iants (A and B) of is second 1Q Illotil, a result of alternative splicing. 
and a Basic Tail domain (974-1,278 aa for isoform I and 
974-1.258 aa for isofornt II) (fig. I B and table I). The 
latter is thought to be involved in membrane binding. Re-
cent studies have shown that it can also bind to actin fil-
aments (Lee et al. 1999; Liu, Brzeska, and Korn 2000). 
This changes the number of class I myosins in Drosophila 
to three, hence Myosin 95E was renamed Myosin IC. The 
Drosophila Myosin IC does differ from other myosins of 
class I. The unusually long exon 3 results in a 281-aa 
insertion into the head domain. This insertion contains a 
partial AAA doniain, a conserved region that contains an 
ATP-binding site. So far, no other myosins from class I 
have been identified which contain such an insertion. 
Mo28B (Myosin VIIB) 
The amino acid sequence of the Myosin 28B head 
showed 61% identity (74% similarity) to ck-Drosophila 
myosin VIIA. It also exhibited a very high identity of 
58% (7217c similarity) to Myosin VItA from zebrafish and 
to other class VII myosins. Analysis of Myosin 28B re-
vealed that it has four IQ nioti s (753-845 aa), the third 
being poorly conserved (figs. I B and 5). Two Myosin 
Tail Homology 4 (MyTH4) (1.070-1.246 and 1,681-
1,826 aa), two FERM (1,246-1.454 and 1,826-2,039 aa), 
and one 5H3 (Src homology 3) (1.561-1,626 aa) domains 
were identified (fig. 6A and B). The function of the 
MyTH4 domains is unknown. The FERM domain (the 
name stands for Band 4.1, ezrin, radixin. nioesin-homol-
ogy) is believed to be involved in linking cytoskeletal 
proteins to the membrane as well as in dimerization. Tal-
in, merlin, and philopodin are other major members of 
the FERM superfamily. These deserve mentioning, es-
pecially the Talin, because the FERM domain exhibits 
the highest homology to the FERM domain in Talins (fig. 
7) and less homology to FERM domains from other 
members of the FERM family. The SH3 domain has been 
identified in many proteins involved in signal transduc-
tion. It is believed that the SH3 domains mediate protein-
protein interactions by binding to proline-rich domains. 
Other myosins, such as IV, X, and XV, also contain this 
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Fin. 6.—CLUSTAL W alignment of the predicted (A) MyTH4, (13) SH3. and (C) PDZ domains in the tails of the newly identified Drosophila 
myosi ns. The sequences were shaded on the Box Shade server and manipulated with M icrosoft t Word 98. The parameters set on BoxSllade are 
as follows—output format: RTF New; fraction of sequences: 0.5; input sequence format: MSF or multisequence format (tills is tile output format 
of CLIJSTA L W). Identical am ito ac i ds are shaded in black, simi lar residues are shaded in gray. Myosi n  VII has two MyTI--14 domains. 'file 
first MyTH4 domain in HsM7a, DmCk. CcHp, and Myo2813 I contain an insert of 61-88 aa (legions 1057-1144. 1048-11 35, 971-1055, and 
1 107-1168, respectively) that was not included in the alignment . Accession numbers and abbreviatioil lull tcrnls: Cc. C'm'no,/io/aIiii,s c/e,i,Vl,l,v 
(Myosin VII. 'r25888): Hp. hypothetical protein; Diu, Drosophila ,ni'loiiogii.slr'r (ck, VI IA, AAF449 IS; Myo2813. AAF52530: PDZ-Myosin. 
AE0037 II): ck. crinkled: Hs. Homo .capis',l.s (M7A. Q 13402: Myosin XV, A59266; PDZ-Myosin. A1.080245 and /98949); Dr. Da,tio ierio 
(Myosin VIIA. CAC054 18); Mm. Mu,r ,nusculirs (Myosin VI IA, 1?97479: Myosin XV, A59295; PDZ- Myosin. BAA93660). 
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500.... I_________ 
Myosin VIIA (D.sIos30r) 	42; 67% 	 30; 49% 
Myosin VIIB (D.nolwloEaskr) 20; 461% 	 18; 47% 
Myosin XV (D.me!000gnoier) 	 17; 30% 
I? 
Myosin XV (M. 	non/as) 	 21; 93% 	 19:34% 
lIIIXv am 
Ftc. 7—Sequence comparison of the FERM domains found in 
Drosophila Myosin VII and XV. These were aligned separately to the 
Talin domain from C. elegans Talin protein. Multiple alignment was not 
appropriate in this case because the similarity between FERM I and 
FERM 2 to the Talin domain (from the Talin protein) is very low and 
results in unordered alignment. The comparison was performed by 
CLUSTAL W )http:/Iwww2.ehi.ac.uk/clustalw/). In addition, the FERM 
domains froni Mus ,nu.ccuhis Myosin XV were included in the diagram. 
In general, FERMI motifs from Myosin VII show --121/,-211/(      similar-
ity to proteins from the FERM family and 16% to the hand 4.1 protein. 
	
FERM2 domains (Myosin Vill show a higher similarity of 	7%—I 
to band 4.1 protein and - 18%-20% to proteins from the FERM family. 
FERM domains from Myosin XV show less similarity of 9Yc-17% to 
FERM proteins and -14% to the band 4.1 protein. Accession numbers 
are—C. elegans (Talin): AAA74747: D. inelanogaster (Myosin VIIA): 
CAC05418. (Myosin VIIB): AAF52536. (Myosin 10A-XV): 
AAF47980: M. inuseulus (niyosin XV): AAF05904. 
motif. A short coiled-coil domain (849-908 aa) was pre-
dicted by the Paircoil program (fig. 8). 
!VIvoIOA (Myosin XV) 
An RT-PCR analysis was used to verify the exon 
composition and the exon length of M'o10A transcripts. It 
was found that there are at least two transcripts, which are 
expressed from the larval stage onward (fig. 3). The longer 
transcript (7,462 bp) consists of all the previously known 
five exons and represents no more than 5% of the total 
amount of mRNA for this myosin. The shorter transcript 
(7,189 bp) lacks exon 2 and is expressed abundantly. The 
two transcripts translate into two protein isoforms of 2,424 
and 2,333 aa, respectively. A BLAST search with the con-
served head domain showed significant 47% identity (64% 
similarity) to mouse and human myosin XV. MvolOA is 
also related to human and mouse myosin VIIA with an 
identity of 42% (59% similarity). A specific N-terminal 
domain was identified in Myosin IOA (1-149 aa). The 
latter showed no similarity to the characteristic N-terminal 
domain found in other class XV myosins. The shorter pro-
tein isoform lacks this N-terminal domain. In the neck 
region three IQ domains (841-9 10 aa) were identified (fig. 
5). Immediately after the IQ motifs there is a short coiled-
coil region (919-946 aa) (fig. 8). Analysis of the tail re-
vealed the presence of one MyTH4 domain (1,014-1.173 
aa) (fig. 6), a glutamine-proline-alanine (QPA)-rich do-
main, a proline-rich domain (the borders of QPA and the 
proline-rich domain were not clearly defined), a short 
transmembrane motif (2,194 aa) (fig. IB). and an FERM 
domain (2,220-2.424 aa). The latter showed a very high 
identity of 40% (59% similarity) to the first and 13% iden-
tity (30% similarity) to the second FERM domain from 
mouse myosin XV and a limited similarity of 38% (17% 
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Fto. 8.—Predicted coiled-coil structures in the tails of the newly 
identified Drosophila myosins. Only three of the live imlyosins are like-
ly to form coiled-coils, these being myosin 28B-VIIB, myosin 10A-
XV, and Mhcl-PDZ. Both myosin 28B-VIIB and 10A-XV produced 
scores close to the lower threshold. Whether they form coiled-coils or 
not can only be determined experimentally. 
Mhcl (Myosin XVIII) 
A partial sequence of this gene has been submitted 
to the GenBank Data Base by Biru (1999). It shows high 
similarity to the Mhc type II of myosins and was termed 
Myosin heavy chain—like. Subsequently, the full length 
for this myosin was published by Celera (Adams et al. 
2000). The RT-PCR analysis we have undertaken shows 
that Mhcl has a very complex structure and expresses 
multiple transcripts throughout the Drosophila life cycle 
(fig. 3). Data from the available ESTs for Mud, PCR 
analysis, and a Promoter-predicting program (http:// 
www.fruitfly.org/seq_tools/promoter.htrnl) suggest that 
the seven identified transcripts are transcribed from four 
putative promoters. Transcripts 1(6,603 bp) and III (6.909 
bp) are highly expressed. The other five identified tran-
scripts are expressed at comparatively lower levels. Tran-
scripts I and III are composed of 18 exons (the gene 
comprises 19 exons), lacking exon 15. The difference 
between them is that transcript III has the second intron 
spliced out, which introduces a stop codon in the ORE 
One unusual feature of Mhcl is the fact that it contains 
three other genes within it (fig. 3). The exons of these 
genes are not found in combination with any of the exons 
of the myosin gene. Importantly, there are ESTs for each 
of the three genes. One of the genes has been previously 
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identified as phosphatidylserine-specific phospholipase 
Al (CG4979). It is located in intron 9, and its reading 
frame is in the opposite direction to that of the Mhcl 
reading frame (EST: GH 15759). The other two genes 
have ORFs in the same direction as the main (Mh(-I) gene. 
The gene in intron 10 (ESTs: RE41368, RE44374) is a 
novel gene and does not show any significant homology 
to previously characterized genes. The gene in intron 12 
(ESTs: LP08646, LP05315) shows a limited identity of 
35% (46% similarity) to bovine synaptojanine 1 protein 
(synaptic inositol- I ,4,5-trisphosphate 5-phosphatase I). 
The Mlicl transcripts translate into a set of protein iso-
forms—I: 2,200 aa; II: 2,139 aa; LII: 439 aa; IV: 899 aa; 
V: 730 aa; VI: 512 aa; and VII: 479 aa. Only the isoforms 
produced by transcripts I and II contain the conserved 
motor domain. BLAST analysis showed that Myosin 
heavy chain—like is most closely related to mouse PDZ-
Myosin (41% identity) and human PDZ-Myosin (40% 
identity). It showed a limited identity of 28%-29% to 
smooth muscle and nonrnuscle myosins and less than 
25% to skeletal muscle myosin. BLAST searches re-
vealed that the tail domain shows the highest similarity, 
32%, to PDZ-containing myosins and less than 25% sim-
ilarity to other types of myosins. Interestingly, this my-
osin was not predicted to contain a PDZ domain. We used 
the DNA sequence encoding the mouse PDZ domain to 
search the genomic sequence (AE0037I I) surrounding 
Mud (approximately 10 kb in each direction). This de-
tected a PDZ domain 4,810 bp upstream of the predicted 
start for the Mhcl mRNA (the domain was found in the 
borders of the predicted genomic DNA for this gene but 
has not been previously included in its ORF). The pres-
ence of the PDZ domain was verified by RT-PCR, and 
the sequence was submitted to the NCBI database 
(AF454347). A sequence alignment of the PDZ domains 
from Drosophila, mouse, and human is given in figure 6. 
Interestingly, transcript III translates into a truncated pro-
tein containing only this PDZ domain (349-429 aa). PDZ 
domains are known to bind C-terminal or internal (non—
C-terminal) polypeptides. Two IQ domains were found in 
MhcI (1,379-1,428 aa) (figs. lB and 5), although the sec-
ond differed slightly from the consensus sequence. The 
Paircoil program predicted two coiled-coil domains at 
1,439-1,549 and 1,616-2,121 aa (fig. 8). 
Myo29D 
Database searches suggested that the first three ex-
ons of Mvo29D are probably part of a gene adjacent to 
the myosin. Subsequent RT-PCR showed that they splice 
together with the other three myosin exons to produce 
at least two different transcripts. Transcript I (4,402 bp) 
contains all the six exons, whereas transcript II (2,530 
bp) lacks exon 5. Transcripts I and II are present during 
all the stages of Drosophila development, with transcript 
I being expressed at the higher levels. Transcript II pro-
cluces a truncated form of the protein, lacking most of 
the motor head domain. Analysis of the conserved head 
domain revealed that Myosin 29D is not similar to any 
of the known classes of myosins. It showed 29% identity 
(45% similarity) to myosin VII. X, and V from different  
species, which is sufficient for it to be considered as a 
myosin but not enough to be related to a given class. A 
search with the available ESTs for this myosin showed 
36%-39% identity to myosin V from different species 
and 31%-36% to vertebrate Myosin heavy chains (my-
osin II). Motif search programs detected in Myosin 29D 
a specific N-terminal extension (1-338 aa), two IQ mo-
tifs (1,089-1,136 aa), the second being poorly con-
served, and a short transmembrane motif in the tail 
(1,144-1,279 aa) (fig. IB). 
The detailed search of the translated Drosophila 
genome sequence produced several low-score hits. 
Close analysis of these (searches up and downstream of 
the respective sequences) revealed that they are not true 
myosins. Despite exhibiting certain similarities to given 
parts of the myosins, none of them showed high ho-
mology to a larger part of the head domain. AE003 112 
showed similarity to the highly conserved region (GES-
GAGKT) from the P-loop of the head domain. Its poly-
tene chromosome location remains undetermined. 
AE003614 (COil 199) showed homology to the myosin 
tail, containing coiled-coil and FERM domains. It is lo-
cated on the chromosome arm 2L (27E), next to the 
ninaC gene. AE003495 (CG12047) also showed simi-
larity to the myosin tail, containing coiled-coil and 
FERM domains. This is located on the X chromosome 
(12E1), close to the newly identified MvolOA. 
The BLAST search retrieved one more myosin-like 
gene CG15831 in the AE002795 genome scaffolding. 
This is a single-exon gene, 219 bp long. The chromo-
some position of AE002795 has not been determined 
previously. The program showed similarity to a highly 
conservative part of the myosin head domain (LGV 
LDIFGFENFSHNSFEQLCINYTNEKLHKFFNH). 
We found that the DNA surrounding the gene shows no 
similarity to the myosin genes (at the DNA or protein 
level). This suggests that AE002795 is either incorrectly 
assembled in the genome or that the gene CG15831 is 
a partial duplication of a myosin gene (this might be 
either a part of Mhc [muscle myosin III or didum [My-
osin V], which produced the highest score for this se-
quence, 59% and 54% identity, respectively). 
Discussion 
The myosin family has grown significantly in the 
past decade to encompass more than 177 myosins these 
days. All these myosins, with a few exceptions, fall into 
18 classes. Myosins are expressed in both prokaryotes 
(though these have not been well studied) and eukaryotes. 
The annotation of the genome sequences for S. cer-
evisiae, Dictvostelium discoideum, Arabidopsi.s thaliana, 
C. elegans, Drosophila melanogaster, and Homo sapiens 
made it possible to identify the complete sets of myosin 
genes in these organisms. It appears that all eukaryotes 
have an essential set of three myosin genes. these being 
from classes I, II, and V, as well as a number of species-
specific myosins. In Drosophila 13 different myosin genes 
were identified. The fruitfly has three I. two II (one en-
coding for muscle and one for nonmuscle myosins), one 
Ill, one V, one VI, two VII, one XV, and one XVIII myosin 
Myosins of Drosophila inelanogaser 1051 
genes, and one yet to be classified myosin gene. These 
classes of myosins have been found in a wide range of 
invertebrate and vertebrate animals. It has been shown that 
they have a role in a variety of cell functions. including 
membrane trafficking, signal transduction, and mainte-
nance of the cell architecture. Several new myosin genes 
were identified in the fruitfly. The genome data provided 
cDNA sequences for four of them (Mvo28B, MvoIOA, 
Mite!, and Mvo29D). The sequences and the ORF for these 
myosins were verified by RT-PCR and sequencing. In ad-
dition, a fifth myosin was found (Mvo95E). Using the fruitf-
ly genomic sequence, we were able to predict and subse-
quently isolate and sequence this gene. 
Only two of the live newly identified genes in Dro-
sophila fell directly into previously known classes, these 
being Myosin VIIB (Mvo2SB) and Myosin heavy chain-
like (Mud). Myosin VIIB is from the well-studied class 
VII myosins with a role in the membrane trafficking and 
stereocilia function. 
Mhcl is a member of the recently defined class 
XVIII of myosins, which consists of only two other 
members, mouse and human PDZ-containing myosins. 
The PDZ domain, also called DHR (DIg homologous 
region), is known to bind either C-terminal or internal 
(non-C-terminal) polypepticles. These domains have 
been identified in a broad range of signaling proteins 
from bacteria, yeast, plants, insects, and vertebrates. 
PDZ domains have been implicated in targeting signal-
ing molecules to submembranous sites. 
Myosin IC (Mv05E) is the third member of class 
I myosins in Drosophila. It contains the Basic Tail do-
main (TH I) specific to all class I myosins. It is thought 
that TH I binds to acidic phospholipids and actin fila-
ments. Interestingly, this myosin contains an additional 
N-terminal insertion, which is similar to the AAA motif, 
a conserved region of about 220 aa that contains an 
ATP-binding site. This domain is inserted in the region 
of the loop I of the motor domain, the other legion 
associated with the hydrolysis site for ATP, and probably 
modulates its activity. 
MvoIOA is closely related to class XV myosins. This 
myosin has a short N-terminal extension, which differs 
from the N-terminal domain characteristic for vertebrate 
myosins of class XV. It also lacks the SH3 and the second 
MyTH4 domain found in other myosin XV tails. Instead. 
the Drosophila Myosin XV tail contains three addition 
motifs, a glycine-pioline-glutamine-rich domain, a pro-
line-rich domain, and a small transmembrane domain. 
The proline-rich sequences have been demonstrated to 
bind to SH3, a small 50-aa motif. SH3 domains have 
been identified in a wide variety of intracellular and 
membrane-associated proteins and are implicated in sig-
nal transduction, linking signals transmitted from the cell 
surface by protein tyrosine kinases to effector proteins 
located downstream on the hierarchical pathways. 
Myosin 29D is a highly divergent member of the 
myosin superfamily. Presently, it forms a class of its 
own. This myosin contains an unusual N-terminal ex-
tension, which shows no homology to other proteins. It 
also has a small transmembrane domain in its tail rich 
in proline residues. 
Drosophila melanogaster expresses many myosins 
genes. Apart from the essential myosins (classes I, II, 
and V), it also has myosins from classes III, VI, VII, 
XV, and XVIII, as well as a novel type of myosin. This 
new data should help to design experiments to investi-
gate the roles of these newly identified myosins in the 
cell histology and development of Drosophila. 
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